"AHC","PY","nTotDoc","meanAUPerArt","meanAU_IN_PerArt","meanArtWith_AU_IN_FIRST","meanArtWith_AU_IN_LAST","meanArtWith_AU_IN_CORR","mean_articles_per_internal_author","mean_articles_per_internal_first_author","mean_articles_per_internal_last_author","mean_articles_per_internal_corresponding_author","ArtOA","singleAuArt","Q1_nSJR","Q2_nSJR","Q3_nSJR","Q4_nSJR","Q1_percSJR","Q2_percSJR","Q3_percSJR","Q4_percSJR","meanTCperArt","mean_NTC","meanCitationTrend","InternCoauthorship","AffCoauthorship","GC_AUIN_wFractional","GC_AUIN_FIRSTname","GC_AUIN_LASTname","GC_AUIN_CORRESP","top_AU","top_AU_freq","top_AU_wFract","top_AU_freq_wFract","top_AUIN","top_AUIN_freq","top_AUIN_wFract","top_AUIN_freq_wFract","topAUbyCit","topAUbyCit_TC","topAUINbyCit","topAUINbyCit_TC","topAUINbyCit_norm_byYear","topAUINbyCit_TC_norm_byYear","topConcept_L0","topFreq_L0","topConcept_L1","topFreq_L1","topConcept_L2","topFreq_L2","topConcept_L3","topFreq_L3","topConcept_L4","topFreq_L4","topMESH","topMESH_n","topprimary_topic.display_name","topprimary_topic.display_name_n","topDE","topDE_n","topTI_TM","topTI_TM_n","topAB_TM","topAB_TM_n","nDoc_wALTM","percDoc_wALTM","altmetric_score_thirdQu","cited_by_accounts_count_thirdQu","cited_by_fbwalls_count_thirdQu","cited_by_feeds_count_thirdQu","cited_by_gplus_count_thirdQu","cited_by_msm_count_thirdQu","cited_by_patents_count_thirdQu","cited_by_peer_review_sites_count_thirdQu","cited_by_policies_count_thirdQu","cited_by_posts_count_thirdQu","cited_by_rdts_count_thirdQu","cited_by_rh_count_thirdQu","cited_by_tweeters_count_thirdQu","cited_by_videos_count_thirdQu","cited_by_wikipedia_count_thirdQu","cohorts.com_thirdQu","cohorts.doc_thirdQu","cohorts.pub_thirdQu","cohorts.sci_thirdQu","readers.citeulike_thirdQu","readers.connotea_thirdQu","readers.mendeley_thirdQu","readers_count_thirdQu","n_patentsDistinct","nPatentStatus_Abandoned","nPatentStatus_Granted","nPatentStatus_N/A","nPatentStatus_Pending","nPatentStatus_Active","nPatentStatus_Not-in-force","nPatentStatus_Expired - Fee Related","nPatentStatus_Withdrawn","nPatentStatus_Ceased","nPatentStatus_Revoked","nPatentStatus_Expired - Lifetime","nPatentPubType_Application","nPatentPubType_Grant","nPatentPubType_N/A","avg_citations_Patent","avg_Inventors_Patent","inventor_per_AUIN_100","avg_InstitutesInvolved_Patent","nPatent_singleInventor","n_Patents_CoAff","n_Jurisdiction_distinct","nJurisd_AU","nJurisd_CA","nJurisd_EP","nJurisd_IN","nJurisd_CN","nJurisd_US","nJurisd_DE","nJurisd_ES","nJurisd_IT","nJurisd_AT","nJurisd_BR","nJurisd_WO","nJurisd_JP","nJurisd_DK","nJurisd_IL","nJurisd_PT","nJurisd_PL","nJurisd_FR","nJurisd_SA","nJurisd_MY","nJurisd_KR","nJurisd_NL","nJurisd_CO","nJurisd_SM","nJurisd_SI","nJurisd_HR","nJurisd_RU","nJurisd_EA","nJurisd_MX","nJurisd_HK","nPatentKC_A1","nPatentKC_A","nPatentKC_A2","nPatentKC_B1","nPatentKC_D1","nPatentKC_T3","nPatentKC_B2","nPatentKC_T1","nPatentKC_A3","nPatentKC_C","nPatentKC_B","nPatentKC_C2","nPatentKC_C0","nPatentKC_A8","nPatentKC_E","nPatentKC_T4","nPatentKC_D0","nPatentKC_T2","nPatentKC_A0","nPatentKC_B8","nPatentKC_A4","nPatentKC_T8","nPatentKC_C1","nPatentKC_U1","nPatentKC_T5","nPatentKC_B3","nPatentKC_T7","nPatentKC_A9","top_Inventor names_Patent","top_Inventor names_Patent_n","top_Original assignee names_Patent","top_Original assignee names_Patent_n","top_Fields of Research (ANZSRC 2020)_Patent","top_Fields of Research (ANZSRC 2020)_Patent_n","top_RCDC Categories_Patent","top_RCDC Categories_Patent_n","top_HRCS RAC Categories_Patent","top_HRCS RAC Categories_Patent_n","top_IPCR_Patent","top_IPCR_Patent_n","top_CPC_Patent","top_CPC_Patent_n","n_clTrial","avg_durationYear_clTrial","avg_participants_clTrial","clTrial_perAUIN_100","nClTrial_w_AltmScore","cl_AltmS_rel","avg_sponsor_clTrial","nclTrialPhase_Phase 1","nclTrialPhase_Phase 1/2","nclTrialPhase_Phase 2","nclTrialPhase_Phase 2/3","nclTrialPhase_Phase 3","nclTrialPhase_Phase 3/4","nclTrialPhase_Phase 4","nclTrialPhase_N/A","nclTrialPhase_Post Authorisation Studies","nclTrial_StudyType_Interventional","nclTrial_StudyType_Observational","nclTrial_StudyType_Other","nclTrial_StudyType_Expanded access","nclTrial_StudyType_Active surveillance","nclTrial_StudyType_Non-interventional","nclTrial_StudyType_RCT","nclTrial_StudyType_CCT","nclTrial_Gender_All","nclTrial_Gender_Female","nclTrial_Gender_Male","nclTrial_Registry_ClinicalTrials.gov","nclTrial_Registry_EU-CTR","nclTrial_Registry_ENCePP","nclTrial_Registry_ISRCTN","nclTrial_Registry_ANZCTR","nclTrial_Registry_GCTR","nclTrial_Registry_PACTR","nclTrial_Registry_CTRI","nclTrial_Registry_ReBEC","nclTrial_Registry_UMIN-CTR","top_funder_country","top_funder_country_n","top_Fields of Research (ANZSRC 2020)_clTrial","top_Fields of Research (ANZSRC 2020)_clTrial_n","top_RCDC Categories_clTrial","top_RCDC Categories_clTrial_n","top_HRCS HC Categories_clTrial","top_HRCS HC Categories_clTrial_n","top_HRCS RAC Categories_clTrial","top_HRCS RAC Categories_clTrial_n","top_Cancer Types_clTrial","top_Cancer Types_clTrial_n","top_CSO Categories_clTrial","top_CSO Categories_clTrial_n","n_grants","avg_funding_EUR","avg_funding_EUR_perOrganization","avg_durationYear_grant","avg_Organization_per_grant","avg_countries_per_grant","perc_grant_internationalColl","avg_ResultingPublications_per_grant","totFundingOrgbyActivedGrant","avgPubByActivedFundingGrant_1000","top_Research Organization - standardized_Grants","top_Research Organization - standardized_n_Grants","top_Funder_Grants","top_Funder_n_Grants","top_Funder Group_Grants","top_Funder Group_n_Grants","top_Program_Grants","top_Program_n_Grants","top_Fields of Research (ANZSRC 2020)_Grants","top_Fields of Research (ANZSRC 2020)_n_Grants","top_RCDC Categories_Grants","top_RCDC Categories_n_Grants","top_HRCS HC Categories_Grants","top_HRCS HC Categories_n_Grants","top_HRCS RAC Categories_Grants","top_HRCS RAC Categories_n_Grants","top_Cancer Types_Grants","top_Cancer Types_n_Grants","top_CSO Categories_Grants","top_CSO Categories_n_Grants","top_Units of Assessment_Grants","top_Units of Assessment_n_Grants","top_Sustainable Development Goals_Grants","top_Sustainable Development Goals_n_Grants","n_dataset","top_Repository_Dataset","top_Repository_Dataset_n","top_Fields of Research (ANZSRC 2020)_Dataset","top_Fields of Research (ANZSRC 2020)_Dataset_n","top_RCDC Categories_Dataset","top_RCDC Categories_Dataset_n","top_HRCS HC Categories_Dataset","top_HRCS HC Categories_Dataset_n","top_HRCS RAC Categories_Dataset","top_HRCS RAC Categories_Dataset_n","top_Health Research Areas_Dataset","top_Health Research Areas_Dataset_n","top_Broad Research Areas_Dataset","top_Broad Research Areas_Dataset_n","top_Cancer Types_Dataset","top_Cancer Types_Dataset_n","top_Sustainable Development Goals_Dataset","top_Sustainable Development Goals_Dataset_n"
"AOUSSN_UMBERTOI",2000,114,5.82456140350877,2.48245614035088,0.763157894736842,0.403508771929825,0.789473684210526,1.19409282700422,1.12987012987013,1.15,1.13924050632911,0.149122807017544,9,42,23,5,40,0.37,0.2,0.04,0.35,31.79,0.701274831312548,NA,0.131578947368421,0.456140350877193,0.378,0.255,0.256,0.253,"C PARLAPIANO;E. CAMPAÑÁ;TERESA GIOVANNIELLO;P PANTONE;M CARBONI;CIRA DI GIOIA;VINCENZO MARIGLIANO;A BARBAROSOS;GIANFRANCO PICCIRILLO;TOMMASO BOCCHETTI;FRANCESCO ZARACA;ANTONIO BOLOGNESE;NICOLA BASSO;ALESSANDRO POGGI;STEFANO VALABREGA;MAURO CACCIAFESTA;GIULIA D’AMATI;ERASMO SPAZIANI;VINCENZO SCIACCA;CARLA GIORDANO","5;5;5;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3","F. GAJ;ROBERTO AMBRA;FRANCESCO BARILLÀ;STEFANIA ANGOTTI;M. MUSCOLO;ENRICO CORAZZIARI;A. DE SANTIS;FEDERICO VENUTA;LUIGI FERRANTE SERGIO MORELLI;CIRA DI GIOIA;VINCENZO SCIACCA;G FLATI;SALVATORE MINISOLA;ELISABETTA ROMAGNOLI;GIULIA D’AMATI;CARLA GIORDANO;C PARLAPIANO;E. CAMPAÑÁ;TERESA GIOVANNIELLO;P PANTONE","1.33;1;1;1;1;1;1;1;1;0.98;0.78;0.73;0.67;0.67;0.65;0.65;0.65;0.65;0.65;0.65","C PARLAPIANO;E. CAMPAÑÁ;TERESA GIOVANNIELLO;P PANTONE;M CARBONI;CIRA DI GIOIA;VINCENZO MARIGLIANO;A BARBAROSOS;GIANFRANCO PICCIRILLO;TOMMASO BOCCHETTI;FRANCESCO ZARACA;ANTONIO BOLOGNESE;NICOLA BASSO;ALESSANDRO POGGI;STEFANO VALABREGA;MAURO CACCIAFESTA;GIULIA D’AMATI;ERASMO SPAZIANI;VINCENZO SCIACCA;CARLA GIORDANO","5;5;5;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3","F. GAJ;ROBERTO AMBRA;FRANCESCO BARILLÀ;STEFANIA ANGOTTI;M. MUSCOLO;ENRICO CORAZZIARI;A. DE SANTIS;FEDERICO VENUTA;LUIGI FERRANTE SERGIO MORELLI;CIRA DI GIOIA;VINCENZO SCIACCA;G FLATI;SALVATORE MINISOLA;ELISABETTA ROMAGNOLI;GIULIA D’AMATI;CARLA GIORDANO;C PARLAPIANO;E. CAMPAÑÁ;TERESA GIOVANNIELLO;P PANTONE","1.33;1;1;1;1;1;1;1;1;0.98;0.78;0.73;0.67;0.67;0.65;0.65;0.65;0.65;0.65;0.65","ARNALDO DE MENDONÇA;C. L. SPRUNG;F. CANTRAINE;JEAN‐LOUIS VINCENT;JUKKA TAKALA;MASSIMO ANTONELLI;N. M. DEARDEN;P. M. SUTER;RUI P. MORENO;FANG WEN;JAMES R. FERAMISCO;JEAN Y. J. WANG;KUMIKO TAMURA;KUNJAN S. BHAKTA;MICHAEL KARIN;PAMELA J. WOODRING;PREM PURI;ZHENGUO WU;RAFFAELE MASCIANGELO;FRANCESCA MACCIONI","728;728;728;728;728;728;728;728;728;468;468;468;468;468;468;468;468;468;389;311","MASSIMO ANTONELLI;PREM PURI;RAFFAELE MASCIANGELO;ANGELO VISCIDO;FRANCESCA MACCIONI;LAURA BROGLIA;M. MARROLLO;PLINIO ROSSI;R. CAPRILLI;VITO L. BURGIO;ENRICO CORAZZIARI;NICOLA BASSO;ANTONIO DE LEO;P. ROSATO;GIULIA D’AMATI;E CALZOLARI;ROSITA VERTERAMO;VINCENZO MILITE;ERASMO SPAZIANI;A. PRIMAVERA","728;468;389;284;284;284;284;284;284;222;198;195;172;172;138;105;105;105;102;101","C PARLAPIANO;ANTONIO BOLOGNESE;GIANFRANCO PICCIRILLO;GIULIA D’AMATI;M CARBONI;MAURO CACCIAFESTA;NICOLA BASSO;SALVATORE MINISOLA;VINCENZO MARIGLIANO;VINCENZO SCIACCA;A BARBAROSOS;A FANTINI;ALESSANDRO POGGI;ANTONIO DE LEO;CARLO DELLA ROCCA;CIRA DI GIOIA;E. CAMPAÑÁ;ERASMO SPAZIANI;F. GAJ;FRANCESCO ZARACA","5;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;MATHEMATICS;COMPUTER SCIENCE;ECONOMICS;SOCIOLOGY;PSYCHOLOGY;GEOGRAPHY;MATERIALS SCIENCE","108;31;11;10;8;4;3;3;2;1;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;RADIOLOGY;CARDIOLOGY;BIOCHEMISTRY;ENDOCRINOLOGY;GENETICS;ANESTHESIA;GASTROENTEROLOGY;ENVIRONMENTAL HEALTH;PSYCHIATRY;IMMUNOLOGY;GENERAL SURGERY;PALEONTOLOGY;FAMILY MEDICINE;GYNECOLOGY;OPTICS;PHARMACOLOGY;GEOMETRY;OBSTETRICS;ONCOLOGY;PEDIATRICS;UROLOGY","77;44;28;17;16;15;12;12;11;11;8;8;7;6;6;5;5;5;5;4;4;4;4;4","CANCER;DISEASE;ALTERNATIVE MEDICINE;GENE;POPULATION;BLOOD PRESSURE;HEART FAILURE;PREGNANCY;ABDOMINAL SURGERY;RECEPTOR;CARCINOMA;CHEMOTHERAPY;COMPLICATION;ENZYME;HEMORRHOIDS;HUMAN IMMUNODEFICIENCY VIRUS (HIV);INCIDENCE (GEOMETRY);LUNG;PROSPECTIVE COHORT STUDY;SURVIVAL RATE;ULTRASOUND","20;17;8;8;7;6;6;6;5;5;4;4;4;4;4;4;4;4;4;4;4","COLORECTAL CANCER;PLACEBO;BREAST CANCER;REFLUX;SEMINOMA;TESTICULAR CANCER;TOLERABILITY;VASCULAR SURGERY;VIRAL LOAD;ANAL CANAL;ANAL CANCER;AUTOANTIBODY;CALCITRIOL;DIAPHRAGM (ACOUSTICS);ENDOTHELIN RECEPTOR;FETUS;FOCAL NODULAR HYPERPLASIA;GASTRECTOMY;ISLET;LUNG TRANSPLANTATION;NEUROPEPTIDE;NEURORADIOLOGY;PARATHYROID HORMONE;RADIAL ARTERY;RNA;SYPHILIS;SYSTEMIC LUPUS ERYTHEMATOSUS;THYROIDECTOMY;TUNEL ASSAY","7;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ANTIRETROVIRAL THERAPY;AMYLIN;CALCITONIN GENE-RELATED PEPTIDE;CONDOM;IN SITU NICK-END LABELING;RIBOSOME;TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE;TOTAL MESORECTAL EXCISION;UMBILICAL ARTERY;ABDOMINOPERINEAL RESECTION;ACRYLONITRILE;ALLELE FREQUENCY;AMNIOTIC FLUID;ANAL CARCINOMA;ANDROGEN DEPRIVATION THERAPY;APGAR SCORE;ATROPHIC GASTRITIS;BAROREFLEX;BREAST CARCINOMA;BREAST DISEASE;BREAST TISSUE;BRONCHOPLEURAL FISTULA;BRONCHUS;BRUCH'S MEMBRANE;CA15-3;CARDIOTOCOGRAPHY;CD3;CD81;CLADE;COLONOSCOPY;DIASTOLIC HEART FAILURE;DIFFUSING CAPACITY;ENDOTHELINS;ENHANCER;ESOPHAGITIS;FAMILY PLANNING;FIBROCYSTIC BREAST DISEASE;GASTROPARESIS;GERD;HEPACIVIRUS;HIATAL HERNIA;HYPERTHERMOPHILE;IMIPENEM;INFERIOR THYROID ARTERY;ISOTYPE;MALE INFERTILITY;MAMMOGRAPHY;MASTECTOMY;MEF2C;MEROPENEM;METASTATIC BREAST CANCER;MIGRAINE WITH AURA;MULTINODULAR GOITRE;MYOD;NISSEN FUNDOPLICATION;NS2-3 PROTEASE;OPERON;OSTEOCALCIN;P38 MITOGEN-ACTIVATED PROTEIN KINASES;PARATHYROIDECTOMY;PHOSPHATE BINDER;POLYCYSTIC OVARY;POLYMORPHISM (COMPUTER SCIENCE);POLYPLOID;PRENATAL DIAGNOSIS;PROSTATE-SPECIFIC ANTIGEN;PROSTATECTOMY;PROTEIN KINASE DOMAIN;SECONDARY HYPERPARATHYROIDISM;SIDA;T-CELL RECEPTOR;THERMOTOGA MARITIMA;THREONINE;TOTAL THYROIDECTOMY;TUMORAL CALCINOSIS;VIRAL ENTRY","3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;ADULT;MIDDLE AGED;;AGED;ADENOCARCINOMA;ADOLESCENT;STOMACH NEOPLASMS;FOLLOW-UP STUDIES;ITALY;LIVER NEOPLASMS;AGED, 80 AND OVER;CROSS INFECTION;TESTICULAR NEOPLASMS;TREATMENT OUTCOME;POSTOPERATIVE COMPLICATIONS;RECTAL NEOPLASMS;ACUTE KIDNEY INJURY","86;55;50;46;44;26;26;15;14;12;10;10;10;9;9;9;9;8;8;7","ANORECTAL SURGICAL PROCEDURES;COLORECTAL CANCER RESEARCH AND TREATMENT;DIAGNOSIS AND MANAGEMENT OF APPENDICITIS;ORGAN TRANSPLANTATION AND REJECTION;SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME;CHOLESTEROL-LOWERING TREATMENT;COMPLICATIONS AND TECHNIQUES IN THYROID SURGERY;DIAGNOSIS AND MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE;EPIDEMIOLOGY, CLASSIFICATION, AND CLINICAL FEATURES OF INFLAMMATORY MYOPATHIES;FUNCTIONAL BOWEL DISORDERS AND GASTROINTESTINAL HEALTH;GASTRIC CANCER RESEARCH AND TREATMENT;MANAGEMENT OF HYPERTENSION AND CARDIOVASCULAR RISK FACTORS;MANAGEMENT OF POSTOPERATIVE PAIN AND COMPLICATIONS;MINERAL METABOLISM IN CHRONIC KIDNEY DISEASE;MOLECULAR MECHANISMS OF APOPTOSIS AND CELL DEATH;PATHOGENESIS AND TREATMENT OF SYSTEMIC SCLEROSIS;ROLE OF NEUROPEPTIDES IN PHYSIOLOGY AND DISEASE;;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;ADVANCEMENTS IN PROSTATE CANCER RESEARCH","5;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1","HYPERTENSION;CARDIOVASCULAR EVALUATION;HEART RATE VARIABILITY;HEMORRHOIDS;ROPIVACAINE;TOLERABILITY;TREATMENT;VASCULAR SURGERY;AMYLIN;ANAL CANCER;APOPTOSIS;CONSTIPATION;CONTINUOUS BLOOD PRESSURE ESTIMATION;DEMOGRAPHICS;DERMATOMYOSITIS;DIAGNOSIS;DIAPHRAGM (ACOUSTICS);DISCONTINUATION;EMERGENCY DEPARTMENT CROWDING;FOCAL NODULAR HYPERPLASIA","4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","ACUTE MYOCARDIAL;LUPUS ERYTHEMATOSUS;MYOCARDIAL INFARCTION;RECTAL CANCER;SURGICAL TREATMENT;SYSTEMIC LUPUS;BLOOD PRESSURE;CANCER PATIENTS;CELL CANCER;DIAGNOSTIC MARKER;DISEASE ACTIVITY;GASTRIC CARCINOMA;GERM CELL;MESORECTAL EXCISION;PROSPECTIVE STUDY;RISK FACTORS;TESTICULAR GERM;TOTAL MESORECTAL;ACUTE ABDOMEN;ACUTE RENAL;ADENOMA SIMULATING;ADIPOSE TISSUE;ADRENOCORTICAL INSUFFICIENCY;ADRENOMEDULLIN ASSAY;ADVANCED COLORECTAL;ADVANCED PHASE;ADVERSE EVENTS;AGE-RELATED MACULAR;AIRWAY MANAGEMENT;ANAL CANAL","3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","AIRWAY MANAGEMENT;CONTROL ARM;LARYNGEAL MASK;EXPERIMENTAL ARM;MASK AIRWAY;BLOOD PRESSURE;CONTINUOUS INFUSION;MANAGEMENT FAILURE;NORMAL VALUES;SUPEROXIDE ANION;TRACHEAL INTUBATION;AIRWAY POOLSIDE;BUPIVACAINE WTVOL;CD LEL;CD-HCV INTERACTION;CUFFED OROPHARYNGEAL;FREE-FLOATING RESTRAINED;HCV BINDING;INFUSION -FU;INTUBATING LARYNGEAL;LARYNGOSCOPE-GUIDED TRACHEAL;MMHG SD;MWOA PATIENTS;OROPHARYNGEAL AIRWAY;PATIENTS TREATED;POOLSIDE FREE-FLOATING;ADVANCED COLORECTAL;ALKALINE PHOSPHATASE;AMBULATORY CARE;ARM CONSISTING","7;6;6;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2",12,0.11,6.06,3.25,1,1,0,0,7,0,1,3.25,0,0,2.5,0,1.25,1,1,1,0,0,0,55.5,56.25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,0,203,0.88,0,0,28,0,0,1,0,1,0,0,0,0,2,0,0,0,0,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,"Belgium","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3204 IMMUNOLOGY","2;2;1","CANCER;CLINICAL RESEARCH;PATIENT SAFETY;RARE DISEASES;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HEMATOLOGY;LUNG;LUNG CANCER;ORPHAN DRUG","2;2;2;2;1;1;1;1;1","CANCER","2","6.1 PHARMACEUTICALS;6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES","2;1","LEUKEMIA / LEUKAEMIA;LUNG CANCER","1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.5 COMBINATIONS OF LOCALIZED AND SYSTEMIC THERAPIES;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","2;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_UMBERTOI",2001,135,6.41481481481481,2.45185185185185,0.777777777777778,0.311111111111111,0.777777777777778,1.324,1.19318181818182,1.23529411764706,1.19318181818182,0.111111111111111,8,41,15,16,53,0.3,0.11,0.12,0.39,22.26,0.48715421210157,NA,0.133333333333333,0.488888888888889,0.372,0.268,0.338,0.268,"P PIETROPAOLI;R CORTESINI;MARIA GABRIELLA COSTA;L. POMPEI;CECILIA COCCIA;MAURO CACCIAFESTA;FEDERICO VENUTA;CARLO DELLA ROCCA;DANIELE PENZO;C PARLAPIANO;GIANFRANCO PICCIRILLO;ERINO ANGELO RENDINA;TERESA GIOVANNIELLO;P PANTONE;TIZIANO DE GIACOMO;FABIO GUARRACINO;MASSIMO ROSSI;VINCENZO BARNABA;VINCENZO MARIGLIANO;GIANFRANCO TONNARINI","8;7;6;6;6;5;5;5;4;4;4;4;4;4;4;4;4;3;3;3","ERINO ANGELO RENDINA;P PIETROPAOLI;DAVIDE LOMANTO;L. ANGELINI;G. GASPARINI;GIOVANNI DELOGU;ANDREA LENZI;E BONUCCI;MARCO CAVALLINI;R CORTESINI;FRANCESCO VIOLI;FEDERICO VENUTA;RICCARDO IANNACCONE;TIZIANO DE GIACOMO;MARIA GABRIELLA COSTA;L. POMPEI;CECILIA COCCIA;MAURO CACCIAFESTA;DANIELE PENZO;FABIO GUARRACINO","1.8;1.28;1;1;1;1;1;1;1;0.87;0.83;0.79;0.75;0.69;0.68;0.68;0.68;0.64;0.62;0.62","P PIETROPAOLI;R CORTESINI;MARIA GABRIELLA COSTA;L. POMPEI;CECILIA COCCIA;MAURO CACCIAFESTA;FEDERICO VENUTA;CARLO DELLA ROCCA;DANIELE PENZO;C PARLAPIANO;GIANFRANCO PICCIRILLO;ERINO ANGELO RENDINA;TERESA GIOVANNIELLO;P PANTONE;TIZIANO DE GIACOMO;FABIO GUARRACINO;MASSIMO ROSSI;VINCENZO BARNABA;VINCENZO MARIGLIANO;GIANFRANCO TONNARINI","8;7;6;6;6;5;5;5;4;4;4;4;4;4;4;4;4;3;3;3","ERINO ANGELO RENDINA;P PIETROPAOLI;DAVIDE LOMANTO;L. ANGELINI;G. GASPARINI;GIOVANNI DELOGU;ANDREA LENZI;E BONUCCI;MARCO CAVALLINI;R CORTESINI;FRANCESCO VIOLI;FEDERICO VENUTA;RICCARDO IANNACCONE;TIZIANO DE GIACOMO;MARIA GABRIELLA COSTA;L. POMPEI;CECILIA COCCIA;MAURO CACCIAFESTA;DANIELE PENZO;FABIO GUARRACINO","1.8;1.28;1;1;1;1;1;1;1;0.87;0.83;0.79;0.75;0.69;0.68;0.68;0.68;0.64;0.62;0.62","ANDREA VECCHIONE;FRANCESCO NARDI;ALESSANDRA GASBARRI;ARMANDO BARTOLAZZI;ASHRAF KHAN;FABIO ORLANDI;FERDINANDO MARANDINO;G BUSSOLATI;HIDENORI INOHARA;MAURO PAPOTTI;OLLE LARSSON;RAFFAELE TECCE;TERESINA LUCANTE;ENRICO SCHIAFFELLA;VINCENZO BARNABA;VITTORIO FRANCAVILLA;ALESSANDRA MICOZZI;CLAUDIO CARTONI;EDOARDO PESCARMONA;F MANDELLI","431;421;415;415;415;415;415;415;415;415;415;415;415;187;187;187;184;184;184;184","ANDREA VECCHIONE;FRANCESCO NARDI;TERESINA LUCANTE;ALESSANDRA MICOZZI;CLAUDIO CARTONI;EDOARDO PESCARMONA;F MANDELLI;FRANCESCO DRAGONI;GIOVANNA MELONI;MARIA CONCETTA PETTI;PIERO CHIRLETTI;SERGIO MECAROCCI;BRUNO ANNIBALE;ELENA FATTORI;VINCENZO BARNABA;EMANUELE LEZOCHE;GIANFRANCO PICCIRILLO;MAURO CACCIAFESTA;VINCENZO MARIGLIANO;ANTONIO MOISÈ","415;415;415;184;184;184;184;184;184;184;184;184;179;160;129;128;124;124;124;117","R CORTESINI;CARLO DELLA ROCCA;P PIETROPAOLI;CECILIA COCCIA;ERINO ANGELO RENDINA;FABIO GUARRACINO;L. POMPEI;MARIA GABRIELLA COSTA;MASSIMO ROSSI;A. BACHETONI;C PARLAPIANO;ENRICO CORTESI;FEDERICO VENUTA;P. CICCONETTI;VINCENZO MARIGLIANO;A. VARDANEGA;DANIELE PENZO;GIANFRANCO PICCIRILLO;MAURO CACCIAFESTA;A CAVALLARO","7;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;2","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;COMPUTER SCIENCE;PSYCHOLOGY;ECONOMICS;ENGINEERING;MATERIALS SCIENCE;MATHEMATICS;BUSINESS;PHILOSOPHY;POLITICAL SCIENCE;SOCIOLOGY","129;28;15;12;6;5;2;2;2;2;1;1;1;1","INTERNAL MEDICINE;SURGERY;CARDIOLOGY;PATHOLOGY;IMMUNOLOGY;ANESTHESIA;RADIOLOGY;GASTROENTEROLOGY;ENDOCRINOLOGY;BIOCHEMISTRY;OPTICS;PSYCHIATRY;GENETICS;VIROLOGY;GENERAL SURGERY;ANATOMY;CELL BIOLOGY;ENVIRONMENTAL HEALTH;GYNECOLOGY;DERMATOLOGY;NUCLEAR MEDICINE;NURSING;UROLOGY","81;52;25;25;24;21;21;15;14;13;13;13;12;9;7;6;6;6;6;5;5;5;5","CANCER;BLOOD PRESSURE;INCIDENCE (GEOMETRY);ANTIBODY;CHEMOTHERAPY;DISEASE;GENE;VIRUS;LUNG;TRANSPLANTATION;COMPLICATION;ENZYME;HEART FAILURE;HEMODYNAMICS;INFLAMMATION;POPULATION;RECEPTOR;IMMUNE SYSTEM;ISCHEMIA;LAPAROSCOPY;PREGNANCY;PULMONARY ARTERY","16;11;10;8;8;8;8;8;7;7;6;6;6;6;6;6;6;5;5;5;5;5","COLORECTAL CANCER;HEART RATE;EJECTION FRACTION;CD8;GASTRITIS;CARDIAC OUTPUT;FAMILIAL HYPERCHOLESTEROLEMIA;HEPATITIS C VIRUS;LAPAROSCOPIC SURGERY;NEURORADIOLOGY;PRELOAD;PROSTATE;T CELL;ABDOMINAL AORTA;APOLIPOPROTEIN B;CANCER REGISTRY;CERVICAL CANCER;CERVIX;CHOLESTYRAMINE;CYTOTOXIC T CELL;DENDRITIC CELL;ENDOTHELIN 1;ENDOTHELIN RECEPTOR;EOSINOPHIL;FETUS;FINE-NEEDLE ASPIRATION;FLUORESCEIN ANGIOGRAPHY;HEPATITIS B VIRUS;INTESTINAL METAPLASIA;LIPOPROTEIN;LIVER TRANSPLANTATION;LYMPHOCYTOPENIA;MYOCARDIAL ISCHEMIA;OPIOID;POLYMERASE CHAIN REACTION;PULMONARY EDEMA;PULMONARY WEDGE PRESSURE;SYSTEMIC INFLAMMATION;VASCULAR RESISTANCE;VENOUS THROMBOSIS;VIRAL DISEASE","7;7;5;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","LDL APHERESIS;PULMONARY ARTERY CATHETER;ATROPHIC GASTRITIS;AUTONOMIC NERVOUS SYSTEM;CARDIAC INDEX;CENTRAL VENOUS PRESSURE;COLONOSCOPY;ENKEPHALIN;HBSAG;PROSTATECTOMY;STROKE VOLUME;ADVANCED GLYCATION END-PRODUCT;ANTIRETROVIRAL THERAPY;BARRETT'S OESOPHAGUS;BREAST RECONSTRUCTION;CAGA;CARDIAC SKELETON;CERVICAL INTRAEPITHELIAL NEOPLASIA;CHRONIC GASTRITIS;COLPOSCOPY;COXSACKIEVIRUS;DIAPHRAGMATIC RUPTURE;DYNAMIC HYPERINFLATION;ECHOVIRUS;ELISPOT;ENDOTHELINS;ENTEROCHROMAFFIN CELL;EOSINOPHIL CATIONIC PROTEIN;ESOPHAGEAL VARICES;EZRIN;FLAVIVIRIDAE;HEART RATE VARIABILITY;IMMUNOPEROXIDASE;INDOCYANINE GREEN ANGIOGRAPHY;INTERNAL ANAL SPHINCTER;INTRAVENOUS DRUG;IRINOTECAN;IΚBΑ;KAPOSI'S SARCOMA;LOWER URINARY TRACT SYMPTOMS;LUNG VOLUME REDUCTION SURGERY;MEAN ARTERIAL PRESSURE;MORBID OBESITY;NOCTURNAL PENILE TUMESCENCE;ORTHOTOPIC LIVER TRANSPLANTATION;OXALIPLATIN;P-SELECTIN;P38 MITOGEN-ACTIVATED PROTEIN KINASES;P50;PLACENTA;PNEUMOCYSTIS CARINII;PNEUMOCYSTIS PNEUMONIA;POLYARTERITIS NODOSA;RAPID UREASE TEST;RELATIVE SURVIVAL;SEMEN CRYOPRESERVATION;SEROPREVALENCE;SEVERE OBESITY;SULFOLOBUS;SULFOLOBUS SOLFATARICUS;SYSTEMIC VASCULITIS;THERAPEUTIC ABORTION;THERMOLUMINESCENT DOSIMETER;THREATENED ABORTION;THROMBOMODULIN;TOTAL MESORECTAL EXCISION;UMBILICAL ARTERY;URINARY URGENCY;UTERINE ARTERY;VARIX;WHITE COAT HYPERTENSION","3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;MIDDLE AGED;ADULT;AGED;;ADOLESCENT;MYOCARDIAL ISCHEMIA;AGED, 80 AND OVER;CHILD;FOLLOW-UP STUDIES;LUNG NEOPLASMS;POSTOPERATIVE COMPLICATIONS;CHILD, PRESCHOOL;LIVER NEOPLASMS;RECTAL NEOPLASMS;AORTIC ANEURYSM, ABDOMINAL;AORTITIS;CARCINOID TUMOR","106;69;64;54;50;36;24;15;15;13;13;12;12;12;11;10;10;9;9;9","COLORECTAL CANCER RESEARCH AND TREATMENT;DIAGNOSIS AND MANAGEMENT OF BILIARY TRACT DISORDERS;HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER;HEPATITIS B INFECTION AND TREATMENT;MANAGEMENT OF VALVULAR HEART DISEASE;OPTIMIZATION OF PERIOPERATIVE FLUID THERAPY;ADVANCEMENTS IN LUNG CANCER RESEARCH;ANESTHESIA AND SEDATION MANAGEMENT;ATRIAL FIBRILLATION;CHOLESTEROL-LOWERING TREATMENT;CLINICAL MANAGEMENT OF TRACHEAL AND AIRWAY DISORDERS;EPIDEMIOLOGY AND MANAGEMENT OF NEUROENDOCRINE TUMORS;GENETICS AND PATHOGENESIS OF TYPE 1 DIABETES;HUMAN IMMUNODEFICIENCY VIRUS/ACQUIRED IMMUNODEFICIENCY SYNDROME;IMMUNOBIOLOGY OF DENDRITIC CELLS;MANAGEMENT AND PATHOPHYSIOLOGY OF ABDOMINAL AORTIC ANEURYSMS;MANAGEMENT OF MESENTERIC ISCHEMIA AND ANEURYSMS;MANAGEMENT OF POSTOPERATIVE PAIN AND COMPLICATIONS;MOLECULAR MECHANISMS OF CARDIAC ARRHYTHMIAS;PERIOPERATIVE CARDIAC RISK ASSESSMENT AND MANAGEMENT","3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ECHOCARDIOGRAPHY;ETIOLOGY;INTRAOPERATIVE FLUID MANAGEMENT;CHOLESTEROL-LOWERING;HEMODYNAMIC MONITORING;HIV;LDL APHERESIS;LDL CHOLESTEROL;NEURORADIOLOGY;PRELOAD;PROSTHETIC VALVES EVALUATION;PULMONARY ARTERY CATHETER;TRANSCATHETER AORTIC-VALVE REPLACEMENT;TREATMENT;ABDOMINAL AORTA;ADRENAL VEIN SAMPLING;ANAL CANCER;ATRIAL FIBRILLATION;ATROPHIC GASTRITIS;CANCER SURVIVORSHIP","4;4;4;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2","LUNG CANCER;MYOCARDIAL ISCHEMIA;ABDOMINAL AORTA;AUTONOMIC NERVOUS;CELL LUNG;CIRCULATING LEVELS;CURRENT STATUS;CYTOKINE PROFILE;DECISION-MAKING PROCESS;DISEASE ACTIVITY;HUMAN DENDRITIC;INFLAMMATORY ANEURYSM;LAPAROSCOPIC CHOLECYSTECTOMY;LIPOPROTEIN APHERESIS;LIVER TRANSPLANTATION;NERVOUS SYSTEM;NITRIC OXIDE;PATIENT AGED;PATIENTS UNDERGOING;PERSONAL EXPERIENCE;PULMONARY ARTERY;QT-INTERVAL VARIABILITY;RECTAL CANCER;REGURGITANT MITRAL;RENAL TRANSPLANTATION;SINGLE AGENT;TRANSOESOPHAGEAL ECHOCARDIOGRAPHY;VIRUS EXPOSURE;VIRUS INFECTION;ABDOMINAL FLAPS","4;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1","BLOT ANALYSIS;WESTERN BLOT;INTERCOSTAL MUSCLE;MUSCLE FLAP;SERUM LEVELS;SYSTEMIC VASCULITIDES;CANCER PATIENTS;PULMONARY ARTERY;CLINICAL TRIALS;IV INFUSION;CAGA STATUS;IGFBP- LEVELS;INFUSION RATE;LUNG CANCER;PERIPHERAL BLOOD;SLEEVE RESECTION;STUDIED PATIENTS;STUNTED GROWTH;ABNORMAL ACCUMULATION;ACID LABILE;ADVANCED OVARIAN;AGE LEVELS;ASSESSABLE PATIENTS;BASELINE LEVELS;BLOOD LYMPHOCYTES;BRONCHIAL SLEEVE;CAGA GENE;CERVICOGENIC HEADACHE;CHILDREN BORN;CHRONIC INFLAMMATION","10;10;9;7;7;7;5;5;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2",8,0.06,6,2,0,1,0,0,2,0,1.75,2,0,0,1,0,3,0,0,1,0,0,0,36.75,34.25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,5,6829,2.21,0,0,243,0,0,0,1,3,0,1,0,0,5,0,0,0,0,0,0,0,5,0,0,5,0,0,0,0,0,0,0,0,0,"Germany;Italy;United States","2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;3202 CLINICAL SCIENCES","5;2;2;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;CARDIOVASCULAR;HEART DISEASE;PATIENT SAFETY;AGING;COLO-RECTAL CANCER;DENTAL/ORAL AND CRANIOFACIAL DISEASE;DIGESTIVE DISEASES;HEART DISEASE - CORONARY HEART DISEASE;HIV/AIDS;ORPHAN DRUG;RARE DISEASES;UROLOGIC DISEASES","5;5;2;2;2;2;1;1;1;1;1;1;1;1;1","CANCER;CARDIOVASCULAR;INFECTION","2;2;1","6.1 PHARMACEUTICALS","5","BLADDER CANCER;COLON AND RECTAL CANCER","1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","2",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_UMBERTOI",2002,103,6.30097087378641,2.33980582524272,0.757281553398058,0.310679611650485,0.766990291262136,1.2,1.2,1.18518518518519,1.17910447761194,0.12621359223301,7,32,17,6,43,0.31,0.17,0.06,0.42,26.72,0.484304352082563,NA,0.116504854368932,0.54368932038835,0.395,0.248,0.296,0.258,"ROBERTO PASSARIELLO;ANDREA LAGHI;RICCARDO IANNACCONE;IACOPO CARBONE;FRANCESCO MORINI;DENIS A. COZZI;MARIA GABRIELLA COSTA;P PIETROPAOLI;CARLO CATALANO;ALESSANDRO STASOLLA;CECILIA COCCIA;VINCENZO MARIGLIANO;FILIPPO MANGIAPANE;GIANFRANÇO SILECCHIA;FRANCESCA MACCIONI;MARIO MARINI;A CANCRINI;EMANUELE LEZOCHE;G FISCHETTI;ROBERTO CAMPAGNACCI","6;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;2;2;2;2","FRANCESCA MACCIONI;FLAVIA LONGO;ANTONIO CARBONE;MARIO CURIONE;E. BONUCCI;R GRAMOLINI;LUCIA DITO;ALESSANDRO STASOLLA;ROBERTO PASSARIELLO;MARIO MARINI;ANDREA LAGHI;RICCARDO IANNACCONE;FRANCESCO MORINI;DENIS A. COZZI;MARIA GABRIELLA COSTA;P PIETROPAOLI;CECILIA COCCIA;IACOPO CARBONE;ELSA IANNICELLI;CARLO CATALANO","1.33;1;1;1;1;1;1;1;0.92;0.83;0.8;0.8;0.68;0.68;0.66;0.66;0.66;0.63;0.58;0.57","ROBERTO PASSARIELLO;ANDREA LAGHI;RICCARDO IANNACCONE;IACOPO CARBONE;FRANCESCO MORINI;DENIS A. COZZI;MARIA GABRIELLA COSTA;P PIETROPAOLI;CARLO CATALANO;ALESSANDRO STASOLLA;CECILIA COCCIA;VINCENZO MARIGLIANO;FILIPPO MANGIAPANE;GIANFRANÇO SILECCHIA;FRANCESCA MACCIONI;MARIO MARINI;EMANUELE LEZOCHE;G FISCHETTI;ENEA BONCI;MARIA GRAZIA PORPORA","6;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;2;2;2;2","FRANCESCA MACCIONI;FLAVIA LONGO;ANTONIO CARBONE;MARIO CURIONE;E. BONUCCI;R GRAMOLINI;LUCIA DITO;ALESSANDRO STASOLLA;ROBERTO PASSARIELLO;MARIO MARINI;ANDREA LAGHI;RICCARDO IANNACCONE;FRANCESCO MORINI;DENIS A. COZZI;MARIA GABRIELLA COSTA;P PIETROPAOLI;CECILIA COCCIA;IACOPO CARBONE;ELSA IANNICELLI;CARLO CATALANO","1.33;1;1;1;1;1;1;1;0.92;0.83;0.8;0.8;0.68;0.68;0.66;0.66;0.66;0.63;0.58;0.57","GUSTAVO SPADETTA;MONICA ROCCO;G. UMBERTO MEDURI;GIORGIO CONTI;M. BUFI;MASSIMO ANTONELLI;PAOLO NAVALESI;CECILIA COCCIA;MARIA GABRIELLA COSTA;P PIETROPAOLI;ALBERTO MARAN;ALESSANDRO POSCIA;ANTONIO TIENGO;AURELIA BELLOMO;C. CREPALDI;DOMENICO CUCINOTTA;E. DE PAOLI VITALI;FAUSTO SANTEUSANIO;FRANCESCO GIORGINO;FRIDA LEONETTI","371;371;368;368;368;368;368;205;205;205;203;203;203;203;203;203;203;203;203;203","GUSTAVO SPADETTA;M. BUFI;MONICA ROCCO;FRIDA LEONETTI;MÁRIA CRISTINA RIBAUDO;UMBERTO DI MARIO;CARLO CATALANO;CECILIA COCCIA;MARIA GABRIELLA COSTA;P PIETROPAOLI;GIORGIO DELLA ROCCA;LIVIA POMPEI;PIERANGELO DI MARCO;ROBERTO PASSARIELLO;ANDREA LAGHI;GIANFRANÇO SILECCHIA;IACOPO CARBONE;RICCARDO IANNACCONE;ANGELO RESTUCCIA;UGO ELMORE","368;368;368;203;203;203;197;170;170;170;162;162;162;146;143;130;126;126;118;118","ANDREA LAGHI;CECILIA COCCIA;MARIA GABRIELLA COSTA;P PIETROPAOLI;CARLO CATALANO;DENIS A. COZZI;FRANCESCA MACCIONI;FRANCESCO MORINI;GIANFRANÇO SILECCHIA;ROBERTO PASSARIELLO;ALESSANDRA CASATI;ANGELO RESTUCCIA;CARLO DELLA ROCCA;EMANUELE LEZOCHE;FABIO GUARRACINO;FABRIZIO FANELLI;FRANCESCO MARIA DRUDI;G FISCHETTI;GIORGIO DELLA ROCCA;IACOPO CARBONE","5;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;COMPUTER SCIENCE;MATHEMATICS;CHEMISTRY;ECONOMICS;PHYSICS;ENGINEERING;BUSINESS;PHILOSOPHY;POLITICAL SCIENCE;GEOGRAPHY;PSYCHOLOGY;SOCIOLOGY","97;26;9;7;6;5;5;4;3;3;2;1;1;1","INTERNAL MEDICINE;SURGERY;RADIOLOGY;PATHOLOGY;ANESTHESIA;ENDOCRINOLOGY;CARDIOLOGY;GASTROENTEROLOGY;BIOCHEMISTRY;IMMUNOLOGY;PSYCHIATRY;GENETICS;GENERAL SURGERY;ANATOMY;NUCLEAR MEDICINE;PALEONTOLOGY;VIROLOGY;INTENSIVE CARE MEDICINE;ENVIRONMENTAL HEALTH;MEDICAL EMERGENCY;NURSING;OPTICS;UROLOGY","59;42;25;23;14;13;12;12;10;10;10;9;8;6;6;6;6;5;4;4;4;4;4","CANCER;GENE;ALTERNATIVE MEDICINE;INTERVENTIONAL RADIOLOGY;VIRUS;BLOOD PRESSURE;COMPUTED TOMOGRAPHY;DISEASE;LAPAROSCOPY;MAGNETIC RESONANCE IMAGING;TRANSPLANTATION;CARCINOMA;DIABETES MELLITUS;HEMODYNAMICS;HUMAN IMMUNODEFICIENCY VIRUS (HIV);INCIDENCE (GEOMETRY);NEUROLOGY;PREGNANCY;RECTUM;ANASTOMOSIS;ARTERY;ASYMPTOMATIC;CORONARY ARTERY DISEASE;HEART FAILURE;IMMUNE SYSTEM;IN VITRO;LESION;LUNG;MULTISLICE;OBESITY;OCCLUSION;PATHOLOGICAL;POPULATION;PULMONARY ARTERY;QUALITY (PHILOSOPHY);RADIATION THERAPY;RETROSPECTIVE COHORT STUDY;SPINAL CORD;THORACOTOMY","17;7;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","HEART RATE;BREAST CANCER;CARDIAC OUTPUT;COLORECTAL CANCER;HEPATITIS C VIRUS;NEURORADIOLOGY;ANAL CANAL;PRELOAD;PULMONARY WEDGE PRESSURE;VIRAL LOAD;WEIGHT LOSS;CARDIOMYOPATHY;ESOPHAGEAL CANCER;FUNCTIONAL CONSTIPATION;GENOTYPE;INFERTILITY;INJURY PREVENTION;LAPAROSCOPIC SURGERY;PLACEBO;PROSTATE;UNIVARIATE ANALYSIS","5;4;4;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2","CARDIAC INDEX;CENTRAL VENOUS PRESSURE;PULMONARY ARTERY CATHETER;STROKE VOLUME;COLONOSCOPY;GASTRIC BYPASS;MORBID OBESITY;ANEUPLOIDY;ANTIGEN PRESENTATION;ANTIGEN-PRESENTING CELL;ANTIRETROVIRAL THERAPY;ARTICULAR CARTILAGE;BILE REFLUX;BILLROTH I;BILLROTH II;BREAST RECONSTRUCTION;CD81;CONTINUOUS GLUCOSE MONITORING;DUAL-ENERGY X-RAY ABSORPTIOMETRY;ESOPHAGEAL NEOPLASM;ESOPHAGECTOMY;ESOPHAGITIS;ESTROGEN RECEPTOR;EURYARCHAEOTA;EXTERNAL ANAL SPHINCTER;FOLINIC ACID;GENETICALLY MODIFIED MOUSE;GENOTYPING;GERMLINE MUTATION;HEART RATE VARIABILITY;HYPERTRIGLYCERIDEMIA;HYPOPNEA;INTRAEPITHELIAL NEOPLASIA;LAMIVUDINE;LOSARTAN;MASTECTOMY;MHC CLASS I;MHC CLASS II;OSTEOCALCIN;PLACEBO GROUP;PLATELET-DERIVED GROWTH FACTOR RECEPTOR;POSTERIOR VITREOUS DETACHMENT;PROSTATECTOMY;PYROCOCCUS FURIOSUS;RETINOSCHISIS;SIDA;SULFOLOBUS;SULFOLOBUS SOLFATARICUS;TRUNCUS ARTERIOSUS;VARICOCELE","4;4;3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;ADULT;MIDDLE AGED;AGED;TOMOGRAPHY, X-RAY COMPUTED;;TREATMENT OUTCOME;MAGNETIC RESONANCE IMAGING;DIAGNOSIS, DIFFERENTIAL;FOLLOW-UP STUDIES;ADOLESCENT;CONSTIPATION;CORONARY ARTERY DISEASE;ENDOMETRIOSIS;KIDNEY NEOPLASMS;AGED, 80 AND OVER;CHILD;HEMANGIOMA","85;62;59;44;43;26;15;14;14;13;11;11;10;10;9;8;8;7;7;7","DIAGNOSIS AND MANAGEMENT OF BILIARY TRACT DISORDERS;HEPATITIS C INFECTION AND TREATMENT;OPTIMIZATION OF PERIOPERATIVE FLUID THERAPY;ANORECTAL SURGICAL PROCEDURES;CLASSIFICATION AND TREATMENT OF VASCULAR ANOMALIES;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;EFFECTS OF BARIATRIC SURGERY ON OBESITY AND DIABETES;ESOPHAGEAL INTERVENTION TECHNIQUES;HUMAN IMMUNODEFICIENCY VIRUS/ACQUIRED IMMUNODEFICIENCY SYNDROME;IMPACT OF HEALTHCARE ACCREDITATION ON QUALITY IMPROVEMENT;INSULIN-LIKE GROWTH FACTORS IN HEALTH AND DISEASE;INTESTINAL MALROTATION AND OBSTRUCTION DISORDERS;MOLECULAR MECHANISMS OF CARDIAC ARRHYTHMIAS;PREOPERATIVE CHEMORADIOTHERAPY FOR ESOPHAGEAL CANCER;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;ASTHMA;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;BODY CONTOURING TECHNIQUES AND PROCEDURES;BREAST MAGNETIC RESONANCE IMAGING IN ONCOLOGY;CANCER OF UNKNOWN PRIMARY SITE","3;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1","INTERVENTIONAL RADIOLOGY;CARDIAC INDEX;NEURORADIOLOGY;TREATMENT;INTRAOPERATIVE FLUID MANAGEMENT;MULTISLICE;PRELOAD;PULMONARY ARTERY CATHETER;PULMONARY WEDGE PRESSURE;THORACOTOMY;ARRHYTHMIA DETECTION;BILIARY DRAINAGE;BOLUS (DIGESTION);BONE METASTASES;BONE REMODELING;CARDIOVASCULAR RISK ASSESSMENT;ESOPHAGEAL CARCINOMA;FETAL LUNG DEVELOPMENT;FUNCTIONAL CONSTIPATION;HIV","6;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2","COMPUTED TOMOGRAPHY;LUNG TRANSPLANTATION;MULTISLICE SPIRAL;PULMONARY ARTERY;ARTERY OCCLUSION;BLOOD VOLUME;CARDIAC PERFORMANCE;INDEX PULMONARY;INTRATHORACIC BLOOD;LAPAROSCOPIC CHOLECYSTECTOMY;OCCLUSION PRESSURE;PERSONAL EXPERIENCE;PRELOAD INDEX;PRESSURE VERSUS;RANDOMIZED STUDY;SPIRAL CT;VERSUS INTRATHORACIC;VOLUME MONITORING;ABDOMINAL AORTIC;ABDOMINAL APPROACH;ACQUIRED TUFTED;ACTIVATING TSH;ACTIVE ANTIRETROVIRAL;ACUTE DIVERTICULITIS;ACUTE HEXARELIN;ACUTE MYOCARDIAL;ACUTE PANCREATITIS;ADENOMATOUS POLYPS;AGE RELATED;AIDS PATIENT","3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","FEVER EPISODES;LUNG TRANSPLANTATION;PULMONARY ARTERY;ANG II;HIV RNA;HUMAN CD;DILUTION TECHNIQUE;HCV INFECTION;HIV INFECTION;PICCO SYSTEM;PRELOAD INDEX;SITUS VISCERUM;TRANSGENIC MICE;VENOUS BLOOD;VISCERUM INVERSUS;VOLUME INDEX;ANG II-INDUCED;ANGIOTENSIN II;BLOOD GLUCOSE;DIABETIC PATIENTS;INTRACELLULAR CALCIUM;PDGF SYSTEM;ARTERIAL OXYGEN;ARTERY CATHETER;ARTERY OCCLUSION;ARTERY THERMODILUTION;BINDING EXPERIMENTS;BLOOD CELLS;BLOOD VOLUME;CARDIAC INDEX","7;6;6;5;5;5;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2",10,0.1,9,3.75,0,0,0,0,12,0,3,4.75,0,0,1,0,0,0,0,1,1,0,0,24,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,4.67,2582,1.61,1,0.33,131.33,0,0,0,0,3,0,0,0,0,3,0,0,0,0,0,0,0,3,0,0,3,0,0,0,0,0,0,0,0,0,"Italy;United States","1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","3;2;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;NUTRITION;RARE DISEASES;CARDIOVASCULAR;COMPLEMENTARY AND INTEGRATIVE HEALTH;CYSTIC FIBROSIS;HEART DISEASE;LUNG;OSTEOPOROSIS;PREVENTION","3;2;2;2;1;1;1;1;1;1;1","CARDIOVASCULAR;CONGENITAL;MUSCULOSKELETAL","1;1;1","6.1 PHARMACEUTICALS","3","MYELOMA","1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_UMBERTOI",2003,112,6.50892857142857,2.60714285714286,0.758928571428571,0.285714285714286,0.758928571428571,1.17338709677419,1.1038961038961,1.14285714285714,1.1038961038961,0.214285714285714,10,36,23,7,39,0.32,0.21,0.06,0.35,30.46,0.575412139096046,NA,0.178571428571429,0.571428571428571,0.416,0.235,0.315,0.237,"ROBERTO PASSARIELLO;ANDREA LAGHI;FILIPPO MANGIAPANE;ANTONIO ROSSILLO;RICCARDO IANNACCONE;CARLO CATALANO;FRANCESCA PIACENTINI;ANTONIO RAVIELE;SAKIS THEMISTOCLAKIS;ALDO BONSO;FRANCESCO MORINI;SANDRO BOSCO;DENIS A. COZZI;ERASMO SPAZIANI;FRANCESCO SCOPINARO;GUIDO VALESINI;FRANCESCO COZZI;M. BARBATO;FRANCESCO REA;DOMENICO MERANTE","8;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;2;2","VINCENZO SCIACCA;ANTONIO ROSSILLO;C. DE ANGELIS;FEDERICO VENUTA;ROBERTO PASSARIELLO;UMBERTO DI MARIO;FLAVIA LONGO;CARLINA V. ALBANESE;DANIELE DIACINTI;S THEMISTOCLAKIS;ANDREA LAGHI;CARLO CATALANO;FILIPPO MANGIAPANE;RICCARDO IANNACCONE;FRANCESCA PIACENTINI;MARIO PESCATORI;ROBERTO RUSSO;MARIA CLARA BRAGA;G M ANATRA;BLEGINA SHASHAJ","2;1.38;1.33;1.33;1.07;1.06;1;1;1;1;0.69;0.58;0.57;0.57;0.57;0.5;0.5;0.5;0.5;0.5","ROBERTO PASSARIELLO;ANDREA LAGHI;FILIPPO MANGIAPANE;ANTONIO ROSSILLO;RICCARDO IANNACCONE;CARLO CATALANO;FRANCESCA PIACENTINI;ANTONIO RAVIELE;SAKIS THEMISTOCLAKIS;ALDO BONSO;FRANCESCO MORINI;SANDRO BOSCO;DENIS A. COZZI;ERASMO SPAZIANI;FRANCESCO SCOPINARO;GUIDO VALESINI;FRANCESCO COZZI;GIANLUCA IACOBELLIS;LUIGI RAPARELLI;IACOPO CARBONE","8;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2","VINCENZO SCIACCA;ANTONIO ROSSILLO;C. DE ANGELIS;FEDERICO VENUTA;ROBERTO PASSARIELLO;UMBERTO DI MARIO;FLAVIA LONGO;CARLINA V. ALBANESE;DANIELE DIACINTI;S THEMISTOCLAKIS;ANDREA LAGHI;CARLO CATALANO;FILIPPO MANGIAPANE;RICCARDO IANNACCONE;FRANCESCA PIACENTINI;ROBERTO RUSSO;MARIA CLARA BRAGA;G CARDARELLI;LUIGI BASSO;N. SULLI","2;1.38;1.33;1.33;1.07;1.06;1;1;1;1;0.69;0.58;0.57;0.57;0.57;0.5;0.5;0.5;0.5;0.5","ROBERTO PASSARIELLO;ANDREA LAGHI;ALDO BONSO;ANDREA NATALE;ANTONIO RAVIELE;ANTONIO ROSSILLO;CYNTHIA P. SAAD;DAVID O. MARTIN;DEMET ERCIYES;DIANNA BASH;DOMENICO POTENZA;EDUARDO SAAD;ENNIO PISANÒ;J. BRACHMANN;JAMES M. ADAMS;MANDEEP BHARGAVA;MICHELLE WILLIAMS‐ANDREWS;NASSIR F. MARROUCHE;RAFFAELE FANELLI;ROBERT A. SCHWEIKERT","408;373;353;353;353;353;353;353;353;353;353;353;353;353;353;353;353;353;353;353","ALDO BONSO;ANDREA NATALE;ANTONIO RAVIELE;ANTONIO ROSSILLO;CYNTHIA P. SAAD;DAVID O. MARTIN;DEMET ERCIYES;DIANNA BASH;DOMENICO POTENZA;EDUARDO SAAD;ENNIO PISANÒ;J. BRACHMANN;JAMES M. ADAMS;MANDEEP BHARGAVA;MICHELLE WILLIAMS‐ANDREWS;NASSIR F. MARROUCHE;RAFFAELE FANELLI;ROBERT A. SCHWEIKERT;SAKIS THEMISTOCLAKIS;SALWA BEHEIRY","353;353;353;353;353;353;353;353;353;353;353;353;353;353;353;353;353;353;353;353","ROBERTO PASSARIELLO;ANDREA LAGHI;ANTONIO ROSSILLO;ALDO BONSO;ANTONIO RAVIELE;SAKIS THEMISTOCLAKIS;CARLO CATALANO;RICCARDO IANNACCONE;C. DE ANGELIS;ENRICO SBARIGIA;FEDERICO VENUTA;FILIPPO MANGIAPANE;FRANCESCA PIACENTINI;FRANCESCO MARIA DRUDI;FRANCESCO MORINI;FRANCESCO SPEZIALE;GIANFRANÇO SILECCHIA;GIANLUCA IACOBELLIS;GUIDO VALESINI;IACOPO CARBONE","5;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;ENGINEERING;COMPUTER SCIENCE;MATHEMATICS;POLITICAL SCIENCE;PSYCHOLOGY;BUSINESS;ECONOMICS;GEOLOGY;PHILOSOPHY","108;24;8;7;6;3;3;3;3;1;1;1;1","INTERNAL MEDICINE;SURGERY;RADIOLOGY;PATHOLOGY;ENDOCRINOLOGY;NUCLEAR MEDICINE;CARDIOLOGY;GASTROENTEROLOGY;BIOCHEMISTRY;GENERAL SURGERY;IMMUNOLOGY;GENETICS;PSYCHIATRY;ANATOMY;ANESTHESIA;INTENSIVE CARE MEDICINE;PEDIATRICS;UROLOGY;ENVIRONMENTAL HEALTH;OPTICS;PALEONTOLOGY","80;50;33;26;17;14;12;12;11;11;9;7;7;6;6;5;5;5;4;4;4","CANCER;DISEASE;ALTERNATIVE MEDICINE;CHEMOTHERAPY;DIABETES MELLITUS;GENE;ATRIAL FIBRILLATION;KIDNEY;LESION;MAGNETIC RESONANCE IMAGING;PERIPHERAL;THYROID;ARTERY;BIOPSY;CYTOKINE;HEPATOLOGY;HORMONE;ISOLATION (MICROBIOLOGY);POPULATION;RECEPTOR;SCINTIGRAPHY;STENOSIS;VIRUS","21;11;6;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4","COLORECTAL CANCER;BREAST CANCER;PULMONARY VEIN;PLACEBO;COELIAC DISEASE;GLUTEN FREE;HEPATITIS C VIRUS;PEDIATRIC GASTROENTEROLOGY;PROSTATE;RADIOFREQUENCY ABLATION;THYROID DISEASE;BONE DENSITY;BONE MINERAL;CATHETER ABLATION;GROWTH HORMONE;HEPATECTOMY;LEPTIN;METASTASIS;NEURORADIOLOGY;RENAL ARTERY;SCOPUS;THYROID FUNCTION;THYROID FUNCTION TESTS;VIRAL DISEASE","8;6;5;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","COLONOSCOPY;ACROMEGALY;CROSSOVER STUDY;MAMMOGRAPHY;METASTATIC LESION;RADIOFREQUENCY CATHETER ABLATION;RENAL ARTERY STENOSIS;ALCOHOL INTOXICATION;ALCOHOL USE DISORDERS IDENTIFICATION TEST;ALPHA-TOCOPHEROL;ATYPICAL ADENOMATOUS HYPERPLASIA;AXILLA;BAROREFLEX;BLADDER TUMOR;BONE METASTASIS;BREAST RECONSTRUCTION;BREAST SURGERY;BREAST TISSUE;CD28;CHEMOKINE RECEPTOR;CRITICAL LIMB ISCHEMIA;CRYOGLOBULINEMIA;DUAL ENERGY;ENDOVASCULAR ANEURYSM REPAIR;GLUCURONIDATION;HEART RATE VARIABILITY;IN SITU HYBRIDIZATION;INFLAMMATORY BREAST CANCER;INSULIN PUMP;INTRAEPITHELIAL NEOPLASIA;IΚB KINASE;JURKAT CELLS;KARYOTYPE;LAMIVUDINE;MACE;MALE INFERTILITY;MAMMOTOME;MASTECTOMY;MELANOCORTIN RECEPTOR;NFKB1;OSTEOCALCIN;OXALIPLATIN;PLACEBO GROUP;PROSTATECTOMY;PULMONARY VEIN STENOSIS;RECTAL EXAMINATION;RIBAVIRIN;RIBOSOME;SEMEN ANALYSIS;SENTINEL LYMPH NODE;SEVERE OBESITY;SIDA;SPINAL CORD STIMULATOR;STAPHYLOCOCCAL INFECTIONS;TOCOPHEROL;TRANSLATION (BIOLOGY);TRANSRECTAL ULTRASONOGRAPHY;TRANSSPHENOIDAL SURGERY;VINCRISTINE;VINORELBINE","6;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;MIDDLE AGED;ADULT;AGED;;AGED, 80 AND OVER;COLORECTAL NEOPLASMS;BREAST NEOPLASMS;FOLLOW-UP STUDIES;ADOLESCENT;RETROSPECTIVE STUDIES;HYPOGLYCEMIC AGENTS;COLONIC POLYPS;COLONOGRAPHY, COMPUTED TOMOGRAPHIC;SENSITIVITY AND SPECIFICITY;TREATMENT OUTCOME;CELIAC DISEASE;CHILD","94;64;60;56;40;38;17;16;15;14;14;13;12;11;10;10;10;10;9;9","ATRIAL FIBRILLATION;GLOBAL TRENDS IN COLORECTAL CANCER RESEARCH;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME;ADVANCEMENTS IN LUNG CANCER RESEARCH;DIAGNOSIS AND TREATMENT OF RENAL ARTERY STENOSIS;HEPATITIS C INFECTION AND TREATMENT;HEPATOCELLULAR CARCINOMA;MANAGEMENT OF MESENTERIC ISCHEMIA AND ANEURYSMS;MANAGEMENT OF SPLEEN TRAUMA IN POLYTRAUMA PATIENTS;MICROSURGICAL RECONSTRUCTION TECHNIQUES;MOLECULAR CHARACTERIZATION OF COLORECTAL CANCER;NEUROENDOCRINE REGULATION OF APPETITE AND BODY WEIGHT;OSTEOPOROSIS;PATHOGENESIS AND MANAGEMENT OF BILIARY ATRESIA;SARCOMA RESEARCH AND TREATMENT;TREATMENT AND MECHANISMS OF COMPLEX PAIN SYNDROMES;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;ANALYSIS AND APPLICATIONS OF HEART RATE VARIABILITY","5;5;4;3;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1","ATRIAL FIBRILLATION;TREATMENT;COLONOSCOPY;DIABETES;ISOLATION (MICROBIOLOGY);CONSERVATIVE TREATMENT;CONTINUOUS GLUCOSE MONITORING;EPICARDIAL ABLATION;ETIOLOGY;GLUTEN FREE;INSULIN THERAPY;PEDIATRIC GASTROENTEROLOGY;RADIOFREQUENCY ABLATION;RENAL ARTERY STENOSIS;THYROID DISEASE;ANEURYSM SCREENING;CANCER;CATHETER ABLATION;CELIAC DISEASE;CONSERVATIVE MANAGEMENT","5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2","ATRIAL FIBRILLATION;PULMONARY VEIN;CT COLONOGRAPHY;VEIN ISOLATION;CELIAC DISEASE;A- FEASIBILITY;A- PULMONARY;ACUTE DIGITALIS;ARRAY INTRACARDIAC;ARTERY STENOSIS;AUTOIMMUNE THYROID;BLOOD PRESSURE;BOWEL NECROSIS;CANCER PATIENTS;CATHETER ABLATION;CELL LUNG;COLORECTAL LESIONS;CORD STIMULATION;CRITICAL LIMB;DIGITALIS POISONING;FIBRILLATION EFFECTIVENESS;HEALTH CARE;HEMORRHAGIC BOWEL;INTRACARDIAC ECHOCARDIOGRAPHY;ISOLATION GUIDED;LIMB ISCHEMIA;LOWER EXTREMITIES;LUNG CANCER;LUPUS ERYTHEMATOSUS;NON-SMALL CELL","5;5;4;4;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CG INTOXICATION;ABDOMINAL PAIN;BOWEL NECROSIS;PREABLATION AF;ACUTE CG;BAROREFLEX SENSITIVITY;CONTROL SUBJECTS;HEMORRHAGIC BOWEL;HEMORRHAGIC NECROSIS;TRANSISTHMIC ABLATION;AFL INDUCED;INSULIN SENSITIVITY;L-CARNITINE THERAPY;MEDIAN AGE;MESENTERIC ISCHEMIA;MXA MRNA;NEUTRALIZING ANTIBODIES;PV STENOSIS;STENT IMPLANTATION;TYPICAL AFL;ABDOMINAL X-RAY;AF OCCURRENCE;AFL COEXISTENT;ANTIBODY FRAGMENTS;ARTERIOVE-NOUS ﬁSTULA;ARTERIOVENOUS ﬁSTULA;ARTERY ANEURYSM;ATRIA FIBRILLATION;ATRIA FLUTTER;AUTOIMMUNE THYROID","10;8;8;8;7;7;5;5;5;5;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3",6,0.05,6.94,2.75,1,1,0,2,2.25,0,1,2.75,0,0,1,1,2,0,0,1,0,0,0,65,65,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,4,518,0.85,0,0,129,0,0,1,0,1,0,0,0,0,2,0,0,0,0,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,"Germany;United States","1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","2;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;BRAIN DISORDERS;HEMATOLOGY;NEUROSCIENCES;PATIENT SAFETY;RARE DISEASES;STROKE","2;2;1;1;1;1;1;1","STROKE","1","6.1 PHARMACEUTICALS","2","LEUKEMIA / LEUKAEMIA","1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_UMBERTOI",2004,121,6.5702479338843,2.74380165289256,0.68595041322314,0.330578512396694,0.702479338842975,1.28294573643411,1.25757575757576,1.11111111111111,1.25,0.181818181818182,9,49,21,15,28,0.4,0.17,0.12,0.23,31.94,0.678845824739017,NA,0.132231404958678,0.487603305785124,0.412,0.243,0.287,0.24,"ROBERTO PASSARIELLO;VINCENZO MARIGLIANO;FLAVIA LONGO;RICCARDO IANNACCONE;FRANCESCO SPEZIALE;EVARISTO ETTORRE;ROBERTO BECELLI;CARLO CATALANO;GIANCARLO RENZI;ÉRIC DUCASSE;C MODINI;P PUPPINCK;R. PRETAGOSTINI;M ASSENZA;GIANFRANCO PICCIRILLO;DAMIANO MAGRÌ;ANDREA LAGHI;FILIPPO MANGIAPANE;MARIALUCE NOCCO;SILVIA DI CARLO","6;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","FLAVIA LONGO;FRANCESCO DI SABATO;GIOVANNI MANSUETO;L. SPERDUTI;GIANLUCA IACOBELLIS;MAURIZIO SOLDINI;GIANFRANÇO SILECCHIA;A. SAGGIORO;GABRIELE FORCINA;P VERNIA;ROBERTO PASSARIELLO;ROBERTO BECELLI;GIANCARLO RENZI;ANTONELLO TRECCA;FABIO GAJ;GIOVANNI MANSUETO;ANNA PAOLA IORI;RICCARDO IANNACCONE;CARLO CATALANO;ANTONIO RAVIELE","2;2;1.5;1.17;1;1;1;1;1;1;0.84;0.8;0.8;0.75;0.75;0.7;0.62;0.61;0.61;0.56","ROBERTO PASSARIELLO;VINCENZO MARIGLIANO;FLAVIA LONGO;RICCARDO IANNACCONE;FRANCESCO SPEZIALE;EVARISTO ETTORRE;CARLO CATALANO;GIANCARLO RENZI;ÉRIC DUCASSE;R. PRETAGOSTINI;M ASSENZA;GIANFRANCO PICCIRILLO;DAMIANO MAGRÌ;ANDREA LAGHI;FILIPPO MANGIAPANE;MARIALUCE NOCCO;SILVIA DI CARLO;CLAUDIO LETIZIA;CAMILLA NASO;GIOVANNI MANSUETO","6;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3","FLAVIA LONGO;FRANCESCO DI SABATO;GIOVANNI MANSUETO;L. SPERDUTI;GIANLUCA IACOBELLIS;MAURIZIO SOLDINI;GIANFRANÇO SILECCHIA;A. SAGGIORO;GABRIELE FORCINA;P VERNIA;ROBERTO PASSARIELLO;GIANCARLO RENZI;FABIO GAJ;GIOVANNI MANSUETO;RICCARDO IANNACCONE;CARLO CATALANO;FRANCESCO SPEZIALE;ÉRIC DUCASSE;FILIPPO LA TORRE;GABRIELLA CANCRINI","2;2;1.5;1.17;1;1;1;1;1;1;0.84;0.8;0.75;0.7;0.61;0.61;0.53;0.53;0.5;0.5","ROBERTO PASSARIELLO;CARLO CATALANO;RICCARDO IANNACCONE;ANDREA LAGHI;FILIPPO MANGIAPANE;A SCHILLACI;ANTONIETTA LAMAZZA;FRANCESCA PIACENTINI;GIOVANNI SINIBALDI;ITALO NOFRONI;MASATOSHI HORI;PAOLO SAMMARTINO;TAKAMICHI MURAKAMI;VINCENZO STIPA;ANDRÉ GRIMALDI;ANNA NOVIALS;G. SCHERNTHANER;GUY E.H.M. RUTTEN;JÓZEF DRZEWOSKI;KENNETH SHAW","460;312;312;304;304;296;296;296;296;296;296;296;296;296;264;264;264;264;264;264","A SCHILLACI;ANTONIETTA LAMAZZA;ITALO NOFRONI;UMBERTO DI MARIO;FRANCESCO SPEZIALE;ÉRIC DUCASSE;PAOLO FIORANI;ALESSANDRO CALISTI;LUIGI RIZZO;MARIA MISURACA;BRUNO TORCHIO;MANUELA MOTTA;A. SAGGIORO;ANTONIO ROSSILLO;G. SILVESTRINI;PLINIO ROSSI;SALVATORE MINISOLA;SIMONA DE GERONIMO;GIUSEPPE RONGA;ELISABETTA RISTORI","296;296;296;264;231;227;217;202;202;202;201;201;173;153;138;133;125;125;108;100","FRANCESCO SPEZIALE;GIANFRANCO PICCIRILLO;VINCENZO MARIGLIANO;ANTONIO MOISÈ;CAMILLA NASO;DAMIANO MAGRÌ;EVARISTO ETTORRE;MARIALUCE NOCCO;PAOLO FIORANI;RICCARDO IANNACCONE;SILVIA DI CARLO;ÉRIC DUCASSE;A TOCCHI;A. DE PASQUALE CERATTI;A. GARGIULO;ANDREA MORELLI;ANTONIO AVALLONE;C. DI FONZO;CARLO CATALANO;DILETTA CASSINI","4;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;ENGINEERING;MATHEMATICS;PHILOSOPHY;POLITICAL SCIENCE;PSYCHOLOGY;SOCIOLOGY;BUSINESS;ECONOMICS;MATERIALS SCIENCE;ART;GEOGRAPHY;GEOLOGY;HISTORY","113;30;10;8;8;7;6;5;5;5;4;3;2;2;1;1;1;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;RADIOLOGY;GASTROENTEROLOGY;CARDIOLOGY;ENDOCRINOLOGY;GENERAL SURGERY;GENETICS;BIOCHEMISTRY;ENVIRONMENTAL HEALTH;IMMUNOLOGY;ONCOLOGY;UROLOGY;ANESTHESIA;ANATOMY;INTENSIVE CARE MEDICINE;PHARMACOLOGY;PSYCHIATRY;CELL BIOLOGY;LAW;MOLECULAR BIOLOGY;NUCLEAR MEDICINE;PALEONTOLOGY","79;48;23;20;16;14;13;11;11;10;10;10;10;10;8;7;7;6;6;5;5;5;5;5","CANCER;POPULATION;ADVERSE EFFECT;ALTERNATIVE MEDICINE;CHEMOTHERAPY;RECEPTOR;TRANSPLANTATION;BLOOD PRESSURE;DISEASE;GENE;LUNG;LUNG CANCER;ANGIOGRAPHY;CARCINOMA;CREATININE;DIABETES MELLITUS;HEART FAILURE;INCIDENCE (GEOMETRY);PLATELET;RADIOLOGICAL WEAPON;RETROSPECTIVE COHORT STUDY;STENT","16;10;7;7;7;7;7;6;6;6;6;5;4;4;4;4;4;4;4;4;4;4","COLORECTAL CANCER;ALLELE;BONE MINERAL;EJECTION FRACTION;HEART RATE;PLACEBO;RESPIRATORY DISEASE;ABDOMINAL AORTIC ANEURYSM;ADRENOMEDULLIN;ALZHEIMER'S DISEASE;APHERESIS;ARGININE;AZATHIOPRINE;BLADDER CANCER;CARCINOGENESIS;CD34;CD8;CHEMOKINE;CHONDROCYTE;CYCLOPHOSPHAMIDE;CYTOTOXIC T CELL;DNA REPAIR;GENOTYPE;HYPERHOMOCYSTEINEMIA;INTIMAL HYPERPLASIA;MULTISLICE COMPUTED TOMOGRAPHY;NEURORADIOLOGY;OSTEOARTHRITIS;PACLITAXEL;SPIRAL COMPUTED TOMOGRAPHY;THYROID CARCINOMA;TOLERABILITY;TYPE 2 DIABETES;UNIVARIATE ANALYSIS;WEIGHT LOSS","5;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ARTICULAR CARTILAGE;AUTONOMIC NERVOUS SYSTEM;HEART RATE VARIABILITY;OSTEOPENIA;ACCESSORY SPLEEN;ANTIGEN-PRESENTING CELL;ANTIRETROVIRAL THERAPY;AORTOENTERIC FISTULA;ARABIDOPSIS;ARTIFICIAL VENTILATION;ATHERECTOMY;BASILIXIMAB;BIFIDOBACTERIUM;BREAST CARCINOMA;BRONCHIOLITIS OBLITERANS;BRONCHUS;CAPECITABINE;CARBOPLATIN;CARDIAC INDEX;CARDIAC RESYNCHRONIZATION THERAPY;CHROMOSOME 17 (HUMAN);COLON CARCINOMA;COLONOSCOPY;CTL*;CXCR4;DIFFUSING CAPACITY;DNA MISMATCH REPAIR;DNA-BINDING PROTEIN;DNA-PKCS;ENDOVASCULAR ANEURYSM REPAIR;FEBRILE NEUTROPENIA;FLUDARABINE;FLUORESCENCE IN SITU HYBRIDIZATION;FOURNIER GANGRENE;FUNGAL PROTEIN;GASTRIC BYPASS;GLIMEPIRIDE;HAPLOTYPE;HERPESVIRIDAE;HPV INFECTION;HYDROGEN BREATH TEST;INTERLEUKIN 12;INTERLEUKIN 21;ISCHEMIC CARDIOMYOPATHY;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS PLANTARUM;LARYNGOTRACHEAL STENOSIS;LEUKAPHERESIS;METASTATIC BREAST CANCER;MICROCOCCACEAE;MICROSATELLITE;MIGRAINE WITH AURA;MYXOID LIPOSARCOMA;NATURAL KILLER CELL;NATURAL KILLER T CELL;NEUROSPORA CRASSA;NO REFLOW PHENOMENON;OLIGODENDROGLIOMA;PLATELET-DERIVED GROWTH FACTOR RECEPTOR;PLEXIFORM NEUROFIBROMA;POSTERIOR INTEROSSEOUS NERVE;PRIMARY TUMOR;RIGHT CORONARY ARTERY;SINGLE-NUCLEOTIDE POLYMORPHISM;STAPHYLOCOCCAL INFECTIONS;STAPHYLOCOCCUS EPIDERMIDIS;SUPRAORBITAL NERVE;TILT TABLE TEST;TIMI;TRANSITIONAL CELL CARCINOMA;TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT","2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;MIDDLE AGED;ADULT;AGED;;ADOLESCENT;NEOPLASMS;TREATMENT OUTCOME;CARDIOVASCULAR DISEASES;RETROSPECTIVE STUDIES;ADENOCARCINOMA;ANIMALS;CHILD;COLORECTAL NEOPLASMS;HEMORRHOIDS;ANTIBODIES, MONOCLONAL;DEOXYCYTIDINE;LUNG NEOPLASMS","97;73;68;50;49;39;15;15;15;14;12;11;10;10;10;10;10;9;9;9","ANORECTAL SURGICAL PROCEDURES;NATURAL KILLER CELLS IN IMMUNITY;ANALYSIS AND APPLICATIONS OF HEART RATE VARIABILITY;CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER TREATMENT;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;DIAGNOSIS AND TREATMENT OF BLADDER CANCER;EFFECTS OF BARIATRIC SURGERY ON OBESITY AND DIABETES;EPIDEMIOLOGY AND TREATMENT OF HEAD AND NECK CANCER;GLIOMAS;IMPACT OF CHRONIC STRESS ON CANCER PROGRESSION;INFLAMMATION'S ROLE IN CANCER DEVELOPMENT AND PROGRESSION;MANAGEMENT AND DIAGNOSIS OF THYROID CANCER;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;OPTIMIZATION OF PERIOPERATIVE FLUID THERAPY;ORAL MUCOSAL DISORDERS AND MALIGNANT TRANSFORMATION RISK;OSTEOARTHRITIS AND CARTILAGE REPAIR;PHEOCHROMOCYTOMA AND PARAGANGLIOMA;ROLE OF NEUROPEPTIDES IN PHYSIOLOGY AND DISEASE;ACUTE MYELOID LEUKEMIA;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH","5;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1","HEART RATE VARIABILITY;CUFF;HISTOLOGY;HYPERTENSION;ADRENOMEDULLIN;ANEURYSM RUPTURE;AORTIC ANEURYSMS;BLADDER CANCER;BLOOD PRESSURE;BONE REMODELING;CARDIAC IMAGING;CELECOXIB;CLINICAL SIGNIFICANCE;CYCLOOXYGENASE-2 INHIBITORS;DEEP VEIN THROMBOSIS;DERMATOLOGICAL TOXICITY;DIAGNOSIS;DIFFERENTIATED THYROID CANCER;DISCONTINUATION;DRY SKIN","4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CELL LUNG;LUNG CANCER;NON-SMALL CELL;ADVANCED NON-SMALL;CANCER NSCLC;ANNUAL MEETING;ASCO ANNUAL;ADVERSE EFFECTS;ALZHEIMER DISEASE;BLOOD PRESSURE;BONE METABOLISM;BOWEL SYNDROME;CARDIOVASCULAR RISK;CHRONIC HEART;COMPUTED TOMOGRAPHY;CUTANEOUS ADVERSE;EMERGENCY DEPARTMENT;HEART FAILURE;HEART RATE;II STUDY;INTIMAL HYPERPLASIA;IRRITABLE BOWEL;LOCAL TREATMENT;MULTISLICE COMPUTED;NSCLC SURPRISING;PERIPHERAL BLOOD;PHASE II;PRETREATED ADVANCED;RENAL TRANSPLANT;RISK FACTORS","5;5;5;4;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ROME ITALY;POLICLINICO UMBERTO;RADIOLOGICAL SCIENCES;ROMELA SAPIENZA;SAPIENZA POLICLINICO;SCIENCES UNIVERSITY;VEIN CUFF;CAROTID BODY;COMPUTED TOMOGRAPHY;CT ANGIOGRAPHY;BODY TUMOR;ARTERIOVENOUS FISTULA;BASILIXIMAB PLACEBO;BASILIXIMAB STEROIDS;BLOOD PRESSURE;CARDIAC OUTPUT;GLYCAEMIC CONTROL;INTIMAL HYPERPLASIA;MULTISLICE COMPUTED;NK CELLS;SPIRAL CT;TYPE DIABETES;VOLUME RENDERING;CAROTID BIFURCATION;CD BRIGHT;DNA DAMAGE;HBAC LEVELS;LMIN NA;MULTISLICE SPIRAL;RICCARDO IANNACCONE","14;12;12;12;12;12;11;8;7;7;6;5;5;5;5;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4",12,0.1,9.25,7.75,0,0,0,1.75,9.5,0,2.5,8.75,0,0,1,1,4,0,1,1,0,0,0,59.5,59.75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,5.67,206.75,3.27,1,0.12,40,0,0,1,1,2,0,3,1,0,4,0,0,1,0,0,0,0,7,0,1,5,3,0,0,0,0,0,0,0,0,"Belgium;Germany;Italy","1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3204 IMMUNOLOGY;3207 MEDICAL MICROBIOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;3215 REPRODUCTIVE MEDICINE;36 CREATIVE ARTS AND WRITING;3605 SCREEN AND DIGITAL MEDIA;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","8;3;1;1;1;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;AUTOIMMUNE DISEASE;BRAIN DISORDERS;CARDIOVASCULAR;INFECTIOUS DISEASES;NEUROSCIENCES;AGING;ATHEROSCLEROSIS;BIOMEDICAL IMAGING;CANCER;CHILDHOOD LEUKEMIA;DIABETES;DIGESTIVE DISEASES;DIGESTIVE DISEASES - (PEPTIC ULCER);EMERGING INFECTIOUS DISEASES;HEART DISEASE;HEART DISEASE - CORONARY HEART DISEASE;HEMATOLOGY","5;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","CARDIOVASCULAR;CANCER;INFECTION;INFLAMMATORY AND IMMUNE SYSTEM;METABOLIC AND ENDOCRINE;NEUROLOGICAL","2;1;1;1;1;1","6.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;7.1 INDIVIDUAL CARE NEEDS","6;1;1;1","LEUKEMIA / LEUKAEMIA","1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_UMBERTOI",2005,116,8.12931034482759,3.47413793103448,0.672413793103448,0.491379310344828,0.672413793103448,1.21084337349398,1.14705882352941,1.16326530612245,1.16417910447761,0.232758620689655,3,48,23,17,22,0.41,0.2,0.15,0.19,44.86,0.847353787160652,NA,0.163793103448276,0.663793103448276,0.348,0.228,0.275,0.229,"P.B. BERLOCO;FEDERICO VENUTA;LUIGI NOVELLI;ERINO ANGELO RENDINA;F. NUDO;MASSIMO ROSSI;FRANCESCO VIOLI;G. ROSA;C MODINI;FRANCESCO PUGLIESE;LUCA BERTINI;EMANUELA CAROLI;R. PRETAGOSTINI;E POLETTINI;EMANUELE CASCIANI;MAURIZIO SALVATI;FRANCESCO SPEZIALE;S. MARTELLI;GIORGIO F. COLONI;ENRICO CORTESI","6;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3","NADIA PALLOTTA;L. GANDINI;FLAVIA LONGO;A.F. ATTILI;GIOVANNI MANSUETO;FEDERICO VENUTA;ERINO ANGELO RENDINA;G. ROSA;GIANLUCA IACOBELLIS;LISA FRANCHI;FRIDA LEONETTI;MARCO FALCONE;P.B. BERLOCO;C MODINI;EMANUELA CAROLI;MAURIZIO SALVATI;LUCA BERTINI;E POLETTINI;EMANUELE CASCIANI;GIAN FRANCO GUALDI","1;1;1;1;1;0.84;0.77;0.71;0.67;0.67;0.67;0.64;0.55;0.54;0.51;0.51;0.51;0.51;0.51;0.51","P.B. BERLOCO;FEDERICO VENUTA;LUIGI NOVELLI;ERINO ANGELO RENDINA;F. NUDO;MASSIMO ROSSI;FRANCESCO VIOLI;G. ROSA;FRANCESCO PUGLIESE;LUCA BERTINI;EMANUELA CAROLI;R. PRETAGOSTINI;E POLETTINI;EMANUELE CASCIANI;MAURIZIO SALVATI;FRANCESCO SPEZIALE;S. MARTELLI;GIORGIO F. COLONI;ENRICO CORTESI;GIAN FRANCO GUALDI","6;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3","NADIA PALLOTTA;L. GANDINI;FLAVIA LONGO;A.F. ATTILI;FEDERICO VENUTA;ERINO ANGELO RENDINA;G. ROSA;GIANLUCA IACOBELLIS;LISA FRANCHI;MARCO FALCONE;P.B. BERLOCO;EMANUELA CAROLI;MAURIZIO SALVATI;LUCA BERTINI;E POLETTINI;EMANUELE CASCIANI;GIAN FRANCO GUALDI;CECILIA NENCINI;R. PRETAGOSTINI;FRANCESCO VIOLI","1;1;1;1;0.84;0.77;0.71;0.67;0.67;0.64;0.55;0.51;0.51;0.51;0.51;0.51;0.51;0.5;0.46;0.44","ANDREA MINGOLI;A. RECHER;ANDREA SANSONETTI;CECILIA PONZANO;CRISTIANO HUSCHER;GIOVANNA SGARZINI;M. DI PAOLA;FRANCESCO VIOLI;FRIDA LEONETTI;GIANLUCA IACOBELLIS;CLAUDIO RONCO;GABRIELLA SALVATORI;GIUSEPPE D’AMICO;IRENE BOLGAN;MAURIZIO DAN;MONICA BONELLO;PASQUALE PICCINNI;ZACCARIA RICCI;PASQUALE PIGNATELLI;ANTONIO RAVIELE","873;841;841;841;841;841;841;351;346;346;303;303;303;303;303;303;303;303;302;274","ANDREA MINGOLI;GIANLUCA IACOBELLIS;FRANCESCO VIOLI;ZACCARIA RICCI;PASQUALE PIGNATELLI;LISA FRANCHI;STEFANO DI SANTO;MARIA GABRIELLA MAZZUCCONI;FEDERICO VENUTA;G. ROSA;ANTONELLA VERRIENTI;CLAUDIO TIBERTI;EMANUELA FILIPPI;ENRICO CORTESI;FEDERICA SENTINELLI;MARA FALLARINO;MARZIA FANELLI;STEFANO ROMEO;ADOLFO DE PASQUALE CERATTI;ALESSANDRO BRUNELLI","873;346;331;303;302;218;200;192;164;124;123;123;123;123;123;123;123;123;111;102","FEDERICO VENUTA;F. NUDO;G. ROSA;LUIGI NOVELLI;MASSIMO ROSSI;P.B. BERLOCO;ENRICO CORTESI;FRANCESCO PUGLIESE;FRANCESCO VIOLI;S. MARTELLI;GIORGIO F. COLONI;A TORRINI;ALBERTO SIGNORE;ALESSANDRO BUSSOTTI;ANDREA MINGOLI;ANGELO VISCIDO;C DANESE;CARMELA IMPERIALE;DAMIANO MAGRÌ;DANIELE DISO","5;4;4;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;ENGINEERING;PSYCHOLOGY;SOCIOLOGY;MATHEMATICS;GEOGRAPHY;MATERIALS SCIENCE;POLITICAL SCIENCE","107;33;15;7;6;5;4;3;2;1;1;1","INTERNAL MEDICINE;SURGERY;RADIOLOGY;ENDOCRINOLOGY;BIOCHEMISTRY;GASTROENTEROLOGY;PATHOLOGY;CARDIOLOGY;ANESTHESIA;CELL BIOLOGY;GENETICS;IMMUNOLOGY;ONCOLOGY;INTENSIVE CARE MEDICINE;GENERAL SURGERY;MOLECULAR BIOLOGY;OPTICS;PALEONTOLOGY;PHARMACOLOGY;CANCER RESEARCH;ENVIRONMENTAL HEALTH;MECHANICAL ENGINEERING;MICROBIOLOGY","77;42;21;20;19;18;18;13;11;11;8;8;8;7;5;5;5;5;5;4;4;4;4","CANCER;GENE;CHEMOTHERAPY;BLOOD PRESSURE;DISEASE;RECEPTOR;ENZYME;IN VITRO;INSULIN;ATRIAL FIBRILLATION;CARCINOMA;CONFIDENCE INTERVAL;MAGNETIC RESONANCE IMAGING;SIGNAL TRANSDUCTION;TRANSPLANTATION;ALTERNATIVE MEDICINE;BIOPSY;CLINICAL TRIAL;DIABETES MELLITUS;HORMONE;LAPAROSCOPY;PLATELET;POPULATION;VEIN","12;10;9;7;7;7;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4","HEART RATE;INSULIN RESISTANCE;BREAST CANCER;DIASTOLE;GENE EXPRESSION;GENOTYPE;MUTANT;PROSTATE;PROSTATE CANCER;PROTEIN KINASE A;ADRENOMEDULLIN;CELL CYCLE;CLINICAL ENDPOINT;COELIAC DISEASE;COLORECTAL CANCER;CROHN'S DISEASE;DEEP VEIN;DILATED CARDIOMYOPATHY;HEPATITIS B VIRUS;INFLIXIMAB;KIDNEY TRANSPLANTATION;LAPAROSCOPIC SURGERY;METASTASIS;MUTATION;PACLITAXEL;PNEUMONECTOMY;REMIFENTANIL;THROMBOXANE A2;TRACHEAL INTUBATION;VASCULAR SMOOTH MUSCLE;VASOVAGAL SYNCOPE","4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ADIPONECTIN;BREAST CARCINOMA;HBSAG;HEART RATE VARIABILITY;LAMIVUDINE;PROSTATITIS;SINGLE-NUCLEOTIDE POLYMORPHISM;TILT TABLE TEST;ABLATION OF ATRIAL FIBRILLATION;ADENOSQUAMOUS CARCINOMA;AUTONOMIC NERVOUS SYSTEM;BARORECEPTOR;BAROREFLEX;BASILIXIMAB;BRAIN METASTASIS;CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY;CLAVULANIC ACID;CORE BIOPSY;CYCLIN D1;CYCLIN-DEPENDENT KINASE;CYCLIN-DEPENDENT KINASE 2;DNA METHYLATION;DONOR SPECIFIC ANTIBODIES;EPIRUBICIN;FARNESYLTRANSFERASE;FETAL HEMOGLOBIN;FOLINIC ACID;FULMINANT HEPATIC FAILURE;GESTATIONAL DIABETES;HAPLOTYPE;IMATINIB MESYLATE;IN SITU HYBRIDIZATION;INTERLEUKIN 12;INTESTINAL CANCER;INTRACYTOPLASMIC SPERM INJECTION;KIDNEY TRANSPLANT;LARYNGOMALACIA;LEYDIG CELL;MATURITY ONSET DIABETES OF THE YOUNG;MECHANICAL INDEX;METASTATIC BREAST CANCER;METHYLTRANSFERASE;MISSENSE MUTATION;NEOINTIMA;NEOPLASTIC TRANSFORMATION;NEUROSPORA CRASSA;OSTEOCYTE;OSTEOPROTEGERIN;PANCREATIC ISLETS;PANEL REACTIVE ANTIBODY;PLATELET-DERIVED GROWTH FACTOR RECEPTOR;POLY ADP RIBOSE POLYMERASE;POLYCYSTIC OVARY;POPLITEAL VEIN;PRIMARY TUMOR;PROBAND;PROSTATECTOMY;RANKL;RECEPTOR ANTAGONIST;RESPONSE REGULATOR;SOCS2;SOCS3;SOCS6;SUPPRESSOR OF CYTOKINE SIGNALING 1;TAXANE;TESTICULAR VOLUME;TRICHODERMA REESEI;TUNABLE DIODE LASER ABSORPTION SPECTROSCOPY;UREA BREATH TEST;VANCOMYCIN","3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;MIDDLE AGED;ADULT;AGED;ADENOCARCINOMA;POSTOPERATIVE COMPLICATIONS;;TREATMENT OUTCOME;BREAST NEOPLASMS;GALLBLADDER NEOPLASMS;MAGNETIC RESONANCE IMAGING;CASE-CONTROL STUDIES;RETROSPECTIVE STUDIES;RNA, MESSENGER;TUMOR NECROSIS FACTOR-ALPHA;ADOLESCENT;ATRIAL FIBRILLATION;CARDIOMYOPATHY, DILATED","97;67;65;51;44;34;15;15;14;13;11;11;11;10;10;10;10;9;9;9","ATRIAL FIBRILLATION;CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER TREATMENT;CHOLANGIOCARCINOMA;ANALYSIS AND APPLICATIONS OF HEART RATE VARIABILITY;ANESTHESIA AND SEDATION MANAGEMENT;DIAGNOSIS AND MANAGEMENT OF BILIARY TRACT DISORDERS;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;DIAGNOSIS AND MANAGEMENT OF SYNCOPE;DIAGNOSIS AND TREATMENT OF GASTROINTESTINAL STROMAL TUMORS;DIAGNOSIS AND TREATMENT OF LUNG CANCER;HEPATITIS B INFECTION AND TREATMENT;INFLAMMATION AND OBESITY-RELATED METABOLIC DISORDERS;KIDNEY TRANSPLANTATION;MALE REPRODUCTIVE HEALTH;MANAGEMENT OF POSTOPERATIVE PAIN AND COMPLICATIONS;ROLE OF NEUROPEPTIDES IN PHYSIOLOGY AND DISEASE;ANTIPLATELET THERAPY IN CARDIOVASCULAR DISEASE;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;BREAST PATHOLOGY AND IMAGING TECHNIQUES","3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1","TREATMENT;HEART RATE VARIABILITY;DIAGNOSIS;REGIMEN;TRANSPLANTATION;ACUTE-ON-CHRONIC LIVER FAILURE;ADRENOMEDULLIN;ATRIAL FIBRILLATION;BREAST CARCINOMA;CELL CYCLE REGULATION;CHOLECYSTITIS;CLINICAL ENDPOINT;COMA (OPTICS);COMPLICATIONS;DEEP VEIN THROMBOSIS;DILATED CARDIOMYOPATHY;GALLBLADDER CANCER;HYPERTENSION;INSULIN SIGNALING;LIVER TRANSPLANTATION","5;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ATRIAL FIBRILLATION;DILATED CARDIOMYOPATHY;PATIENTS UNDERGOING;ARTERY DISEASE;COELIAC DISEASE;CORONARY ARTERY;CROHNS DISEASE;GENE EXPRESSION;HEART RATE;IDIOPATHIC DILATED;INTRACRANIAL SURGERY;PROSTATE CANCER;PULMONARY EMBOLISM;SPECTROSCOPIC IMAGING;SURGICAL TREATMENT;TUMOR NECROSIS;UNDERGOING CHEMOTHERAPY;ABDOMINAL AORTIC;ABDOMINAL CT;ACID SUPPLEMENTING;ACOUSTIC RHINOMETRY;ACUTE APPENDICITIS;ACUTE CORONARY;ACUTE HEPATIC;ACUTE LIVER;ACUTE PULMONARY;ACUTE RENAL;ADDITIVE PROGNOSTIC;ADENOSQUAMOUS CELL;ADEQUACY CALCULATOR","4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","GASTRIC EMPTYING;CHRONIC OBSTRUCTIVE;OBSTRUCTIVE PULMONARY;POSTOPERATIVE FEV;VARICOSE VEINS;ANTRAL VOLUME;OBESE SUBJECTS;PULMONARY DISEASE;DELAYED GASTRIC;FASTING ANTRAL;INHIBITOR DEVELOPMENT;LEYDIG CELL;PANCREATIC ISLETS;RANGE WEEKS;SUBTOTAL GASTRECTOMY;WEEKS RANGE;ADEQUACY CALCULATOR;ALT LEVELS;CELL TUMORS;DISEASE INDEX;FEVFVC SIGNIFICANTLY;GASTRIC CANCER;HEALTHY VEINS;HUMAN PANCREATIC;RENAL REPLACEMENT;SIGNIFICANTLY DECREASED;TESTICULAR VOLUME;TUMOR CELL;UNCOMPLICATED OBESE;ALT ACTIVITY","9;7;7;7;7;6;6;6;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;3",12,0.1,3.75,3,0,1,0,1,4,0,1,3,0,0,0,0,3,0,0,0,0,0,0,30,30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,6.5,469.75,1.29,2,0.5,52,0,0,1,0,3,0,0,0,0,4,0,0,0,0,0,0,0,4,0,0,4,0,0,0,0,0,0,0,0,0,"Italy;United States","2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","4;2;2;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HEMATOLOGY;RARE DISEASES;CANCER;CYSTIC FIBROSIS;DIABETES;LUNG;NUTRITION;PATIENT SAFETY;PREVENTION;REGENERATIVE MEDICINE;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - HUMAN;TRANSPLANTATION","4;4;2;2;1;1;1;1;1;1;1;1;1;1;1","CANCER;CONGENITAL","3;1","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.2 CELLULAR AND GENE THERAPIES;6.2 CELLULAR AND GENE THERAPIES;7.1 INDIVIDUAL CARE NEEDS","4;1;1;1;1","NON-HODGKIN'S LYMPHOMA;HODGKIN'S DISEASE;LEUKEMIA / LEUKAEMIA;MYELOMA;STOMACH CANCER","2;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","3",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_UMBERTOI",2006,139,7.16546762589928,2.94964028776978,0.697841726618705,0.37410071942446,0.733812949640288,1.32258064516129,1.1547619047619,1.18181818181818,1.17241379310345,0.165467625899281,5,52,34,19,26,0.37,0.24,0.14,0.19,29.08,0.569306134569882,NA,0.0935251798561151,0.525179856115108,0.444,0.285,0.352,0.282,"G. NAPODANO;R. SANSEVERINO;U. DI MAURO;GIANFRANCO GUALDI;O. INTILLA;ANTONIO RAVIELE;FLAVIA LONGO;SANTO MORABITO;T. REALFONSO;EMANUELE CASCIANI;GIOVANNI MANSUETO;C MODINI;GIUSEPPE CAVALLARO;GIORGIO DE TOMA;SAKIS THEMISTOCLAKIS;GIANFRANCO PICCIRILLO;DAMIANO MAGRÌ;A. BARELA;ALDO BONSO;ALESSANDRO PIERUCCI","7;7;6;6;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3","FLAVIA LONGO;GIOVANNI MANSUETO;GIANFRANCO GUALDI;SALVATORE CUCCHIARA;FRANCESCO VIOLI;G. NAPODANO;R. SANSEVERINO;EMANUELE CASCIANI;SANDRO MAZZAFERRO;PHILIPPA MUNGRA;DANILO TONI;CONSALVO MATTIA;U. DI MAURO;GIAN FRANCO GUALDI;O. INTILLA;R COROSU;CHIARA ANDREOLI;SANTO MORABITO;T. REALFONSO;V. SANTIEMMA","1.83;1.43;1.28;1.24;1.17;1.17;1.17;1.12;1;1;1;1;1;0.84;0.83;0.75;0.7;0.68;0.67;0.64","G. NAPODANO;R. SANSEVERINO;U. DI MAURO;GIANFRANCO GUALDI;O. INTILLA;ANTONIO RAVIELE;FLAVIA LONGO;SANTO MORABITO;T. REALFONSO;EMANUELE CASCIANI;C MODINI;GIUSEPPE CAVALLARO;GIORGIO DE TOMA;SAKIS THEMISTOCLAKIS;GIANFRANCO PICCIRILLO;DAMIANO MAGRÌ;A. BARELA;ALDO BONSO;MARZIA MAGNANTI;ISABELLA GUZZO","7;7;6;6;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","FLAVIA LONGO;GIANFRANCO GUALDI;SALVATORE CUCCHIARA;FRANCESCO VIOLI;G. NAPODANO;R. SANSEVERINO;EMANUELE CASCIANI;SANDRO MAZZAFERRO;PHILIPPA MUNGRA;DANILO TONI;CONSALVO MATTIA;U. DI MAURO;GIAN FRANCO GUALDI;O. INTILLA;R COROSU;CHIARA ANDREOLI;SANTO MORABITO;T. REALFONSO;V. SANTIEMMA;FÁBIO ROSSI","1.83;1.28;1.24;1.17;1.17;1.17;1.12;1;1;1;1;1;0.84;0.83;0.75;0.7;0.68;0.67;0.64;0.64","SALVATORE CUCCHIARA;F. CHIARINI;I ZAMBONI;JOHN OSBORN;L SEGANTI;M. PENTA;MARIA PIA CONTE;OSVALDO BORRELLI;P. FALCONIERI;SERENA SCHIPPA;ANTONIO RAVIELE;ALDO BONSO;ANDREA NATALE;ROBERT A. SCHWEIKERT;SAKIS THEMISTOCLAKIS;P PIETROPAOLI;JENNIFER E. CUMMINGS;A TORRINI;DAMIANO MAGRÌ;GIANFRANCO GUALDI","373;372;372;372;372;372;372;372;372;372;266;265;265;265;265;244;242;238;238;238","F. CHIARINI;I ZAMBONI;JOHN OSBORN;L SEGANTI;M. PENTA;MARIA PIA CONTE;OSVALDO BORRELLI;P. FALCONIERI;SERENA SCHIPPA;ANTONIO RAVIELE;ALDO BONSO;SAKIS THEMISTOCLAKIS;P PIETROPAOLI;A TORRINI;DAMIANO MAGRÌ;GIANFRANCO PICCIRILLO;MARZIA MAGNANTI;SABRINA MATERA;SILVIA MIGLIACCIO;RAFFAELE QUAGLIONE","372;372;372;372;372;372;372;372;372;266;265;265;244;238;238;238;238;238;190;184","ANTONIO RAVIELE;FLAVIA LONGO;GIANFRANCO GUALDI;A TORRINI;ALDO BONSO;ALFONSO MARIA D’ARCO;DAMIANO MAGRÌ;GIANFRANCO PICCIRILLO;MARZIA MAGNANTI;SABRINA MATERA;SAKIS THEMISTOCLAKIS;CORA BERTONE;FÁBIO ROSSI;V. SANTIEMMA;A FORTE;ANDREA LENZI;ANTONIO ROSSILLO;CATELLO CALIFANO;CHIARA ANDREOLI;EMANUELE CASCIANI","4;4;4;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2","MEDICINE;BIOLOGY;PHYSICS;ENGINEERING;COMPUTER SCIENCE;CHEMISTRY;PSYCHOLOGY;POLITICAL SCIENCE;PHILOSOPHY;MATHEMATICS;ART;GEOGRAPHY;BUSINESS;ECONOMICS;ENVIRONMENTAL SCIENCE;HISTORY;MATERIALS SCIENCE","135;25;15;10;9;8;8;6;5;4;3;2;1;1;1;1;1","INTERNAL MEDICINE;SURGERY;RADIOLOGY;PATHOLOGY;CARDIOLOGY;GASTROENTEROLOGY;GENETICS;PSYCHIATRY;IMMUNOLOGY;ENDOCRINOLOGY;INTENSIVE CARE MEDICINE;ONCOLOGY;ANESTHESIA;BIOCHEMISTRY;GENERAL SURGERY;OPTICS;UROLOGY;GYNECOLOGY;LAW;ENVIRONMENTAL HEALTH;MECHANICAL ENGINEERING;MICROBIOLOGY;VIROLOGY","92;51;31;24;16;15;14;13;11;10;10;9;8;8;8;7;7;6;6;5;5;5;5","CANCER;DISEASE;COMPLICATION;CHEMOTHERAPY;MAGNETIC RESONANCE IMAGING;HEART FAILURE;LESION;RADIATION THERAPY;CARCINOMA;GENE;RECEPTOR;INCIDENCE (GEOMETRY);LAPAROSCOPY;PATHOLOGICAL;PREGNANCY;EMERGENCY DEPARTMENT;GALLBLADDER;KIDNEY;MYOCARDIAL INFARCTION;POPULATION;STENT;STROKE (ENGINE)","23;14;11;9;8;7;7;7;6;6;6;5;5;5;5;4;4;4;4;4;4;4","BREAST CANCER;PROSTATE CANCER;COLORECTAL CANCER;PROSTATE;EJECTION FRACTION;NEURORADIOLOGY;SPLENECTOMY;ACUTE CHOLECYSTITIS;ANGIOTENSIN II;CATHETER ABLATION;CHOLECYSTITIS;CYCLOPHOSPHAMIDE;GESTATION;IMATINIB;ISCHEMIC STROKE;NEPHRECTOMY;OPIOID;OVARIAN CANCER;PERCUTANEOUS CORONARY INTERVENTION;PI3K/AKT/MTOR PATHWAY;PLACEBO;PROTEIN KINASE B;PULMONARY VEIN;RESTENOSIS;STROMAL TUMOR;ULCERATIVE COLITIS","5;5;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ESTROGEN RECEPTOR;IMATINIB MESYLATE;OXYCODONE;PROSTATECTOMY;ABDOMINOPERINEAL RESECTION;AXILLA;BACTERIAL ADHESIN;BMPR2;BONE MORPHOGENETIC PROTEIN 7;BONE MORPHOGENETIC PROTEIN RECEPTOR;BRAIN METASTASIS;CARBOPLATIN;CARDIAC RESYNCHRONIZATION THERAPY;CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING;CLINICAL GLOBAL IMPRESSION;COLONOSCOPY;CONSENSUS SEQUENCE;CONTINUOUS GLUCOSE MONITORING;CYSTIC HYGROMA;DASATINIB;DEEP BRAIN STIMULATION;DIGITAL IMAGE PROCESSING;ERLOTINIB;ESOPHAGEAL MOTILITY DISORDER;EXTERNAL BEAM RADIOTHERAPY;FACTOR V LEIDEN;FLUDARABINE;FOCAL SEGMENTAL GLOMERULOSCLEROSIS;GERMLINE MUTATION;GROWTH HORMONE SECRETAGOGUE RECEPTOR;HEART RATE VARIABILITY;HPV INFECTION;HYPERALGESIA;IMPAIRED GLUCOSE TOLERANCE;INJURY SEVERITY SCORE;KILLIP CLASS;LACUNAR STROKE;LEISHMANIA INFANTUM;LEUKAPHERESIS;LIVING DONOR LIVER TRANSPLANTATION;MALE INFERTILITY;MAMMOGRAPHY;MEGLUMINE ANTIMONIATE;MEMBRANOUS NEPHROPATHY;MICROCOCCACEAE;MISSENSE MUTATION;MYOEPITHELIOMA;NEOINTIMA;NEOINTIMAL HYPERPLASIA;NICOTINE GUM;NICOTINE PATCH;NILOTINIB;OPPORTUNISTIC INFECTION;OSTEONECROSIS OF THE JAW;OSTEOPENIA;PAPILLOMAVIRIDAE;PARATHYROID NEOPLASM;PATHOGENIC ESCHERICHIA COLI;PLACENTAL ABRUPTION;PNEUMOCYSTIS PNEUMONIA;PROBAND;PROMOTER;PROTEIN S DEFICIENCY;REFRACTORY ANEMIA;RENAL MASS;REPORTER GENE;SEMEN ANALYSIS;SEVERE SEPSIS;SIDA;SPLENIC DISEASE;TRANSURETHRAL RESECTION OF THE PROSTATE;VANCOMYCIN","2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;ADULT;MIDDLE AGED;AGED;;TREATMENT OUTCOME;FOLLOW-UP STUDIES;ADOLESCENT;HEART FAILURE;AGED, 80 AND OVER;ITALY;MAGNETIC RESONANCE IMAGING;POSTOPERATIVE COMPLICATIONS;BREAST NEOPLASMS;COLORECTAL NEOPLASMS;RETROSPECTIVE STUDIES;ANTINEOPLASTIC AGENTS;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS","109;67;66;46;40;38;28;22;17;14;14;12;12;12;11;10;10;10;9;9",";GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;DIAGNOSIS AND MANAGEMENT OF BILIARY TRACT DISORDERS;MANAGEMENT OF SPLEEN TRAUMA IN POLYTRAUMA PATIENTS;ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;BOTULINUM TOXIN IN NEUROLOGY AND MEDICINE;CATHETER ABLATION OF CARDIAC ARRHYTHMIAS;DIAGNOSIS AND MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE;DIAGNOSIS AND TREATMENT OF GASTROINTESTINAL STROMAL TUMORS;DIAGNOSIS AND TREATMENT OF HEART FAILURE;EPIDEMIOLOGY AND MANAGEMENT OF MAXILLOFACIAL TRAUMA;EPIDEMIOLOGY AND MANAGEMENT OF STROKE;GLOBAL TRENDS IN COLORECTAL CANCER RESEARCH;HERPESVIRUSES: EPIDEMIOLOGY, PATHOGENESIS, AND MANAGEMENT;LIVER CIRRHOSIS AND ASSOCIATED COMPLICATIONS;MALE CIRCUMCISION FOR HIV PREVENTION AND PENILE HEALTH;MECHANISMS OF ESTROGEN RECEPTOR SIGNALING","4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","TREATMENT;STROKE (ENGINE);CHEMOTHERAPY;CHOLECYSTITIS;ENDOSCOPIC STENTING;ETIOLOGY;NEURORADIOLOGY;REFRACTORY (PLANETARY SCIENCE);RENAL REPLACEMENT THERAPY;;ARRHYTHMIA DETECTION;ATRIAL FIBRILLATION;BONE METASTASIS;CARDIAC RESYNCHRONIZATION THERAPY;CATHETER ABLATION;COLONOSCOPY;DOUBLE-BALLOON ENTEROSCOPY;DYNAMIC CONTRAST-ENHANCED MRI;ECHOCARDIOGRAPHY;FUNCTIONAL MRI","9;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2","HEART FAILURE;ATRIAL FIBRILLATION;BOTULINUM TOXIN;CATHETER ABLATION;CHRONIC HEART;CONTINUOUS RENAL;HUMAN AORTIC;LEFT VENTRICULAR;MAGNETIC RESONANCE;MRI FINDINGS;OVARIAN CANCER;PATIENTS SUFFERING;PATIENTS UNDERGOING;PROGNOSTIC SIGNIFICANCE;PROSTATE CANCER;QT VARIABILITY;RENAL REPLACEMENT;TOXIN TYPE;ABDOMINAL SURGERY;ABSCESS RADIOLOGICAL;ACCELERATED PHASE;ACOUSTIC UHTHOFF-LIKE;ACUMINATUM BUSCHKE-LÖWENSTEIN;ACUTE CHOLECYSTITIS;ACUTE MYELOID;ACUTE MYOCARDIAL;ACUTE PHASE;ACUTE RENAL;ACUTE SEMPLICI;ACUTE ZOSTER","3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","PUBMED SCOPUS;CROSSREF PUBMED;MLMINUTE IQR;SUDDEN DEATH;THROMBIN GENERATION;CLOTTING ACTIVATION;LC PATIENTS;PORTAL CIRCULATION;CHRONIC LIVER;GASTROINTESTINAL BLEEDING;INTRAVASCULAR COAGULATION;LF POWER;LIPOSOMAL DOXORUBICIN;OVARIAN CANCER;PEGYLATED LIPOSOMAL;PERIPHERAL CIRCULATION;SPERM PARAMETERS;ABNORMAL HEMOSTASIS;BIOPSY SPECIMENS;CIRRHOSISGASTROENTEROLOGY -ABSTRACT;CLOTTING FACTORS;CSII TREATMENT;DISSEMINATED INTRAVASCULAR;DONORS WEIGHING;ECG RECORDING;FACTORS INCLUDE;HAEMOST -ABSTRACT;HEMOSTASIS TESTS;HR CI;INCREASED RISK","15;8;8;6;6;5;5;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3",9,0.06,6,5,0,0,0,1,6.25,0,1,5,0,0,1,0,2,0,0,1,0,0,0,51,51,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,3,613.25,1.66,1,0.2,81,0,0,1,1,2,0,1,0,0,4,0,0,0,0,0,0,0,4,1,0,4,1,0,0,0,0,0,0,0,0,"Italy;Japan;United Kingdom;United States","1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3202 CLINICAL SCIENCES;3204 IMMUNOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","5;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PATIENT SAFETY;PREVENTION;AGING;ASSISTIVE TECHNOLOGY;AUTOIMMUNE DISEASE;BIOENGINEERING;BRAIN DISORDERS;CANCER;DIGESTIVE DISEASES;IMMUNIZATION;LIVER DISEASE;LUPUS;MIND AND BODY;NEURODEGENERATIVE;NEUROSCIENCES;OVARIAN CANCER;PARKINSON'S DISEASE;RARE DISEASES","4;4;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;CARDIOVASCULAR;INFLAMMATORY AND IMMUNE SYSTEM;NEUROLOGICAL","1;1;1;1","6.1 PHARMACEUTICALS","3","OVARIAN CANCER","1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_UMBERTOI",2007,139,8.02877697841727,3.86330935251798,0.733812949640288,0.474820143884892,0.741007194244604,1.34924623115578,1.21428571428571,1.24528301886792,1.22619047619048,0.20863309352518,1,52,37,20,26,0.37,0.27,0.14,0.19,44.24,0.838347201606629,NA,0.172661870503597,0.640287769784173,0.35,0.282,0.312,0.285,"GIUSEPPE CAVALLARO;VINCENZO MARIGLIANO;E POLETTINI;FRANCESCO FEDELE;GENNARO SARDELLA;C MODINI;P.B. BERLOCO;GIORGIO DE TOMA;GIANFRANCO GUALDI;ANDREA POLISTENA;MAURO CACCIAFESTA;MASSIMO MANCONE;P. CICCONETTI;G. NAPODANO;R. SANSEVERINO;GUIDO VALESINI;GIORGIO IANNETTI;U. DI MAURO;ALDO BARATTA;LAURA TAFARO","5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3","ANTONIO MINNI;C MODINI;E POLETTINI;GIORGIO IANNETTI;GIUSEPPE CAVALLARO;G. NAPODANO;R. SANSEVERINO;FRANCESCO FEDELE;GENNARO SARDELLA;GUIDO VALESINI;GIANFRANCO GUALDI;P PIETROPAOLI;VINCENZO MARIGLIANO;A MELONE;GIORGIO DE TOMA;ANDREA POLISTENA;MASSIMO MANCONE;U. DI MAURO;EMANUELE LEZOCHE;ALESSANDRO M. PAGANINI","1;0.98;0.95;0.77;0.7;0.67;0.67;0.65;0.65;0.63;0.61;0.57;0.55;0.54;0.53;0.53;0.53;0.5;0.5;0.5","GIUSEPPE CAVALLARO;VINCENZO MARIGLIANO;E POLETTINI;FRANCESCO FEDELE;GENNARO SARDELLA;C MODINI;P.B. BERLOCO;GIORGIO DE TOMA;GIANFRANCO GUALDI;ANDREA POLISTENA;MAURO CACCIAFESTA;MASSIMO MANCONE;P. CICCONETTI;G. NAPODANO;R. SANSEVERINO;GUIDO VALESINI;GIORGIO IANNETTI;U. DI MAURO;ALDO BARATTA;LAURA TAFARO","5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3","ANTONIO MINNI;C MODINI;E POLETTINI;GIORGIO IANNETTI;GIUSEPPE CAVALLARO;G. NAPODANO;R. SANSEVERINO;FRANCESCO FEDELE;GENNARO SARDELLA;GUIDO VALESINI;GIANFRANCO GUALDI;P PIETROPAOLI;VINCENZO MARIGLIANO;GIORGIO DE TOMA;ANDREA POLISTENA;MASSIMO MANCONE;U. DI MAURO;EMANUELE LEZOCHE;ALESSANDRO M. PAGANINI;FLAVIA LONGO","1;0.98;0.95;0.77;0.7;0.67;0.67;0.65;0.65;0.63;0.61;0.57;0.55;0.53;0.53;0.53;0.5;0.5;0.5;0.5","GIULIANA ALIMENA;AARON WEITZMAN;FRANCIS J. GILES;HAGOP M. KANTARJIAN;KAPIL N. BHALLA;PHILIPP LE COUTRE;ANDREAS HOCHHAUS;DEBRA RESTA;FRANCESCA PALANDRI;FRANCISCO CERVANTES;FRANCK-EMMANUEL NICOLINI;GERT J. OSSENKOPPELE;MARK R. LITZOW;MD ARIFUL HAQUE;NORBERT GATTERMANN;RAVI BHATIA;STEPHEN G. O’BRIEN;YAPING SHOU;ANDREW P. LANDSTROM;ANGELO SELICORNI","782;759;759;759;759;759;744;744;744;744;744;744;744;744;744;744;744;744;656;656","GIULIANA ALIMENA;BRUNO MARINO;ANTONIO RAVIELE;SAKIS THEMISTOCLAKIS;ENRICO CORTESI;ILARIA STOLFI;ROBERTO PEDICINO;ALBERTO SOBRERO;ANDREA SARTORE‐BIANCHI;CARLO BARONE;CARLO CARNAGHI;EMILIO BAJETTA;GABRIELE LUPPI;GIUSEPPE COLUCCI;MARCELLO GAMBACORTA;MAURO MORONI;MICHELE NICHELATTI;SALVATORE SIENA;SILVIO VERONESE;STEFANO CASCINU","782;656;410;410;357;337;337;321;321;321;321;321;321;321;321;321;321;321;321;321","GENNARO SARDELLA;MASSIMO MANCONE;VINCENZO MARIGLIANO;FRANCESCO FEDELE;G. NAPODANO;MAURO CACCIAFESTA;P. CICCONETTI;P.B. BERLOCO;R. SANSEVERINO;GIORGIO IANNETTI;GIUSEPPE CAVALLARO;SARA SAVELLI;ENRICO CORTESI;GIANFRANCO GUALDI;P PIETROPAOLI;RICCARDO COLANTONIO;ROBERTO PASSARIELLO;VITO CANTISANI;ALDO BARATTA;LAURA TAFARO","6;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;COMPUTER SCIENCE;ENGINEERING;PSYCHOLOGY;PHILOSOPHY;MATHEMATICS;ECONOMICS;MATERIALS SCIENCE;POLITICAL SCIENCE;ENVIRONMENTAL SCIENCE;SOCIOLOGY","130;30;14;11;10;7;6;5;4;2;2;2;1;1","INTERNAL MEDICINE;SURGERY;RADIOLOGY;PATHOLOGY;GASTROENTEROLOGY;GENETICS;IMMUNOLOGY;BIOCHEMISTRY;CARDIOLOGY;GENERAL SURGERY;ANESTHESIA;ENDOCRINOLOGY;ENVIRONMENTAL HEALTH;ONCOLOGY;UROLOGY;NUCLEAR MEDICINE;OPTICS;PSYCHIATRY;ANATOMY;INTENSIVE CARE MEDICINE;PEDIATRICS","95;49;24;20;17;17;15;13;12;12;10;10;10;10;9;7;7;7;5;5;5","CANCER;DISEASE;GENE;POPULATION;MYOCARDIAL INFARCTION;TRANSPLANTATION;ALTERNATIVE MEDICINE;MAGNETIC RESONANCE IMAGING;ANTIBODY;CHEMOTHERAPY;PREGNANCY;RANDOMIZED CONTROLLED TRIAL;BLOOD PRESSURE;IMMUNOHISTOCHEMISTRY;INFLAMMATION;URINARY SYSTEM;ABDOMINAL SURGERY;ADVERSE EFFECT;ASYMPTOMATIC;CARCINOMA;HORMONE;IN VITRO;INCIDENCE (GEOMETRY);LAPAROSCOPY;OSTEOPOROSIS;PROSPECTIVE COHORT STUDY;RECEPTOR;THROMBOSIS;TOXICITY;TUMOR NECROSIS FACTOR ALPHA;ULTRASOUND","27;15;14;10;8;8;7;7;6;6;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4","COLORECTAL CANCER;BREAST CANCER;CONVENTIONAL PCI;LIVER TRANSPLANTATION;PERCUTANEOUS CORONARY INTERVENTION;PROINFLAMMATORY CYTOKINE;PROSTATE CANCER;BISPHOSPHONATE;BLADDER CANCER;PARATHYROID HORMONE;PROSTATE;STAPHYLOCOCCUS AUREUS;TRANSCRIPTION FACTOR;ADENOCARCINOMA;ANTRUM;AUTOANTIBODY;AUTOIMMUNE DISEASE;AVASCULAR NECROSIS;CHRONIC MYELOGENOUS LEUKEMIA;CLINICAL ENDPOINT;COLORECTAL SURGERY;CORONARY FLOW RESERVE;CROHN'S DISEASE;DIASTOLE;EJECTION FRACTION;EMBRYO TRANSFER;EPIDERMAL GROWTH FACTOR RECEPTOR;ETANERCEPT;FETUS;FLUCONAZOLE;GASTRECTOMY;GENE EXPRESSION;GROWTH HORMONE;HAZARD RATIO;IMATINIB;IMMUNOGLOBULIN E;IN VITRO FERTILISATION;INFLIXIMAB;INSEMINATION;INTERSTITIAL CELL OF CAJAL;LAPAROSCOPIC SURGERY;METASTASIS;MUTATION;NEURALGIA;NEURORADIOLOGY;OSTEOBLAST;OZONE THERAPY;PACLITAXEL;PLACEBO;PORTAL HYPERTENSION;PREGNANCY RATE;PSORIATIC ARTHRITIS;PYLORUS;REPRODUCTIVE MEDICINE;STRESS ECHOCARDIOGRAPHY;THYROID CARCINOMA;THYROIDITIS","7;6;5;5;5;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","COLONOSCOPY;TIMI;AUTOIMMUNE THYROIDITIS;CYSTECTOMY;EMBRYO QUALITY;IMATINIB MESYLATE;KRAS;NILOTINIB;OSTEONECROSIS OF THE JAW;PROSTATE-SPECIFIC ANTIGEN;PROSTATECTOMY;VANCOMYCIN;ACROMEGALY;ANEUPLOIDY;ANTI-NUCLEAR ANTIBODY;ANTIANDROGEN;AXILLA;BASDAI;BOND STRENGTH;BONE DENSITY CONSERVATION AGENTS;BREAST DISEASE;BREAST SURGERY;CARBOPLATIN;CD23;CD40;CENTRAL SENSITIZATION;CHEMOIMMUNOTHERAPY;CHILD ABUSE;COLOANAL ANASTOMOSIS;COMET ASSAY;COPY-NUMBER VARIATION;CORDECTOMY;CORTICOTROPIC CELL;DASATINIB;DIFFUSION IMAGING;DOPPLER ECHOCARDIOGRAPHY;DOPPLER IMAGING;ELECTROPHORETIC MOBILITY SHIFT ASSAY;ENDOGLIN;ENDOMYSIUM;FETAL HEMOGLOBIN;FIBROADENOMA;GASTRIC ANTRUM;GEFITINIB;GERIATRIC DEPRESSION SCALE;GERMLINE MUTATION;HAEMOPHILIA B;HAPLOTYPE;HYPERALGESIA;IMMUNOGLOBULIN D;INTERNATIONAL PROGNOSTIC INDEX;KNEE PAIN;MEAN ARTERIAL PRESSURE;MECHANICAL INDEX;MEDULLARY CARCINOMA;METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS;MINI–MENTAL STATE EXAMINATION;MISSENSE MUTATION;MULTICENTER TRIAL;NOD2;NONALCOHOLIC FATTY LIVER DISEASE;OCCIPITAL NEURALGIA;OPPORTUNISTIC INFECTION;OSTEOCYTE;OSTEOPENIA;OSTEOPROTEGERIN;PAPILLARY CARCINOMA;PARATHYROIDECTOMY;PEAK INSPIRATORY PRESSURE;PHILADELPHIA CHROMOSOME;PLACENTA;PLACENTAL ABRUPTION;POINT MUTATION;PORTOSYSTEMIC SHUNT;PRENATAL DIAGNOSIS;PROBAND;PROCTOCOLECTOMY;PROMOTER;PROSTATE BIOPSY;PYOGENIC LIVER ABSCESS;RADIOIMMUNOTHERAPY;RANKL;RECTAL EXAMINATION;RHODOCOCCUS EQUI;RIBAVIRIN;SCLERODACTYLY;SCLEROSTIN;SECONDARY HYPERPARATHYROIDISM;SINGLE EMBRYO TRANSFER;STAPHYLOCOCCAL INFECTIONS;STAPHYLOCOCCUS;TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT;TRANSRECTAL ULTRASONOGRAPHY;TRANSSPHENOIDAL SURGERY;TRANSURETHRAL RESECTION OF THE PROSTATE","3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;MIDDLE AGED;ADULT;AGED;;TREATMENT OUTCOME;AGED, 80 AND OVER;ADOLESCENT;ANTIBODIES, MONOCLONAL;PROSTATIC NEOPLASMS;ANTINEOPLASTIC AGENTS;COLORECTAL NEOPLASMS;POSTOPERATIVE COMPLICATIONS;ADENOMA;BETA-THALASSEMIA;COLONIC NEOPLASMS;CORONARY THROMBOSIS;ITALY","112;76;72;57;47;46;25;19;14;12;12;12;11;11;11;10;10;10;10;10","ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;ANESTHESIA AND SEDATION MANAGEMENT;BREAST PATHOLOGY AND IMAGING TECHNIQUES;CLASSIFICATION AND TREATMENT OF SPONDYLOARTHRITIS;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;DIAGNOSIS AND MANAGEMENT OF BILIARY TRACT DISORDERS;DIAGNOSIS AND MANAGEMENT OF PITUITARY DISORDERS;DIAGNOSIS AND TREATMENT OF BLADDER CANCER;DIAGNOSIS AND TREATMENT OF GASTROINTESTINAL STROMAL TUMORS;DIAGNOSIS AND TREATMENT OF LUNG CANCER;EFFICACY AND RESISTANCE IN CML TREATMENT;ETHICAL AND MEDICAL ASPECTS OF ORGAN DONATION;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;HEPATOCELLULAR CARCINOMA;HERNIA REPAIR TECHNIQUES AND MATERIALS;INTUSSUSCEPTION AND MECKEL'S DIVERTICULUM;LIVER TRANSPLANTATION AND GRAFT SURVIVAL ANALYSIS","5;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CARDIAC IMAGING;CARDIOVASCULAR RISK ASSESSMENT;METASTATIC GASTRIC CANCER;PROINFLAMMATORY CYTOKINE;TREATMENT;BONE REMODELING;CARDIAC ELECTROPHYSIOLOGY;ETIOLOGY;HERNIA REPAIR;MYOCARDIAL PERFUSION;PARATHYROID HORMONE;PROSTATE CANCER;RADIOTHERAPY;TIMI;TOTAL MESORECTAL EXCISION;ANKYLOSING SPONDYLITIS;AUTOIMMUNE THYROIDITIS;AVASCULAR NECROSIS;BILIARY COMPLICATIONS;BONE RESORPTION","5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2","LIVER TRANSPLANTATION;NECROSIS FACTOR;PARATHYROID HORMONE;PATIENTS UNDERGOING;PROSTATE CANCER;ADVERSE PREGNANCY;ANKYLOSING SPONDYLITIS;CHRONIC MYELOGENOUS;CHRONIC PHASE;CORONARY FLOW;DIPYRIDAMOLE STRESS;DIVERSION ROME;FLOW RESERVE;GROWTH FACTOR;INDUCTION THERAPY;IVF OUTCOME;LUNG CANCER;MYELOGENOUS LEUKEMIA;MYOCARDIAL BLUSH;MYOCARDIAL INFARCTION;NUCHAL TRANSLUCENCY;NUTRITIONAL STATUS;OZONE THERAPY;PATIENTS TREATED;PHASE II;PREGNANCY OUTCOME;RAT BONE;RISK FACTORS;ROME POUCH;TUMOR NECROSIS","4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","VARICOSE VEINS;SD VERSUS;VERSUS SD;DELLO SHUNT;EMBRYO TRANSFER;GT NGML;ACTIVE DISEASE;BAX GENE;CELLS SD;CGA LEVELS;CHROMOSOME POLYSOMY;CROHNS DISEASE;DISEASE STATUS;EGFR GCN;GRADE GRADE;GT BU;LIFE EXPECTANCY;POSITIVE CELLS;PRIMARY VARICOSE;PROGRESSION-FREE SURVIVAL;PSA PROGRESSION;RISK FACTORS;TNFΑ ANTAGONIST;BCR-ABL MUTATIONS;BINDING ACTIVITY;CHRONIC DISEASES;CLINICAL RESPONSE;CONTINUOUS VENOVENOUS;DELIVERED DOSE;ENDOTHELIAL FUNCTION","8;6;6;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3",18,0.13,5.31,3.75,2,0,0,1,4.5,0,1,3.75,0,1,1,0,4,1,1,1,0,0,0,81,81.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7,4.83,1036.83,1.84,2,0.29,52.29,0,0,0,0,6,0,0,1,0,6,0,0,0,0,0,0,0,7,0,0,6,1,0,0,0,0,0,0,0,0,"Italy;United States","2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3009 VETERINARY SCIENCES","7;6;2;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;BRAIN DISORDERS;NEUROSCIENCES;CANCER;DIGESTIVE DISEASES;NEURODEGENERATIVE;PATIENT SAFETY;CARDIOVASCULAR;CHRONIC LIVER DISEASE AND CIRRHOSIS;COLO-RECTAL CANCER;COMPARATIVE EFFECTIVENESS RESEARCH;EPILEPSY;HEMATOLOGY;HEPATITIS;HEPATITIS - B;INFECTIOUS DISEASES;LIVER DISEASE;LUNG;LUNG CANCER","6;6;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;INFECTION;NEUROLOGICAL","2;1;1","6.1 PHARMACEUTICALS","7","COLON AND RECTAL CANCER;LIVER CANCER;LUNG CANCER;MYELOMA","1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","4",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_UMBERTOI",2008,170,8.02941176470588,3.22941176470588,0.658823529411765,0.411764705882353,0.670588235294118,1.2737819025522,1.19148936170213,1.12903225806452,1.2,0.211764705882353,2,68,37,21,27,0.4,0.22,0.12,0.16,37.02,0.674726940189612,NA,0.182352941176471,0.647058823529412,0.353,0.33,0.31,0.329,"E POLETTINI;LAURA BALLESIO;G. NAPODANO;R. SANSEVERINO;C MODINI;U. DI MAURO;EMANUELE CASCIANI;NICOLA BASSO;LUCIANO IZZO;LUCIA MANGANARO;SARA SAVELLI;P.B. BERLOCO;IRENE FLORIANI;GABRIELE MASSELLI;GIANFRANÇO SILECCHIA;PIERFRANCESCO DI CELLO;A. CAMPITELLI;O. INTILLA;VITTORIO PASTA;ANTONIO RAVIELE","6;6;6;6;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;3","NICOLA BASSO;FLAVIA LONGO;G. NAPODANO;R. SANSEVERINO;MARIA ROSARIA CARDILLO;E POLETTINI;U. DI MAURO;LAURA BALLESIO;EMANUELE CASCIANI;VALERIA PANEBIANCO;ROBERTO PASSARIELLO;LUCIANO IZZO;A. CAMPITELLI;O. INTILLA;MAURIZIO SALVATI;LUCIA MANGANARO;SARA SAVELLI;GABRIELE MASSELLI;A MATURO;C MODINI","1.57;1.07;1.01;1.01;1;0.93;0.81;0.78;0.76;0.75;0.75;0.69;0.68;0.67;0.64;0.64;0.64;0.64;0.61;0.59","E POLETTINI;LAURA BALLESIO;G. NAPODANO;R. SANSEVERINO;C MODINI;U. DI MAURO;EMANUELE CASCIANI;NICOLA BASSO;LUCIANO IZZO;LUCIA MANGANARO;SARA SAVELLI;P.B. BERLOCO;IRENE FLORIANI;GABRIELE MASSELLI;GIANFRANÇO SILECCHIA;PIERFRANCESCO DI CELLO;A. CAMPITELLI;O. INTILLA;VITTORIO PASTA;ANTONIO RAVIELE","6;6;6;6;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;3","NICOLA BASSO;FLAVIA LONGO;G. NAPODANO;R. SANSEVERINO;MARIA ROSARIA CARDILLO;E POLETTINI;U. DI MAURO;LAURA BALLESIO;EMANUELE CASCIANI;VALERIA PANEBIANCO;ROBERTO PASSARIELLO;LUCIANO IZZO;A. CAMPITELLI;O. INTILLA;LUCIA MANGANARO;SARA SAVELLI;GABRIELE MASSELLI;C MODINI;VITTORIO PASTA;MARIO VENDITTI","1.57;1.07;1.01;1.01;1;0.93;0.81;0.78;0.76;0.75;0.75;0.69;0.68;0.67;0.64;0.64;0.64;0.59;0.56;0.56","MASSIMO ROSSI;ALEJANDRO FORNER;ANDREW K. BURROUGHS;BART VAN HOEK;FEDJA A. ROCHLING;GIAN LUCA GRAZI;GIORGIO ENRICO GERUNDA;I. BOIN;JACQUES BELGHITI;JAN LERUT;JEAN GUGENHEIM;JORDI BRUIX;JOSEP M. LLOVET;LUCIANO DE CARLIS;LUIGI MARIANI;MARCELLO SCHIAVO;MAURO SALIZZONI;MYRON SCHWARTZ;P. NEUHAUS;PIETRO MAJNO","1836;1817;1817;1817;1817;1817;1817;1817;1817;1817;1817;1817;1817;1817;1817;1817;1817;1817;1817;1817","MASSIMO ROSSI;GIANFRANÇO SILECCHIA;E POLETTINI;GABRIELE MASSELLI;FRANCESCO VIOLI;PASQUALE PIGNATELLI;ANGELO DI GIORGIO;ANTONIO CIARDI;DANIELE BIACCHI;E NATICCHIONI;FABIO ACCARPIO;MARISA DI SERI;MONICA ROCCO;PAOLO SAMMARTINO;SERGIO TARQUINI;SIMONE SIBIO;GIAN FRANCO GUALDI;NICOLA BASSO;ANDREA LENZI;ENRICO CORTESI","1836;466;279;279;237;237;228;228;228;228;228;228;228;228;228;228;226;204;186;186","G. NAPODANO;R. SANSEVERINO;A. CAMPITELLI;GIANFRANÇO SILECCHIA;MARIA TERESA PETRUCCI;NICOLA BASSO;P.B. BERLOCO;ALDO BONSO;ANDREA CORRADO;ANTONIO RAVIELE;ANTONIO ROSSILLO;SAKIS THEMISTOCLAKIS;E POLETTINI;EMANUELE CASCIANI;ENRICO CORTESI;GABRIELE MASSELLI;GENNARO SARDELLA;LAURA BALLESIO;LUCIANO IZZO;MASSIMO ROSSI","6;6;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;MATERIALS SCIENCE;PSYCHOLOGY;ENGINEERING;MATHEMATICS;SOCIOLOGY;ART;BUSINESS;COMPUTER SCIENCE;PHILOSOPHY;ECONOMICS;ENVIRONMENTAL SCIENCE;GEOLOGY","163;34;23;13;5;5;4;4;4;2;2;2;2;1;1;1","INTERNAL MEDICINE;SURGERY;RADIOLOGY;PATHOLOGY;CARDIOLOGY;GASTROENTEROLOGY;GENERAL SURGERY;IMMUNOLOGY;UROLOGY;BIOCHEMISTRY;GENETICS;PSYCHIATRY;NUCLEAR MEDICINE;ONCOLOGY;OPTICS;PHARMACOLOGY;ANESTHESIA;ENDOCRINOLOGY;INTENSIVE CARE MEDICINE;ANATOMY;ENVIRONMENTAL HEALTH;GYNECOLOGY;MICROBIOLOGY;PEDIATRICS;VIROLOGY","115;65;43;20;17;17;16;16;15;14;14;12;10;10;10;10;9;7;7;6;6;6;6;6;6","CANCER;MAGNETIC RESONANCE IMAGING;COMPLICATION;LAPAROSCOPY;ADVERSE EFFECT;CHEMOTHERAPY;DISEASE;GENE;ALTERNATIVE MEDICINE;BIOPSY;INCIDENCE (GEOMETRY);POPULATION;PREGNANCY;RANDOMIZED CONTROLLED TRIAL;TRANSPLANTATION;ULTRASOUND;ATRIAL FIBRILLATION;BLOOD PRESSURE;DIABETES MELLITUS;PROSPECTIVE COHORT STUDY;RECEPTOR;VIRUS","36;9;8;8;7;7;7;7;6;6;6;6;6;6;6;6;5;5;5;5;5;5","COLORECTAL CANCER;BREAST CANCER;PROSTATE;NEURORADIOLOGY;WEIGHT LOSS;ADENOCARCINOMA;BLADDER CANCER;BORTEZOMIB;CONVENTIONAL PCI;ESCHERICHIA COLI;FETUS;LIVER TRANSPLANTATION;NEUTROPENIA;PERCUTANEOUS CORONARY INTERVENTION;PLACEBO;PROSTATE CANCER;CATHETER ABLATION;CERVICAL CANCER;CORONARY ANGIOGRAPHY;DEEP FEMORAL ARTERY;FEMUR FRACTURE;FLUOROURACIL;HEPATITIS B VIRUS;KIDNEY TRANSPLANTATION;LAPAROSCOPIC SURGERY;LENALIDOMIDE;MELPHALAN;METASTASIS;MULTICENTER STUDY;OPIOID;PALSY;PSEUDOANEURYSM;RECURRENT LARYNGEAL NERVE;SEROLOGY;SINUS (BOTANY);SUPERFICIAL FEMORAL ARTERY;THYROIDECTOMY;VIRAL DISEASE","13;7;6;4;4;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","PROSTATECTOMY;MAMMOGRAPHY;MORBID OBESITY;ABLATION OF ATRIAL FIBRILLATION;ENTEROBACTERIACEAE;HBSAG;IRINOTECAN;TIMI;TOTAL MESORECTAL EXCISION;TRANSURETHRAL RESECTION OF THE PROSTATE;ABDUCENS NERVE;ABORTIFACIENT;ABSOLUTE NEUTROPHIL COUNT;ACTIVE TUBERCULOSIS;AMES TEST;ANTIGEN-PRESENTING CELL;AUGMENTATION MAMMOPLASTY;BASIC FIBROBLAST GROWTH FACTOR;BOSENTAN;BRAIN METASTASIS;BREAST CARCINOMA;CADASIL;CAPECITABINE;CETUXIMAB;CHRONIC ALLOGRAFT NEPHROPATHY;COLONIC CANCER;COLONOSCOPY;CYTOREDUCTIVE SURGERY;DEBULKING;DIASTOLIC FUNCTION;DIHYDROTESTOSTERONE;DOPPLER ECHOCARDIOGRAPHY;DOUBLE BLIND;DRUG-ELUTING STENT;DUCTAL CARCINOMA;ELISPOT;ENOS;EPIRUBICIN;ESOPHAGEAL VARICES;ESTROGEN RECEPTOR;EXTRAVERSION AND INTROVERSION;FAMILY PLANNING;FEBRILE NEUTROPENIA;FEBUXOSTAT;FETAL HEART;FINASTERIDE;FOLINIC ACID;GASTRO-;HERPESVIRIDAE;HISTONE DEACETYLASE;HPV INFECTION;HYDROGEN BREATH TEST;HYPERTRIGLYCERIDEMIA;INFERIOR THYROID ARTERY;INTEGRON;INTRADUCTAL PAPILLOMA;INTRAEPITHELIAL NEOPLASIA;KRAS;LAMIVUDINE;MALE INFERTILITY;MILAN CRITERIA;MILK ALLERGY;MISSENSE MUTATION;MUCINOUS CARCINOMA;MULTINODULAR GOITRE;NARINGENIN;NEOADJUVANT THERAPY;NISSEN FUNDOPLICATION;NOCARDIOSIS;ORAL ANTICOAGULANT;OXALIPLATIN;OXYCODONE;P38 MITOGEN-ACTIVATED PROTEIN KINASES;PANCREAS TRANSPLANTATION;PAPILLARY THYROID CANCER;PARAAORTIC LYMPH NODES;PARS PLANA;PERCUTANEOUS ETHANOL INJECTION;PERITONEAL CARCINOMATOSIS;PHOTOABLATION;POLYCYSTIC LIVER DISEASE;PORTOGRAPHY;PRENATAL DIAGNOSIS;PRIMARY ANGIOPLASTY;PULMONARY VEIN STENOSIS;RADICAL HYSTERECTOMY;S9 FRACTION;SPERM BANK;TROCHLEAR NERVE;TUBERCULOSIS DIAGNOSIS;TUMOR ANTIGEN;VANCOMYCIN;VARDENAFIL","5;4;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;MIDDLE AGED;AGED;ADULT;;TREATMENT OUTCOME;POSTOPERATIVE COMPLICATIONS;COLORECTAL NEOPLASMS;RETROSPECTIVE STUDIES;AGED, 80 AND OVER;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;ADENOCARCINOMA;FOLLOW-UP STUDIES;BRAIN NEOPLASMS;ITALY;MAGNETIC RESONANCE IMAGING;PROSPECTIVE STUDIES;BREAST NEOPLASMS","120;84;81;70;66;57;43;36;31;25;24;23;19;18;17;15;15;14;14;13","PROSTATE CANCER RESEARCH AND TREATMENT;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;COLORECTAL CANCER RESEARCH AND TREATMENT;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;EFFECTS OF BARIATRIC SURGERY ON OBESITY AND DIABETES;HEPATITIS C INFECTION AND TREATMENT;MICROSURGICAL RECONSTRUCTION TECHNIQUES;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;ANESTHESIA AND SEDATION MANAGEMENT;ANORECTAL SURGICAL PROCEDURES;ASTHMA;ATRIAL FIBRILLATION;BREAST MAGNETIC RESONANCE IMAGING IN ONCOLOGY;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;COMPLICATIONS AND TECHNIQUES IN THYROID SURGERY;DIAGNOSIS AND TREATMENT OF BLADDER CANCER;EPIDEMIOLOGY AND MANAGEMENT OF SEXUAL DYSFUNCTION;GLIOMAS;GLOBAL CHALLENGE OF ANTIBIOTIC RESISTANCE IN BACTERIA","5;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","CARDIAC IMAGING;BREAST MRI;COMPUTED TOMOGRAPHY ANGIOGRAPHY;INTERNATIONAL MYELOMA WORKING GROUP;NEURORADIOLOGY;TREATMENT;BLADDER CANCER;CARDIOVASCULAR RISK ASSESSMENT;CONCOMITANT;DIAGNOSIS;ENDOSCOPIC STENTING;GASTRIC BYPASS;HYPERTENSION;INTERVENTIONAL RADIOLOGY;MAGNETIC RESONANCE IMAGING;MICROSURGICAL RECONSTRUCTION;MRI IMAGING;PHARMACOTHERAPY;PRENATAL DIAGNOSIS;PROSTATE CANCER","8;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3","COLORECTAL CANCER;MAGNETIC RESONANCE;MULTIPLE MYELOMA;PHASE II;RADICAL PROSTATECTOMY;RANDOMIZED TRIAL;RESONANCE IMAGING;ATRIAL FIBRILLATION;COMPUTED TOMOGRAPHY;MYELOMA RESULTS;PROSPECTIVE STUDY;ADJUSTABLE GASTRIC;ADJUVANT CHEMOTHERAPY;ARTERY BRANCH;BLADDER CANCER;BLOOD PRESSURE;BRANCH PSEUDOANEURYSM;CANCER PATIENTS;CARBON NANOTUBES;CHRONIC HEPATITIS;CLINICAL PRACTICE;CORONARY ANGIOGRAPHY;CORONARY ARTERY;CT COLONOGRAPHY;DEEP FEMORAL;DYNAMIC CONTRAST-ENHANCED;ENDOVASCULAR REPAIR;EXTRAPERITONEAL RECTAL;FEMORAL ARTERY;FEMUR FRACTURE","5;5;4;4;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CR OXYCODONE;COLORECTAL CANCER;PLATELET AGGREGATION;ASTHMATIC CHILDREN;CI CI;SEMINAL PLASMA;SYNCOPE UNIT;WINE INTAKE;SURFACE REGISTRATION;ARTERY BRANCH;CANCER PATIENTS;COFFEE DRINKING;COMBINATION THERAPY;DEEP FEMORAL;EFFUSION ASSESSED;ELDERLY PATIENTS;FEMORAL ARTERY;FEMUR FRACTURE;IMAGE DISTANCE;MALIGNANT MELANOMA;MM NA;MODERATE WINE;NEUROPATHIC PAIN;PATIENTS UNDERWENT;POINT-TO-CT IMAGE;SIJ EFFUSION;WEIGHT LOSS;ANGIOGRAPHIC REPERFUSION;BRANCH CAUSED;CARBON NANOTUBES","9;7;7;6;6;6;6;6;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3",15,0.09,8.12,6,8.5,1,0,2,4.5,0,1.25,6.5,0,1,8,0,2,4,1,6.25,3,0,0,57,57.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,10,4.43,668.25,2.48,3,0.3,72.3,0,0,1,0,6,0,1,2,0,7,1,0,0,0,0,0,0,9,0,1,8,2,0,0,0,0,0,0,0,0,"Italy;United States","2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3204 IMMUNOLOGY;3208 MEDICAL PHYSIOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;4203 HEALTH SERVICES AND SYSTEMS","10;7;2;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;CARDIOVASCULAR;DIABETES;HEART DISEASE;PATIENT SAFETY;ATHEROSCLEROSIS;AUTOIMMUNE DISEASE;CANCER;COLO-RECTAL CANCER;DIGESTIVE DISEASES;HEALTH SERVICES;HEART DISEASE - CORONARY HEART DISEASE;LUNG;NUTRITION;PREVENTION;TRANSPLANTATION","7;4;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","CARDIOVASCULAR;CANCER;INFECTION;METABOLIC AND ENDOCRINE;STROKE","3;1;1;1;1","6.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES","6;1;1;1","COLON AND RECTAL CANCER;MYELOMA","1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","2",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_UMBERTOI",2009,176,8.28409090909091,4,0.715909090909091,0.534090909090909,0.732954545454545,1.32082551594747,1.21153846153846,1.18987341772152,1.19444444444444,0.323863636363636,4,71,44,20,31,0.4,0.25,0.11,0.18,38.4,0.830091506322245,NA,0.136363636363636,0.664772727272727,0.342,0.286,0.286,0.291,"MASSIMO ROSSI;LUCA BERTINI;E POLETTINI;EMANUELE CASCIANI;LUCIANO IZZO;LUCIA MANGANARO;SARA SAVELLI;FEDERICO VENUTA;ANTONELLA GIANCOTTI;P.B. BERLOCO;CLAUDIA STEFANUTTI;CLAUDIO LETIZIA;STEFANO GINANNI CORRADINI;F. GENTILI;MANUELA MERLI;GIANLUCA MENNINI;GIUSEPPE CAVALLARO;MARCO DI MAURIZIO;ALESSANDRA TOMEI;GIUSEPPE RONGA","6;5;5;5;5;5;5;5;5;4;4;4;4;4;4;3;3;3;3;3","FEDERICO VENUTA;CLAUDIA STEFANUTTI;SILVIA MIGLIACCIO;D ANDREANI;GIUSEPPE GIANCASPRO;LUCIANO IZZO;MASSIMO ROSSI;LUCA BERTINI;E POLETTINI;EMANUELE CASCIANI;LUCIA MANGANARO;SARA SAVELLI;C PARLAPIANO;DENIS A. COZZI;TIZIANO DE GIACOMO;GIORGIO F. COLONI;MARCO ANILE;ANTONELLA GIANCOTTI;P.B. BERLOCO;A. LEONARDI","1.6;1.42;1.11;1;0.7;0.68;0.67;0.67;0.67;0.67;0.59;0.56;0.5;0.5;0.48;0.48;0.48;0.47;0.45;0.45","MASSIMO ROSSI;LUCA BERTINI;E POLETTINI;EMANUELE CASCIANI;LUCIANO IZZO;LUCIA MANGANARO;SARA SAVELLI;FEDERICO VENUTA;ANTONELLA GIANCOTTI;P.B. BERLOCO;CLAUDIA STEFANUTTI;CLAUDIO LETIZIA;STEFANO GINANNI CORRADINI;F. GENTILI;MANUELA MERLI;GIANLUCA MENNINI;GIUSEPPE CAVALLARO;MARCO DI MAURIZIO;ALESSANDRA TOMEI;GIUSEPPE RONGA","6;5;5;5;5;5;5;5;5;4;4;4;4;4;4;3;3;3;3;3","FEDERICO VENUTA;CLAUDIA STEFANUTTI;SILVIA MIGLIACCIO;D ANDREANI;GIUSEPPE GIANCASPRO;LUCIANO IZZO;MASSIMO ROSSI;LUCA BERTINI;E POLETTINI;EMANUELE CASCIANI;LUCIA MANGANARO;SARA SAVELLI;DENIS A. COZZI;TIZIANO DE GIACOMO;GIORGIO F. COLONI;MARCO ANILE;ANTONELLA GIANCOTTI;P.B. BERLOCO;A. LEONARDI;FRANCESCO VIOLI","1.6;1.42;1.11;1;0.7;0.68;0.67;0.67;0.67;0.67;0.59;0.56;0.5;0.48;0.48;0.48;0.47;0.45;0.45;0.44","GIOVANNI CASELLA;MARIO RIZZELLO;NICOLA BASSO;CLAUDIO LETIZIA;ALFONSO JIMÉNEZ;ANTONIO NICOLUCCI;ELENA ALESSI;F. FALLUCCA;F. FERNANDO;GIUSEPPE PUGLIESE;PATRIZIA CARDELLI;SARA FALLUCCA;SILVANO ZANUSO;STEFANO BALDUCCI;STEFANO CAVALLO;A FANTINI;FRANCESCA ABBATINI;FRIDA LEONETTI;GIORGIO ALESSANDRI;MASSIMO ROSSI","668;668;668;567;535;535;535;535;535;535;535;535;535;535;535;416;376;376;376;347","CLAUDIO LETIZIA;A FANTINI;GIOVANNI CASELLA;MARIO RIZZELLO;NICOLA BASSO;FRANCESCA ABBATINI;DANILO TONI;GARY A. FORD;JOSÉ CASTILLO;KENNEDY R. LEES;MARKKU KASTE;MICHAEL BRAININ;NIAZ AHMED;NILS WAHLGREN;F. GENTILI;MANUELA MERLI;STEFANO GINANNI CORRADINI;MASSIMO ROSSI;A.F. ATTILI;M. GIUSTO","567;416;416;416;416;376;333;333;333;333;333;333;333;333;330;330;330;322;305;305","ANTONELLA GIANCOTTI;LUCA BERTINI;LUCIANO IZZO;MASSIMO ROSSI;CLAUDIO LETIZIA;E POLETTINI;EMANUELE CASCIANI;F. GENTILI;FEDERICO VENUTA;MANUELA MERLI;SARA SAVELLI;STEFANO GINANNI CORRADINI;CLAUDIA STEFANUTTI;A. FRANCIOSO;A. VIVENZIO;A.F. ATTILI;ALESSANDRA TOMEI;ANNA PAOLA IORI;F. CORATELLA;FRANCESCA FIERRO","5;5;5;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3","MEDICINE;BIOLOGY;PHYSICS;ENGINEERING;CHEMISTRY;PSYCHOLOGY;COMPUTER SCIENCE;MATERIALS SCIENCE;SOCIOLOGY;ART;MATHEMATICS;ECONOMICS;GEOLOGY;PHILOSOPHY","167;46;20;10;9;8;7;3;3;2;2;1;1;1","INTERNAL MEDICINE;SURGERY;RADIOLOGY;PATHOLOGY;CARDIOLOGY;GENETICS;GASTROENTEROLOGY;ENDOCRINOLOGY;IMMUNOLOGY;PSYCHIATRY;ANESTHESIA;BIOCHEMISTRY;GENERAL SURGERY;OPTICS;PEDIATRICS;ENVIRONMENTAL HEALTH;INTENSIVE CARE MEDICINE;NUCLEAR MEDICINE;ONCOLOGY;PALEONTOLOGY","114;67;39;28;26;22;19;17;16;13;12;12;12;11;11;10;10;8;8;8","CANCER;DISEASE;GENE;COMPLICATION;PREGNANCY;DIABETES MELLITUS;POPULATION;TRANSPLANTATION;MAGNETIC RESONANCE IMAGING;ALTERNATIVE MEDICINE;ASYMPTOMATIC;BLOOD PRESSURE;INCIDENCE (GEOMETRY);OBESITY;MYOCARDIAL INFARCTION;RECEPTOR;VIRUS;CHEMOTHERAPY;RANDOMIZED CONTROLLED TRIAL;ANTIBODY;BODY MASS INDEX;CHOLESTEROL;CORONARY ARTERY DISEASE;INSULIN;ISCHEMIA;LUNG CANCER;RADIATION THERAPY;ULTRASOUND","17;15;12;11;11;10;10;10;9;8;8;8;8;8;7;7;7;6;6;5;5;5;5;5;5;5;5;5","FETUS;GESTATIONAL AGE;INSULIN RESISTANCE;LIVER TRANSPLANTATION;COLORECTAL CANCER;HEART RATE;HEPATITIS B VIRUS;HEPATITIS C VIRUS;TYPE 2 DIABETES;WEIGHT LOSS;GESTATION;METABOLIC SYNDROME;MUTATION;PROSTATE CANCER;RESTENOSIS;WAIST;ACUTE CHOLECYSTITIS;APHERESIS;BACK PAIN;BIRTH WEIGHT;BREAST CANCER;C-REACTIVE PROTEIN;CAROTID ENDARTERECTOMY;CROHN'S DISEASE;DIFFUSION MRI;EFFECTIVE DIFFUSION COEFFICIENT;ENDARTERECTOMY;ESCHERICHIA COLI;HEMATOPOIETIC STEM CELL TRANSPLANTATION;HUMAN LEUKOCYTE ANTIGEN;HYPOGLYCEMIA;INFLAMMATORY BOWEL DISEASE;ISCHEMIC STROKE;KIDNEY TRANSPLANTATION;LAPAROSCOPIC SURGERY;LOW BACK PAIN;NEURORADIOLOGY;NEUTROPENIA;OVERWEIGHT;PARATHYROID HORMONE;PERINATAL MEDICINE;PLACEBO;PNEUMONECTOMY;PRECUNEUS;PROGRESSIVE DISEASE;PSEUDOMONAS AERUGINOSA;RETINITIS PIGMENTOSA;STELLATE GANGLION;TRIGLYCERIDE;TYPE 1 DIABETES;ULCERATIVE COLITIS;VENTRAL HERNIA;VIRAL DISEASE;VIRULENCE","5;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HBSAG;GASTRIC BYPASS;ADIPONECTIN;AUTONOMIC NERVOUS SYSTEM;BRADYCARDIA;DRUG-ELUTING STENT;ENTEROBACTERIACEAE;HEART RATE VARIABILITY;PRENATAL DIAGNOSIS;RIBAVIRIN;ABCIXIMAB;ABLATION OF ATRIAL FIBRILLATION;ABLATION THERAPY;ACROMEGALY;ADJUVANT CHEMOTHERAPY;ANGIOTENSIN RECEPTOR BLOCKERS;ANTIPLATELET DRUG;AUGMENTATION MAMMOPLASTY;BARE METAL;BAROREFLEX;BREAST RECONSTRUCTION;BRONCHOPLEURAL FISTULA;CALCIUM-SENSING RECEPTOR;CAROTID ARTERY DISEASE;CERVICAL LYMPH NODES;CLINICAL DEMENTIA RATING;CORONARY RESTENOSIS;CYSTIC HYGROMA;DNA METHYLATION;DONOR SPECIFIC ANTIBODIES;DOPPLER ECHOCARDIOGRAPHY;DYSKINESIA;E2F1;ENTEROBACTER;EPTIFIBATIDE;ESOPHAGITIS;FIRST TRIMESTER;GAMETE INTRAFALLOPIAN TRANSFER;GENE MUTATION;GERMLINE MUTATION;GESTATIONAL HYPERTENSION;HERPESVIRIDAE;HISTONE ACETYLTRANSFERASES;HOMEOSTATIC MODEL ASSESSMENT;HYPERTRIGLYCERIDEMIA;IMIPENEM;IN SITU HYBRIDIZATION;INTRAVENOUS DRUG;KRAS;LAMIVUDINE;LDL APHERESIS;MAMMOPLASTY;MCCUNE–ALBRIGHT SYNDROME;MEROPENEM;MESALAZINE;MISSENSE MUTATION;MODEL FOR END-STAGE LIVER DISEASE;MODIFIED RANKIN SCALE;MONASCUS PURPUREUS;MULTIPLEX POLYMERASE CHAIN REACTION;NISSEN FUNDOPLICATION;NOD2;PARATHYROID CHIEF CELL;PARTIAL AGONIST;PATHERGY;PCAF;PROLAMIN;PROTEUS;PROTEUS MIRABILIS;RADIOIODINE THERAPY;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;RHODOCOCCUS EQUI;RUPTURE OF MEMBRANES;SECONDARY HYPERPARATHYROIDISM;SMALL FOR GESTATIONAL AGE;TAKAYASU'S ARTERITIS;TERIPARATIDE;THORACIC AORTIC ANEURYSM;TOLL-LIKE RECEPTOR;TOTAL MESORECTAL EXCISION;TOTAL THYROIDECTOMY;TRANSRECTAL ULTRASONOGRAPHY;VANCOMYCIN;VASCULAR DEMENTIA;VENTRICULOMEGALY;VENTROMEDIAL PREFRONTAL CORTEX","4;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;MIDDLE AGED;ADULT;AGED;;TREATMENT OUTCOME;YOUNG ADULT;ADOLESCENT;AGED, 80 AND OVER;ITALY;FOLLOW-UP STUDIES;MAGNETIC RESONANCE IMAGING;CORONARY ARTERY DISEASE;CAROTID STENOSIS;POSTOPERATIVE COMPLICATIONS;RETROSPECTIVE STUDIES;LAPAROSCOPY;TOMOGRAPHY, X-RAY COMPUTED","132;100;100;74;70;53;43;43;30;26;26;23;21;20;18;17;16;16;15;15","DEVELOPMENT AND DISORDERS OF FETAL BRAIN;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;CHOLESTEROL-LOWERING TREATMENT;CLINICAL MANAGEMENT OF TRACHEAL AND AIRWAY DISORDERS;EFFECTS OF BARIATRIC SURGERY ON OBESITY AND DIABETES;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;LIVER CIRRHOSIS AND ASSOCIATED COMPLICATIONS;ANALYSIS AND APPLICATIONS OF HEART RATE VARIABILITY;ANALYSIS OF BRAIN FUNCTIONAL CONNECTIVITY NETWORKS;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;COLORECTAL CANCER RESEARCH AND TREATMENT;DIAGNOSIS AND MANAGEMENT OF BILIARY TRACT DISORDERS;DIAGNOSIS AND MANAGEMENT OF FUNGAL INFECTIONS;DIAGNOSIS AND MANAGEMENT OF PANCREATITIS;DYSPHAGIA AND SWALLOWING DISORDERS;EPIDEMIOLOGY AND MANAGEMENT OF MAXILLOFACIAL TRAUMA;GENOMIC REARRANGEMENT DISORDERS IN SKIN DISEASES;GLOBAL CHALLENGE OF ANTIBIOTIC RESISTANCE IN BACTERIA;HERNIA REPAIR TECHNIQUES AND MATERIALS","4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","TREATMENT;CAROTID ARTERY STENOSIS;DIABETES;FETAL MRI;LIVER TRANSPLANTATION;CARDIAC IMAGING;CARDIAC ULTRASOUND;CARDIOVASCULAR RISK ASSESSMENT;DIAGNOSTIC ACCURACY;ETIOLOGY;GASTRIC BYPASS;HERNIA REPAIR;LIVER BIOPSY;LIVER DISEASE;OXIDATIVE STRESS;SLEEVE GASTRECTOMY;STROKE (ENGINE);TYPE 2 DIABETES;ANTIFUNGAL THERAPY;ARTERIAL STIFFNESS","10;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2","LIVER TRANSPLANTATION;METABOLIC SYNDROME;TYPE DIABETES;EMERGENCY DEPARTMENT;FETAL MRI;MULTICENTRE STUDY;SLEEVE GASTRECTOMY;STUDY COMPARING;ACTIVITY MEASURED;ACUTE CHOLECYSTITIS;ACUTE PANCREATITIS;ADI NUTRITIONAL;ARTERY DISEASE;ATRIAL FIBRILLATION;AUTONOMIC NERVOUS;CANCER ANALYSIS;CAROTID ARTERY;CELL TRANSPLANTATION;CLINICAL EXPERIENCE;CONTROLLED TRIAL;CORONARY ARTERY;DISEASE PATIENTS;DONOR KIDNEY;EPIDERMAL NEVUS;HEALTHY DOGS;HEART FAILURE;HEART RATE;HEPATOCELLULAR CARCINOMA;HIGH-DEGREE CYSTOCELE;INTERACTION METHOD","4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","INSULIN THERAPY;APACHE II;CAROTID ARTERY;CELL LUNG;LUNG CANCER;MAGNETIC RESONANCE;PERITONEAL LAVAGE;CAROTID REVASCULARIZATION;CORONARY ARTERY;DE NOVO;GSW DISCHARGES;INTENSIVE INSULIN;MYOCARDIAL INFARCTION;NERVE ACTIVITY;NORMAL CORONARY;PATIENTS UNDERGOING;PREVALENCE RATE;PULMONARY ARTERY;SYSTOLIC BP;ACUTE PANCREATITIS;ALCOHOL INTAKE;ANTIHYPERTENSIVE THERAPY;ARTERY DISEASE;ATRIAL-PV JUNCTION;BLOOD GLUCOSE;BORDERLINE VENTRICULOMEGALY;CONSECUTIVE PATIENTS;GESTATIONAL AGE;II SCORES;INCREASED RISK","7;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4",25,0.14,5.15,2,0,1,0,1,2,0,1,2,0,1,1,1,2,1,0,1.25,0,0,0,84,84,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,14,5.2,563,2.73,6,0.43,77.07,0,0,0,0,7,0,5,2,0,11,0,0,0,0,0,0,0,13,1,0,11,3,0,0,0,0,0,0,0,0,"United States;Italy;Canada;Japan","4;3;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3204 IMMUNOLOGY;3207 MEDICAL MICROBIOLOGY;4203 HEALTH SERVICES AND SYSTEMS","14;10;3;2;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;DIGESTIVE DISEASES;CARDIOVASCULAR;HEART DISEASE;HEMATOLOGY;INFECTIOUS DISEASES;PATIENT SAFETY;RARE DISEASES;ARTHRITIS;AUTOIMMUNE DISEASE;BIOENGINEERING;CHRONIC LIVER DISEASE AND CIRRHOSIS;COLO-RECTAL CANCER;COMPARATIVE EFFECTIVENESS RESEARCH;EMERGING INFECTIOUS DISEASES;HEALTH SERVICES;HEART DISEASE - CORONARY HEART DISEASE;HEPATITIS","12;11;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","INFECTION;CANCER;CARDIOVASCULAR;ORAL AND GASTROINTESTINAL;INFLAMMATORY AND IMMUNE SYSTEM","4;3;2;2;1","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;6.3 MEDICAL DEVICES;7.3 MANAGEMENT AND DECISION MAKING","10;2;2;1;1","CERVICAL CANCER;COLON AND RECTAL CANCER;LIVER CANCER;LUNG CANCER;NON-HODGKIN'S LYMPHOMA;OVARIAN CANCER","1;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","4;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_UMBERTOI",2010,171,7.72514619883041,3.81286549707602,0.678362573099415,0.485380116959064,0.713450292397661,1.34504132231405,1.12621359223301,1.27692307692308,1.11926605504587,0.233918128654971,6,47,58,23,28,0.27,0.34,0.13,0.16,26.81,0.593328463895116,NA,0.134502923976608,0.666666666666667,0.4,0.316,0.314,0.312,"ANDREA VIAZZO;EMANUELE FERRERO;PIA CUMBO;FRANCO NESSI;MASSIMO ROSSI;GIUSEPPE BERARDI;ANDREA GAGGIANO;SALVATORE PIAZZA;EMANUELE SORICELLI;GABRIELE MASSELLI;E POLETTINI;EMANUELE CASCIANI;NICOLA BASSO;FRANCESCO SPEZIALE;GIOVANNI CASELLA;ENRICO SBARIGIA;MICHELANGELO FERRI;GIANLUCA MENNINI;LUCA BERTINI;LAURA CAPOCCIA","7;7;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5;4;4;4","MARIO VENDITTI;GIUSEPPE BÁRBARO;FRANCESCO SPEZIALE;ENRICO SBARIGIA;CLAUDIA STEFANUTTI;DENIS A. COZZI;ANTONIO V. STERPETTI;D'ANGELI;EMANUELE SORICELLI;NICOLA BASSO;GIOVANNI CASELLA;MASSIMO ROSSI;LAURA CAPOCCIA;EMANUELE CASCIANI;A FANTINI;ANDREA VIAZZO;EMANUELE FERRERO;MARCO CASTORI;PAOLA GRAMMATICO;ALOISA LIBRANDO","1.12;1.07;1.03;1.03;1;1;1;1;0.93;0.93;0.93;0.84;0.82;0.77;0.77;0.71;0.71;0.69;0.69;0.67","ANDREA VIAZZO;EMANUELE FERRERO;PIA CUMBO;FRANCO NESSI;MASSIMO ROSSI;GIUSEPPE BERARDI;SALVATORE PIAZZA;EMANUELE SORICELLI;GABRIELE MASSELLI;E POLETTINI;EMANUELE CASCIANI;NICOLA BASSO;FRANCESCO SPEZIALE;GIOVANNI CASELLA;ENRICO SBARIGIA;MICHELANGELO FERRI;GIANLUCA MENNINI;LUCA BERTINI;LAURA CAPOCCIA;GIANFRANCO GUALDI","7;7;6;6;6;6;6;5;5;5;5;5;5;5;5;5;4;4;4;4","MARIO VENDITTI;GIUSEPPE BÁRBARO;FRANCESCO SPEZIALE;ENRICO SBARIGIA;CLAUDIA STEFANUTTI;DENIS A. COZZI;ANTONIO V. STERPETTI;D'ANGELI;EMANUELE SORICELLI;NICOLA BASSO;GIOVANNI CASELLA;MASSIMO ROSSI;LAURA CAPOCCIA;EMANUELE CASCIANI;A FANTINI;ANDREA VIAZZO;EMANUELE FERRERO;ALOISA LIBRANDO;E POLETTINI;ROBERTO PASSARIELLO","1.12;1.07;1.03;1.03;1;1;1;1;0.93;0.93;0.93;0.84;0.82;0.77;0.77;0.71;0.71;0.67;0.66;0.65","CLAUDIA CELLETTI;FILIPPO CAMEROTA;MARCO CASTORI;PAOLA GRAMMATICO;ANDREA CHIECCHIO;L. LOMBARDO;MONICA FOTI;O. RUGGIA;MARIO MARINI;VALTER SANTILLI;VINCENZO MARIA SARACENI;CARLA LUBRANO;ANDREA LENZI;ROBERTO PASSARIELLO;EMANUELE SORICELLI;GIOVANNI CASELLA;NICOLA BASSO;GABRIELE MASSELLI;GIANFRANCO GUALDI;GIORGIO ALESSANDRI","351;351;321;321;316;316;316;316;312;298;292;282;239;223;221;221;221;217;217;205","CLAUDIA CELLETTI;FILIPPO CAMEROTA;ANDREA CHIECCHIO;VINCENZO MARIA SARACENI;CARLA LUBRANO;VALTER SANTILLI;ANDREA LENZI;MARIO MARINI;ROBERTO PASSARIELLO;EMANUELE SORICELLI;C DANESE;ANTÔNIO AVERSA;CLAUDIA ANNOSCIA;EMANUELA A. GRECO;FABIO ROSSI;GIANCARLO PROSSOMARITI;GIOVANNI SPERA;LORENZO M. DONINI;MARINA BRAMA;RACHELE FORNARI","351;351;316;292;282;257;239;236;223;221;202;199;199;199;199;199;199;199;199;199","EMANUELE FERRERO;MASSIMO ROSSI;EMANUELE SORICELLI;A FANTINI;ANDREA VIAZZO;FRANCO NESSI;GIANLUCA MENNINI;GIOVANNI CASELLA;MICHELANGELO FERRI;NICOLA BASSO;NICOLÒ SCUDERI;ROBERTO PASSARIELLO;STEFANO GINANNI CORRADINI;GIUSEPPE BERARDI;P.B. BERLOCO;A. LINGUANTI;ALBERTO PECCHIO;C. LUCIDI;CLAUDIA CELLETTI;ENRICO CORTESI","6;6;5;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3","MEDICINE;BIOLOGY;PHYSICS;ENGINEERING;PSYCHOLOGY;MATHEMATICS;POLITICAL SCIENCE;CHEMISTRY;COMPUTER SCIENCE;ECONOMICS;MATERIALS SCIENCE;PHILOSOPHY;ART;BUSINESS;HISTORY;SOCIOLOGY","165;36;10;8;6;5;5;4;4;4;2;2;1;1;1;1","INTERNAL MEDICINE;SURGERY;RADIOLOGY;PATHOLOGY;CARDIOLOGY;GASTROENTEROLOGY;GENETICS;IMMUNOLOGY;PSYCHIATRY;ANESTHESIA;GENERAL SURGERY;INTENSIVE CARE MEDICINE;PHYSICAL THERAPY;ENDOCRINOLOGY;PEDIATRICS;ENVIRONMENTAL HEALTH;ANATOMY;BIOCHEMISTRY;MECHANICAL ENGINEERING;NUCLEAR MEDICINE;UROLOGY","107;68;42;31;24;24;20;15;13;12;11;10;10;9;9;8;7;7;7;7;7","CANCER;MAGNETIC RESONANCE IMAGING;DISEASE;GENE;MYOCARDIAL INFARCTION;TRANSPLANTATION;ANEURYSM;POPULATION;OBESITY;ULTRASOUND;ABDOMINAL SURGERY;ALTERNATIVE MEDICINE;COHORT;PREGNANCY;PROSPECTIVE COHORT STUDY;CYTOKINE;ENDOSCOPY;EPILEPSY;IMMUNE SYSTEM;INFLAMMATION;PATHOLOGICAL;RECEPTOR;STENOSIS","25;15;14;12;11;9;8;8;7;7;6;6;6;6;6;5;5;5;5;5;5;5;5","COLORECTAL CANCER;BREAST CANCER;CAROTID ENDARTERECTOMY;GENOTYPE;ABDOMINAL AORTIC ANEURYSM;LIVER TRANSPLANTATION;WEIGHT LOSS;ENDARTERECTOMY;GASTRECTOMY;GESTATIONAL AGE;PERCUTANEOUS CORONARY INTERVENTION;VIRAL LOAD;AORTIC ANEURYSM;AORTIC DISSECTION;BONE MINERAL;COMPUTED TOMOGRAPHY ANGIOGRAPHY;FETUS;GESTATION;METASTASIS;OSTEOARTHRITIS;PHENOTYPE;REVASCULARIZATION","10;7;6;6;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","COLONOSCOPY;GASTRIC BYPASS;ANTIRETROVIRAL THERAPY;KNEE PAIN;ECHINOCANDIN;ENDOVASCULAR ANEURYSM REPAIR;GENOTYPE-PHENOTYPE DISTINCTION;GQ ALPHA SUBUNIT;MASTECTOMY;METHYLTRANSFERASE;MICAFUNGIN;MORBID OBESITY;ABCIXIMAB;ALLELE FREQUENCY;ANTHRACYCLINE;ANTIVIRAL THERAPY;APREPITANT;BENTALL PROCEDURE;BIPOLAR II DISORDER;BONE METASTASIS;BREAST CARCINOMA;BREAST TISSUE;BRONCHOPULMONARY DYSPLASIA;CAGA;CARDIAC ABLATION;CASPOFUNGIN;CD38;CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING;CLOSTRIDIUM DIFFICILE COLITIS;COMPOUND HETEROZYGOSITY;CROHN DISEASE;CYANOACRYLATE;DISTANT METASTASIS;DNA METHYLATION;DOPAMINE RECEPTOR D1;DRUG-ELUTING STENT;DUAL-ENERGY X-RAY ABSORPTIOMETRY;DUCTUS VENOSUS;ELECTRICAL INJURIES;ENOS;ETHAMBUTOL;EXTERNAL BEAM RADIOTHERAPY;EXTRAMEDULLARY HEMATOPOIESIS;FEBRILE NEUTROPENIA;FUNCTIONAL RESIDUAL CAPACITY;GENE PREDICTION;GENOMICS;GENOTYPING;GERD;GROWTH HORMONE DEFICIENCY;HARM AVOIDANCE;HIATAL HERNIA;HYDROGEN BREATH TEST;HYPERALGESIA;IL-2 RECEPTOR;INTERFERON ALFA;INTRAUTERINE GROWTH RESTRICTION;IRINOTECAN;LENTIVIRUS;LEUKOARAIOSIS;LUNG VOLUME REDUCTION SURGERY;MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY;MALE INFERTILITY;MAMMOGRAPHY;MANIA;METASTATIC BREAST CANCER;MITOCHONDRIAL DISEASE;MITOCHONDRIAL MYOPATHY;MMP2;MYCOBACTERIUM MARINUM;NICKEL ALLERGY;NOD2;OSTEOCALCIN;OSTEOPENIA;OXALIPLATIN;PALONOSETRON;PANCREATIC CARCINOMA;PHOSPHOINOSITIDE PHOSPHOLIPASE C;PLACENTA;POUCHITIS;PREMATURE BIRTH;PRETERM DELIVERY;PRETERM LABOUR;PRIMARY ANGIOPLASTY;PROMOTER;PROVIRUS;PSEUDOGENE;PSEUDOMEMBRANOUS COLITIS;RECTAL CARCINOMA;REMYELINATION;REVERSE TRANSCRIPTASE;RIBAVIRIN;SCIENTIFIC CONSENSUS;SENTINEL LYMPH NODE;SINGLE-NUCLEOTIDE POLYMORPHISM;SUBSTANCE P;SULFOLOBUS;SULFOLOBUS SOLFATARICUS;TAMOXIFEN;TARGET LESION;TAXANE;TIMI;TOLTERODINE;TOTAL MESORECTAL EXCISION;TOTAL THYROIDECTOMY;TRANSITIONAL CELL CARCINOMA;WHOLE GENOME SEQUENCING","5;5;3;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;MIDDLE AGED;AGED;ADULT;TREATMENT OUTCOME;ITALY;;AGED, 80 AND OVER;MYOCARDIAL INFARCTION;RETROSPECTIVE STUDIES;PROSPECTIVE STUDIES;CAROTID STENOSIS;ADOLESCENT;TIME FACTORS;AORTIC ANEURYSM, ABDOMINAL;MAGNETIC RESONANCE IMAGING;YOUNG ADULT;BREAST NEOPLASMS","138;100;93;78;61;58;36;32;30;24;22;22;21;20;19;19;18;17;16;14","DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;EFFECTS OF BARIATRIC SURGERY ON OBESITY AND DIABETES;EPILEPSY AND SEIZURES;MANAGEMENT AND PATHOPHYSIOLOGY OF ABDOMINAL AORTIC ANEURYSMS;CATHETER ABLATION OF CARDIAC ARRHYTHMIAS;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;GENETIC AND MOLECULAR STUDIES OF CONNECTIVE TISSUE DISORDERS;MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION;MANAGEMENT OF VALVULAR HEART DISEASE;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;CARDIAC REHABILITATION AND CARDIOVASCULAR HEALTH INTERVENTIONS;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;DIAGNOSIS AND MANAGEMENT OF BILIARY TRACT DISORDERS;DIAGNOSIS AND MANAGEMENT OF CONGENITAL DIAPHRAGMATIC HERNIA;DIAGNOSIS AND MANAGEMENT OF FUNGAL INFECTIONS;DIAGNOSIS AND MANAGEMENT OF GASTROINTESTINAL BLEEDING;ESOPHAGEAL INTERVENTION TECHNIQUES;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;GLIOMAS;GLOBAL TRENDS IN COLORECTAL CANCER RESEARCH","7;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2","TREATMENT;CAROTID ARTERY STENOSIS;ANEURYSM RUPTURE;AORTIC DISSECTION;ENDARTERECTOMY;SLEEVE GASTRECTOMY;ANEURYSM SCREENING;COMPUTED TOMOGRAPHY ANGIOGRAPHY;STROKE (ENGINE);AORTIC ANEURYSMS;BREAST CANCER;CEREBROVASCULAR EVENTS;DIAGNOSIS;DYNAMIC CONTRAST-ENHANCED MRI;EHLERS-DANLOS SYNDROME;ENDOVASCULAR REPAIR;EPILEPSY;GASTRIC BYPASS;GASTRIC OUTLET OBSTRUCTION;HIV","7;6;5;5;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3","MAGNETIC RESONANCE;SLEEVE GASTRECTOMY;ABDOMINAL AORTIC;AORTIC ANEURYSM;LIVER TRANSPLANTATION;ANEURYSM REPAIR;AORTIC DISSECTION;CAROTID ARTERY;CAROTID ENDARTERECTOMY;CHRONIC OBSTRUCTIVE;OBSTRUCTIVE PULMONARY;PULMONARY DISEASE;SINGLE CENTER;ACUTE AORTIC;AORTIC VALVE;ATHEROSCLEROTIC PLAQUES;BREAST CANCER;CARDIOVASCULAR RISK;CAROTID ATHEROSCLEROTIC;CAROTID SURGERY;CHEST PAIN;CHRONIC LIVER;COLORECTAL CANCER;CROHNS DISEASE;DEPRESSION SYNDROME;DYNAMIC CONTRAST-ENHANCED;EHLERSDANLOS SYNDROME;ELDERLY PATIENTS;GROWTH HORMONE;HYPERMOBILITY TYPE","5;5;4;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","NIHSS SCORE;COMPUTED TOMOGRAPHY;ILEO-COLONIC ANASTOMOSIS;PATIENTS UNDERWENT;ILEOCOLIC ARTERY;INTRAMURAL LESIONS;RISK FACTORS;SUPERIOR MESENTERIC;WALL THICKNESS;CARDIOVASCULAR RISK;CAROTID STENOSIS;CROHNS DISEASE;ILEAL BRANCH;NEO-TERMINAL ILEUM;BASAL CELL;CAROTID ENDARTERECTOMY;CAROTID REVASCULARIZATION;CELL CARCINOMA;DEMYELINATING DISEASES;DEPRESSIVE SYNDROME;ENDARTERECTOMY CEA;ENDOSCOPIC LESIONS;LUNG TRANSPLANTATION;MAGNETIC RESONANCE;NERVOUS SYSTEM;AIRWAY PRESSURE;ATHEROSCLEROTIC PLAQUES;AV BLOCK;BREAST CANCER;BREAST CONSERVING","14;7;7;7;6;6;6;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3",25,0.15,4,6,5,1,0,37,7,1,1,6,0,1,4.75,3,1,1,2,4,1.5,0,0,79,79,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,16,4.09,224.36,3.5,2,0.12,22.25,0,0,3,0,6,0,5,2,0,12,0,0,0,0,0,0,0,12,2,2,10,4,0,1,1,0,0,0,0,0,"Italy;United States;Japan","5;2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE","15;8;5;3;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;CANCER;CARDIOVASCULAR;HEMATOLOGY;AGING;ATHEROSCLEROSIS;HEART DISEASE;HEART DISEASE - CORONARY HEART DISEASE;LUNG;PEDIATRIC;BIOENGINEERING;BIOMEDICAL IMAGING;CHILDHOOD LEUKEMIA;CHRONIC OBSTRUCTIVE PULMONARY DISEASE;CHRONIC PAIN;CYSTIC FIBROSIS;NEUROSCIENCES;ORPHAN DRUG","9;6;6;4;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1","CARDIOVASCULAR;BLOOD;CANCER;CONGENITAL;MUSCULOSKELETAL;RENAL AND UROGENITAL;RESPIRATORY","5;2;2;1;1;1;1","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.2 CELLULAR AND GENE THERAPIES;6.4 SURGERY;6.7 PHYSICAL;7.1 INDIVIDUAL CARE NEEDS","6;1;1;1;1;1","KIDNEY CANCER;LEUKEMIA / LEUKAEMIA;OVARIAN CANCER;SARCOMA","1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","3",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_UMBERTOI",2011,230,8.87826086956522,3.46086956521739,0.560869565217391,0.41304347826087,0.573913043478261,1.46494464944649,1.37234042553191,1.3768115942029,1.36082474226804,0.321739130434783,3,71,71,39,32,0.31,0.31,0.17,0.14,27.93,0.656759160508156,NA,0.121739130434783,0.708695652173913,0.415,0.349,0.379,0.334,"FILIPPO CAMEROTA;ANDREA VIAZZO;FRANCO NESSI;EMANUELE FERRERO;CLAUDIA CELLETTI;BENEDETTA MARIGLIANO;MICHELANGELO FERRI;MARCO CASTORI;MASSIMO ROSSI;ALBERTO PECCHIO;RICCARDO CASABONA;ALESSANDRO ROBALDO;FABRIZIO SANSONE;ADRIANO REDLER;MANUELA GALLI;PIA CUMBO;PASQUALE FINO;GIUSEPPE BERARDI;QUIRINO LAI;FEDERICO VENUTA","9;9;9;9;9;8;8;7;7;7;6;6;5;5;5;5;5;5;5;5","FILIPPO CAMEROTA;CLAUDIA CELLETTI;MARCO CASTORI;ANDREA VIAZZO;FRANCO NESSI;EMANUELE FERRERO;ARTICO;VINCENZO CINOSI;JUN LI;RICCARDO CASABONA;MICHELANGELO FERRI;PASQUALE FINO;FABRIZIO SANSONE;BENEDETTA MARIGLIANO;NICOLÒ SCUDERI;FEDERICO VENUTA;MASSIMO ROSSI;ALBERTO PECCHIO;GIUSEPPE LA TORRE;EMANUELE CIGNA","1.53;1.53;1.26;1.13;1.13;1.13;1;1;1;0.96;0.88;0.88;0.85;0.84;0.78;0.78;0.77;0.75;0.75;0.73","FILIPPO CAMEROTA;ANDREA VIAZZO;FRANCO NESSI;EMANUELE FERRERO;CLAUDIA CELLETTI;BENEDETTA MARIGLIANO;MICHELANGELO FERRI;MASSIMO ROSSI;ALBERTO PECCHIO;RICCARDO CASABONA;ALESSANDRO ROBALDO;FABRIZIO SANSONE;ADRIANO REDLER;PIA CUMBO;GIUSEPPE BERARDI;QUIRINO LAI;FEDERICO VENUTA;SALVATORE PIAZZA;C MODINI;CORRADO GIRMENIA","9;9;9;9;9;8;8;7;7;6;6;5;5;5;5;5;5;5;4;4","FILIPPO CAMEROTA;CLAUDIA CELLETTI;ANDREA VIAZZO;FRANCO NESSI;EMANUELE FERRERO;VINCENZO CINOSI;JUN LI;RICCARDO CASABONA;MICHELANGELO FERRI;FABRIZIO SANSONE;BENEDETTA MARIGLIANO;NICOLÒ SCUDERI;FEDERICO VENUTA;MASSIMO ROSSI;ALBERTO PECCHIO;GIUSEPPE LA TORRE;EMANUELE CIGNA;STEFANO DEL PONTE;DENIS A. COZZI;ANTONIO SPADARO","1.53;1.53;1.13;1.13;1.13;1;1;0.96;0.88;0.85;0.84;0.78;0.78;0.77;0.75;0.75;0.73;0.72;0.68;0.68","CORRADO GIRMENIA;ANDREA VIAZZO;EMANUELE FERRERO;FRANCO NESSI;FEDERICO VENUTA;MICHELANGELO FERRI;ADA RITA FLORIO;ANNA MARIA TORTORANO;ANTONIETTA VELLA;BRUNELLA POSTERARO;CAMILLA COLOZZA;CORNELIA LASS‐FLÖRL;ELENA DE CAROLIS;GUIDO FADDA;MAURIZIO SANGUINETTI;RICCARDO TORELLI;ALESSANDRO PECCI;ANNA SAVOIA;CARLO L. BALDUINI;CATERINA MARCONI","340;312;312;312;310;288;259;259;259;259;259;259;259;259;259;259;257;257;257;257","CORRADO GIRMENIA;CAMILLA COLOZZA;ANDREA VIAZZO;EMANUELE FERRERO;FRANCO NESSI;GIOVANNI AMENDOLA;ALBERTO PECCHIO;MICHELANGELO FERRI;DANILA CAPOCCIA;FRIDA LEONETTI;MASSIMO ROSSI;NICOLA BASSO;CLAUDIA CELLETTI;FILIPPO CAMEROTA;FEDERICA COCCIA;FRANCESCA ABBATINI;GIOVANNI CASELLA;MARCO ANILE;GIOVANNI DI NARDO;SALVATORE CUCCHIARA","329;259;258;258;258;257;234;234;233;233;228;205;203;203;202;202;202;197;183;183","CLAUDIA CELLETTI;FILIPPO CAMEROTA;ANDREA VIAZZO;EMANUELE FERRERO;FRANCO NESSI;ALBERTO PECCHIO;MICHELANGELO FERRI;RICCARDO CASABONA;MASSIMO ROSSI;FABRIZIO SANSONE;GIUSEPPE BERARDI;PIA CUMBO;SALVATORE PIAZZA;ADRIANO REDLER;ALESSANDRO ROBALDO;QUIRINO LAI;BENEDETTA MARIGLIANO;DOMENICO GIANNOTTI;FABIO PELLE;FRANCESCA FREZZOTTI","8;8;8;8;8;7;7;6;6;5;5;5;5;5;5;5;5;4;4;4","MEDICINE;BIOLOGY;PSYCHOLOGY;PHYSICS;CHEMISTRY;ENGINEERING;MATHEMATICS;ECONOMICS;COMPUTER SCIENCE;MATERIALS SCIENCE;PHILOSOPHY;SOCIOLOGY;POLITICAL SCIENCE;BUSINESS;GEOGRAPHY;HISTORY","223;56;19;18;15;9;8;7;6;4;4;4;3;1;1;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;RADIOLOGY;GENETICS;GASTROENTEROLOGY;CARDIOLOGY;IMMUNOLOGY;PHYSICAL THERAPY;ENDOCRINOLOGY;PSYCHIATRY;ENVIRONMENTAL HEALTH;INTENSIVE CARE MEDICINE;BIOCHEMISTRY;PEDIATRICS;GENERAL SURGERY;DERMATOLOGY;PHARMACOLOGY;PHYSICAL MEDICINE AND REHABILITATION;ANATOMY;ANESTHESIA;ONCOLOGY","145;101;46;43;37;32;28;28;24;19;19;18;18;17;17;14;12;12;12;10;10;10","DISEASE;CANCER;GENE;PREGNANCY;POPULATION;TRANSPLANTATION;ALTERNATIVE MEDICINE;CHEMOTHERAPY;MAGNETIC RESONANCE IMAGING;MYOCARDIAL INFARCTION;RANDOMIZED CONTROLLED TRIAL;ANEURYSM;ARTERY;INCIDENCE (GEOMETRY);COMPLICATION;PROSPECTIVE COHORT STUDY;LAPAROSCOPY;DRUG;EMBOLIZATION;IMMUNE SYSTEM;IN VITRO;INFLAMMATION;OBESITY;REHABILITATION;STEM CELL;STENT","28;27;19;16;15;15;13;12;12;11;10;9;9;9;8;8;7;6;6;6;6;6;6;6;6;6","COLORECTAL CANCER;FETUS;LIVER TRANSPLANTATION;DEMENTIA;OSTEOARTHRITIS;WEIGHT LOSS;COGNITIVE IMPAIRMENT;GAIT ANALYSIS;GENE EXPRESSION;GENOTYPE;INFLAMMATORY BOWEL DISEASE;PERCUTANEOUS CORONARY INTERVENTION;ULCERATIVE COLITIS;ANGINA;AORTIC ANEURYSM;BONE MINERAL;BREAST CANCER;CAROTID ENDARTERECTOMY;CLINICAL ENDPOINT;CORONARY ANGIOGRAPHY;EJECTION FRACTION;GASTRECTOMY;GESTATION;GESTATIONAL AGE;GLYCOPEPTIDE;HAEMATOPOIESIS;METASTASIS;PERFORATION;PLACEBO;PNEUMONECTOMY;REFLUX;STAPHYLOCOCCUS AUREUS;WHITE MATTER","8;7;7;6;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","GASTRIC BYPASS;COGNITIVE DECLINE;COLONOSCOPY;VANCOMYCIN;BARRETT'S ESOPHAGUS;COLECTOMY;DNA METHYLATION;DRUG-ELUTING STENT;GERD;GERIATRIC DEPRESSION SCALE;HBSAG;INTRAUTERINE GROWTH RESTRICTION;MACE;METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS;NISSEN FUNDOPLICATION;RIGHT CORONARY ARTERY;STAPHYLOCOCCAL INFECTIONS;THORACIC AORTIC ANEURYSM;THROMBOPOIETIN;TRACTOGRAPHY","4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;FEMALE;MALE;MIDDLE AGED;ADULT;AGED;TREATMENT OUTCOME;;ITALY;ADOLESCENT;TIME FACTORS;YOUNG ADULT;AGED, 80 AND OVER;ANEURYSM;RETROSPECTIVE STUDIES;EHLERS-DANLOS SYNDROME;PROSPECTIVE STUDIES;CHILD;LAPAROSCOPY;SKIN NEOPLASMS","179;135;130;92;84;78;54;47;41;29;27;26;25;23;23;20;20;18;18;18","GENETIC AND MOLECULAR STUDIES OF CONNECTIVE TISSUE DISORDERS;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;MANAGEMENT OF MESENTERIC ISCHEMIA AND ANEURYSMS;DIAGNOSIS AND MANAGEMENT OF FUNGAL INFECTIONS;VASCULAR ACCESS FOR CORONARY PROCEDURES AND TRAUMA MANAGEMENT;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ATRIAL FIBRILLATION;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;COLORECTAL CANCER RESEARCH AND TREATMENT;COMPOSITION AND HEALTH EFFECTS OF HUMAN MILK;EFFECTS OF BARIATRIC SURGERY ON OBESITY AND DIABETES;HEPATITIS B INFECTION AND TREATMENT;LIVER TRANSPLANTATION AND GRAFT SURVIVAL ANALYSIS;METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTIONS;SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME;ADVANCEMENTS IN LUNG CANCER RESEARCH;ASTHMA;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;BREAST RECONSTRUCTION TECHNIQUES AND OUTCOMES;CLASSIFICATION AND TREATMENT OF SPONDYLOARTHRITIS","7;5;5;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2","TREATMENT;EHLERS-DANLOS SYNDROME;CARDIAC IMAGING;CARDIOVASCULAR RISK ASSESSMENT;CAROTID ARTERY STENOSIS;LIVING DONOR LIVER TRANSPLANTATION;BARRETT'S ESOPHAGUS;DEPRESSION (ECONOMICS);EHLERS–DANLOS SYNDROME;ETIOLOGY;JOINT HYPERMOBILITY;LIVER TRANSPLANTATION;PATHOGENESIS;SLEEVE GASTRECTOMY;SPLENIC ARTERY ANEURYSMS;STROKE (ENGINE);TYPE 2 DIABETES;VISCERAL ARTERY ANEURYSMS;ANEURYSM RUPTURE;AORTIC ANEURYSMS","12;6;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;3;3","LIVER TRANSPLANTATION;ATRIAL FIBRILLATION;BOWEL DISEASE;INFLAMMATORY BOWEL;SINGLE CENTER;SLEEVE GASTRECTOMY;ACUTE MYELOID;ARTERY ANEURYSM;BOVINE LACTOFERRIN;EHLERSDANLOS SYNDROME;ENDOVASCULAR TREATMENT;FUNGAL INFECTIONS;HEPATOCELLULAR CARCINOMA;HYPERMOBILITY TYPE;INVASIVE FUNGAL;JOINT HYPERMOBILITY;LEFT VENTRICULAR;MYELOID LEUKEMIA;PEDIATRIC PATIENTS;RISK FACTORS;SURGICAL TREATMENT;TYPE DIABETES;ALZHEIMERS DISEASE;ANKYLOSING SPONDYLITIS;AORTIC INTIMAMEDIA;ARCHITECT HBSAG;ARTERY ANEURYSMS;BONE MINERAL;CARCINOMA WAITING;CARDIAC SURGERY","6;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2","PUBMED SCOPUS;CROSSREF PUBMED;AIR LEAKS;MIDDLE LOBE;NEUROPATHIC PAIN;AMCI PATIENTS;HIPPOCAMPAL VOLUME;UPPER LOBECTOMY;ACUTE MYELOID;AXONAL POLYNEUROPATHY;CARDIOTHORAC SURG;EHLERS-DANLOS SYNDROME;LEFT ATRIAL;LIVER TRANSPLANTATION;LOBAR TORSION;NUTRITIONAL STATUS;STATISTICALLY SIGNIFICANT;SURG -CROSSREF;WEEKS GESTATION;ELECTRON MICROSCOPY;FIBER DISSECTION;FUNGAL DISEASES;HEALTHY CONTROLS;INVASIVE FUNGAL;LEFT VENTRICULAR;MMHG EXPERIMENTAL;NIHSS SCORE;PATIENTS UNDERGOING;SURG -ABSTRACT;ANTIFUNGAL PROPHYLAXIS","26;14;8;8;8;7;7;7;6;6;6;6;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5;5;4",33,0.14,6.95,4,1,1,1,1,8,0,1,4,0,1,3.25,0,1,0,1.5,3,2,0,0,88,86,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,28,5.78,452.05,5.46,1,0.04,32.11,0,1,6,0,7,0,5,9,0,15,7,0,0,0,0,0,0,27,1,0,21,6,0,0,1,0,0,0,0,0,"Italy;United States;Finland","7;3;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;31 BIOLOGICAL SCIENCES;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;42 HEALTH SCIENCES;3105 GENETICS;3107 MICROBIOLOGY;3207 MEDICAL MICROBIOLOGY;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;4207 SPORTS SCIENCE AND EXERCISE;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","27;16;5;4;2;2;2;2;2;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CARDIOVASCULAR;RARE DISEASES;CANCER;HEART DISEASE;DIGESTIVE DISEASES;HEMATOLOGY;NEUROSCIENCES;PATIENT SAFETY;CHRONIC LIVER DISEASE AND CIRRHOSIS;HEART DISEASE - CORONARY HEART DISEASE;LIVER DISEASE;LUNG;PREVENTION;ATHEROSCLEROSIS;HEPATITIS;AGING;BIOENGINEERING;BRAIN DISORDERS","23;15;8;8;6;6;5;5;5;5;4;4;4;4;4;3;3;2;2;2","CARDIOVASCULAR;CANCER;RESPIRATORY;BLOOD;INFECTION;METABOLIC AND ENDOCRINE;ORAL AND GASTROINTESTINAL;STROKE;CONGENITAL","7;5;3;2;2;2;2;2;1","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.4 SURGERY;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;6.2 CELLULAR AND GENE THERAPIES;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;5.2 CELLULAR AND GENE THERAPIES;5.7 PHYSICAL;6.3 MEDICAL DEVICES;6.7 PHYSICAL;7.1 INDIVIDUAL CARE NEEDS","15;3;3;2;2;1;1;1;1;1;1;1","LIVER CANCER;CERVICAL CANCER;COLON AND RECTAL CANCER;LEUKEMIA / LEUKAEMIA;LUNG CANCER;MYELOMA;NEUROBLASTOMA;OVARIAN CANCER","3;1;1;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;2.1 EXOGENOUS FACTORS IN THE ORIGIN AND CAUSE OF CANCER;4.1 TECHNOLOGY DEVELOPMENT AND/OR MARKER DISCOVERY;3.3 CHEMOPREVENTION;5.7 RESOURCES AND INFRASTRUCTURE RELATED TO TREATMENT AND THE PREVENTION OF RECURRENCE;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","4;2;2;1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_UMBERTOI",2012,251,9.76494023904382,3.46613545816733,0.589641434262948,0.450199203187251,0.625498007968127,1.48464163822526,1.2436974789916,1.3452380952381,1.26612903225806,0.334661354581673,2,110,48,33,41,0.44,0.19,0.13,0.16,48.04,1.150054383857,4.50631578947369,0.167330677290837,0.745019920318725,0.403,0.382,0.36,0.381,"GENNARO SARDELLA;FLAVIA LONGO;PASQUALE FINO;FRANCESCO FEDELE;FILIPPO CAMEROTA;MARIA GIUSEPPINA ONESTI;CLAUDIA CELLETTI;TOMMASO STROFFOLINI;PAOLO FIORAMONTI;NICOLÒ SCUDERI;VALENTINA PISTOLESI;ALESSANDRO PIERUCCI;SANTO MORABITO;MASSIMO MANCONE;QUIRINO LAI;FRANCESCA POLISTENA;SALVATORE MINISOLA;AGNESE FABBRI;MARCO CASTORI;NICOLA BASSO","11;10;9;8;7;7;7;7;7;7;6;6;6;6;6;5;5;5;5;5","PASQUALE FINO;MARIA GIUSEPPINA ONESTI;NICOLÒ SCUDERI;FRANCESCO GIOVAGNORIO;PAOLO FIORAMONTI;FABRIZIO SANSONE;FEDERICO MIOZZI;GIUSEPPE GENOVESI;FILIPPO CAMEROTA;CLAUDIA CELLETTI;M ASSENZA;GENNARO SARDELLA;FRANCESCO FEDELE;FLAVIA LONGO;MAURIZIO DOMENICUCCI;PAOLO MISSORI;VALENTINA PISTOLESI;ALESSANDRO PIERUCCI;SANTO MORABITO;FILIPPO MANTI","1.67;1.33;1.33;1.33;1.3;1.27;1;1;0.97;0.97;0.96;0.89;0.86;0.84;0.83;0.83;0.8;0.8;0.8;0.73","GENNARO SARDELLA;FLAVIA LONGO;PASQUALE FINO;FRANCESCO FEDELE;FILIPPO CAMEROTA;MARIA GIUSEPPINA ONESTI;CLAUDIA CELLETTI;TOMMASO STROFFOLINI;PAOLO FIORAMONTI;NICOLÒ SCUDERI;VALENTINA PISTOLESI;ALESSANDRO PIERUCCI;SANTO MORABITO;MASSIMO MANCONE;QUIRINO LAI;FRANCESCA POLISTENA;SALVATORE MINISOLA;AGNESE FABBRI;NICOLA BASSO;GIOVANNI CASELLA","11;10;9;8;7;7;7;7;7;7;6;6;6;6;6;5;5;5;5;5","PASQUALE FINO;MARIA GIUSEPPINA ONESTI;NICOLÒ SCUDERI;FRANCESCO GIOVAGNORIO;PAOLO FIORAMONTI;FABRIZIO SANSONE;FEDERICO MIOZZI;GIUSEPPE GENOVESI;FILIPPO CAMEROTA;CLAUDIA CELLETTI;M ASSENZA;GENNARO SARDELLA;FRANCESCO FEDELE;FLAVIA LONGO;MAURIZIO DOMENICUCCI;PAOLO MISSORI;VALENTINA PISTOLESI;ALESSANDRO PIERUCCI;SANTO MORABITO;FILIPPO MANTI","1.67;1.33;1.33;1.33;1.3;1.27;1;1;0.97;0.97;0.96;0.89;0.86;0.84;0.83;0.83;0.8;0.8;0.8;0.73","FLAVIA LONGO;ENRICO CORTESI;A. VERGNENÈGRE;ALESSANDRA BEARZ;ALFONSO ILLIANO;AMELIA INSA;ANA DROZDOWSKYJ;BARTOMEU MASSUTÍ;CHRISTIAN ROLFO;CINTA PALLARÉS;CRISTINA QUERALT;DELVYS RODRÍGUEZ‐ABREU;DOLORES ISLA;ENRIC CARCERENY;ENRIQUETA FELIP;FILIPPO DE MARINIS;G. ROBINET;GIUSEPPE ALTAVILLA;GUILLERMO LÓPEZ-VIVANCO;ISABEL BOVER","5285;5158;5154;5154;5154;5154;5154;5154;5154;5154;5154;5154;5154;5154;5154;5154;5154;5154;5154;5154","FLAVIA LONGO;N. SULLI;GIOVANNI CASELLA;NICOLA BASSO;ANTONIO GIORDANO;MARIO VENDITTI;EMANUELE SORICELLI;FRANCESCA ABBATINI;TOMMASO STROFFOLINI;ANGELO IOSSA;BENEDETTO CALÌ;GENNARO SARDELLA;CLAUDIA CELLETTI;FILIPPO CAMEROTA;FRIDA LEONETTI;CARLO COLOSIMO;FRANCESCO VIOLI;ADA FRANCIA;MARCO PAOLONI;VALTER SANTILLI","5285;454;341;341;319;319;300;300;280;268;268;254;247;247;229;213;207;197;185;185","GENNARO SARDELLA;FLAVIA LONGO;TOMMASO STROFFOLINI;FRANCESCO FEDELE;MASSIMO MANCONE;SANTO MORABITO;ALESSANDRO PIERUCCI;CLAUDIA CELLETTI;EMANUELE CANALI;FILIPPO CAMEROTA;FRANCESCA POLISTENA;MASSIMO ROSSI;QUIRINO LAI;VALENTINA PISTOLESI;SALVATORE MINISOLA;FRIDA LEONETTI;DANIELA ADUA;LAURA ZEPPILLI;LUIGI LUCISANO;LUIGI TRITAPEPE","11;11;7;7;6;6;5;5;5;5;5;5;5;5;5;4;4;4;4;4","MEDICINE;BIOLOGY;PHYSICS;PSYCHOLOGY;ENGINEERING;COMPUTER SCIENCE;CHEMISTRY;MATHEMATICS;SOCIOLOGY;ECONOMICS;MATERIALS SCIENCE;GEOGRAPHY;HISTORY;PHILOSOPHY;POLITICAL SCIENCE;ART","241;52;22;17;14;12;11;9;9;8;5;3;3;3;3;2","INTERNAL MEDICINE;SURGERY;PATHOLOGY;CARDIOLOGY;RADIOLOGY;ONCOLOGY;ANESTHESIA;GENETICS;ENDOCRINOLOGY;GASTROENTEROLOGY;ENVIRONMENTAL HEALTH;PSYCHIATRY;BIOCHEMISTRY;IMMUNOLOGY;PHYSICAL THERAPY;PHARMACOLOGY;INTENSIVE CARE MEDICINE;OPTICS;PEDIATRICS;ANATOMY;GENERAL SURGERY","171;108;45;40;39;29;27;26;25;25;21;21;19;18;17;14;12;12;12;10;10","CANCER;CHEMOTHERAPY;DISEASE;POPULATION;MYOCARDIAL INFARCTION;CONFIDENCE INTERVAL;PREGNANCY;ALTERNATIVE MEDICINE;RANDOMIZED CONTROLLED TRIAL;RETROSPECTIVE COHORT STUDY;TRANSPLANTATION;DIABETES MELLITUS;GENE;COHORT;INCIDENCE (GEOMETRY);ADVERSE EFFECT;MAGNETIC RESONANCE IMAGING;OBESITY;BIOPSY;MULTIVARIATE ANALYSIS;ODDS RATIO;STENT;VIRUS","40;25;23;21;20;15;14;13;13;13;13;11;11;10;10;9;9;9;8;8;8;8;8","COLORECTAL CANCER;PERCUTANEOUS CORONARY INTERVENTION;LIVER TRANSPLANTATION;CLINICAL ENDPOINT;CONVENTIONAL PCI;HAZARD RATIO;WEIGHT LOSS;BEVACIZUMAB;BREAST CANCER;HEPATITIS C VIRUS;REVASCULARIZATION;UNIVARIATE ANALYSIS;DOCETAXEL;EPIDERMAL GROWTH FACTOR RECEPTOR;GENOTYPE;HEART RATE;PERFORATION;ANTIEMETIC;AORTIC VALVE REPLACEMENT;BLADDER CANCER;CHEMOTHERAPY REGIMEN;CISPLATIN;CLOPIDOGREL;DYSLIPIDEMIA;FETUS;GESTATION;GESTATIONAL AGE;HEPATITIS B VIRUS;METASTASIS;NEURORADIOLOGY;PLACEBO;RESTENOSIS;TOLERABILITY;TYPE 2 DIABETES","13;10;7;6;6;6;6;5;5;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","GASTRIC BYPASS;KRAS;COLONOSCOPY;CONTINUOUS GLUCOSE MONITORING;DRUG-ELUTING STENT;ERLOTINIB;HEART RATE VARIABILITY;PALONOSETRON;RIBAVIRIN;APREPITANT;CAPECITABINE;CARBOPLATIN;CARFILZOMIB;CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING;GERD;HBSAG;INSULIN PUMP;INTERNATIONAL PROGNOSTIC SCORING SYSTEM;ISOPROSTANES;MACE;P2Y12;PEMETREXED;PRASUGREL;TRANSITIONAL CELL CARCINOMA;UROTHELIAL CELL","4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;FEMALE;MALE;MIDDLE AGED;;ADULT;AGED;TREATMENT OUTCOME;ITALY;PROSPECTIVE STUDIES;RETROSPECTIVE STUDIES;AGED, 80 AND OVER;YOUNG ADULT;MYOCARDIAL INFARCTION;RISK FACTORS;TIME FACTORS;FOLLOW-UP STUDIES;STROKE;ADOLESCENT;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS","163;124;111;103;85;71;65;44;36;28;28;26;25;22;22;22;21;21;18;16","CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;GENETIC AND MOLECULAR STUDIES OF CONNECTIVE TISSUE DISORDERS;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;ADVANCEMENTS IN LUNG CANCER RESEARCH;EFFECTS OF BARIATRIC SURGERY ON OBESITY AND DIABETES;HEPATITIS C INFECTION AND TREATMENT;DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION;MANAGEMENT AND OUTCOMES OF ACUTE KIDNEY INJURY;ANTIPLATELET THERAPY IN CARDIOVASCULAR DISEASE;CRANIOFACIAL RECONSTRUCTION TECHNIQUES;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;HEPATITIS B INFECTION AND TREATMENT;LIVER TRANSPLANTATION AND GRAFT SURVIVAL ANALYSIS;MANAGEMENT OF DIABETES MELLITUS AND HYPOGLYCEMIA;OSTEOPOROSIS;PREVENTION AND MANAGEMENT OF POSTOPERATIVE NAUSEA AND VOMITING;ACUTE MYELOID LEUKEMIA;ANALYSIS AND APPLICATIONS OF HEART RATE VARIABILITY;CHEMOTHERAPY-INDUCED DERMATOLOGICAL TOXICITY;CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER TREATMENT","7;7;5;5;5;5;4;4;3;3;3;3;3;3;3;3;2;2;2;2","TREATMENT;STROKE (ENGINE);CLINICAL ENDPOINT;DIABETES;JOINT HYPERMOBILITY;METASTATIC BREAST CANCER;DRUG-ELUTING STENTS;EHLERS-DANLOS SYNDROME;EHLERS–DANLOS SYNDROME;HYPERMOBILITY (TRAVEL);LIVER TRANSPLANTATION;METASTATIC COLORECTAL CANCER;REGIMEN;UNIVARIATE ANALYSIS;CORONARY STENTS;GLYCEMIC CONTROL;HEAD AND NECK RECONSTRUCTION;HEPATITIS C;LIVING DONOR LIVER TRANSPLANTATION;PERFORATION","14;7;6;6;6;6;5;5;5;5;5;5;5;5;4;4;4;4;4;4","HYPERMOBILITY TYPE;SYNDROME HYPERMOBILITY;CONTROLLED TRIAL;LUNG CANCER;RETROSPECTIVE ANALYSIS;CITRATE ANTICOAGULATION;JOINT HYPERMOBILITY;MAGNETIC RESONANCE;REGIONAL CITRATE;CELL CARCINOMA;CITRATE SOLUTION;CLINICAL CHARACTERISTICS;COLON CANCER;COLORECTAL CANCER;CONTINUOUS GLUCOSE;GLUCOSE MONITORING;LIVER TRANSPLANTATION;METASTATIC COLORECTAL;MULTICENTRIC RETROSPECTIVE;NSCLC PATIENTS;OBESE PATIENTS;POOLED ANALYSIS;RANDOMIZED CONTROLLED;SLEEVE GASTRECTOMY;TYPE DIABETES;VIRUS INFECTION;BREAST CANCER;C-REACTIVE PROTEIN;CANCER NSCLC;CANCER PATIENTS","6;6;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2","STYLEFONT-SIZE PX;TSPAN STYLEFONT-SIZE;YTSPAN TSPAN;HCV INFECTION;Β PI-PLC;PI-PLC Β;OVARIAN CANCER;PI-PLC Δ;COELIAC DISEASE;PLAQUE SURFACE;ARR CI;BLADDER CANCER;CHRONIC HEPATITIS;DAY REGIMEN;HIGH-DOSE CLOPIDOGREL;ANTIVIRAL TREATMENT;HIV DIAGNOSIS;MOTHERHOOD DESIRE;OXIDATIVE STRESS;PATIENTS TREATED;PROGNOSTIC FACTORS;RISK FACTORS;VIROLOGICAL RESPONSE;CAROTID PLAQUE;CONSECUTIVE PATIENTS;DRUG ADDICTS;GENE EXPRESSION;MEDIAN AGE;METABOLIC SYNDROME;MULTIVARIATE ANALYSIS","21;21;14;12;12;11;10;10;9;9;8;8;8;8;8;7;7;7;7;7;7;7;7;6;6;6;6;6;6;6",62,0.25,4.74,4,1,2.5,2,1.75,15.75,0,1,4,1,1,3,1,4.75,1,1,3,2,0,0,91,89.75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,26,4.33,693.5,4.83,8,0.31,56.69,0,0,3,1,8,0,8,6,0,14,4,0,0,0,0,0,0,23,0,3,18,8,0,0,0,0,0,0,0,0,"Italy;United States;Switzerland","3;3;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3009 VETERINARY SCIENCES;31 BIOLOGICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3210 NUTRITION AND DIETETICS;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;52 PSYCHOLOGY;5203 CLINICAL AND HEALTH PSYCHOLOGY","23;15;6;3;2;1;1;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;PATIENT SAFETY;CARDIOVASCULAR;PREVENTION;HEART DISEASE;HEMATOLOGY;RARE DISEASES;AGING;ATHEROSCLEROSIS;BIOMEDICAL IMAGING;BREAST CANCER;HEART DISEASE - CORONARY HEART DISEASE;LUNG;LUNG CANCER;NEURODEGENERATIVE;NEUROSCIENCES;AUTOIMMUNE DISEASE;BIOENGINEERING","18;12;7;7;5;5;3;3;3;2;2;2;2;2;2;2;2;2;1;1","CARDIOVASCULAR;CANCER;METABOLIC AND ENDOCRINE;BLOOD;GENERIC HEALTH RELEVANCE;INFECTION;INJURIES AND ACCIDENTS;NEUROLOGICAL;ORAL AND GASTROINTESTINAL;RENAL AND UROGENITAL;RESPIRATORY","6;4;3;1;1;1;1;1;1;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;6.4 SURGERY;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.3 MEDICAL DEVICES;7.1 INDIVIDUAL CARE NEEDS","12;2;2;1;1;1;1","BREAST CANCER;LIVER CANCER;LUNG CANCER;PROSTATE CANCER;COLON AND RECTAL CANCER;KIDNEY CANCER;LEUKEMIA / LEUKAEMIA","2;2;2;2;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;2.1 EXOGENOUS FACTORS IN THE ORIGIN AND CAUSE OF CANCER;3.2 NUTRITIONAL SCIENCE IN CANCER PREVENTION;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","6;1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,"PUBLIC LIBRARY OF SCIENCE","2","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3101 BIOCHEMISTRY AND CELL BIOLOGY;3204 IMMUNOLOGY","4;2;2;1;1","CANCER;OVARIAN CANCER;RARE DISEASES","1;1;1","CANCER","2","5.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES","2;1;1","BIOMEDICAL;CLINICAL","1;1","BASIC SCIENCE;CLINICAL MEDICINE AND SCIENCE","1;1","OVARIAN CANCER;GENITAL SYSTEM, FEMALE","2;1",NA,NA
"AOUSSN_UMBERTOI",2013,299,9.08361204013378,3.60535117056856,0.635451505016722,0.454849498327759,0.695652173913043,1.58615611192931,1.28378378378378,1.51111111111111,1.26060606060606,0.414715719063545,7,109,66,45,45,0.36,0.22,0.15,0.15,30.06,0.861411491357114,4.80406001765225,0.140468227424749,0.762541806020067,0.401,0.341,0.395,0.342,"FEDERICO VENUTA;MARZIA DUSE;PASQUALE FINO;MARIA GIUSEPPINA ONESTI;LUCIA MANGANARO;FRANCESCO FEDELE;PIERLUIGI BENEDETTI PANICI;FEDERICA TOMAO;GENNARO SARDELLA;NICOLÒ SCUDERI;ADRIANO REDLER;ANNA MARIA ZICARI;SIMONE CALCAGNO;MAURO PENNACCHI;VALENTINA DE VITTORI;LUIGI LUCISANO;FRANCESCA POLISTENA;DANIELE DISO;GABRIELLA D’ETTORRE;ANNALISA DI COSTE","12;11;10;7;7;7;7;7;7;7;6;6;6;6;6;6;5;5;5;5","CORRADO GIRMENIA;PASQUALE FINO;FEDERICO VENUTA;MARZIA DUSE;LUIGI BASSO;DANIELA MUSIO;GABRIELE MASSELLI;MARIA GIUSEPPINA ONESTI;NICOLÒ SCUDERI;ALESSANDRO LANDI;FEDERICO ZANGRANDO VALERIO ALLEMANINI;ADRIANO REDLER;PIERLUIGI BENEDETTI PANICI;GENNARO SARDELLA;PAOLO FIORAMONTI;LUCIA MANGANARO;SIMONE CALCAGNO;MAURO PENNACCHI;DANIELE DISO;ANNA MARIA ZICARI","2.27;1.8;1.66;1.45;1.42;1.33;1.31;1.25;1.17;1;1;0.96;0.94;0.94;0.91;0.88;0.87;0.82;0.82;0.79","FEDERICO VENUTA;MARZIA DUSE;PASQUALE FINO;MARIA GIUSEPPINA ONESTI;LUCIA MANGANARO;FRANCESCO FEDELE;PIERLUIGI BENEDETTI PANICI;FEDERICA TOMAO;GENNARO SARDELLA;NICOLÒ SCUDERI;ADRIANO REDLER;ANNA MARIA ZICARI;SIMONE CALCAGNO;MAURO PENNACCHI;VALENTINA DE VITTORI;LUIGI LUCISANO;FRANCESCA POLISTENA;DANIELE DISO;GABRIELLA D’ETTORRE;ANNALISA DI COSTE","12;11;10;7;7;7;7;7;7;7;6;6;6;6;6;6;5;5;5;5","CORRADO GIRMENIA;PASQUALE FINO;FEDERICO VENUTA;MARZIA DUSE;LUIGI BASSO;DANIELA MUSIO;GABRIELE MASSELLI;MARIA GIUSEPPINA ONESTI;NICOLÒ SCUDERI;ALESSANDRO LANDI;FEDERICO ZANGRANDO VALERIO ALLEMANINI;ADRIANO REDLER;PIERLUIGI BENEDETTI PANICI;GENNARO SARDELLA;PAOLO FIORAMONTI;LUCIA MANGANARO;SIMONE CALCAGNO;MAURO PENNACCHI;DANIELE DISO;ANNA MARIA ZICARI","2.27;1.8;1.66;1.45;1.42;1.33;1.31;1.25;1.17;1;1;0.96;0.94;0.94;0.91;0.88;0.87;0.82;0.82;0.79","VITO CANTISANI;ADRIAN SǍFTOIU;ANDREA KLAUSER;CHRISTIAN JENSSEN;DAVID O. COSGROVE;ELENI E. DRAKONAKI;FABIO PISCAGLIA;FABRIZIO CALLIADA;FRITZ SCHAEFER;IOAN SPOREA;J. FROMAGEAU;JEAN-MICHEL CORRÉAS;JEFFREY C. BAMBER;MATHIAS FINK;MIREEN FRIEDRICH‐RUST;MIRKO D’ONOFRIO;ODD HELGE GILJA;R OHLINGER;ROALD FLESLAND HAVRE;CHRISTOPH F. DIETRICH","1992;1965;1965;1965;1965;1965;1965;1965;1965;1965;1965;1965;1965;1965;1965;1965;1965;1965;1965;1088","VITO CANTISANI;FLAVIA LONGO;MARCO FALCONE;SALVATORE MINISOLA;FEDERICO VENUTA;ALESSANDRO RUSSO;MARIO VENDITTI;CARLO CATALANO;GENNARO SARDELLA;GABRIELLA D’ETTORRE;ENRICO CORTESI;MARIA GRAZIA PORPORA;COSTANTINO LEONARDO;GIORGIO FRANCO;S. BERTASI;SERENA QUATTRUCCI;GIULIA D’AMATI;PIERLUIGI BENEDETTI PANICI;CLAUDIA CELLETTI;FILIPPO CAMEROTA","1965;476;472;251;208;205;203;196;183;168;164;163;154;154;154;154;148;148;146;146","FEDERICO VENUTA;MARZIA DUSE;MASSIMO MANCONE;PIERLUIGI BENEDETTI PANICI;ADRIANO REDLER;FRANCESCO FEDELE;LUCIA MANGANARO;LUIGI LUCISANO;MARIA GIUSEPPINA ONESTI;PASQUALE FINO;VALENTINA DE VITTORI;CARLO CATALANO;EMANUELE FERRERO;MARCO ANILE;MARIA PALMA CARBONE;MAURO PENNACCHI;VALERIA VINCI;DANIELE DISO;GABRIELLA D’ETTORRE;GENNARO SARDELLA","12;9;8;7;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;ENGINEERING;MATHEMATICS;COMPUTER SCIENCE;PSYCHOLOGY;SOCIOLOGY;POLITICAL SCIENCE;MATERIALS SCIENCE;BUSINESS;ECONOMICS;PHILOSOPHY;ART","293;64;22;22;20;13;12;11;6;5;4;2;2;2;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;RADIOLOGY;CARDIOLOGY;GENETICS;IMMUNOLOGY;GASTROENTEROLOGY;ONCOLOGY;BIOCHEMISTRY;DERMATOLOGY;ENVIRONMENTAL HEALTH;PHYSICAL THERAPY;PSYCHIATRY;ANESTHESIA;ENDOCRINOLOGY;ANATOMY;MECHANICAL ENGINEERING;OPTICS;PEDIATRICS","185;146;64;54;37;34;27;26;26;21;20;20;17;17;15;15;14;14;14;14","CANCER;DISEASE;CHEMOTHERAPY;POPULATION;MAGNETIC RESONANCE IMAGING;MYOCARDIAL INFARCTION;GENE;RANDOMIZED CONTROLLED TRIAL;ALTERNATIVE MEDICINE;COHORT;MULTIVARIATE ANALYSIS;PREGNANCY;RETROSPECTIVE COHORT STUDY;ULTRASOUND;INCIDENCE (GEOMETRY);LESION;COMPLICATION;STROKE (ENGINE);HEART FAILURE;RADIATION THERAPY","50;24;23;19;18;18;15;15;13;12;12;12;12;12;11;11;10;10;9;9","COLORECTAL CANCER;OVARIAN CANCER;UNIVARIATE ANALYSIS;BREAST CANCER;BEVACIZUMAB;PERCUTANEOUS CORONARY INTERVENTION;AUTOANTIBODY;CLINICAL ENDPOINT;CONVENTIONAL PCI;FETUS;ISCHEMIC STROKE;LIVER TRANSPLANTATION;METASTASIS;CARDIOMYOPATHY;RESTENOSIS;RITUXIMAB;ADENOCARCINOMA;ALLELE;AORTIC ANEURYSM;ASCENDING AORTA;BONE DENSITY;BONE MINERAL;CYCLOPHOSPHAMIDE;DIFFUSION MRI;EJECTION FRACTION;HEART RATE;INSULIN RESISTANCE;MULTICENTER STUDY;MUTATION;NEURORADIOLOGY;NEUTROPENIA;PROSTATE CANCER;REVASCULARIZATION;SPIROMETRY;STAPHYLOCOCCUS AUREUS;THROMBOLYSIS","17;10;9;8;7;6;5;5;5;5;5;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","MODIFIED RANKIN SCALE;DEBULKING;DRUG-ELUTING STENT;IRINOTECAN;AUTONOMIC NERVOUS SYSTEM;BONE METASTASIS;CYTOREDUCTIVE SURGERY;EPITHELIAL OVARIAN CANCER;HIATAL HERNIA;IN UTERO;KRAS;METASTATIC BREAST CANCER;NEOADJUVANT THERAPY;OXALIPLATIN;PENETRANCE;PRIMARY TUMOR;RADICAL HYSTERECTOMY;SUBLINGUAL IMMUNOTHERAPY;TARGET LESION;TERIPARATIDE;VANCOMYCIN","4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;MALE;FEMALE;MIDDLE AGED;;ADULT;AGED;TREATMENT OUTCOME;AGED, 80 AND OVER;RETROSPECTIVE STUDIES;ITALY;FOLLOW-UP STUDIES;POSTOPERATIVE COMPLICATIONS;YOUNG ADULT;ADOLESCENT;TIME FACTORS;BONE NEOPLASMS;TOMOGRAPHY, X-RAY COMPUTED;BIOMARKERS;CHILD","202;150;149;114;91;84;84;63;41;38;32;31;31;30;28;24;22;21;20;20","CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;MICROSURGICAL RECONSTRUCTION TECHNIQUES;NEUROFIBROMATOSIS TYPE 1 AND TYPE 2;COLORECTAL CANCER RESEARCH AND TREATMENT;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;DIAGNOSIS AND MANAGEMENT OF FUNGAL INFECTIONS;EPIDEMIOLOGY AND MANAGEMENT OF STROKE;GENETICS AND DEVELOPMENT OF CRANIOFACIAL ABNORMALITIES;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;EPIDEMIOLOGY AND MANAGEMENT OF OCULAR INFLAMMATORY DISEASES;ESOPHAGEAL INTERVENTION TECHNIQUES;GENETIC AND MOLECULAR STUDIES OF CONNECTIVE TISSUE DISORDERS;GENOMIC STUDIES AND TREATMENT OF OVARIAN CARCINOMA;LYMPHOID NEOPLASMS;MANAGEMENT OF SPINAL METASTATIC TUMORS;MANAGEMENT OF VALVULAR HEART DISEASE;OSTEOPOROSIS;PREVALENCE AND TREATMENT OF HYPERHIDROSIS","5;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3","TREATMENT;STROKE (ENGINE);UNIVARIATE ANALYSIS;CAROTID ARTERY STENOSIS;CLINICAL ENDPOINT;INFARCTION TREATMENT;MICROSURGICAL RECONSTRUCTION;NEUROFIBROMATOSIS;AORTIC ANEURYSMS;AORTIC DISSECTION;AORTIC ROOT REPLACEMENT;BRAIN METASTASES;DISTAL RADIUS FRACTURES;GROUP B;PERFORATOR FLAP;SINGLE CENTER;ADJUVANT CHEMOTHERAPY;ANTIFUNGAL THERAPY;ASTHMA;BONE METASTASES","11;10;9;6;5;5;5;5;4;4;4;4;4;4;4;4;3;3;3;3","OVARIAN CANCER;RETROSPECTIVE STUDY;COLORECTAL CANCER;CYSTIC FIBROSIS;MAGNETIC RESONANCE;BREAST CANCER;CONTROLLED TRIAL;ISCHEMIC STROKE;MYOCARDIAL INFARCTION;PILOT STUDY;REAL LIFE;ACUTE ISCHEMIC;ADVANCED OVARIAN;COHERENCE TOMOGRAPHY;EPITHELIAL OVARIAN;FIRST-LINE TREATMENT;LIVER TRANSPLANTATION;LUNG CANCER;METASTATIC COLORECTAL;OPTICAL COHERENCE;PHASE III;RANDOMIZED CONTROLLED;RECTAL CANCER;RESONANCE IMAGING;TRIBE TRIAL;ACUTE MYOCARDIAL;ADOLESCENT IDIOPATHIC;ALLELIC VARIANTS;AORTIC ANEURYSMS;AORTIC ROOT","7;7;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2","OVARIAN CANCER;COMPUTED TOMOGRAPHY;PATIENTS RECEIVED;PATIENTS TREATED;CONFIDENCE INTERVAL;MYOCARDIAL INFARCTION;PATIENTS UNDERGOING;Β Β;PUBMED SCOPUS;CORONARY ARTERY;INDUCTION THERAPY;MAGNETIC RESONANCE;ODDS RATIO;STENT GRAFT;AORTIC REPAIR;MACULAR EDEMA;MMLMATH XMLNSMMLHTTPWWWWORGMATHMATHML;MONTHS NA;SURGICAL EXCISION;THORACIC AORTA;THORACOSCOPIC SYMPATHECTOMY;CF PATIENTS;COMPENSATORY SWEATING;FAECAL MICROBIOTA;HEALTHY SUBJECTS;LEFT VENTRICULAR;MM MM;MORTALITY RATE;PATIENTS AFFECTED;PATIENTS UNDERWENT","19;11;11;11;10;10;10;10;9;8;8;8;8;8;7;7;7;7;7;7;7;6;6;6;6;6;6;6;6;6",68,0.23,5,5,2,1,1,1.5,2.5,1,1,6,1,1,5.25,1,2.5,1,2,5,4,0,0,74,80,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,32,4.52,1692.07,5.01,11,0.34,117.09,0,1,6,0,12,0,2,11,0,19,9,0,0,0,0,0,0,28,4,0,27,4,0,0,1,0,0,0,0,0,"United States;Italy;Switzerland;United Kingdom;Germany;Belgium","9;6;3;3;2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3212 OPHTHALMOLOGY AND OPTOMETRY;3213 PAEDIATRICS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;35 COMMERCE, MANAGEMENT, TOURISM AND SERVICES;3505 HUMAN RESOURCES AND INDUSTRIAL RELATIONS;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;42 HEALTH SCIENCES;4205 NURSING;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","31;16;7;3;1;1;1;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PATIENT SAFETY;CANCER;CARDIOVASCULAR;HEART DISEASE;RARE DISEASES;ATHEROSCLEROSIS;DIGESTIVE DISEASES;HEART DISEASE - CORONARY HEART DISEASE;BRAIN DISORDERS;HEMATOLOGY;AUTOIMMUNE DISEASE;NEUROSCIENCES;AGING;ARTHRITIS;DIABETES;INFECTIOUS DISEASES;LUNG;LYMPHOMA","25;13;9;8;8;7;7;6;6;6;4;4;3;3;2;2;2;2;2;2","CARDIOVASCULAR;CANCER;INFLAMMATORY AND IMMUNE SYSTEM;NEUROLOGICAL;EYE;INFECTION","7;6;2;2;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.2 CELLULAR AND GENE THERAPIES;6.3 MEDICAL DEVICES","19;4;2;1;1;1","COLON AND RECTAL CANCER;BRAIN TUMOR;BREAST CANCER;LEUKEMIA / LEUKAEMIA;LUNG CANCER;MYELOMA;NON-HODGKIN'S LYMPHOMA;NOT SITE-SPECIFIC CANCER;OVARIAN CANCER","2;1;1;1;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","8;1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,"PUBLIC LIBRARY OF SCIENCE","3","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3107 MICROBIOLOGY;3202 CLINICAL SCIENCES;3207 MEDICAL MICROBIOLOGY","6;4;2;2;2","CLINICAL RESEARCH;CYSTIC FIBROSIS;INFECTIOUS DISEASES;LUNG;ORPHAN DRUG;RARE DISEASES","1;1;1;1;1;1","CONGENITAL;INFECTION","3;2","2.2 FACTORS RELATING TO THE PHYSICAL ENVIRONMENT;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","2;1","BIOMEDICAL","1","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE","2;1","LUNG CANCER","1",NA,NA
"AOUSSN_UMBERTOI",2014,299,10.3979933110368,2.93311036789298,0.45819397993311,0.408026755852843,0.525083612040134,1.37519623233909,1.21238938053097,1.31182795698925,1.20769230769231,0.454849498327759,12,101,84,44,36,0.34,0.28,0.15,0.12,23.34,0.617537501070824,4.79908675799086,0.20066889632107,0.882943143812709,0.42,0.341,0.403,0.333,"FEDERICO VENUTA;STEFANO CALVIERI;FILIPPO CAMEROTA;ERINO ANGELO RENDINA;CLAUDIA CELLETTI;VINCENZO TOMBOLINI;MARCO FALCONE;GENNARO SARDELLA;PASQUALE PIGNATELLI;MARIA GRAZIA PORPORA;VINCENZO MARIA SARACENI;TERESA PAOLUCCI;SOLMAZ ABDOLRAHIMZADEH;ANDREA LENZI;MASSIMO ROSSI;VALTER SANTILLI;FRANCESCO VIOLI;MARIO VENDITTI;ANNA MARIA CICCONE;CLAUDIO ANDREETTI","13;10;7;7;7;6;6;6;5;5;5;5;5;5;5;5;5;5;5;4","FEDERICO VENUTA;FILIPPO CAMEROTA;CLAUDIA CELLETTI;GIOVANNI PAOLINO;STEFANO CALVIERI;ALESSANDRO LANDI;ROCCO EDOARDO STIO;VINCENZO TOMBOLINI;CLAUDIA STEFANUTTI;ALESSANDRO SCIARRA;V ALEANDRI;E. BONUCCI;ANNAMARIA IAGNOCCO;VINGOLO EM ARANGIO P;LUIGI VENTURINI DANIELE FERRARO;MARCO FALCONE;MASSIMO MANCONE;SOLMAZ ABDOLRAHIMZADEH;FRANCESCA DE FELICE;DANIELA MUSIO","2.96;1.72;1.72;1.37;1.36;1.2;1.17;1.01;1;1;1;1;1;1;1;0.85;0.85;0.84;0.83;0.83","FEDERICO VENUTA;STEFANO CALVIERI;FILIPPO CAMEROTA;CLAUDIA CELLETTI;VINCENZO TOMBOLINI;MARCO FALCONE;GENNARO SARDELLA;PASQUALE PIGNATELLI;MARIA GRAZIA PORPORA;VINCENZO MARIA SARACENI;TERESA PAOLUCCI;SOLMAZ ABDOLRAHIMZADEH;ANDREA LENZI;MASSIMO ROSSI;VALTER SANTILLI;FRANCESCO VIOLI;MARIO VENDITTI;GIOVANNI PAOLINO;ROBERTO DELFINI;FEDERICO ZANGRANDO","13;10;7;7;6;6;6;5;5;5;5;5;5;5;5;5;5;4;4;4","FEDERICO VENUTA;FILIPPO CAMEROTA;CLAUDIA CELLETTI;GIOVANNI PAOLINO;STEFANO CALVIERI;ALESSANDRO LANDI;ROCCO EDOARDO STIO;VINCENZO TOMBOLINI;CLAUDIA STEFANUTTI;ALESSANDRO SCIARRA;V ALEANDRI;E. BONUCCI;ANNAMARIA IAGNOCCO;VINGOLO EM ARANGIO P;LUIGI VENTURINI DANIELE FERRARO;MARCO FALCONE;MASSIMO MANCONE;SOLMAZ ABDOLRAHIMZADEH;FRANCESCA DE FELICE;DANIELA MUSIO","2.96;1.72;1.72;1.37;1.36;1.2;1.17;1.01;1;1;1;1;1;1;1;0.85;0.85;0.84;0.83;0.83","FEDERICO VENUTA;GENNARO SARDELLA;ENRICO RUFFINI;ALAIDE CHIEFFO;ANTONIO COLOMBO;PATRIZIA PRESBITERO;ERINO ANGELO RENDINA;ALBERTO MENOZZI;ARIAN FRASHERI;BRUNO MARIO CESANA;EDOARDO PUCCI;GENNARO GIUSTINO;GIUSEPPE TARANTINI;J. DOMÍNGUEZ;JOSEPA MAURI;LUIGI STEFFANON;MÓNICA MASOTTI-CENTOL;NEUS SALVATELLA;ROBERTO GARBO;ALESSANDRO BRUNELLI","643;467;442;410;410;410;408;402;402;402;402;402;402;402;402;402;402;402;402;372","FEDERICO VENUTA;GENNARO SARDELLA;SERENA QUATTRUCCI;CORRADO MORETTI;PAOLA PAPOFF;FRANCESCO PARISI;MAGDA GHARBIYA;MARCO FALCONE;CORRADO GIRMENIA;ILARIA STOLFI;ROBERTO PEDICINO;ALESSANDRO BUSCA;ANNA CANDONI;ANNA CHIERICHINI;DOMENICO RUSSO;FABIO PAVAN;GENNARO DE ROSA;SIMONA BASSI;ALESSANDRA CAMPANELLI;ALESSANDRO TREBBASTONI","643;460;331;256;256;204;204;190;187;176;176;154;154;154;154;154;154;154;150;150","FEDERICO VENUTA;CLAUDIA CELLETTI;FILIPPO CAMEROTA;STEFANO CALVIERI;GENNARO SARDELLA;MARCO FALCONE;ANDREA LENZI;MARIA GRAZIA PORPORA;MARIO VENDITTI;SOLMAZ ABDOLRAHIMZADEH;VALTER SANTILLI;VINCENZO TOMBOLINI;CLAUDIO TERZANO;DANIELA MUSIO;DELIAR YAZDANIAN;FEDERICO ZANGRANDO;FRANCESCA DE FELICE;LAURA CAPOCCIA;MARIA TERESA PETRUCCI;MASSIMO MANCONE","13;6;6;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4","MEDICINE;BIOLOGY;PSYCHOLOGY;PHYSICS;CHEMISTRY;COMPUTER SCIENCE;ENGINEERING;MATHEMATICS;SOCIOLOGY;ECONOMICS;MATERIALS SCIENCE;PHILOSOPHY;POLITICAL SCIENCE;GEOGRAPHY;HISTORY;ART;BUSINESS","289;73;27;26;22;16;15;10;9;8;8;8;7;3;2;1;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;RADIOLOGY;GASTROENTEROLOGY;GENETICS;CARDIOLOGY;ONCOLOGY;PSYCHIATRY;BIOCHEMISTRY;ENVIRONMENTAL HEALTH;IMMUNOLOGY;INTENSIVE CARE MEDICINE;ENDOCRINOLOGY;DERMATOLOGY;PEDIATRICS;PHYSICAL THERAPY;ANESTHESIA;CANCER RESEARCH;ANATOMY;OPHTHALMOLOGY;PALEONTOLOGY","189;101;56;43;38;38;35;35;31;25;23;23;21;19;18;18;18;14;14;12;12;12","CANCER;DISEASE;GENE;POPULATION;CHEMOTHERAPY;MYOCARDIAL INFARCTION;PREGNANCY;RETROSPECTIVE COHORT STUDY;ALTERNATIVE MEDICINE;COHORT;DIABETES MELLITUS;LUNG;ADVERSE EFFECT;BLOOD PRESSURE;CONFIDENCE INTERVAL;INCIDENCE (GEOMETRY);RADIATION THERAPY;TRANSPLANTATION;HEART FAILURE;HORMONE;MAGNETIC RESONANCE IMAGING;OBESITY;RANDOMIZED CONTROLLED TRIAL;VIRUS","42;34;28;20;18;18;13;13;12;12;11;11;10;9;9;9;9;9;8;8;8;8;8;8","BREAST CANCER;COLORECTAL CANCER;PROSTATE CANCER;GENOTYPE;HAZARD RATIO;METASTASIS;PERCUTANEOUS CORONARY INTERVENTION;CLINICAL ENDPOINT;CONVENTIONAL PCI;BEVACIZUMAB;HEART RATE;METABOLIC SYNDROME;MUTATION;PROSTATE;TYPE 2 DIABETES;FATTY LIVER;HEPATITIS B VIRUS;INFERTILITY;LIVER TRANSPLANTATION;TOLERABILITY","11;9;9;7;7;7;7;6;6;5;5;5;5;5;5;4;4;4;4;4","BONE METASTASIS;HBSAG;PROSTATE-SPECIFIC ANTIGEN;ANAPLASTIC ASTROCYTOMA;ANDROGEN DEPRIVATION THERAPY;ANDROGEN RECEPTOR;AUTONOMIC NERVOUS SYSTEM;DISCOVERY AND DEVELOPMENT OF MTOR INHIBITORS;DUTASTERIDE;ENOS;FINASTERIDE;FRACTIONAL FLOW RESERVE;HEART RATE VARIABILITY;KLEBSIELLA PNEUMONIAE;MALE INFERTILITY;METASTATIC BREAST CANCER;MISSENSE MUTATION;PDGFRA;RANIBIZUMAB;UTERINE ARTERY;VANCOMYCIN","3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;FEMALE;MALE;MIDDLE AGED;;ADULT;AGED;ITALY;TREATMENT OUTCOME;RETROSPECTIVE STUDIES;AGED, 80 AND OVER;YOUNG ADULT;FOLLOW-UP STUDIES;TIME FACTORS;ADOLESCENT;THYMUS NEOPLASMS;RISK FACTORS;BIOMARKERS;PROSPECTIVE STUDIES;THYMOMA","195;143;138;117;101;91;82;53;40;38;37;33;25;24;23;21;19;18;18;18","CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;NEUROFIBROMATOSIS TYPE 1 AND TYPE 2;HEPATITIS B INFECTION AND TREATMENT;MYASTHENIA GRAVIS AND THYMIC TUMORS RESEARCH;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;GENETIC AND MOLECULAR STUDIES OF CONNECTIVE TISSUE DISORDERS;GLIOMAS;NEONATAL LUNG DEVELOPMENT AND RESPIRATORY MORBIDITY;RENAL CELL CARCINOMA;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;AGE-RELATED MACULAR DEGENERATION RESEARCH;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;DIAGNOSIS AND TREATMENT OF LUNG CANCER;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;GUILLAIN-BARRÉ SYNDROME AND RELATED NEUROPATHIES;PATHOPHYSIOLOGY OF LUMBAR DISC DEGENERATION AND TREATMENT","7;6;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","CLINICAL ENDPOINT;TREATMENT;CONCOMITANT;DIAGNOSIS;NEUROFIBROMATOSIS;STROKE (ENGINE);CARDIAC IMAGING;COPD;DRUG-ELUTING STENTS;EHLERS–DANLOS SYNDROME;ETIOLOGY;HYPERMOBILITY (TRAVEL);JOINT HYPERMOBILITY;PATHOGENESIS;THYMIC TUMORS;TOLERABILITY;AORTIC DISSECTION;ATRIAL FIBRILLATION;CARDIOTHORACIC SURGERY;CORONARY FLOW RESERVE","7;7;6;6;5;5;4;4;4;4;4;4;4;4;4;4;3;3;3;3","ITALIAN SOCIETY;ATRIAL FIBRILLATION;BREAST CANCER;CELL CARCINOMA;COHORT STUDY;COLORECTAL CANCER;HYPERMOBILITY TYPE;JOINT HYPERMOBILITY;KIDNEY DISEASE;METASTATIC RENAL;MYOCARDIAL INFARCTION;NEUROFIBROMATOSIS TYPE;PATIENTS PTS;PRELIMINARY RESULTS;PROSTATE CANCER;RENAL CELL;SYNDROME HYPERMOBILITY;ABDOMINAL AORTIC;ACUTE MYOCARDIAL;AGE-RELATED MACULAR;CHRONIC KIDNEY;COMPLETE REMISSION;CORONARY FLOW;FLOW RESERVE;LIVER TRANSPLANTATION;MACULAR DEGENERATION;METABOLIC SYNDROME;MULTICENTRE STUDY;MULTIPLE MYELOMA;NEWLY DIAGNOSED","6;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","STATISTICALLY SIGNIFICANT;GT YRS;PTS AGED;MONTHS RANGE;FATTY LIVER;ITALIAN SOCIETY;NON-ALCOHOLIC FATTY;RECONSTRUCTIVE SURGERY;UTERINE ARTERY;AGED YRS;HEALTHY CONTROLS;PATIENTS TREATED;RISK FACTORS;SPORTS SCORE;SURGICAL TREATMENT;AGED GT;COMPLETE RESECTION;CUMULATIVE INCIDENCE;LIVER DISEASE;MASAOKA-KOGA STAGE;MEDIAN TIME;MULTIVARIATE ANALYSIS;ODDS RATIO;OXIDATIVE STRESS;PATIENT UNDERWENT;SHOULDER INSTABILITY;VISUAL ACUITY;VOLUME LOSS;XMLNSMMLHTTPWWWWORGMATHMATHML IDMMMLMIPMMLMIMMLMOLTMMLMOMMLMNMMLMNMMLMATH;ADJUVANT CHEMOTHERAPY","12;11;10;9;8;8;8;8;8;7;7;7;7;7;7;6;6;6;6;6;6;6;6;6;6;6;6;6;6;5",87,0.29,4.53,3,1,1,1,2,7,1,1,4,0,0,3,0,1,1,1,2,1.25,0,0,71,71.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,20,4.32,370.53,3.41,7,0.35,48.55,0,0,5,0,5,0,0,10,0,13,6,0,0,0,0,0,0,19,1,0,19,1,0,0,0,0,0,0,0,0,"Italy;United States","5;5","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3204 IMMUNOLOGY;3207 MEDICAL MICROBIOLOGY;4203 HEALTH SERVICES AND SYSTEMS","19;11;7;5;4;3;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;DIGESTIVE DISEASES;RARE DISEASES;CHRONIC PAIN;COMPARATIVE EFFECTIVENESS RESEARCH;LUNG;NEUROSCIENCES;PAIN RESEARCH;BEHAVIORAL AND SOCIAL SCIENCE;COLO-RECTAL CANCER;CYSTIC FIBROSIS;HEMATOLOGY;LUNG CANCER;MENTAL HEALTH;ORPHAN DRUG;PREVENTION;REHABILITATION;ACQUIRED COGNITIVE IMPAIRMENT","17;12;9;6;5;4;4;4;4;4;2;2;2;2;2;2;2;2;2;1","CANCER;CONGENITAL;MUSCULOSKELETAL;GENERIC HEALTH RELEVANCE;INFECTION;MENTAL HEALTH;NEUROLOGICAL;ORAL AND GASTROINTESTINAL","7;2;2;1;1;1;1;1","6.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;6.6 PSYCHOLOGICAL AND BEHAVIOURAL;6.2 CELLULAR AND GENE THERAPIES;6.4 SURGERY","11;2;2;1;1","COLON AND RECTAL CANCER;LUNG CANCER;NON-HODGKIN'S LYMPHOMA;BREAST CANCER;MELANOMA;MYELOMA;NOT SITE-SPECIFIC CANCER;PANCREATIC CANCER","3;2;2;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;2.1 EXOGENOUS FACTORS IN THE ORIGIN AND CAUSE OF CANCER;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","6;2;1;1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"PUBLIC LIBRARY OF SCIENCE","5","31 BIOLOGICAL SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3107 MICROBIOLOGY;3204 IMMUNOLOGY;3207 MEDICAL MICROBIOLOGY","2;2;1;1;1","CHRONIC LIVER DISEASE AND CIRRHOSIS;CLINICAL RESEARCH;DIGESTIVE DISEASES;EMERGING INFECTIOUS DISEASES;HEPATITIS;HEPATITIS - B;HEPATITIS - C;HIV/AIDS;INFECTIOUS DISEASES;LIVER DISEASE","1;1;1;1;1;1;1;1;1;1","INFECTION","1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","1","BIOMEDICAL","1","BASIC SCIENCE","1","LIVER CANCER","1",NA,NA
"AOUSSN_UMBERTOI",2015,369,11.2764227642276,2.86720867208672,0.436314363143631,0.357723577235772,0.479674796747967,1.48732394366197,1.21969696969697,1.3469387755102,1.24647887323944,0.449864498644986,18,145,99,52,35,0.39,0.27,0.14,0.09,28.25,0.758145995161418,4.77029840388618,0.281842818428184,0.89159891598916,0.443,0.411,0.382,0.408,"ROBERTO PETRIOLI;LETIZIA LAERA;EDOARDO FRANCINI;GIANDOMENICO ROVIELLO;ANNA IDA FIASCHI;FEDERICO VENUTA;FRANCESCO VIOLI;LAURA CAPOCCIA;VINCENZO BIANCO;MASSIMO BRECCIA;ERINO ANGELO RENDINA;VITO CANTISANI;FRANCESCO SPEZIALE;CRISTINA SANTORO;PASQUALINO SIRIGNANO;WASSIM MANSOUR;DANIELE MARRELLI;ROBERTO CANGEMI;MARIA GABRIELLA MAZZUCCONI;PASQUALE PIGNATELLI","15;14;14;14;11;11;9;8;8;8;7;7;7;7;7;7;7;7;7;6","MASSIMO BRECCIA;ROBERTO PETRIOLI;ANTONIO V. STERPETTI;LETIZIA LAERA;EDOARDO FRANCINI;GIANDOMENICO ROVIELLO;GABRIELE MASSELLI;LUCIA MANGANARO;ANNA IDA FIASCHI;NICOLA MAROTTA;MAGDA GHARBIYA;EMANUELE CASCIANI;FRANCESCA ROMANA SPINELLI;PASQUALE FINO;FEDERICO VENUTA;LAURA CAPOCCIA;ONESTI MG FINO P;LEONARDO CALÒ;ALESSANDRO COPPOLA;FILIACI FABIO","3.19;2.72;2.67;1.72;1.72;1.72;1.61;1.45;1.36;1.34;1.31;1.24;1.2;1.2;1.17;1.02;1;1;1;1","ROBERTO PETRIOLI;EDOARDO FRANCINI;FEDERICO VENUTA;FRANCESCO VIOLI;LAURA CAPOCCIA;VINCENZO BIANCO;MASSIMO BRECCIA;VITO CANTISANI;FRANCESCO SPEZIALE;CRISTINA SANTORO;PASQUALINO SIRIGNANO;WASSIM MANSOUR;ROBERTO CANGEMI;MARIA GABRIELLA MAZZUCCONI;PASQUALE PIGNATELLI;VINCENZO TOMBOLINI;FRANCESCA DE FELICE;FLAVIA LONGO;DANIELE PASTORI;LUCIA MANGANARO","15;14;11;9;8;8;8;7;7;7;7;7;7;7;6;6;6;6;6;6","MASSIMO BRECCIA;ROBERTO PETRIOLI;ANTONIO V. STERPETTI;EDOARDO FRANCINI;GABRIELE MASSELLI;LUCIA MANGANARO;NICOLA MAROTTA;MAGDA GHARBIYA;EMANUELE CASCIANI;FRANCESCA ROMANA SPINELLI;PASQUALE FINO;FEDERICO VENUTA;LAURA CAPOCCIA;ONESTI MG FINO P;LEONARDO CALÒ;ALESSANDRO COPPOLA;FILIACI FABIO;FADDA MARIA TERESA;VINCENZO BIANCO;ENRICO CORTESI","3.19;2.72;2.67;1.72;1.61;1.45;1.34;1.31;1.24;1.2;1.2;1.17;1.02;1;1;1;1;1;0.92;0.87","GENNARO SARDELLA;ALESSANDRA REPETTO;ALESSANDRO LUPI;ANDREA GAGNOR;ANDREA SANTARELLI;ANTONIO ZINGARELLI;ARTURO AUSIELLO;BERNARDO CORTESE;CARLO BRIGUORI;DIK HEG;ENRICO FRIGOLI;FERDINANDO VARBELLA;GIOVANNI ESPOSITO;GIUSEPPE ANDÒ;MARCO VALGIMIGLI;MARTINA ROTHENBÜHLER;NICOLETTA DE CESARE;PAOLO CALABRÒ;PAOLO RUBARTELLI;PAOLO SGANZERLA","1595;1472;1472;1472;1472;1472;1472;1472;1472;1472;1472;1472;1472;1472;1472;1472;1472;1472;1472;1472","GENNARO SARDELLA;SILVIA MEZI;ALICE CONIGLIARO;CLAUDIO CARTONI;VITO CANTISANI;FLAVIA LONGO;FRANCESCA DE FELICE;FRANCESCO VIOLI;VINCENZO TOMBOLINI;FEDERICO VENUTA;ANGELA MUSELLA;CLÁUDIA MARCHETTI;MARCO CATANI;FABRIZIO CEREATTI;FAUSTO FIOCCA;LUDOVICO MUZII;PIERLUIGI BENEDETTI PANICI;ROBERTO CANGEMI;ELISABETTA DI CASTRO;VALENTINA ARCANGELI","1594;919;394;299;287;228;216;216;215;209;185;185;170;168;168;166;166;165;163;154","EDOARDO FRANCINI;FEDERICO VENUTA;LAURA CAPOCCIA;VINCENZO BIANCO;FRANCESCO VIOLI;WASSIM MANSOUR;FRANCESCA DE FELICE;MARIA GABRIELLA MAZZUCCONI;FRANCESCO SPEZIALE;PASQUALINO SIRIGNANO;VINCENZO TOMBOLINI;ANTONIO V. STERPETTI;A.F. ATTILI;DANILO MENNA;GABRIELE MASSELLI;GENNARO SARDELLA;GUIDO VALESINI;MASSIMO BRECCIA;NUNZIO MONTELIONE;SOLMAZ ABDOLRAHIMZADEH","14;10;8;8;7;7;7;7;6;6;6;5;5;5;5;5;5;5;5;5","MEDICINE;BIOLOGY;ENGINEERING;PHYSICS;PSYCHOLOGY;CHEMISTRY;COMPUTER SCIENCE;MATHEMATICS;ECONOMICS;PHILOSOPHY;GEOLOGY;MATERIALS SCIENCE;POLITICAL SCIENCE;SOCIOLOGY;ART;GEOGRAPHY;HISTORY;BUSINESS","359;73;29;28;20;18;16;14;8;6;5;5;5;4;3;3;2;1","INTERNAL MEDICINE;SURGERY;RADIOLOGY;ONCOLOGY;PATHOLOGY;GASTROENTEROLOGY;CARDIOLOGY;GENETICS;PSYCHIATRY;IMMUNOLOGY;ENDOCRINOLOGY;OPTICS;PEDIATRICS;ENVIRONMENTAL HEALTH;ANATOMY;BIOCHEMISTRY;MECHANICAL ENGINEERING;PHYSICAL THERAPY;GENERAL SURGERY;NURSING","240;165;61;53;52;49;36;36;34;24;23;20;20;19;18;18;18;18;16;16","CANCER;DISEASE;CHEMOTHERAPY;GENE;ADVERSE EFFECT;COHORT;POPULATION;RANDOMIZED CONTROLLED TRIAL;CONFIDENCE INTERVAL;STENT;INCIDENCE (GEOMETRY);PROSPECTIVE COHORT STUDY;DIABETES MELLITUS;STROKE (ENGINE);ABDOMINAL SURGERY;ALTERNATIVE MEDICINE;MYOCARDIAL INFARCTION;RADIATION THERAPY;RETROSPECTIVE COHORT STUDY;ANEURYSM;CLINICAL TRIAL;PREGNANCY;THROMBOSIS","62;40;39;25;22;22;19;18;17;17;16;16;15;14;13;13;13;13;13;12;12;12;12","COLORECTAL CANCER;BEVACIZUMAB;BREAST CANCER;HAZARD RATIO;PROSTATE CANCER;TOLERABILITY;CLINICAL ENDPOINT;DOCETAXEL;UNIVARIATE ANALYSIS;GENOTYPE;NEURORADIOLOGY;PERCUTANEOUS CORONARY INTERVENTION;PHENOTYPE;ABDOMINAL AORTIC ANEURYSM;CYCLOPHOSPHAMIDE;INSULIN RESISTANCE;NEUTROPENIA;TYPE 2 DIABETES;CISPLATIN;OVARIAN CANCER;SORAFENIB;VENOUS THROMBOSIS","17;15;14;11;11;10;9;8;8;7;7;7;7;6;6;6;6;6;5;5;5;5","ANDROGEN DEPRIVATION THERAPY;OXALIPLATIN;METASTATIC BREAST CANCER;KRAS;ANDROGEN RECEPTOR;ENDOVASCULAR ANEURYSM REPAIR;EPIRUBICIN;GASTRIC BYPASS;IRINOTECAN;NILOTINIB;RANIBIZUMAB;VINORELBINE;AFLIBERCEPT;AORTOENTERIC FISTULA;BIVALIRUDIN;BREAST RECONSTRUCTION;CAPECITABINE;CYTOGENETICS;CYTOREDUCTIVE SURGERY;EDINBURGH POSTNATAL DEPRESSION SCALE;ENDOCRINE DISEASE;ERLOTINIB;FEBRILE NEUTROPENIA;GENOTYPING;GLYCATED HEMOGLOBIN;INCRETIN;IVABRADINE;KARYOTYPE;LEYDIG CELL;MASTECTOMY;METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS;PRENATAL DIAGNOSIS;PROSTATECTOMY;TOTAL MESORECTAL EXCISION;VANCOMYCIN","7;7;6;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;FEMALE;MALE;MIDDLE AGED;;AGED;ADULT;TREATMENT OUTCOME;RETROSPECTIVE STUDIES;AGED, 80 AND OVER;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;ITALY;LUNG NEOPLASMS;YOUNG ADULT;PROSPECTIVE STUDIES;FOLLOW-UP STUDIES;RISK FACTORS;LIVER NEOPLASMS;ADOLESCENT;POSTOPERATIVE COMPLICATIONS","244;172;169;133;122;122;114;62;54;52;46;45;38;37;30;28;28;27;26;26","ADVANCEMENTS IN PROSTATE CANCER RESEARCH;HEPATOCELLULAR CARCINOMA;ATRIAL FIBRILLATION;EFFECTS OF BARIATRIC SURGERY ON OBESITY AND DIABETES;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;GENOMIC STUDIES AND TREATMENT OF OVARIAN CARCINOMA;MANAGEMENT AND PATHOPHYSIOLOGY OF ABDOMINAL AORTIC ANEURYSMS;ADVANCEMENTS IN LUNG CANCER RESEARCH;AGE-RELATED MACULAR DEGENERATION RESEARCH;ANORECTAL SURGICAL PROCEDURES;CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER TREATMENT;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;EFFICACY AND RESISTANCE IN CML TREATMENT;GLIOMAS;HERNIA REPAIR TECHNIQUES AND MATERIALS;MANAGEMENT OF VASCULAR ACCESS IN HEALTHCARE;MOLECULAR PATHOGENESIS OF MYELOPROLIFERATIVE DISORDERS;VASCULAR ACCESS FOR CORONARY PROCEDURES AND TRAUMA MANAGEMENT;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE","8;7;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;3;3","STROKE (ENGINE);TOLERABILITY;CLINICAL ENDPOINT;INTERVENTIONAL RADIOLOGY;REGIMEN;UNIVARIATE ANALYSIS;ANEURYSM SCREENING;CONCOMITANT;NEURORADIOLOGY;TREATMENT;DIABETES;ENDOVASCULAR REPAIR;ETIOLOGY;ABIRATERONE ACETATE;ANEURYSM RUPTURE;BEVACIZUMAB;CABAZITAXEL;HEPATOCELLULAR CARCINOMA;INTRAVITREAL INJECTION;ALPHA PARTICLE THERAPY","14;10;9;9;8;8;7;7;7;7;6;6;6;5;5;5;5;5;5;4","PROSTATE CANCER;PILOT STUDY;BREAST CANCER;LUNG CANCER;ATRIAL FIBRILLATION;CELL CARCINOMA;CANCER PATIENTS;CASTRATION-RESISTANT PROSTATE;COHORT STUDY;ENDOVASCULAR REPAIR;OVARIAN CANCER;PATIENTS TREATED;SLEEVE GASTRECTOMY;TYPE DIABETES;ABIRATERONE ACETATE;ACUTE CORONARY;ADULT PATIENTS;ELDERLY PATIENTS;FINAL RESULTS;HEPATOCELLULAR CARCINOMA;LAPAROSCOPIC SLEEVE;LIVER TRANSPLANT;METASTATIC BREAST;RETROSPECTIVE ANALYSIS;SINGLE-INSTITUTION EXPERIENCE;SURGICAL TREATMENT;ADVANCED CANCER;AGE-RELATED MACULAR;BEVACIZUMAB MAINTENANCE;CARDIOVASCULAR RISK","9;8;7;7;6;6;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3","PATIENTS TREATED;HR CI;ADVERSE EVENTS;CLINICAL PRACTICE;RISK FACTORS;MEDIAN AGE;OBSERVATIONAL STUDY;PUBMED SCOPUS;HAZARD RATIO;MEDIAN OS;CONFIDENCE INTERVAL;CROSSREF PUBMED;INCIDENCE RATE;INCREASED RISK;RATE RATIO;CONSECUTIVE PATIENTS;ECOG PS;EUROPEAN STROKE;MEDIASTINAL LIPOMATOSIS;METASTATIC COLORECTAL;PATIENTS UNDERWENT;PERFORMANCE STATUS;STROKE ORGANISATION;VISUAL ACUITY;BETAGLATIRAMER ACETATE;CARDIOVASCULAR DISEASE;CERBB POSITIVE;ELDERLY PTS;ENDOAORTIC BALLOON;EPISODIC BREATHLESSNESS","24;20;17;15;14;13;12;12;11;11;10;10;10;10;10;9;9;9;9;9;9;9;9;9;8;8;8;8;8;8",130,0.35,5.01,5,1,1.5,2,2.75,2.5,0,1,6,1,1,5,2.75,1,1.75,2,4,1.25,0,0,63.25,63.25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,27,3.31,829.27,4.14,11,0.41,62.59,0,0,8,0,6,0,0,13,0,21,5,0,0,0,0,0,0,24,2,1,26,1,0,0,0,0,0,0,0,0,"Italy;Germany;United States;Belgium;Japan","11;3;3;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;40 ENGINEERING;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3006 FOOD SCIENCES;3212 OPHTHALMOLOGY AND OPTOMETRY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;4003 BIOMEDICAL ENGINEERING;4203 HEALTH SERVICES AND SYSTEMS;4205 NURSING;4207 SPORTS SCIENCE AND EXERCISE;4208 TRADITIONAL, COMPLEMENTARY AND INTEGRATIVE MEDICINE;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","25;13;6;6;2;2;2;1;1;1;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;RARE DISEASES;HEMATOLOGY;NEUROSCIENCES;PATIENT SAFETY;CARDIOVASCULAR;LUNG;BIOENGINEERING;BRAIN DISORDERS;CHRONIC PAIN;DIGESTIVE DISEASES;HEART DISEASE;NUTRITION;ORPHAN DRUG;PAIN RESEARCH;PREVENTION;ASSISTIVE TECHNOLOGY;LIVER DISEASE","24;16;8;7;5;5;5;4;4;3;3;3;3;3;3;3;3;3;2;2","CANCER;CARDIOVASCULAR;INFLAMMATORY AND IMMUNE SYSTEM;MUSCULOSKELETAL;BLOOD;CONGENITAL;EYE;METABOLIC AND ENDOCRINE;NEUROLOGICAL;ORAL AND GASTROINTESTINAL;RESPIRATORY;SKIN;STROKE","7;4;4;2;1;1;1;1;1;1;1;1;1","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;3.3 NUTRITION AND CHEMOPREVENTION;6.2 CELLULAR AND GENE THERAPIES;6.3 MEDICAL DEVICES;6.7 PHYSICAL;7.1 INDIVIDUAL CARE NEEDS","15;3;2;1;1;1;1;1;1","LEUKEMIA / LEUKAEMIA;NOT SITE-SPECIFIC CANCER;BREAST CANCER;LUNG CANCER;NON-HODGKIN'S LYMPHOMA;OVARIAN CANCER","2;2;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","6;4",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,"PUBLIC LIBRARY OF SCIENCE;SPRINGER NATURE","5;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;44 HUMAN SOCIETY;3107 MICROBIOLOGY;3207 MEDICAL MICROBIOLOGY;4409 SOCIAL WORK","10;4;3;2;1;1;1","CLINICAL RESEARCH;ANTIMICROBIAL RESISTANCE;EMERGING INFECTIOUS DISEASES;INFECTIOUS DISEASES;LUNG;PNEUMONIA;PNEUMONIA & INFLUENZA;CHRONIC OBSTRUCTIVE PULMONARY DISEASE;PREVENTION","3;2;2;2;2;2;2;1;1","RESPIRATORY;INFECTION","2;1","8.1 ORGANISATION AND DELIVERY OF SERVICES;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","2;1;1","CLINICAL","2","CLINICAL MEDICINE AND SCIENCE;PUBLIC HEALTH","4;1",NA,NA,NA,NA
"AOUSSN_UMBERTOI",2016,385,11.9454545454545,2.93766233766234,0.428571428571429,0.322077922077922,0.464935064935065,1.56648199445983,1.27906976744186,1.40909090909091,1.29710144927536,0.475324675324675,8,164,106,45,37,0.43,0.28,0.12,0.1,37,1.13913695990262,4.64848484848485,0.267532467532468,0.911688311688312,0.445,0.395,0.397,0.383,"ROBIN FOÀ;FEDERICO VENUTA;VINCENZO TOMBOLINI;FRANCESCA DE FELICE;DANIELA MUSIO;FRANCESCO SPEZIALE;VINCENZO MARIA SARACENI;ANTONIO COLOMBO;PAOLO MARCHETTI;TERESA PAOLUCCI;LUCA PADUA;GLORIA TALIANI;PASQUALINO SIRIGNANO;ELISABETTA DI CASTRO;MARIO VENDITTI;ENRICO CORTESI;GENNARO SARDELLA;FILIPPO CAMEROTA;FEDERICO ZANGRANDO;LAURA CAPOCCIA","10;10;9;9;9;9;8;8;8;8;8;8;8;8;8;8;8;7;7;7","VINCENZO TOMBOLINI;DANIELA MUSIO;FILIPPO CAMEROTA;CLAUDIA CELLETTI;FRANCESCO SPEZIALE;FRANCESCA DE FELICE;PASQUALINO SIRIGNANO;SOLMAZ ABDOLRAHIMZADEH;ANDREA CICCONETTI;ROBIN FOÀ;LUCA PADUA;MASSIMO BIONDI;LUCIANO IZZO;LAURA CAPOCCIA;FEDERICO VENUTA;ANDREA PICCIOLI;SANTI MARIA RECUPERO;G PAPPALARDO;PAOLO EMILIO PUDDU;GIOVANNI ANTONIO COSSIGA","1.4;1.4;1.25;1.25;1.25;1.21;1.21;1.21;1.2;1.18;1.16;1.11;1.09;1.09;1.08;1.01;1.01;1;1;1","ROBIN FOÀ;FEDERICO VENUTA;VINCENZO TOMBOLINI;FRANCESCA DE FELICE;DANIELA MUSIO;FRANCESCO SPEZIALE;VINCENZO MARIA SARACENI;TERESA PAOLUCCI;GLORIA TALIANI;PASQUALINO SIRIGNANO;ELISABETTA DI CASTRO;MARIO VENDITTI;ENRICO CORTESI;GENNARO SARDELLA;FILIPPO CAMEROTA;FEDERICO ZANGRANDO;LAURA CAPOCCIA;VITO CANTISANI;MARCO CARNÌ;CLAUDIA CELLETTI","10;10;9;9;9;9;8;8;8;8;8;8;8;8;7;7;7;7;7;7","VINCENZO TOMBOLINI;DANIELA MUSIO;FILIPPO CAMEROTA;CLAUDIA CELLETTI;FRANCESCO SPEZIALE;FRANCESCA DE FELICE;PASQUALINO SIRIGNANO;SOLMAZ ABDOLRAHIMZADEH;ANDREA CICCONETTI;ROBIN FOÀ;MASSIMO BIONDI;LUCIANO IZZO;LAURA CAPOCCIA;FEDERICO VENUTA;ANDREA PICCIOLI;SANTI MARIA RECUPERO;G PAPPALARDO;PAOLO EMILIO PUDDU;GIOVANNI ANTONIO COSSIGA;PIERO CASCONE","1.4;1.4;1.25;1.25;1.25;1.21;1.21;1.21;1.2;1.18;1.11;1.09;1.09;1.08;1.01;1.01;1;1;1;1","BRUCE THOMPSON;MARCO RANIERI;ANDERS LARSSON;ANTONIO PESENTI;ARTHUR S. SLUTSKY;DANIEL F. MCAULEY;EDDY FAN;FRANK VAN HAREN;GIACOMO BELLANI;GORDON D. RUBENFELD;HERMANN WRIGGE;JOHN G. LAFFEY;LAURENT BROCHARD;LUCIANO GATTINONI;MARTIN DRES;TÀI PHAM;FABIANA MADOTTO;GENNARO SARDELLA;MASSIMO ANTONELLI;LISE PIQUILLOUD","5368;5289;5140;5140;5140;5140;5140;5140;5140;5140;5140;5140;5140;5140;5140;5140;826;646;616;548","MARCO RANIERI;GENNARO SARDELLA;MARIO VENDITTI;VITO CANTISANI;MARIA GABRIELLA MAZZUCCONI;EMANUELE SORICELLI;GIOVANNI CASELLA;LIDIA CASTAGNETO‐GISSEY;NICOLA BASSO;V. MARCO RANIERI;ALFREDO GENCO;ROBERTA MASELLI;GABRIELE MASSELLI;GIANCARLO CECCARELLI;ANDREA MORELLI;FRANCESCA DE FELICE;LAURA STRONATI;SALVATORE CUCCHIARA;ALESSIO FARCOMENI;FRANCESCO ANGELICO","5289;646;502;456;436;404;404;404;404;404;359;359;306;254;236;208;206;206;199;195","GENNARO SARDELLA;FEDERICO VENUTA;FRANCESCA DE FELICE;DANIELA MUSIO;VINCENZO TOMBOLINI;ELISABETTA DI CASTRO;MARIO VENDITTI;ROBIN FOÀ;TERESA PAOLUCCI;VINCENZO MARIA SARACENI;VITO CANTISANI;FRANCESCO SPEZIALE;CLAUDIA CELLETTI;FILIPPO CAMEROTA;MARCO CARNÌ;FEDERICO ZANGRANDO;ENRICO CORTESI;VALTER SANTILLI;PASQUALINO SIRIGNANO;GIANCARLO CECCARELLI","13;9;9;9;9;8;8;8;8;8;7;7;7;7;7;7;6;6;6;5","MEDICINE;BIOLOGY;PHYSICS;MATHEMATICS;ENGINEERING;CHEMISTRY;PSYCHOLOGY;COMPUTER SCIENCE;MATERIALS SCIENCE;POLITICAL SCIENCE;ECONOMICS;PHILOSOPHY;SOCIOLOGY;ART;BUSINESS;GEOLOGY;GEOGRAPHY;HISTORY","370;85;35;26;23;22;20;16;10;9;7;5;4;2;2;2;1;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;RADIOLOGY;GASTROENTEROLOGY;ONCOLOGY;IMMUNOLOGY;GENETICS;CARDIOLOGY;PSYCHIATRY;ENVIRONMENTAL HEALTH;PHYSICAL THERAPY;ENDOCRINOLOGY;INTENSIVE CARE MEDICINE;ANESTHESIA;BIOCHEMISTRY;OPTICS;PALEONTOLOGY;DERMATOLOGY;PEDIATRICS","243;141;58;58;51;48;43;33;29;29;26;26;25;24;23;23;22;22;18;18","CANCER;DISEASE;RETROSPECTIVE COHORT STUDY;CHEMOTHERAPY;RANDOMIZED CONTROLLED TRIAL;POPULATION;ALTERNATIVE MEDICINE;GENE;ADVERSE EFFECT;RADIATION THERAPY;PREGNANCY;STAGE (STRATIGRAPHY);STENT;MYOCARDIAL INFARCTION;OBESITY;COHORT;CONFIDENCE INTERVAL;ULTRASOUND;ANEURYSM;INCIDENCE (GEOMETRY);VIRUS","59;29;29;27;24;23;19;18;17;16;15;15;15;14;14;13;13;13;12;12;12","BREAST CANCER;COLORECTAL CANCER;ABDOMINAL AORTIC ANEURYSM;INSULIN RESISTANCE;AORTIC ANEURYSM;IMMUNOTHERAPY;OVERWEIGHT;PERCUTANEOUS CORONARY INTERVENTION;FETUS;PHENOTYPE;BACTEREMIA;CLINICAL ENDPOINT;HAZARD RATIO;HEPATITIS C VIRUS;OVARIAN CANCER;PLACEBO;PROSTATE CANCER;SEPTIC SHOCK;COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS;CONVENTIONAL PCI;FATTY LIVER;GESTATION;NEUTROPENIA;TYPE 2 DIABETES;VIRAL LOAD","16;11;9;9;8;8;8;8;7;7;6;6;6;6;6;6;6;6;5;5;5;5;5;5;5","NIVOLUMAB;ENDOVASCULAR ANEURYSM REPAIR;NEOADJUVANT THERAPY;ANTIRETROVIRAL THERAPY;DRUG-ELUTING STENT;IMATINIB MESYLATE;MAMMOGRAPHY;NONALCOHOLIC FATTY LIVER DISEASE;OXALIPLATIN;PRENATAL DIAGNOSIS;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;RIBAVIRIN;TRASTUZUMAB;ACUTE LYMPHOCYTIC LEUKEMIA;ADIPOKINE;ANDROGEN DEPRIVATION THERAPY;AORTOENTERIC FISTULA;BENDAMUSTINE;FEBRILE NEUTROPENIA;GASTRIC BYPASS;GERD;HBSAG;IMPAIRED GLUCOSE TOLERANCE;KLEBSIELLA PNEUMONIAE;LAMIVUDINE;LARYNGOTRACHEAL STENOSIS;MACE;METASTATIC BREAST CANCER;MONONEUROPATHY;OMALIZUMAB;PHOSPHOINOSITIDE PHOSPHOLIPASE C;POSACONAZOLE;PRETERM DELIVERY","7;6;5;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;FEMALE;MALE;MIDDLE AGED;;AGED;ADULT;ITALY;TREATMENT OUTCOME;RETROSPECTIVE STUDIES;AGED, 80 AND OVER;ENDOVASCULAR PROCEDURES;AORTIC ANEURYSM, ABDOMINAL;BLOOD VESSEL PROSTHESIS IMPLANTATION;POSTOPERATIVE COMPLICATIONS;PROSPECTIVE STUDIES;ADOLESCENT;RISK FACTORS;YOUNG ADULT;FOLLOW-UP STUDIES","257;206;186;143;125;120;109;76;66;54;39;32;31;31;31;31;29;29;29;26","MANAGEMENT AND PATHOPHYSIOLOGY OF ABDOMINAL AORTIC ANEURYSMS;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;CANCER IMMUNOTHERAPY;GLOBAL CHALLENGE OF ANTIBIOTIC RESISTANCE IN BACTERIA;HEPATITIS C INFECTION AND TREATMENT;CHOLESTEROL-LOWERING TREATMENT;COLORECTAL CANCER RESEARCH AND TREATMENT;DIAGNOSIS AND MANAGEMENT OF FUNGAL INFECTIONS;GENOMIC STUDIES AND TREATMENT OF OVARIAN CARCINOMA;GLOBAL PREVALENCE AND TREATMENT OF GLAUCOMA;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;ANORECTAL SURGICAL PROCEDURES;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;FOCUSED ULTRASOUND TECHNOLOGY AND APPLICATIONS;HEPATITIS B INFECTION AND TREATMENT;MECHANICAL VENTILATION IN RESPIRATORY FAILURE AND ARDS;MOLECULAR RESEARCH ON BREAST CANCER;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;ASTHMA","10;8;7;6;6;6;5;5;5;5;5;4;4;4;4;4;4;4;3;3","TREATMENT;ANEURYSM SCREENING;BREAST CANCER;CLINICAL ENDPOINT;REGIMEN;BACTEREMIA;ENDOVASCULAR ANEURYSM REPAIR;INTRAOCULAR PRESSURE;NEOADJUVANT THERAPY;STROKE (ENGINE);ANEURYSM RUPTURE;CHEMORADIOTHERAPY;CONCOMITANT;DISCONTINUATION;DRUG-ELUTING STENTS;ENDOVASCULAR REPAIR;FUNCTIONAL MRI;HEPATITIS C;PERFUSION IMAGING;CARDIAC IMAGING","17;8;7;7;7;6;6;6;6;6;5;5;5;5;5;5;5;5;5;4","BREAST CANCER;RANDOMIZED CONTROLLED;LUNG CANCER;MULTIPLE SCLEROSIS;PILOT STUDY;REAL LIFE;RETROSPECTIVE ANALYSIS;CELL LUNG;CONTROLLED TRIAL;DISTRESS SYNDROME;DUAL ANTIPLATELET;EXPANDED ACCESS;LOCALLY ADVANCED;RESPIRATORY DISTRESS;RETROSPECTIVE STUDY;ACCESS PROGRAMME;ACUTE LYMPHOBLASTIC;ACUTE RESPIRATORY;ANTIPLATELET THERAPY;AORTIC ANEURYSM;BLOODSTREAM INFECTIONS;CANCER PATIENTS;COHERENCE TOMOGRAPHY;COHORT STUDY;DRUG-ELUTING STENT;ELDERLY PATIENTS;INFECTIONS DUE;LIVER DISEASE;LYMPHOBLASTIC LEUKEMIA;MAGNETIC RESONANCE","10;7;6;6;6;6;6;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4","PUBMED SCOPUS;CYSTIC FIBROSIS;ADVERSE EVENTS;CROSSREF PUBMED;MUTATIONAL SEARCH;HR CI;BREAST CANCER;PATIENTS TREATED;STATISTICALLY SIGNIFICANT;MEDIAN FOLLOW-UP;CONFIDENCE INTERVAL;ITALY DEPARTMENT;MEDICAL ONCOLOGY;ROME ITALY;CLINICAL MACROCATEGORIES;CLINICAL PRACTICE;RETROSPECTIVE STUDY;CANCER INSTITUTE;DAY MORTALITY;MONTHS CI;VOCAL CORDS;CLINICAL FORMS;CONSECUTIVE PATIENTS;LUNG CANCER;MEDIAN AGE;MULTIVARIATE ANALYSIS;NATIONAL CANCER;PATIENTS UNDERGOING;SEPTIC SHOCK;SURVIVAL OS","38;27;23;22;21;19;17;17;16;15;14;14;14;14;12;12;12;10;10;10;10;9;9;9;9;9;9;9;9;9",129,0.34,7.58,5,2,1,1,3,2.75,0,1,6,1,1,4,1,2,1.25,4,3.75,2,0,0,78,78,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,28,3.61,1015.75,4.05,7,0.25,63.39,0,0,3,0,8,0,0,17,0,15,13,0,0,0,0,0,0,27,1,0,28,0,0,0,0,0,0,0,0,0,"United States;Italy;France;Japan;Sweden","7;6;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;42 HEALTH SCIENCES;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3006 FOOD SCIENCES;31 BIOLOGICAL SCIENCES;3105 GENETICS;3204 IMMUNOLOGY;3207 MEDICAL MICROBIOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;4203 HEALTH SERVICES AND SYSTEMS;4206 PUBLIC HEALTH;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","25;16;6;3;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;CARDIOVASCULAR;HEART DISEASE;PATIENT SAFETY;RARE DISEASES;ATHEROSCLEROSIS;DIGESTIVE DISEASES;HEART DISEASE - CORONARY HEART DISEASE;HEMATOLOGY;PREVENTION;ASSISTIVE TECHNOLOGY;BIOENGINEERING;BIOMEDICAL IMAGING;LUNG;NEUROSCIENCES;ORPHAN DRUG;BEHAVIORAL AND SOCIAL SCIENCE;CHRONIC PAIN","25;17;8;8;7;7;7;5;5;5;5;4;3;3;3;3;3;3;2;2","CARDIOVASCULAR;CANCER;MUSCULOSKELETAL;STROKE;INFECTION;METABOLIC AND ENDOCRINE;ORAL AND GASTROINTESTINAL","11;7;2;2;1;1;1","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;2.2 FACTORS RELATING TO THE PHYSICAL ENVIRONMENT;5.6 PSYCHOLOGICAL AND BEHAVIOURAL;6.2 CELLULAR AND GENE THERAPIES;6.3 MEDICAL DEVICES;6.4 SURGERY;6.6 PSYCHOLOGICAL AND BEHAVIOURAL;6.7 PHYSICAL","10;3;1;1;1;1;1;1;1;1","MYELOMA;NON-HODGKIN'S LYMPHOMA;BLADDER CANCER;COLON AND RECTAL CANCER;LEUKEMIA / LEUKAEMIA;LUNG CANCER;PANCREATIC CANCER","2;2;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","5;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,21,"PUBLIC LIBRARY OF SCIENCE;AMERICAN CHEMICAL SOCIETY;THE CAMBRIDGE STRUCTURAL DATABASE","19;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;49 MATHEMATICAL SCIENCES;52 PSYCHOLOGY;3210 NUTRITION AND DIETETICS;34 CHEMICAL SCIENCES;42 HEALTH SCIENCES;4905 STATISTICS;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;3404 MEDICINAL AND BIOMOLECULAR CHEMISTRY;38 ECONOMICS;3801 APPLIED ECONOMICS;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;5203 CLINICAL AND HEALTH PSYCHOLOGY","25;8;4;3;2;2;2;2;1;1;1;1;1;1;1;1","COMPLEMENTARY AND INTEGRATIVE HEALTH;NUTRITION;PREVENTION;BIODEFENSE;CHRONIC LIVER DISEASE AND CIRRHOSIS;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DIGESTIVE DISEASES;LIVER DISEASE;VACCINE RELATED","3;3;3;1;1;1;1;1;1;1","ORAL AND GASTROINTESTINAL;CANCER;INFLAMMATORY AND IMMUNE SYSTEM","3;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","3;2;1","CLINICAL;BIOMEDICAL","7;1","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE","10;1","LIVER CANCER;NOT SITE-SPECIFIC CANCER","3;1",NA,NA
"AOUSSN_UMBERTOI",2017,417,14.0143884892086,3.22541966426858,0.41726618705036,0.328537170263789,0.532374100719424,1.5936018957346,1.27941176470588,1.47311827956989,1.2906976744186,0.522781774580336,14,173,119,53,30,0.41,0.29,0.13,0.07,30,1.01797348861282,4.76012965964343,0.273381294964029,0.916067146282974,0.473,0.421,0.447,0.419,"ENRICO CORTESI;VINCENZO TOMBOLINI;DANIELA MUSIO;FEDERICO VENUTA;ROBIN FOÀ;GABRIELLA D’ETTORRE;MARCELLO ARCA;ERINO ANGELO RENDINA;FRANCESCA DE FELICE;D. TURCI;FRANCESCO SPEZIALE;PIERLUIGI BENEDETTI PANICI;CARLO CATALANO;PASQUALINO SIRIGNANO;WASSIM MANSOUR;GENNARO SARDELLA;DANIELE DISO;GIUSEPPE DE VINCENTIS;GIUSEPPE PROCOPIO;ANDREA LENZI","20;13;13;13;12;11;11;10;10;9;9;9;9;9;9;9;8;8;8;8","PASQUALINO SIRIGNANO;ALESSANDRO BOSCARELLI;VINCENZO TOMBOLINI;DANIELA MUSIO;FABIO GAJ;FRANCESCA DE FELICE;ENRICO CORTESI;ANTONIO V. STERPETTI;FRANCESCO SPEZIALE;WASSIM MANSOUR;CLAUDIO TERZANO;LAURA CAPOCCIA;FEDERICO VENUTA;GIANFRANCO GIOIA;GAETANO IERARDO;GERARDO RICCIO;M. BOLTON;HANS RAVN;GIOVANNI ANTONIO COSSIGA;MARIA SEGNI","3.08;2.33;1.67;1.66;1.58;1.45;1.38;1.25;1.15;1.15;1.14;1.08;1.02;1;1;1;1;1;1;1","ENRICO CORTESI;VINCENZO TOMBOLINI;DANIELA MUSIO;FEDERICO VENUTA;ROBIN FOÀ;GABRIELLA D’ETTORRE;MARCELLO ARCA;ERINO ANGELO RENDINA;FRANCESCA DE FELICE;D. TURCI;FRANCESCO SPEZIALE;PIERLUIGI BENEDETTI PANICI;CARLO CATALANO;PASQUALINO SIRIGNANO;WASSIM MANSOUR;GENNARO SARDELLA;DANIELE DISO;GIUSEPPE DE VINCENTIS;ANDREA LENZI;VINCENZO VULLO","20;13;13;13;12;11;11;10;10;9;9;9;9;9;9;9;8;8;8;8","PASQUALINO SIRIGNANO;ALESSANDRO BOSCARELLI;VINCENZO TOMBOLINI;DANIELA MUSIO;FABIO GAJ;FRANCESCA DE FELICE;ENRICO CORTESI;ANTONIO V. STERPETTI;FRANCESCO SPEZIALE;WASSIM MANSOUR;CLAUDIO TERZANO;LAURA CAPOCCIA;FEDERICO VENUTA;GIANFRANCO GIOIA;GAETANO IERARDO;GERARDO RICCIO;M. BOLTON;HANS RAVN;GIOVANNI ANTONIO COSSIGA;MARIA SEGNI","3.08;2.33;1.67;1.66;1.58;1.45;1.38;1.25;1.15;1.15;1.14;1.08;1.02;1;1;1;1;1;1;1","ROBIN FOÀ;ALESSANDRO RAMBALDI;A. FLEISHMAN;ADELE K. FIELDING;ANDRE C. SCHUH;ANDREW H. WEI;ANTHONY S. STEIN;BRENT L. WOOD;CHRISTOPHER P. HOLLAND;DIRK NAGORSEN;EWA LECH‐MARAŃDA;FATIH DEMIRKAN;HAGOP KANTARJIAN;HEINZ-AUGUST HORST;HERVÉ DOMBRET;JOSEP‐MARÍA RIBERA;JULIE BERGERON;MAX S. TOPP;MIGUEL Á. SANZ;MONIKA BRÜGGEMANN","1862;1850;1634;1634;1634;1634;1634;1634;1634;1634;1634;1634;1634;1634;1634;1634;1634;1634;1634;1634","ROBIN FOÀ;A. FLEISHMAN;ADELE K. FIELDING;ALESSANDRO RAMBALDI;ANDRE C. SCHUH;ANDREW H. WEI;ANTHONY S. STEIN;BRENT L. WOOD;CHRISTOPHER P. HOLLAND;DIRK NAGORSEN;EWA LECH‐MARAŃDA;FATIH DEMIRKAN;HAGOP KANTARJIAN;HEINZ-AUGUST HORST;HERVÉ DOMBRET;JOSEP‐MARÍA RIBERA;JULIE BERGERON;MAX S. TOPP;MIGUEL Á. SANZ;MONIKA BRÜGGEMANN","1773;1634;1634;1634;1634;1634;1634;1634;1634;1634;1634;1634;1634;1634;1634;1634;1634;1634;1634;1634","ENRICO CORTESI;FEDERICO VENUTA;DANIELA MUSIO;GENNARO SARDELLA;ROBIN FOÀ;VINCENZO TOMBOLINI;FRANCESCA DE FELICE;PIERLUIGI BENEDETTI PANICI;FRANCESCO SPEZIALE;PASQUALINO SIRIGNANO;ANDREA LENZI;GABRIELLA D’ETTORRE;WASSIM MANSOUR;DANIELE DISO;CLAUDIA CELLETTI;FILIPPO CAMEROTA;VITO CANTISANI;MARCELLO ARCA;LAURA CAPOCCIA;GIUSEPPE DE VINCENTIS","19;12;12;11;11;11;10;10;9;9;8;8;8;7;7;7;7;7;7;6","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;PHYSICS;ENGINEERING;COMPUTER SCIENCE;MATHEMATICS;ECONOMICS;SOCIOLOGY;MATERIALS SCIENCE;POLITICAL SCIENCE;PHILOSOPHY;GEOLOGY;HISTORY;ART;GEOGRAPHY;ENVIRONMENTAL SCIENCE","403;96;26;25;24;17;16;12;10;8;7;7;5;3;3;2;2;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;ONCOLOGY;RADIOLOGY;GASTROENTEROLOGY;IMMUNOLOGY;GENETICS;PEDIATRICS;CARDIOLOGY;ENDOCRINOLOGY;INTENSIVE CARE MEDICINE;BIOCHEMISTRY;PSYCHIATRY;ENVIRONMENTAL HEALTH;UROLOGY;PHYSICAL THERAPY;PALEONTOLOGY;NUCLEAR MEDICINE;ANESTHESIA","291;132;74;66;65;51;51;48;38;37;36;34;33;33;32;26;24;20;19;18","CANCER;DISEASE;GENE;ADVERSE EFFECT;POPULATION;CHEMOTHERAPY;ALTERNATIVE MEDICINE;COHORT;RANDOMIZED CONTROLLED TRIAL;RETROSPECTIVE COHORT STUDY;TRANSPLANTATION;BLOOD PRESSURE;MAGNETIC RESONANCE IMAGING;MYOCARDIAL INFARCTION;VIRUS;CLINICAL TRIAL;CONFIDENCE INTERVAL;RADIATION THERAPY;DIABETES MELLITUS;EXPANDED ACCESS;QUALITY OF LIFE (HEALTHCARE);STAGE (STRATIGRAPHY)","72;47;35;27;27;26;23;22;19;16;16;15;15;15;15;14;14;14;13;13;13;13","PROSTATE CANCER;COLORECTAL CANCER;IMMUNOTHERAPY;BREAST CANCER;HAZARD RATIO;AORTIC ANEURYSM;CLINICAL ENDPOINT;COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS;ABDOMINAL AORTIC ANEURYSM;METASTASIS;PLACEBO;HEPATITIS B VIRUS;HEPATITIS C VIRUS;MUTATION;PERCUTANEOUS CORONARY INTERVENTION;PROGRESSION-FREE SURVIVAL;CHEMORADIOTHERAPY;FAMILIAL HYPERCHOLESTEROLEMIA;GENOTYPE;HEMATOPOIETIC STEM CELL TRANSPLANTATION;INSULIN RESISTANCE;LIPOPROTEIN;TOLERABILITY","13;12;12;11;11;9;9;9;8;8;8;7;7;7;7;7;6;6;6;6;6;6;6","NIVOLUMAB;ENDOVASCULAR ANEURYSM REPAIR;HBSAG;LDL RECEPTOR;NEOADJUVANT THERAPY;ANDROGEN RECEPTOR;ANTIRETROVIRAL THERAPY;ANDROGEN DEPRIVATION THERAPY;APOLIPOPROTEIN A1;BONE METASTASIS;CD38;COMPOUND HETEROZYGOSITY;IRINOTECAN;KRAS;MAMMOGRAPHY;PROSTATECTOMY;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;RIBAVIRIN;SUICIDAL IDEATION;BOSENTAN;CIRCULATING TUMOR CELL;DASATINIB;DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING;EPITHELIAL–MESENCHYMAL TRANSITION;HEPACIVIRUS;HYPERPHENYLALANINEMIA;INSULIN SENSITIVITY;KLEBSIELLA PNEUMONIAE;LAMIVUDINE;MACE;MEROPENEM;METASTATIC BREAST CANCER;OXALIPLATIN;PLACENTA;PROSTATE-SPECIFIC ANTIGEN;TARGET LESION;TAXANE;TETRAHYDROBIOPTERIN;TOTAL BODY IRRADIATION;TRANSIENT ELASTOGRAPHY;TRASTUZUMAB","11;6;5;5;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;FEMALE;MALE;;MIDDLE AGED;ADULT;AGED;TREATMENT OUTCOME;ITALY;RETROSPECTIVE STUDIES;AGED, 80 AND OVER;YOUNG ADULT;ADOLESCENT;ENDOVASCULAR PROCEDURES;RISK FACTORS;BLOOD VESSEL PROSTHESIS IMPLANTATION;POSTOPERATIVE COMPLICATIONS;CHILD;HYPERLIPOPROTEINEMIA TYPE II;BIOMARKERS","254;201;190;160;155;127;127;69;65;64;53;47;39;37;35;33;32;30;30;29","CHOLESTEROL-LOWERING TREATMENT;MANAGEMENT AND PATHOPHYSIOLOGY OF ABDOMINAL AORTIC ANEURYSMS;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;CANCER IMMUNOTHERAPY;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;GLOBAL CHALLENGE OF ANTIBIOTIC RESISTANCE IN BACTERIA;PELVIC FLOOR DISORDERS;BOTULINUM TOXIN IN NEUROLOGY AND MEDICINE;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;HEPATITIS B INFECTION AND TREATMENT;LYMPHOID NEOPLASMS;RENAL CELL CARCINOMA;COLORECTAL CANCER RESEARCH AND TREATMENT;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;HEPATITIS C INFECTION AND TREATMENT;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;MYASTHENIA GRAVIS AND THYMIC TUMORS RESEARCH;ORGAN TRANSPLANTATION AND REJECTION;VASCULAR ACCESS FOR CORONARY PROCEDURES AND TRAUMA MANAGEMENT;ANORECTAL SURGICAL PROCEDURES","10;10;9;8;7;6;6;5;5;5;5;5;4;4;4;4;4;4;4;3","TREATMENT;EXPANDED ACCESS;CLINICAL ENDPOINT;REGIMEN;ANEURYSM SCREENING;METASTATIC PROSTATE CANCER;CHOLESTEROL-LOWERING;CONCOMITANT;PROGRESSION-FREE SURVIVAL;CHEMORADIOTHERAPY;ENDOVASCULAR ANEURYSM REPAIR;ENDOVASCULAR REPAIR;HBV INFECTION;INTERQUARTILE RANGE;NEOADJUVANT THERAPY;STROKE (ENGINE);TOLERABILITY;CARDIOVASCULAR EVALUATION;CONCORDANCE;CUMULATIVE INCIDENCE","14;13;9;9;8;8;7;7;7;6;6;6;6;6;6;6;6;5;5;5","EXPANDED ACCESS;PROSTATE CANCER;ACCESS PROGRAM;CASTRATION-RESISTANT PROSTATE;CELL CARCINOMA;METASTATIC CASTRATION-RESISTANT;RENAL CELL;MAGNETIC RESONANCE;PROGRAM EAP;RETROSPECTIVE ANALYSIS;CANCER PATIENTS;COHORT STUDY;CONTROLLED TRIAL;LOCALLY ADVANCED;NIVOLUMAB EXPANDED;ACCESS PROGRAMME;CANCER MCRPC;FAMILIAL HYPERCHOLESTEROLEMIA;ITALIAN EXPANDED;ITALIAN NIVOLUMAB;LONG-TERM RESULTS;LUNG CANCER;METASTATIC RENAL;MULTICENTER RETROSPECTIVE;RANDOMIZED CONTROLLED;RESONANCE IMAGING;ACUTE CORONARY;ADVANCED RECTAL;AORTIC VALVE;ARTERIAL HYPERTENSION","13;12;10;9;9;9;8;7;7;7;6;6;6;6;6;5;5;5;5;5;5;5;5;5;5;5;4;4;4;4","ADVERSE EVENTS;PATIENTS TREATED;CLINICAL PRACTICE;GASTRIC ACIDITY;PTS TREATED;HR CI;MEDIAN FOLLOW-UP;PATIENTS PTS;RISK FACTORS;LUNG CANCER;LIVER DISEASE;ADVISORY BOARD;BRISTOL-MYERS SQUIBB;CONFIDENCE INTERVAL;FEMORAL ACCESS;PATIENTS RECEIVING;PTS AGED;MMLMATH XMLNSMMLHTTPWWWWORGMATHMATHML;SPASTIC DYSTONIA;CELL CARCINOMA;PATIENTS UNDERWENT;BOEHRINGER INGELHEIM;CLINICAL TRIAL;COMMON TERMINOLOGY;COMPLETE RESPONSE;FAMILIAL HYPERCHOLESTEROLEMIA;HAZARD RATIO;INCREASED RISK;LOW-DENSITY LIPOPROTEIN;MULTIVARIATE ANALYSIS","34;28;22;22;19;16;16;16;16;15;14;13;13;13;13;13;13;12;12;11;11;10;10;10;10;10;10;10;10;10",148,0.35,6,6.25,2,1,1.75,2,1,1,2,7.25,0,1,6,1,5.5,2,3,5,3,0,0,83,83,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,35,3.51,951.49,4.44,15,0.43,90.71,1,0,4,0,10,0,3,17,0,25,10,0,0,0,0,0,0,31,2,2,35,0,0,0,0,0,0,0,0,0,"Italy;United States;Germany;Japan;Switzerland;United Kingdom","19;12;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3210 NUTRITION AND DIETETICS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;31 BIOLOGICAL SCIENCES;3204 IMMUNOLOGY;3209 NEUROSCIENCES;3213 PAEDIATRICS;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;41 ENVIRONMENTAL SCIENCES;4102 ECOLOGICAL APPLICATIONS","33;16;8;7;5;4;3;3;2;2;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;PATIENT SAFETY;CARDIOVASCULAR;HEART DISEASE;RARE DISEASES;HEMATOLOGY;NEUROSCIENCES;NUTRITION;COMPLEMENTARY AND INTEGRATIVE HEALTH;PAIN RESEARCH;BRAIN DISORDERS;AGING;AUTOIMMUNE DISEASE;BIOENGINEERING;HEADACHES;MIGRAINES;NEURODEGENERATIVE;PEDIATRIC","32;20;10;10;8;8;8;6;6;6;5;5;4;3;3;3;3;3;3;3","CARDIOVASCULAR;CANCER;NEUROLOGICAL;METABOLIC AND ENDOCRINE;RENAL AND UROGENITAL;INFECTION;ORAL AND GASTROINTESTINAL","9;7;3;2;2;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;6.4 SURGERY;7.1 INDIVIDUAL CARE NEEDS","20;3;3;1;1;1","BREAST CANCER;LUNG CANCER;MYELOMA;NON-HODGKIN'S LYMPHOMA;BLADDER CANCER;BLOOD CANCER;HODGKIN'S DISEASE;LEUKEMIA / LEUKAEMIA;OVARIAN CANCER;SKIN CANCER;THYROID CANCER","2;2;2;2;1;1;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","7;1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,21,"PUBLIC LIBRARY OF SCIENCE;TAYLOR & FRANCIS GROUP","20;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;49 MATHEMATICAL SCIENCES;31 BIOLOGICAL SCIENCES;38 ECONOMICS;47 LANGUAGE, COMMUNICATION AND CULTURE;4905 STATISTICS;52 PSYCHOLOGY;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3009 VETERINARY SCIENCES;3203 DENTISTRY;3801 APPLIED ECONOMICS;3802 ECONOMETRICS;43 HISTORY, HERITAGE AND ARCHAEOLOGY;4301 ARCHAEOLOGY;44 HUMAN SOCIETY;4403 DEMOGRAPHY;5202 BIOLOGICAL PSYCHOLOGY","19;8;4;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","CARDIOVASCULAR;HEART DISEASE;INFECTIOUS DISEASES","1;1;1","ORAL AND GASTROINTESTINAL;CANCER;CARDIOVASCULAR;INFECTION;RENAL AND UROGENITAL","2;1;1;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;2.4 SURVEILLANCE AND DISTRIBUTION;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES","2;1;1","CLINICAL","5","CLINICAL MEDICINE AND SCIENCE","12","BREAST CANCER;NOT SITE-SPECIFIC CANCER","1;1","3 GOOD HEALTH AND WELL BEING","1"
"AOUSSN_UMBERTOI",2018,425,14.7811764705882,2.95529411764706,0.334117647058824,0.303529411764706,0.489411764705882,1.67780748663102,1.24561403508772,1.34375,1.26829268292683,0.531764705882353,5,198,107,43,36,0.47,0.25,0.1,0.08,21.1,0.691731792336446,4.76829859428018,0.294117647058824,0.943529411764706,0.432,0.41,0.447,0.399,"ROBIN FOÀ;GENNARO SARDELLA;ENRICO CORTESI;FEDERICO VENUTA;CAMILLA POGGI;PAOLO MARCHETTI;CARLO BRIGUORI;MASSIMILIANO PACILIO;DIANA GIANNARELLI;CIRO VILLANI;VINCENZO TOMBOLINI;ERINO ANGELO RENDINA;VITO CANTISANI;PIERLUIGI BENEDETTI PANICI;MASSIMO BRECCIA;PAOLO CALABRÒ;CLAUDIO ANDREETTI;VALENTINA MAGRI;FRANCESCO COGNETTI;MASSIMO MANCONE","20;18;13;11;10;10;10;10;10;9;9;9;9;9;9;8;8;8;8;8","DOTT. GIOVANNI ANTONIO COSSIGA;ROBIN FOÀ;MASSIMILIANO BASSI;MASSIMILIANO PACILIO;CIRO VILLANI;FEDERICO VENUTA;LEOPOLDO SPADEA;VALERIA SILVESTRI;GENNARO SARDELLA;PIERLUIGI BENEDETTI PANICI;CAMILLA POGGI;ENRICO CORTESI;FRANCESCO SPEZIALE;VINCENZO TOMBOLINI;CRISTIAN BORRAZZO;LUDOVICO MUZII;ERINO ANGELO RENDINA;VIRGINIA A. STALLINGS;CHIARA BERTOLASO;JOAN I. SCHALL","2;1.38;1.21;1.2;1.11;1.04;1;1;0.93;0.92;0.92;0.89;0.89;0.87;0.86;0.85;0.85;0.8;0.8;0.8","ROBIN FOÀ;GENNARO SARDELLA;ENRICO CORTESI;FEDERICO VENUTA;CAMILLA POGGI;MASSIMILIANO PACILIO;CIRO VILLANI;VINCENZO TOMBOLINI;ERINO ANGELO RENDINA;VITO CANTISANI;PIERLUIGI BENEDETTI PANICI;MASSIMO BRECCIA;CLAUDIO ANDREETTI;VALENTINA MAGRI;MASSIMO MANCONE;LUDOVICO MUZII;ANTONIO D’ANDRILLI;MOHSEN IBRAHIM;DANIELA MUSIO;FRANCESCO SPEZIALE","20;18;13;11;10;10;9;9;9;9;9;9;8;8;8;8;8;7;7;7","DOTT. GIOVANNI ANTONIO COSSIGA;ROBIN FOÀ;MASSIMILIANO BASSI;MASSIMILIANO PACILIO;CIRO VILLANI;FEDERICO VENUTA;LEOPOLDO SPADEA;VALERIA SILVESTRI;GENNARO SARDELLA;PIERLUIGI BENEDETTI PANICI;CAMILLA POGGI;ENRICO CORTESI;FRANCESCO SPEZIALE;VINCENZO TOMBOLINI;LUDOVICO MUZII;ERINO ANGELO RENDINA;CHIARA BERTOLASO;LAURA CAPOCCIA;PASQUALINO SIRIGNANO;MASSIMO BIONDI","2;1.38;1.21;1.2;1.11;1.04;1;1;0.93;0.92;0.92;0.89;0.89;0.87;0.85;0.85;0.8;0.79;0.79;0.78","VITO CANTISANI;HELMUT PROSCH;MAIJA RADZIŅA;ODD HELGE GILJA;PAUL S. SIDHU;FRANCESCO MARIA DRUDI;ADRIAN SǍFTOIU;ANDREA KLAUSER;ANNAMARIA DEGANELLO;CARLOS NICOLAU;CHRISTIAN JENSSEN;CHRISTIAN NOLSØE;CHRISTOPH F. DIETRICH;CHRISTOPHER HARVEY;DAVID O. COSGROVE;DIRK‐ANDRÉ CLEVERT;EDWARD LEEN;ERNST-MICHAEL JUNG;EVA BARTELS;FABIO PISCAGLIA","1648;1190;1190;1190;1190;1115;1113;1113;1113;1113;1113;1113;1113;1113;1113;1113;1113;1113;1113;1113","VITO CANTISANI;GENNARO SARDELLA;MARIO VENDITTI;GIANCARLO CECCARELLI;ENRICO CORTESI;MARCO CATANI;ALAIN GELIBTER;LUCIANO GIACOMELLI;CHIARA BERTOLASO;ALFREDO GENCO;VINCENZO VULLO;VINCENZO TOMBOLINI;ISABELLA QUINTI;FEDERICA URBANO;PIERLUIGI BENEDETTI PANICI;ETTORE DE BERARDINIS;CHIARA DI TUCCI;LUDOVICO MUZII;FEDERICO VENUTA;MARIA MANCINI","1591;536;474;388;224;219;169;157;147;145;143;141;134;133;133;131;129;129;128;127","GENNARO SARDELLA;ROBIN FOÀ;ENRICO CORTESI;FEDERICO VENUTA;MASSIMILIANO PACILIO;VINCENZO TOMBOLINI;CAMILLA POGGI;VITO CANTISANI;MARCO CARNÌ;VALENTINA MAGRI;DANIELA MUSIO;FRANCESCO SPEZIALE;MASSIMO MANCONE;PIERLUIGI BENEDETTI PANICI;ALAIN GELIBTER;CIRO VILLANI;FIORINA GIONA;CHIARA DI TUCCI;LAURA CAPOCCIA;LUDOVICO MUZII","21;17;12;11;10;9;8;8;7;7;7;7;7;7;7;6;6;6;6;6","MEDICINE;BIOLOGY;PHYSICS;MATHEMATICS;PSYCHOLOGY;COMPUTER SCIENCE;CHEMISTRY;ENGINEERING;ECONOMICS;SOCIOLOGY;MATERIALS SCIENCE;POLITICAL SCIENCE;GEOGRAPHY;PHILOSOPHY;BUSINESS;ART;HISTORY","415;87;40;29;29;26;25;24;12;11;9;6;4;4;2;1;1","INTERNAL MEDICINE;SURGERY;RADIOLOGY;GASTROENTEROLOGY;ONCOLOGY;CARDIOLOGY;PATHOLOGY;GENETICS;ENVIRONMENTAL HEALTH;IMMUNOLOGY;ENDOCRINOLOGY;BIOCHEMISTRY;PEDIATRICS;PSYCHIATRY;PHYSICAL THERAPY;INTENSIVE CARE MEDICINE;NUCLEAR MEDICINE;OPTICS;CANCER RESEARCH;NURSING","324;135;69;66;61;55;53;47;46;46;34;32;29;29;28;22;22;22;20;18","CANCER;DISEASE;POPULATION;COHORT;GENE;RETROSPECTIVE COHORT STUDY;CHEMOTHERAPY;ADVERSE EFFECT;MYOCARDIAL INFARCTION;MAGNETIC RESONANCE IMAGING;CONFIDENCE INTERVAL;RADIATION THERAPY;STENOSIS;TRANSPLANTATION;INCIDENCE (GEOMETRY);OBESITY;ALTERNATIVE MEDICINE;ANTIBODY;DIABETES MELLITUS;LUNG CANCER;MULTIVARIATE ANALYSIS;OBSERVATIONAL STUDY;PROSPECTIVE COHORT STUDY","74;45;43;31;31;26;25;22;22;21;18;18;16;16;15;15;14;14;14;13;13;13;13","COLORECTAL CANCER;BREAST CANCER;IMMUNOTHERAPY;CLINICAL ENDPOINT;HAZARD RATIO;IMATINIB;PERCUTANEOUS CORONARY INTERVENTION;UNIVARIATE ANALYSIS;NEURORADIOLOGY;PROSTATE CANCER;CONVENTIONAL PCI;HEPATITIS C VIRUS;MUTATION;NEUTROPENIA;OVERWEIGHT;PHASES OF CLINICAL RESEARCH;PLACEBO;PSEUDOMONAS AERUGINOSA;THYROID CANCER;AORTIC VALVE STENOSIS;BACTEREMIA;CRONBACH'S ALPHA;ESCHERICHIA COLI;HEMATOPOIETIC STEM CELL TRANSPLANTATION;LEFT VENTRICULAR HYPERTROPHY;SEPTIC SHOCK;TYPE 2 DIABETES","17;16;11;10;10;10;10;9;8;8;6;6;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5","NIVOLUMAB;IMATINIB MESYLATE;KLEBSIELLA PNEUMONIAE;BIVALIRUDIN;BONE METASTASIS;ACINETOBACTER BAUMANNII;AORTIC VALVULOPLASTY;COLONOSCOPY;DASATINIB;DRUG-ELUTING STENT;MACE;MAMMOGRAPHY;METASTATIC BREAST CANCER;NILOTINIB;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;TRASTUZUMAB;ANTIVIRAL THERAPY;BREAST RECONSTRUCTION;COLECTOMY;CROSSOVER STUDY;ENDOVASCULAR ANEURYSM REPAIR;GASTRIC BYPASS;HBSAG;HEART RATE VARIABILITY;HORMONE RECEPTOR;INTERNATIONAL PROGNOSTIC SCORING SYSTEM;IRINOTECAN;IVACAFTOR;KRAS;LIPOPROTEIN(A);MASTECTOMY;METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS;MILAN CRITERIA;NEOADJUVANT THERAPY;OMALIZUMAB;OVARIAN RESERVE;PAPILLARY THYROID CANCER;PARATHYROIDECTOMY;PAZOPANIB;PR INTERVAL;PROBAND;RIBAVIRIN;TAXANE;V600E","10;5;5;4;4;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;FEMALE;MALE;;MIDDLE AGED;AGED;ADULT;ITALY;TREATMENT OUTCOME;RETROSPECTIVE STUDIES;AGED, 80 AND OVER;RISK FACTORS;PROSPECTIVE STUDIES;ADOLESCENT;POSTOPERATIVE COMPLICATIONS;YOUNG ADULT;CHILD;AORTIC VALVE STENOSIS;BREAST NEOPLASMS;COLORECTAL NEOPLASMS","249;191;176;171;142;122;105;81;66;62;48;39;38;36;32;31;28;26;24;24","CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;EFFICACY AND RESISTANCE IN CML TREATMENT;MANAGEMENT OF VALVULAR HEART DISEASE;CANCER IMMUNOTHERAPY;HEPATITIS C INFECTION AND TREATMENT;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;DEVELOPMENT AND APPLICATIONS OF RADIOPHARMACEUTICALS;GLIOMAS;GLOBAL CHALLENGE OF ANTIBIOTIC RESISTANCE IN BACTERIA;MANAGEMENT AND DIAGNOSIS OF THYROID CANCER;MANAGEMENT AND TREATMENT OF HEMOPHILIA;ACUTE MYELOID LEUKEMIA;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;ATRIAL FIBRILLATION;CHOLESTEROL-LOWERING TREATMENT;DIAGNOSIS AND MANAGEMENT OF BILIARY TRACT DISORDERS;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;DIFFUSION MAGNETIC RESONANCE IMAGING","11;10;10;9;8;6;6;6;5;5;5;5;5;4;4;4;4;4;4;4","TREATMENT;STROKE (ENGINE);CLINICAL ENDPOINT;PERFUSION IMAGING;REGIMEN;TRANSCATHETER AORTIC-VALVE REPLACEMENT;UNIVARIATE ANALYSIS;LIVER DISEASE;NEURORADIOLOGY;PROSTHETIC VALVES EVALUATION;CARDIAC IMAGING;CONCOMITANT;DISCONTINUATION;DRUG-ELUTING STENTS;HEPATITIS C;RADIOTHERAPY;CORONARY STENTS;CYSTIC FIBROSIS;BACTEREMIA;CARDIOVASCULAR RISK ASSESSMENT","20;11;10;10;10;9;9;8;8;8;7;7;7;7;7;7;6;6;5;5","MYELOID LEUKEMIA;CHRONIC MYELOID;MAGNETIC RESONANCE;CYSTIC FIBROSIS;LEUKEMIA PATIENTS;CLINICAL PRACTICE;AORTIC VALVE;COHORT STUDY;LUNG CANCER;TRANSCATHETER AORTIC;BREAST CANCER;COLORECTAL CANCER;CORONARY ARTERY;PATIENTS TREATED;RESONANCE IMAGING;STEM CELL;CANCER NSCLC;CANCER PATIENTS;CELL TRANSPLANTATION;CONTROLLED TRIAL;INTENSIVE CARE;METASTATIC COLORECTAL;OBSERVATIONAL STUDY;PATIENTS AFFECTED;PROSTATE CANCER;ACCESS PROGRAM;ARTERY DISEASE;ATRIAL FIBRILLATION;AUTOLOGOUS STEM;CARE UNIT","12;10;10;9;9;8;7;7;7;7;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5;4;4;4;4;4","SPEAKERS BUREAU;ADVISORY COMMITTEES;ENTITYS BOARD;ADVISORY BOARD;RESEARCH FUNDING;BOARD SPEAKERS;PATIENTS TREATED;HONORARIA MEMBERSHIP;HR CI;RISK FACTORS;CONSULTANCY HONORARIA;COMMITTEES SPEAKERS;MEDIAN AGE;FUNDING SPEAKERS;MEDIAN FOLLOW-UP;PATIENTS RECEIVED;SIGNIFICANT DIFFERENCES;ADVERSE EVENTS;BUREAU ROCHE;NOVO NORDISK;SURVIVAL OS;CUMULATIVE INCIDENCE;MEDIAN TIME;CML PATIENTS;CONFIDENCE INTERVAL;MYOCARDIAL INFARCTION;STATISTICALLY SIGNIFICANT;CLINICAL PRACTICE;HEALTHY SUBJECTS;LIVER TRANSPLANTATION","155;102;102;73;43;41;33;31;29;28;23;20;20;19;17;17;17;16;16;16;16;15;15;14;14;14;14;13;13;13",151,0.36,4.82,5,1,1.5,1,1,2.5,0,1,6,1,1,5,1.5,1.25,1,3,4,3,0,0,60,60,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,31,4.77,615.84,4.51,14,0.45,103.81,0,0,2,1,12,0,0,16,0,22,9,0,0,0,0,0,0,26,5,0,30,0,0,1,0,0,0,0,0,0,"United States;Italy;Finland;Netherlands;Spain;Switzerland","14;5;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;42 HEALTH SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;4203 HEALTH SERVICES AND SYSTEMS;4205 NURSING;3204 IMMUNOLOGY;3207 MEDICAL MICROBIOLOGY;3213 PAEDIATRICS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE","30;21;8;3;3;3;3;2;2;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PATIENT SAFETY;RARE DISEASES;CANCER;AUTOIMMUNE DISEASE;BEHAVIORAL AND SOCIAL SCIENCE;CARDIOVASCULAR;DIGESTIVE DISEASES;INFLAMMATORY BOWEL DISEASE;MIND AND BODY;PAIN RESEARCH;PEDIATRIC;BREAST CANCER;CHRONIC PAIN;HEART DISEASE;LUNG;NUTRITION;PHYSICAL REHABILITATION;REHABILITATION","28;17;11;9;8;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3","CANCER;CARDIOVASCULAR;BLOOD;MUSCULOSKELETAL;ORAL AND GASTROINTESTINAL;INFECTION;INFLAMMATORY AND IMMUNE SYSTEM;NEUROLOGICAL;RENAL AND UROGENITAL","8;4;2;2;2;1;1;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;6.4 SURGERY;6.6 PSYCHOLOGICAL AND BEHAVIOURAL;6.7 PHYSICAL;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.2 CELLULAR AND GENE THERAPIES;6.3 MEDICAL DEVICES;7.1 INDIVIDUAL CARE NEEDS","19;3;3;2;2;1;1;1;1","BREAST CANCER;COLON AND RECTAL CANCER;OVARIAN CANCER;HEAD AND NECK CANCER;LARYNGEAL CANCER;LUNG CANCER;NON-HODGKIN'S LYMPHOMA;ORAL CAVITY AND LIP CANCER;PHARYNGEAL CANCER;SALIVARY GLAND CANCER","3;2;2;1;1;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS","5;3;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,"PUBLIC LIBRARY OF SCIENCE;SPRINGER NATURE","5;3","31 BIOLOGICAL SCIENCES;46 INFORMATION AND COMPUTING SCIENCES;48 LAW AND LEGAL STUDIES;49 MATHEMATICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3105 GENETICS;32 BIOMEDICAL AND CLINICAL SCIENCES;34 CHEMICAL SCIENCES;37 EARTH SCIENCES;3704 GEOINFORMATICS;4610 LIBRARY AND INFORMATION STUDIES;4611 MACHINE LEARNING;4805 LEGAL SYSTEMS;4905 STATISTICS","3;3;3;3;1;1;1;1;1;1;1;1;1;1",NA,NA,"CONGENITAL","1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;2.4 SURVEILLANCE AND DISTRIBUTION","1;1",NA,NA,"CLINICAL MEDICINE AND SCIENCE;PUBLIC HEALTH","1;1",NA,NA,NA,NA
"AOUSSN_UMBERTOI",2019,484,14.5227272727273,3.01239669421488,0.37396694214876,0.303719008264463,0.40702479338843,1.75874547647768,1.34074074074074,1.45544554455446,1.25477707006369,0.547520661157025,8,217,113,55,43,0.45,0.23,0.11,0.09,23.38,0.961478541333869,4.93456736978046,0.297520661157025,0.946280991735537,0.448,0.383,0.42,0.399,"ROBIN FOÀ;PIERLUIGI BENEDETTI PANICI;MASSIMO BRECCIA;GENNARO SARDELLA;GIANCARLO CECCARELLI;VINCENZO TOMBOLINI;DANIELA MUSIO;FABRIZIO CONTI;DANILO TONI;GIUSEPPE LA TORRE;DANIELE SANTINI;ROBERTO LATAGLIATA;FEDERICA URBANO;FRANCESCA DE FELICE;PAOLO MARCHETTI;CHIARA CREMOLINI;GUIDO VALESINI;DIEGO RIBUFFO;FRANCESCA ROMANA MAURO;CARLOTTA ANTONIOTTI","17;13;13;12;11;10;10;10;10;10;10;9;9;9;9;9;9;9;8;8","ANTONIO V. STERPETTI;GIOVANNI ANTONIO COSSIGA;STEFANO CALVIERI;GIUSEPPE LA TORRE;SANDRA GIUSTINI;PIERLUIGI BENEDETTI PANICI;CORRADO GIRMENIA;VINCENZO TOMBOLINI;DIEGO RIBUFFO;FILIPPO LA TORRE;DANIELA MUSIO;EMANUELE MIRAGLIA;OMBRETTA MARTINELLI;FRANCESCA DE FELICE;TIZIANA CLAUDIA ARANZULLA;NADIA BULZONETTI;GUIDO VALESINI;GIUSEPPE DI TARANTO;ANDREA BALLA;GIANCARLO CECCARELLI","4.25;2;1.53;1.5;1.5;1.49;1.25;1.19;1.19;1.14;1.12;1.12;1.02;1.01;1;0.98;0.88;0.87;0.86;0.85","ROBIN FOÀ;PIERLUIGI BENEDETTI PANICI;MASSIMO BRECCIA;GENNARO SARDELLA;GIANCARLO CECCARELLI;VINCENZO TOMBOLINI;DANIELA MUSIO;FABRIZIO CONTI;DANILO TONI;GIUSEPPE LA TORRE;ROBERTO LATAGLIATA;FEDERICA URBANO;FRANCESCA DE FELICE;PAOLO MARCHETTI;GUIDO VALESINI;DIEGO RIBUFFO;FRANCESCA ROMANA MAURO;FRANCESCA ROMANA SPINELLI;SANDRA GIUSTINI;ALAIN GELIBTER","17;13;13;12;11;10;10;10;10;10;9;9;9;9;9;9;8;8;8;8","ANTONIO V. STERPETTI;GIOVANNI ANTONIO COSSIGA;STEFANO CALVIERI;GIUSEPPE LA TORRE;SANDRA GIUSTINI;PIERLUIGI BENEDETTI PANICI;CORRADO GIRMENIA;VINCENZO TOMBOLINI;DIEGO RIBUFFO;FILIPPO LA TORRE;DANIELA MUSIO;EMANUELE MIRAGLIA;OMBRETTA MARTINELLI;FRANCESCA DE FELICE;TIZIANA CLAUDIA ARANZULLA;NADIA BULZONETTI;GUIDO VALESINI;GIUSEPPE DI TARANTO;ANDREA BALLA;GIANCARLO CECCARELLI","4.25;2;1.53;1.5;1.5;1.49;1.25;1.19;1.19;1.14;1.12;1.12;1.02;1.01;1;0.98;0.88;0.87;0.86;0.85","DANILO TONI;PETER D. SCHELLINGER;PHIL WHITE;GUILLAUME TURC;JENS FIEHLER;JOOST DE VRIES;KYRIAKOS LOBOTESIS;MIKAËL MAZIGHI;PERVINDER BHOGAL;POOJA KHATRI;URS FISCHER;GENNARO SARDELLA;DARIUSZ DUDEK;JAVIER ESCANED;CARLO BRIGUORI;ROXANA MEHRAN;SAMANTHA SARTORI;GEORGE DANGAS;USMAN BABER;ADNAN KASTRATI","2048;1824;1193;1176;1176;1176;1176;1176;1176;1176;1176;968;921;876;862;862;862;852;841;808","DANILO TONI;GENNARO SARDELLA;ENRICO CORTESI;ALESSANDRO SCIARRA;VITO CANTISANI;FRANCESCO DEL GIUDICE;ALAIN GELIBTER;GIANCARLO CECCARELLI;RUBEN MANUEL LUCIANO COLUNGA BIANCATELLI;CARLO CATALANO;FABRIZIO CONTI;DIEGO RIBUFFO;ORIANO MECARELLI;ANNA PAOLA IORI;VALERIA PANEBIANCO;FEDERICA URBANO;DANIELA MUSIO;ROBIN FOÀ;ETTORE DE BERARDINIS;VALERIA RICCIERI","2048;968;424;298;268;227;221;207;205;201;187;185;183;182;177;174;173;169;168;166","GENNARO SARDELLA;PIERLUIGI BENEDETTI PANICI;GIANCARLO CECCARELLI;ROBIN FOÀ;DANILO TONI;FABRIZIO CONTI;DANIELA MUSIO;DIEGO RIBUFFO;MASSIMO BRECCIA;VINCENZO TOMBOLINI;FEDERICA URBANO;FRANCESCA DE FELICE;MASSIMO MANCONE;GUIDO VALESINI;ALAIN GELIBTER;FRANCESCA ROMANA MAURO;ENRICO CORTESI;FRANCESCA ROMANA SPINELLI;ROBERTO LATAGLIATA;SANDRA GIUSTINI","14;14;11;11;10;10;10;9;9;9;9;9;9;9;8;8;8;8;8;8","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;COMPUTER SCIENCE;ENGINEERING;PSYCHOLOGY;SOCIOLOGY;ECONOMICS;MATHEMATICS;MATERIALS SCIENCE;PHILOSOPHY;POLITICAL SCIENCE;GEOLOGY;ART;BUSINESS;HISTORY;GEOGRAPHY","466;116;47;30;27;27;27;23;19;18;9;7;7;5;4;4;4;2","INTERNAL MEDICINE;SURGERY;ONCOLOGY;GASTROENTEROLOGY;PATHOLOGY;GENETICS;RADIOLOGY;CARDIOLOGY;IMMUNOLOGY;ENVIRONMENTAL HEALTH;BIOCHEMISTRY;PEDIATRICS;PSYCHIATRY;ENDOCRINOLOGY;OPTICS;PALEONTOLOGY;PHYSICAL THERAPY;INTENSIVE CARE MEDICINE;CANCER RESEARCH;DERMATOLOGY","338;180;80;67;67;64;59;50;39;38;35;34;33;30;29;26;26;25;23;20","CANCER;DISEASE;GENE;POPULATION;CHEMOTHERAPY;ADVERSE EFFECT;COHORT;MYOCARDIAL INFARCTION;CONFIDENCE INTERVAL;INCIDENCE (GEOMETRY);RETROSPECTIVE COHORT STUDY;PREGNANCY;PROSPECTIVE COHORT STUDY;TRANSPLANTATION;CLINICAL TRIAL;MAGNETIC RESONANCE IMAGING;ALTERNATIVE MEDICINE;OBESITY;RANDOMIZED CONTROLLED TRIAL;MULTIVARIATE ANALYSIS;ODDS RATIO;STROKE (ENGINE)","86;49;43;40;37;29;27;26;23;22;20;19;19;18;16;16;15;15;15;14;14;14","BREAST CANCER;COLORECTAL CANCER;HAZARD RATIO;PHENOTYPE;IMMUNOTHERAPY;OVARIAN CANCER;BEVACIZUMAB;MUTATION;UNIVARIATE ANALYSIS;LIVER TRANSPLANTATION;PERCUTANEOUS CORONARY INTERVENTION;CHRONIC LYMPHOCYTIC LEUKEMIA;CONVENTIONAL PCI;CYCLOPHOSPHAMIDE;GENOTYPE;HEMATOPOIETIC STEM CELL TRANSPLANTATION;MYELODYSPLASTIC SYNDROMES;RELIABILITY (SEMICONDUCTOR);THROMBOLYSIS;EJECTION FRACTION;FATTY LIVER;METABOLIC SYNDROME;REVASCULARIZATION","21;20;13;12;10;10;9;9;9;8;8;7;7;7;7;7;7;7;7;6;6;6;6","NIVOLUMAB;IBRUTINIB;IRINOTECAN;MISSENSE MUTATION;BUSULFAN;CORONAVIRUS DISEASE 2019 (COVID-19);DASATINIB;DNA METHYLATION;DRUG-ELUTING STENT;ENDOVASCULAR ANEURYSM REPAIR;EXOME SEQUENCING;FLUDARABINE;HAPLOINSUFFICIENCY;HEREDITARY SPASTIC PARAPLEGIA;HERPESVIRIDAE;LYMPHEDEMA;MACE;MASTECTOMY;METASTATIC BREAST CANCER;MILAN CRITERIA;NILOTINIB;NONALCOHOLIC FATTY LIVER DISEASE;PEMBROLIZUMAB;RUXOLITINIB","7;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","HUMANS;FEMALE;MALE;;MIDDLE AGED;AGED;ADULT;ITALY;TREATMENT OUTCOME;RETROSPECTIVE STUDIES;AGED, 80 AND OVER;PROSPECTIVE STUDIES;ADOLESCENT;POSTOPERATIVE COMPLICATIONS;CHILD;STROKE;YOUNG ADULT;RISK FACTORS;BREAST NEOPLASMS;ANTINEOPLASTIC AGENTS","294;225;207;184;150;132;115;75;74;68;61;42;34;34;32;31;30;29;28;26","GENOMIC ABERRATIONS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA;EPIDEMIOLOGY AND MANAGEMENT OF STROKE;MANAGEMENT OF VALVULAR HEART DISEASE;ACUTE MYELOID LEUKEMIA;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;ATRIAL FIBRILLATION;EFFICACY AND RESISTANCE IN CML TREATMENT;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;COLORECTAL CANCER RESEARCH AND TREATMENT;EPIDEMIOLOGY AND TREATMENT OF HEAD AND NECK CANCER;GENOMIC STUDIES AND TREATMENT OF OVARIAN CARCINOMA;LYMPHOID NEOPLASMS;CANCER IMMUNOTHERAPY;CHOLESTEROL-LOWERING TREATMENT;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;DIAGNOSIS AND MANAGEMENT OF BILIARY TRACT DISORDERS;DIAGNOSIS AND MANAGEMENT OF TEMPOROMANDIBULAR DISORDERS;DIAGNOSIS AND TREATMENT OF DIVERTICULITIS;EPIDEMIOLOGY AND MANAGEMENT OF CYTOMEGALOVIRUS INFECTION;HEPATITIS C INFECTION AND TREATMENT","8;7;7;6;6;6;6;6;5;5;5;5;4;4;4;4;4;4;4;4","TREATMENT;STROKE (ENGINE);REGIMEN;CONCOMITANT;UNIVARIATE ANALYSIS;BREAST CANCER;HEMATOLOGY;INTERQUARTILE RANGE;INFARCTION TREATMENT;DISCONTINUATION;OVARIAN CANCER;PROSTHETIC VALVES EVALUATION;ATRIAL FIBRILLATION;DEPRESSION (ECONOMICS);ENDOVASCULAR REPAIR;LIVER TRANSPLANTATION;METASTATIC COLORECTAL CANCER;TUMOR MICROENVIRONMENT;ANEURYSM SCREENING;AORTIC DISSECTION","29;14;12;10;9;8;8;8;7;6;6;6;5;5;5;5;5;5;4;4","CANCER PATIENTS;BREAST CANCER;ELDERLY PATIENTS;OVARIAN CANCER;POOLED ANALYSIS;CHRONIC LYMPHOCYTIC;DOI CT;EUROPEAN SOCIETY;LOCALLY ADVANCED;LUNG CANCER;LYMPHOCYTIC LEUKEMIA;PATIENTS TREATED;PILOT STUDY;STEM CELL;CELL CARCINOMA;CELL TRANSPLANTATION;CLINICAL PRACTICE;COLORECTAL CANCER;MINIMALLY INVASIVE;PROSPECTIVE STUDY;TRIBE STUDIES;AORTIC VALVE;ATRIAL FIBRILLATION;FATTY LIVER;MECHANICAL THROMBECTOMY;METASTATIC COLORECTAL;MYELOID LEUKEMIA;NEUROFIBROMATOSIS TYPE;OBSERVATIONAL STUDY;PATIENTS UNDERGOING","14;11;9;9;9;7;7;7;7;7;7;7;7;7;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5","SPEAKERS BUREAU;ADVISORY COMMITTEES;ENTITYS BOARD;COMMITTEES SPEAKERS;CONSULTANCY MEMBERSHIP;RESEARCH FUNDING;CONSULTANCY SPEAKERS;CONSULTANCY RESEARCH;PATIENTS TREATED;CLINICAL PRACTICE;ADVERSE EVENTS;DA VINCI;LEONARDO DA;ADVISORY CONSULTANCY;DISEASE ACTIVITY;BREAST CANCER;HR CI;JANSSEN CONSULTANCY;ABBVIE CONSULTANCY;CANCER PATIENTS;MEDIAN AGE;NOVARTIS CONSULTANCY;CLL PATIENTS;PATIENTS RECEIVING;ROCHE CONSULTANCY;SHIRE CONSULTANCY;SIGNIFICANT DIFFERENCES;STATISTICALLY SIGNIFICANT;SURVIVAL OS;CONSECUTIVE PATIENTS","127;125;125;79;65;55;30;29;28;26;23;23;23;22;21;20;20;19;18;18;18;17;16;16;16;16;16;16;16;15",202,0.42,8.44,8,2,1,0,2,2,1,2,8.75,1,1,8,1,1,2,3,6,3,0,0,56,56,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,24,4.21,826.88,3.18,8,0.33,66.71,0,0,4,0,8,0,2,10,0,15,9,0,0,0,0,0,0,22,1,1,24,0,0,0,0,0,0,0,0,0,"Italy;United States;Finland;Germany;Portugal;Spain","5;5;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3204 IMMUNOLOGY;3212 OPHTHALMOLOGY AND OPTOMETRY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","24;16;6;4;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;PATIENT SAFETY;HEMATOLOGY;CANCER;AUTOIMMUNE DISEASE;CARDIOVASCULAR;CHRONIC LIVER DISEASE AND CIRRHOSIS;DIGESTIVE DISEASES;LIVER DISEASE;LUNG;TRANSPLANTATION;BRAIN DISORDERS;LUPUS;LYMPHOMA;NEURODEGENERATIVE;NEUROSCIENCES;ORPHAN DRUG;PREVENTION","23;15;11;10;6;5;3;3;3;3;3;3;3;2;2;2;2;2;2;2","CANCER;INFLAMMATORY AND IMMUNE SYSTEM;CARDIOVASCULAR;EYE;INFECTION;ORAL AND GASTROINTESTINAL","4;4;2;1;1;1","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;2.6 RESOURCES AND INFRASTRUCTURE (AETIOLOGY);5.1 PHARMACEUTICALS;6.3 MEDICAL DEVICES;7.1 INDIVIDUAL CARE NEEDS;7.3 MANAGEMENT AND DECISION MAKING","14;2;1;1;1;1;1","LEUKEMIA / LEUKAEMIA;NON-HODGKIN'S LYMPHOMA;BLOOD CANCER;MYELOMA;HODGKIN'S DISEASE;LIVER CANCER;OVARIAN CANCER;PANCREATIC CANCER","3;3;2;2;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;4.4 RESOURCES AND INFRASTRUCTURE RELATED TO DETECTION, DIAGNOSIS, OR PROGNOSIS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;6.2 SURVEILLANCE","6;2;1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7,"PUBLIC LIBRARY OF SCIENCE","7","31 BIOLOGICAL SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3105 GENETICS;3107 MICROBIOLOGY;3202 CLINICAL SCIENCES;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;34 CHEMICAL SCIENCES;40 ENGINEERING;4010 ENGINEERING PRACTICE AND EDUCATION","10;5;2;2;2;1;1;1;1","BIOTECHNOLOGY;CYSTIC FIBROSIS;GENETIC TESTING;GENETICS;LUNG;PEDIATRIC;RARE DISEASES","2;1;1;1;1;1;1","CONGENITAL;INFECTION","1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES","1;1","BIOMEDICAL;CLINICAL","1;1","CLINICAL MEDICINE AND SCIENCE","2",NA,NA,NA,NA
"AOUSSN_UMBERTOI",2020,626,15.8162939297125,3.19808306709265,0.369009584664537,0.300319488817891,0.452076677316294,2.05230769230769,1.43478260869565,1.49206349206349,1.32863849765258,0.637380191693291,7,241,175,71,38,0.38,0.28,0.11,0.06,20.67,0.820131341639473,5.80233832663501,0.293929712460064,0.939297124600639,0.462,0.435,0.44,0.427,"PAOLO MARCHETTI;CLAUDIO MARIA MASTROIANNI;ANDREA BOTTICELLI;PIERLUIGI BENEDETTI PANICI;FRANCESCO PUGLIESE;CORRADO FICORELLA;ALAIN GELIBTER;GUIDO ANTONELLI;ROBIN FOÀ;FRANCESCA DE FELICE;CARLO LAVALLE;ALESSIO CORTELLINI;VIOLANTE DI DONATO;MARIO OCCHIPINTI;GIANCARLO CECCARELLI;CARLO CATALANO;MASSIMO BRECCIA;DANIELE SANTINI;GABRIELLA D’ETTORRE;VINCENZO TOMBOLINI","24;20;18;18;17;15;15;14;14;13;13;13;13;12;12;12;12;12;11;11","DOTT. GIOVANNI ANTONIO COSSIGA;PIERLUIGI BENEDETTI PANICI;MASSIMO BRECCIA;EMANUELE MIRAGLIA;SANDRA GIUSTINI;FRANCESCA DE FELICE;VIOLANTE DI DONATO;GUIDO ANTONELLI;CLAUDIO MARIA MASTROIANNI;PAOLO MARCHETTI;VINCENZO TOMBOLINI;FRANCESCO PUGLIESE;DANIELA MUSIO;ROBIN FOÀ;FEDERICA TOMAO;STEFANO CALVIERI;CARLO CATALANO;DENIS A. COZZI;VALENTINO VALENTINI;FEDERICO VENUTA","3;2.11;2.07;1.89;1.89;1.82;1.67;1.57;1.28;1.24;1.22;1.21;1.21;1.2;1.18;1.16;1.09;1.08;1.06;1.06","PAOLO MARCHETTI;CLAUDIO MARIA MASTROIANNI;ANDREA BOTTICELLI;PIERLUIGI BENEDETTI PANICI;FRANCESCO PUGLIESE;ALAIN GELIBTER;GUIDO ANTONELLI;ROBIN FOÀ;FRANCESCA DE FELICE;CARLO LAVALLE;VIOLANTE DI DONATO;MARIO OCCHIPINTI;GIANCARLO CECCARELLI;CARLO CATALANO;MASSIMO BRECCIA;GABRIELLA D’ETTORRE;VINCENZO TOMBOLINI;ETTORE DE BERARDINIS;FRANCESCO ALESSANDRI;DANIELA MUSIO","24;20;18;18;17;15;14;14;13;13;13;12;12;12;12;11;11;11;11;11","DOTT. GIOVANNI ANTONIO COSSIGA;PIERLUIGI BENEDETTI PANICI;MASSIMO BRECCIA;EMANUELE MIRAGLIA;SANDRA GIUSTINI;FRANCESCA DE FELICE;VIOLANTE DI DONATO;GUIDO ANTONELLI;CLAUDIO MARIA MASTROIANNI;PAOLO MARCHETTI;VINCENZO TOMBOLINI;FRANCESCO PUGLIESE;DANIELA MUSIO;ROBIN FOÀ;FEDERICA TOMAO;STEFANO CALVIERI;CARLO CATALANO;DENIS A. COZZI;VALENTINO VALENTINI;FEDERICO VENUTA","3;2.11;2.07;1.89;1.89;1.82;1.67;1.57;1.28;1.24;1.22;1.21;1.21;1.2;1.18;1.16;1.09;1.08;1.06;1.06","CLAUDIO MARIA MASTROIANNI;FRANCESCO PUGLIESE;OMBRETTA TURRIZIANI;FRANCESCO ALESSANDRI;PAOLO MARCHETTI;CARLO CATALANO;ALAIN GELIBTER;VALERIA PANEBIANCO;MARIA ROSA CIARDI;ANDREA BOTTICELLI;PAOLO RICCI;MARCO FRANCONE;CHIARA ANDREOLI;FRANCO IAFRATE;MARCO FILETTI;MARIA CHIARA COLAIACOMO;RAFFAELE GIUSTI;LUCIA MANGANARO;MARIO OCCHIPINTI;MARCO RUSSANO","1267;1200;1061;1055;1009;999;951;857;839;819;818;797;791;763;755;755;755;754;753;715","FRANCESCO PUGLIESE;FRANCESCO ALESSANDRI;CARLO CATALANO;ALAIN GELIBTER;PAOLO MARCHETTI;VALERIA PANEBIANCO;PAOLO RICCI;MARCO FRANCONE;CHIARA ANDREOLI;FRANCO IAFRATE;MARIA CHIARA COLAIACOMO;LUCIA MANGANARO;MARIO OCCHIPINTI;FRANCESCO CILIA;GIORGIO MARIA MASCI;SIMONA COCO;PAOLO PALANGE;ANDREA BOTTICELLI;VITO CANTISANI;CECILIA CISTERNINO","1103;1010;999;951;925;850;806;797;791;763;755;754;753;713;713;713;634;626;607;450","PIERLUIGI BENEDETTI PANICI;PAOLO MARCHETTI;FRANCESCA DE FELICE;ANDREA BOTTICELLI;ALAIN GELIBTER;FRANCESCO PUGLIESE;VIOLANTE DI DONATO;CARLO LAVALLE;CLAUDIO MARIA MASTROIANNI;GENNARO SARDELLA;GUIDO ANTONELLI;MARIO OCCHIPINTI;FEDERICA TOMAO;FEDERICO VENUTA;ROBIN FOÀ;CARLO CATALANO;ANTONELLO D’ANDREA;ETTORE DE BERARDINIS;DANIELA MUSIO;MARTINA MAGGI","19;17;16;15;15;14;13;13;12;12;12;12;11;11;11;11;10;10;10;10","MEDICINE;BIOLOGY;PHYSICS;PSYCHOLOGY;ENGINEERING;CHEMISTRY;COMPUTER SCIENCE;MATHEMATICS;ECONOMICS;SOCIOLOGY;PHILOSOPHY;POLITICAL SCIENCE;BUSINESS;GEOGRAPHY;HISTORY;MATERIALS SCIENCE;GEOLOGY;ART;ENVIRONMENTAL SCIENCE","599;131;53;38;37;32;30;23;22;22;14;14;10;7;6;5;3;2;2","INTERNAL MEDICINE;SURGERY;PATHOLOGY;ONCOLOGY;IMMUNOLOGY;RADIOLOGY;CARDIOLOGY;ENVIRONMENTAL HEALTH;GENETICS;GASTROENTEROLOGY;PSYCHIATRY;VIROLOGY;PEDIATRICS;INTENSIVE CARE MEDICINE;BIOCHEMISTRY;NURSING;ENDOCRINOLOGY;OPTICS;ANESTHESIA;PALEONTOLOGY;PHYSICAL THERAPY","457;201;126;92;89;75;74;63;61;57;51;46;45;39;36;31;30;28;27;24;24","CANCER;DISEASE;POPULATION;RETROSPECTIVE COHORT STUDY;COHORT;GENE;OUTBREAK;CHEMOTHERAPY;CONFIDENCE INTERVAL;ALTERNATIVE MEDICINE;INCIDENCE (GEOMETRY);IMMUNE SYSTEM;RANDOMIZED CONTROLLED TRIAL;PREGNANCY;LUNG;ANTIBODY;HEART FAILURE;LUNG CANCER;MYOCARDIAL INFARCTION;CLINICAL TRIAL","122;120;58;45;42;42;34;31;31;29;26;24;24;23;22;21;21;21;21;19","INFECTIOUS DISEASE (MEDICAL SPECIALTY);2019-20 CORONAVIRUS OUTBREAK;COLORECTAL CANCER;BREAST CANCER;IMMUNOTHERAPY;HAZARD RATIO;CLINICAL ENDPOINT;OVARIAN CANCER;PROSTATE CANCER;EJECTION FRACTION;UNIVARIATE ANALYSIS;METASTASIS;PROGRESSION-FREE SURVIVAL;GENOTYPE;HEAD AND NECK CANCER;IMATINIB;IMMUNOGLOBULIN E;PERCUTANEOUS CORONARY INTERVENTION;FETUS;ALLELE;CERVICAL CANCER;NEURORADIOLOGY;PROSTATE","73;29;24;20;20;17;14;12;12;11;11;10;10;9;9;9;9;9;8;7;7;7;7","CORONAVIRUS DISEASE 2019 (COVID-19);NIVOLUMAB;DASATINIB;HBSAG;IBRUTINIB;IMATINIB MESYLATE;MEPOLIZUMAB;METASTATIC BREAST CANCER;NILOTINIB;PEMBROLIZUMAB;PROSTATE BIOPSY;PROSTATECTOMY;BRUTON'S TYROSINE KINASE;CETUXIMAB;CYSTECTOMY;ENDOVASCULAR ANEURYSM REPAIR;HEART RATE VARIABILITY;MACE;OMALIZUMAB;ORAL ALLERGY SYNDROME;SINGLE-NUCLEOTIDE POLYMORPHISM;TICAGRELOR","73;10;8;5;5;5;5;5;5;5;4;4;3;3;3;3;3;3;3;3;3;3",";HUMANS;FEMALE;MALE;MIDDLE AGED;AGED;ITALY;ADULT;RETROSPECTIVE STUDIES;COVID-19;AGED, 80 AND OVER;TREATMENT OUTCOME;POSTOPERATIVE COMPLICATIONS;CORONAVIRUS INFECTIONS;PNEUMONIA, VIRAL;LUNG NEOPLASMS;SARS-COV-2;PANDEMICS;PROSPECTIVE STUDIES;YOUNG ADULT","364;258;150;144;113;95;90;78;71;68;49;45;41;39;38;35;35;29;29;28","IMPACT OF COVID-19 ON CANCER PATIENTS AND CARE;CANCER IMMUNOTHERAPY;CORONAVIRUS DISEASE 2019;GENOMIC STUDIES AND TREATMENT OF OVARIAN CARCINOMA;COLORECTAL CANCER RESEARCH AND TREATMENT;EFFICACY AND RESISTANCE IN CML TREATMENT;MANAGEMENT OF VALVULAR HEART DISEASE;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;ASTHMA;EPIDEMIOLOGY AND TREATMENT OF HEAD AND NECK CANCER;GENOMIC ABERRATIONS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA;PROSTATE CANCER RESEARCH AND TREATMENT;ACUTE MYELOID LEUKEMIA;ANORECTAL SURGICAL PROCEDURES;CATHETER ABLATION OF CARDIAC ARRHYTHMIAS;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;APPLICATIONS OF DEEP LEARNING IN MEDICAL IMAGING;DIAGNOSIS AND TREATMENT OF BLADDER CANCER;GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS","18;17;11;10;9;9;9;8;7;7;7;7;7;6;6;6;6;5;5;5","PANDEMIC;2019-20 CORONAVIRUS OUTBREAK;TREATMENT;STROKE (ENGINE);CLINICAL ENDPOINT;BIOMARKERS FOR IMMUNOTHERAPY;CARDIAC IMAGING;ETIOLOGY;UNIVARIATE ANALYSIS;CONCOMITANT;PROGRESSION-FREE SURVIVAL;HEMATOLOGY;IMMUNE CHECKPOINT BLOCKADE;RADIOTHERAPY;LIVER DISEASE;TRANSCATHETER AORTIC-VALVE REPLACEMENT;BETACORONAVIRUS;CARDIOVASCULAR RISK ASSESSMENT;CLINICAL CHARACTERISTICS;CORONAVIRUS","29;26;25;15;14;11;11;11;11;10;10;9;9;9;8;8;7;7;7;7","MYELOID LEUKEMIA;BREAST CANCER;CANCER PATIENTS;COVID- PANDEMIC;RETROSPECTIVE STUDY;MULTICENTER STUDY;PATIENTS TREATED;CHRONIC MYELOID;LUNG CANCER;OBSERVATIONAL STUDY;AORTIC VALVE;CELL CARCINOMA;CLINICAL PRACTICE;COLORECTAL CANCER;HEART FAILURE;LEUKEMIA PATIENTS;MAGNETIC RESONANCE;OVARIAN CANCER;TRANSCATHETER AORTIC;ACUTE MYELOID;PILOT STUDY;PROSTATE CANCER;RISK FACTORS;SQUAMOUS CELL;CORONAVIRUS DISEASE;DOI CT;LEFT VENTRICULAR;STEM CELL;CERVICAL CANCER;CLINICAL TRIAL","15;14;14;13;11;10;10;9;9;9;8;8;8;8;8;8;8;8;8;7;7;7;7;7;6;6;6;6;5;5","ADVISORY COMMITTEES;ENTITYS BOARD;RESEARCH FUNDING;SPEAKERS BUREAU;CONSULTANCY HONORARIA;HR CI;HONORARIA MEMBERSHIP;COMMITTEES SPEAKERS;PUBMED SCOPUS;PATIENTS TREATED;HONORARIA RESEARCH;CORONAVIRUS DISEASE;HYPERIMMUNE SERUM;PATIENTS UNDERGOING;CUSHINGS SYNDROME;SIGNIFICANT DIFFERENCES;ACUTE RESPIRATORY;COVID- PANDEMIC;MEDIAN AGE;CONSULTANCY MEMBERSHIP;COVID- PATIENTS;FUNDING SPEAKERS;MEDIAN FOLLOW-UP;CROSSREF PUBMED;RISK FACTORS;TRAVEL GRANTS;ABBVIE HONORARIA;JANSSEN HONORARIA;CONSULTANCY RESEARCH;HONORARIA SPEAKERS","206;206;200;151;117;78;60;50;46;40;39;35;34;31;30;29;27;27;26;24;24;24;24;23;23;23;22;22;21;21",295,0.47,8.3,8,1,1.75,0,4,1,1,1,10,1,1,8,1,2.5,2,3.25,6,3,0,0,54,54,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,36,3.89,829.44,4.25,23,0.64,86.67,0,0,8,0,10,0,0,18,0,22,14,0,0,0,0,0,0,35,1,0,36,0,0,0,0,0,0,0,0,0,"United States;Italy;Japan;Germany;Netherlands;United Kingdom","11;4;2;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;52 PSYCHOLOGY;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;5202 BIOLOGICAL PSYCHOLOGY;3204 IMMUNOLOGY;3210 NUTRITION AND DIETETICS","35;20;8;5;4;3;3;3;3;3;2;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;PATIENT SAFETY;RARE DISEASES;CARDIOVASCULAR;HEMATOLOGY;HEART DISEASE;LUNG;PREVENTION;DIGESTIVE DISEASES;GENETICS;AGING;BIOMEDICAL IMAGING;DIABETES;LUNG CANCER;ATHEROSCLEROSIS;AUTOIMMUNE DISEASE;HEART DISEASE - CORONARY HEART DISEASE;INFECTIOUS DISEASES","35;21;12;11;10;7;7;6;6;6;4;4;3;3;3;3;2;2;2;2","CANCER;CARDIOVASCULAR;INFLAMMATORY AND IMMUNE SYSTEM;METABOLIC AND ENDOCRINE;BLOOD;NEUROLOGICAL;SKIN","8;7;3;2;1;1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.4 SURGERY;7.1 INDIVIDUAL CARE NEEDS;8.1 ORGANISATION AND DELIVERY OF SERVICES;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;2.4 SURVEILLANCE AND DISTRIBUTION;5.1 PHARMACEUTICALS;5.2 CELLULAR AND GENE THERAPIES","22;3;2;2;2;2;2;1;1;1;1","BREAST CANCER;LEUKEMIA / LEUKAEMIA;LUNG CANCER;NON-HODGKIN'S LYMPHOMA;BLOOD CANCER;COLON AND RECTAL CANCER;HODGKIN'S DISEASE;LIVER CANCER;MYELOMA;OVARIAN CANCER;PANCREATIC CANCER;THYROID CANCER","3;3;3;3;1;1;1;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;6.2 SURVEILLANCE","8;1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,22,"PUBLIC LIBRARY OF SCIENCE;SPRINGER NATURE;FRONTIERS;KARGER PUBLISHERS","9;8;3;2","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;34 CHEMICAL SCIENCES;3204 IMMUNOLOGY;42 HEALTH SCIENCES;49 MATHEMATICAL SCIENCES;31 BIOLOGICAL SCIENCES;3202 CLINICAL SCIENCES;3205 MEDICAL BIOCHEMISTRY AND METABOLOMICS;3401 ANALYTICAL CHEMISTRY;4905 STATISTICS;3207 MEDICAL MICROBIOLOGY;3212 OPHTHALMOLOGY AND OPTOMETRY;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;4203 HEALTH SERVICES AND SYSTEMS;4206 PUBLIC HEALTH;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","27;8;4;3;3;3;2;2;2;2;2;1;1;1;1;1;1;1","CLINICAL RESEARCH;PREVENTION;BIODEFENSE;CANCER;CHRONIC PAIN;COLO-RECTAL CANCER;DIGESTIVE DISEASES;EMERGENCY CARE;EMERGING INFECTIOUS DISEASES;EYE DISEASE AND DISORDERS OF VISION;HEADACHES;HEMATOLOGY;IMMUNIZATION;INFECTIOUS DISEASES;LUNG;MIGRAINES;NEUROSCIENCES;PAIN RESEARCH;PATIENT SAFETY;PNEUMONIA","4;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;BLOOD;INFECTION;INFLAMMATORY AND IMMUNE SYSTEM;NEUROLOGICAL","8;1;1;1;1","5.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","7;1;1;1","CLINICAL;BIOMEDICAL","4;1","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE;PUBLIC HEALTH","6;5;2","COLON AND RECTAL CANCER;LUNG CANCER","6;2",NA,NA
"AOUSSN_UMBERTOI",2021,691,16.3531114327062,3.34442836468886,0.332850940665702,0.301013024602026,0.389290882778582,2.12603495860166,1.41975308641975,1.47517730496454,1.42328042328042,0.694645441389291,5,240,188,90,46,0.35,0.27,0.13,0.07,11.24,0.729092553989059,6.01420903062839,0.318379160636758,0.952243125904486,0.477,0.482,0.471,0.49,"GIANCARLO CECCARELLI;CLAUDIO MARIA MASTROIANNI;CARLO LAVALLE;CARLO CATALANO;GABRIELLA D’ETTORRE;FRANCESCO DEL GIUDICE;ALAIN GELIBTER;ALESSANDRO SCIARRA;MASSIMO BRECCIA;MICHELE MAGNOCAVALLO;GIAN MARIA BUSETTO;ANTONELLO D’ANDREA;ROCCO SIMONE FLAMMIA;FRANCESCA DE FELICE;PAOLO MARCHETTI;VIOLANTE DI DONATO;MICHELE GALLUCCI;GUIDO ANTONELLI;PIERLUIGI BENEDETTI PANICI;VIVIANA MAESTRINI","27;26;26;22;21;20;18;17;17;16;16;16;15;15;15;15;15;14;14;13","GIANCARLO CECCARELLI;CLAUDIO MARIA MASTROIANNI;FRANCESCA DE FELICE;MASSIMO BRECCIA;CARLO CATALANO;GABRIELLA D’ETTORRE;PAOLO MARCHETTI;MARIA GRAZIA PORPORA;CARLO LAVALLE;FRANCESCO DEL GIUDICE;MARCO MONTI;MASSIMO RALLI;PIERLUIGI BENEDETTI PANICI;LUDOVICO MUZII;VIOLANTE DI DONATO;ALESSANDRO SCIARRA;GUIDO ANTONELLI;GIORGIA PERNIOLA;M SUPPA;LUCA MARINO","2.25;1.99;1.95;1.89;1.87;1.7;1.63;1.52;1.51;1.49;1.46;1.39;1.25;1.24;1.23;1.2;1.16;1.13;1.1;1.1","GIANCARLO CECCARELLI;CLAUDIO MARIA MASTROIANNI;CARLO LAVALLE;CARLO CATALANO;GABRIELLA D’ETTORRE;FRANCESCO DEL GIUDICE;ALAIN GELIBTER;ALESSANDRO SCIARRA;MASSIMO BRECCIA;MICHELE MAGNOCAVALLO;GIAN MARIA BUSETTO;ANTONELLO D’ANDREA;ROCCO SIMONE FLAMMIA;FRANCESCA DE FELICE;PAOLO MARCHETTI;VIOLANTE DI DONATO;MICHELE GALLUCCI;GUIDO ANTONELLI;PIERLUIGI BENEDETTI PANICI;VIVIANA MAESTRINI","27;26;26;22;21;20;18;17;17;16;16;16;15;15;15;15;15;14;14;13","GIANCARLO CECCARELLI;CLAUDIO MARIA MASTROIANNI;FRANCESCA DE FELICE;MASSIMO BRECCIA;CARLO CATALANO;GABRIELLA D’ETTORRE;PAOLO MARCHETTI;MARIA GRAZIA PORPORA;CARLO LAVALLE;FRANCESCO DEL GIUDICE;MARCO MONTI;MASSIMO RALLI;PIERLUIGI BENEDETTI PANICI;LUDOVICO MUZII;VIOLANTE DI DONATO;ALESSANDRO SCIARRA;GUIDO ANTONELLI;GIORGIA PERNIOLA;M SUPPA;LUCA MARINO","2.25;1.99;1.95;1.89;1.87;1.7;1.63;1.52;1.51;1.49;1.46;1.39;1.25;1.24;1.23;1.2;1.16;1.13;1.1;1.1","GIANCARLO CECCARELLI;CLAUDIO MARIA MASTROIANNI;ALESSIO CORTELLINI;GABRIELLA D’ETTORRE;RAFFAELE GIUSTI;CORRADO FICORELLA;PAOLO MARCHETTI;FRANCESCO ALESSANDRI;GENNARO SARDELLA;FRANCESCO DEL GIUDICE;MARCO FILETTI;ALAIN GELIBTER;ALESSANDRO SCIARRA;CARLO LAVALLE;ROSSANA BERARDI;CARLO GENOVA;CRISTIAN BORRAZZO;CARLO CATALANO;GIAN MARIA BUSETTO;ROXANA MEHRAN","568;453;448;398;398;397;392;386;368;360;353;340;326;308;305;299;296;294;292;292","GIANCARLO CECCARELLI;CLAUDIO MARIA MASTROIANNI;GABRIELLA D’ETTORRE;GENNARO SARDELLA;FRANCESCO DEL GIUDICE;ALAIN GELIBTER;ALESSANDRO SCIARRA;FRANCESCO ALESSANDRI;CARLO LAVALLE;CARLO CATALANO;CRISTIAN BORRAZZO;MARTINA MAGGI;ANDREA BOTTICELLI;FRANCESCO PUGLIESE;VALERIA PANEBIANCO;FEDERICA PULVIRENTI;ETTORE DE BERARDINIS;ANTONELLO D’ANDREA;MARIA GIULIA CONTI;MICHELE MAGNOCAVALLO","421;388;371;365;360;340;326;318;308;271;245;245;226;214;209;202;201;198;197;187","CARLO LAVALLE;FRANCESCO DEL GIUDICE;GIANCARLO CECCARELLI;CLAUDIO MARIA MASTROIANNI;CARLO CATALANO;ALAIN GELIBTER;MASSIMO BRECCIA;ALESSANDRO SCIARRA;FRANCESCA DE FELICE;ANTONELLO D’ANDREA;GABRIELLA D’ETTORRE;ROCCO SIMONE FLAMMIA;VIOLANTE DI DONATO;MICHELE MAGNOCAVALLO;GENNARO SARDELLA;MICHELE GALLUCCI;MARTINA MAGGI;MARIA TERESA PETRUCCI;PIERLUIGI BENEDETTI PANICI;ETTORE DE BERARDINIS","25;21;21;20;18;18;17;17;17;16;16;15;15;15;13;13;13;12;12;12","MEDICINE;BIOLOGY;PHYSICS;COMPUTER SCIENCE;ENGINEERING;PSYCHOLOGY;CHEMISTRY;ECONOMICS;MATHEMATICS;POLITICAL SCIENCE;SOCIOLOGY;PHILOSOPHY;BUSINESS;GEOGRAPHY;HISTORY;MATERIALS SCIENCE;GEOLOGY;ART;ENVIRONMENTAL SCIENCE","671;157;69;45;41;37;31;29;26;24;23;19;12;7;4;4;3;2;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;ONCOLOGY;CARDIOLOGY;GENETICS;RADIOLOGY;PEDIATRICS;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;INTENSIVE CARE MEDICINE;IMMUNOLOGY;PSYCHIATRY;OPTICS;PHYSICAL THERAPY;BIOCHEMISTRY;FAMILY MEDICINE;NURSING;VIROLOGY;UROLOGY","516;212;128;112;85;83;78;76;75;60;54;51;51;44;42;41;39;38;36;34","CANCER;DISEASE;POPULATION;COHORT;RETROSPECTIVE COHORT STUDY;GENE;CHEMOTHERAPY;CONFIDENCE INTERVAL;PROSPECTIVE COHORT STUDY;INCIDENCE (GEOMETRY);PROPORTIONAL HAZARDS MODEL;ALTERNATIVE MEDICINE;RANDOMIZED CONTROLLED TRIAL;PREGNANCY;MAGNETIC RESONANCE IMAGING;OBSERVATIONAL STUDY;MYOCARDIAL INFARCTION;RADIATION THERAPY;ADVERSE EFFECT;HEART FAILURE;OUTBREAK","143;121;73;61;56;50;42;41;36;35;33;31;30;29;28;28;27;25;24;23;23","INFECTIOUS DISEASE (MEDICAL SPECIALTY);HAZARD RATIO;PROSTATE CANCER;BREAST CANCER;CLINICAL ENDPOINT;2019-20 CORONAVIRUS OUTBREAK;IMMUNOTHERAPY;COLORECTAL CANCER;EJECTION FRACTION;PROSTATE;BLADDER CANCER;CONVENTIONAL PCI;UNIVARIATE ANALYSIS;IMATINIB;PERCUTANEOUS CORONARY INTERVENTION;PROGRESSION-FREE SURVIVAL;CUMULATIVE INCIDENCE;GENE EXPRESSION;GESTATIONAL AGE;OVARIAN CANCER","64;31;28;27;23;19;18;17;16;13;12;12;12;11;11;11;10;10;10;10","CORONAVIRUS DISEASE 2019 (COVID-19);PROSTATECTOMY;PEMBROLIZUMAB;NILOTINIB;ANTIRETROVIRAL THERAPY;CYSTECTOMY;MASTECTOMY;DASATINIB;PROSTATE BIOPSY;TICAGRELOR;BREAST RECONSTRUCTION;COLONOSCOPY;KLEBSIELLA PNEUMONIAE;METASTATIC BREAST CANCER;NEOADJUVANT THERAPY;PROSTATE-SPECIFIC ANTIGEN;CARBOPLATIN;ELTROMBOPAG;EXTERNAL BEAM RADIOTHERAPY;IBRUTINIB;IMATINIB MESYLATE;LEFT ATRIAL APPENDAGE OCCLUSION","64;14;13;9;7;7;7;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4",";HUMANS;FEMALE;MALE;MIDDLE AGED;AGED;RETROSPECTIVE STUDIES;COVID-19;ADULT;ITALY;SARS-COV-2;TREATMENT OUTCOME;PROSTATIC NEOPLASMS;AGED, 80 AND OVER;PROSPECTIVE STUDIES;RISK FACTORS;URINARY BLADDER NEOPLASMS;CHILD;RISK ASSESSMENT;LUNG NEOPLASMS","354;332;141;130;106;92;92;83;80;78;50;50;44;41;39;29;27;26;25;23","CORONAVIRUS DISEASE 2019;PROSTATE CANCER RESEARCH AND TREATMENT;CANCER IMMUNOTHERAPY;ATRIAL FIBRILLATION;DIAGNOSIS AND TREATMENT OF BLADDER CANCER;EFFICACY AND RESISTANCE IN CML TREATMENT;CORONAVIRUS DISEASE 2019 RESEARCH;IMPACT OF COVID-19 ON CANCER PATIENTS AND CARE;ANTIPLATELET THERAPY IN CARDIOVASCULAR DISEASE;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;GENOMIC STUDIES AND TREATMENT OF OVARIAN CARCINOMA;LYMPHOID NEOPLASMS;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;EPILEPSY AND SEIZURES;MANAGEMENT AND TREATMENT OF HEMOPHILIA;PLATELET DISORDERS AND THROMBOSIS MECHANISMS;RADIOMICS IN MEDICAL IMAGING ANALYSIS;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;EPIDEMIOLOGY AND TREATMENT OF HEAD AND NECK CANCER;GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS","17;17;14;12;12;12;11;11;9;9;8;8;7;7;7;7;7;6;6;6","PANDEMIC;CLINICAL ENDPOINT;2019-20 CORONAVIRUS OUTBREAK;CONCOMITANT;STROKE (ENGINE);TREATMENT;DELPHI METHOD;UNIVARIATE ANALYSIS;PROGRESSION-FREE SURVIVAL;DISCONTINUATION;PROSTATE CANCER;CUMULATIVE INCIDENCE;MRI IMAGING;REGIMEN;ECHOCARDIOGRAPHY;GRADING (ENGINEERING);METASTATIC PROSTATE CANCER;ANTICOAGULANT THERAPY;CANCER IMAGING;CARDIOVASCULAR RISK ASSESSMENT","29;23;21;19;15;15;13;13;12;11;11;10;10;10;9;9;9;8;8;8","CANCER PATIENTS;PROSTATE CANCER;DOI CT;COHORT STUDY;LUNG CANCER;OBSERVATIONAL STUDY;RADICAL PROSTATECTOMY;RETROSPECTIVE STUDY;BREAST CANCER;CHRONIC MYELOID;MYELOID LEUKEMIA;PATIENTS TREATED;ATRIAL FIBRILLATION;ITALIAN SOCIETY;MAGNETIC RESONANCE;MULTIPLE MYELOMA;PROSPECTIVE STUDY;COVID- PANDEMIC;ELDERLY PATIENTS;MINIMALLY INVASIVE;BLADDER CANCER;CLINICAL PRACTICE;CELL LUNG;CHRONIC PHASE;CLINICAL OUTCOMES;CORONARY INTERVENTION;COVID- PATIENTS;HEART FAILURE;INTENSIVE CARE;MULTICENTER STUDY","18;17;15;14;14;14;14;12;11;11;11;10;9;9;9;9;9;8;8;8;7;7;6;6;6;6;6;6;6;6","SPEAKERS BUREAU;ADVISORY COMMITTEES;ENTITYS BOARD;HR CI;CONSULTANCY HONORARIA;PUBMED SCOPUS;ADVISORY BOARD;PATIENTS TREATED;RESEARCH FUNDING;PATIENTS UNDERGOING;SARS-COV- INFECTION;MEDIAN AGE;RISK FACTORS;CROSSREF PUBMED;HAZARD RATIO;STATISTICALLY SIGNIFICANT;CLINICAL PRACTICE;PROSTATE CANCER;COVID- PATIENTS;LOGISTIC REGRESSION;PROPENSITY SCORE;AORTIC VALVE;MASS INDEX;JANSSEN CONSULTANCY;PRIMARY ENDPOINT;RETROSPECTIVE STUDY;ADVERSE EVENTS;BODY MASS;CLINICAL OUTCOMES;LEFT VENTRICULAR","110;103;103;88;87;69;59;56;56;54;41;40;40;38;34;34;31;31;30;30;30;29;29;28;28;27;26;26;26;26",305,0.44,7.95,8,1,1,0,2.75,1,1,1,9,1.25,1,8,1,0,2,4.5,6.75,4,0,0,35,35,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,42,3.98,1153.32,4.26,24,0.57,93.9,0,1,7,3,19,0,1,11,0,33,9,0,0,0,0,0,0,40,1,1,41,0,0,1,0,0,0,0,0,0,"United States;Italy;Japan","15;5;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;42 HEALTH SCIENCES;52 PSYCHOLOGY;3204 IMMUNOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;5202 BIOLOGICAL PSYCHOLOGY;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3006 FOOD SCIENCES;31 BIOLOGICAL SCIENCES;3105 GENETICS;3207 MEDICAL MICROBIOLOGY;4206 PUBLIC HEALTH","41;25;8;6;3;3;2;2;2;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;CANCER;HEMATOLOGY;LUNG;PATIENT SAFETY;PREVENTION;PEDIATRIC;CARDIOVASCULAR;INFECTIOUS DISEASES;ORPHAN DRUG;REGENERATIVE MEDICINE;STEM CELL RESEARCH;TRANSPLANTATION;AUTOIMMUNE DISEASE;BRAIN DISORDERS;HEART DISEASE;LYMPHOMA;NUTRITION","42;29;14;12;11;8;8;8;6;5;5;5;4;4;4;3;3;3;3;3","CANCER;CARDIOVASCULAR;INFECTION;INFLAMMATORY AND IMMUNE SYSTEM;ORAL AND GASTROINTESTINAL;BLOOD;METABOLIC AND ENDOCRINE;NEUROLOGICAL;STROKE","12;9;3;2;2;1;1;1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;2.2 FACTORS RELATING TO THE PHYSICAL ENVIRONMENT;3.4 VACCINES;5.2 CELLULAR AND GENE THERAPIES;6.7 PHYSICAL;7.1 INDIVIDUAL CARE NEEDS","29;5;3;2;1;1;1;1;1","LEUKEMIA / LEUKAEMIA;NON-HODGKIN'S LYMPHOMA;MYELOMA;BLOOD CANCER;BREAST CANCER;COLON AND RECTAL CANCER;HEAD AND NECK CANCER;HODGKIN'S DISEASE;LARYNGEAL CANCER;LIVER CANCER;LUNG CANCER;NOT SITE-SPECIFIC CANCER;ORAL CAVITY AND LIP CANCER;PHARYNGEAL CANCER;SALIVARY GLAND CANCER","5;4;3;2;2;1;1;1;1;1;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;1.4 CANCER PROGRESSION AND METASTASIS;2.1 EXOGENOUS FACTORS IN THE ORIGIN AND CAUSE OF CANCER;3.2 NUTRITIONAL SCIENCE IN CANCER PREVENTION;4.1 TECHNOLOGY DEVELOPMENT AND/OR MARKER DISCOVERY;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","10;1;1;1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9,"FRONTIERS;SPRINGER NATURE;ZENODO;KARGER PUBLISHERS","3;3;2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3202 CLINICAL SCIENCES;3105 GENETICS;3211 ONCOLOGY AND CARCINOGENESIS;3204 IMMUNOLOGY;49 MATHEMATICAL SCIENCES;4905 STATISTICS","12;6;5;3;3;1;1;1","CANCER;AGING;CLINICAL RESEARCH;DENTAL/ORAL AND CRANIOFACIAL DISEASE;DIGESTIVE DISEASES;LUNG;PREVENTION;UROLOGIC DISEASES;AUTOIMMUNE DISEASE;EMERGING INFECTIOUS DISEASES;GENETICS;HUMAN GENOME;IMMUNIZATION;INFECTIOUS DISEASES;PEDIATRIC;PROSTATE CANCER;RARE DISEASES;VACCINE RELATED","4;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","CANCER;INFECTION;INFLAMMATORY AND IMMUNE SYSTEM;RENAL AND UROGENITAL;RESPIRATORY","3;1;1;1;1","6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","2;1;1;1","CLINICAL;BIOMEDICAL","5;1","CLINICAL MEDICINE AND SCIENCE","5","LUNG CANCER;HEAD AND NECK CANCER;NOT SITE-SPECIFIC CANCER;PHARYNGEAL CANCER;PROSTATE CANCER;SALIVARY GLAND CANCER","3;2;2;2;2;2",NA,NA
"AOUSSN_UMBERTOI",2022,744,16.7688172043011,3.30510752688172,0.334677419354839,0.282258064516129,0.360215053763441,1.92109375,1.40677966101695,1.48936170212766,1.40314136125654,0.758064516129032,7,258,177,78,53,0.35,0.24,0.1,0.07,8.99,1.00669339716961,5.66998294485502,0.310483870967742,0.948924731182796,0.498,0.517,0.482,0.514,"MASSIMO BRECCIA;ROCCO SIMONE FLAMMIA;MICHELE GALLUCCI;SHAHROKH F. SHARIAT;FELIX K.‐H. CHUN;FRED SAAD;FRANCESCA DE FELICE;CARLO TERRONE;ANTONELLO D’ANDREA;ALBERTO BRIGANTI;FRANCESCO CHIERIGO;BENEDIKT HOEH;FRANCESCO DEL GIUDICE;CARLO CATALANO;ZHE TIAN;GABRIELE SORCE;PIERRE I. KARAKIEWICZ;MARKUS GRAEFEN;CLAUDIO MARIA MASTROIANNI;QUIRINO LAI","33;32;29;25;24;24;23;23;23;22;22;22;22;21;20;20;20;18;18;17","DOTT. GIOVANNI ANTONIO COSSIGA;MASSIMO BRECCIA;FRANCESCA DE FELICE;SANDRA GIUSTINI;LUIGI VALENTINO BERRA;ROCCO SIMONE FLAMMIA;ANTONELLO D’ANDREA;CARLO CATALANO;QUIRINO LAI;MICHELE GALLUCCI;EMANUELE MIRAGLIA;FELIX K.‐H. CHUN;FRED SAAD;FRANCESCO DEL GIUDICE;INNOCENZA PALAIA;SHAHROKH F. SHARIAT;BENEDIKT HOEH;CLAUDIO MARIA MASTROIANNI;ALBERTO BRIGANTI;DANIELA MUSIO","3;2.91;2.38;2.07;2;1.93;1.85;1.8;1.64;1.63;1.62;1.4;1.4;1.37;1.29;1.28;1.27;1.25;1.23;1.22","MASSIMO BRECCIA;ROCCO SIMONE FLAMMIA;MICHELE GALLUCCI;FRANCESCA DE FELICE;ANTONELLO D’ANDREA;FRANCESCO DEL GIUDICE;CARLO CATALANO;CLAUDIO MARIA MASTROIANNI;QUIRINO LAI;ALESSANDRO SCIARRA;INNOCENZA PALAIA;COSTANTINO LEONARDO;GENNARO SARDELLA;ROBERTO LATAGLIATA;GABRIELLA D’ETTORRE;ANDREA BOTTICELLI;GIANCARLO CECCARELLI;CARLO LAVALLE;VIOLANTE DI DONATO;ENRICO CORTESI","33;32;29;23;23;22;21;18;17;15;15;15;14;13;13;13;13;13;12;12","DOTT. GIOVANNI ANTONIO COSSIGA;MASSIMO BRECCIA;FRANCESCA DE FELICE;SANDRA GIUSTINI;LUIGI VALENTINO BERRA;ROCCO SIMONE FLAMMIA;ANTONELLO D’ANDREA;CARLO CATALANO;QUIRINO LAI;MICHELE GALLUCCI;EMANUELE MIRAGLIA;FRANCESCO DEL GIUDICE;INNOCENZA PALAIA;CLAUDIO MARIA MASTROIANNI;DANIELA MUSIO;ANTONIO SANTORO;STEFANO CALVIERI;COSTANTINO LEONARDO;FEDERICA PULVIRENTI;LUCA D’ANGELO","3;2.91;2.38;2.07;2;1.93;1.85;1.8;1.64;1.63;1.62;1.37;1.29;1.25;1.22;1.21;1.2;1.1;1.08;1.06","ROBERTO BADAGLIACCA;ANDREW J.S. COATS;ANTON VONK NOORDEGRAAF;BLIN NAGAVCI;DAVID G. KIELY;DIOGENES S. FERREIRA;ECKHARD MAYER;GEORGE GIANNAKOULAS;GERGELY MÉSZÁROS;GÁBOR KOVÁCS;GÉRALD SIMONNEAU;GÖRAN RÅDEGRAN;HOSSEIN A. GHOFRANI;JEAN-LUC VACHIÉRY;JENNIFER K QUINT;JOANNA PEPKE‐ŻABA;JØRN CARLSEN;KAREN M. OLSSON;MARC HUMBERT;MARGARITA BRIDA","1009;1003;1003;1003;1003;1003;1003;1003;1003;1003;1003;1003;1003;1003;1003;1003;1003;1003;1003;1003","ROBERTO BADAGLIACCA;MARCO RIVANO CAPPARUCCIA;FRANCESCO DEL GIUDICE;CARLO CATALANO;ANTONELLO D’ANDREA;ROCCO SIMONE FLAMMIA;INNOCENZA PALAIA;VIOLANTE DI DONATO;DANILO TONI;CLAUDIO MARIA MASTROIANNI;MASSIMO BRECCIA;PIERLUIGI BENEDETTI PANICI;MICHELE GALLUCCI;FRANCESCO ALESSANDRI;GENNARO SARDELLA;COSTANTINO LEONARDO;LUDOVICO MUZII;GIORGIA PERNIOLA;FRANCESCA DE FELICE;MARTINA MAGGI","1009;478;312;203;197;185;184;183;165;161;155;151;150;149;134;131;127;125;122;112","ROCCO SIMONE FLAMMIA;MASSIMO BRECCIA;MICHELE GALLUCCI;FRANCESCA DE FELICE;FRANCESCO DEL GIUDICE;ANTONELLO D’ANDREA;CARLO CATALANO;GENNARO SARDELLA;QUIRINO LAI;ALESSANDRO SCIARRA;COSTANTINO LEONARDO;INNOCENZA PALAIA;CARLO LAVALLE;VINCENZO TOMBOLINI;VIOLANTE DI DONATO;CLAUDIO MARIA MASTROIANNI;FEDERICO VENUTA;CRISTINA SANTORO;FRANCESCO PUGLIESE;LUDOVICO MUZII","31;31;28;24;23;22;18;17;16;15;15;14;13;12;12;11;11;10;10;10","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;COMPUTER SCIENCE;ENGINEERING;MATHEMATICS;ECONOMICS;SOCIOLOGY;PSYCHOLOGY;POLITICAL SCIENCE;PHILOSOPHY;BUSINESS;MATERIALS SCIENCE;GEOGRAPHY;ART;GEOLOGY;HISTORY","722;174;67;46;42;40;29;25;24;22;19;16;10;8;5;4;3;3","INTERNAL MEDICINE;SURGERY;ONCOLOGY;PATHOLOGY;CARDIOLOGY;RADIOLOGY;GENETICS;IMMUNOLOGY;GASTROENTEROLOGY;PEDIATRICS;ENVIRONMENTAL HEALTH;INTENSIVE CARE MEDICINE;PSYCHIATRY;PALEONTOLOGY;BIOCHEMISTRY;UROLOGY;OPTICS;VIROLOGY;PHYSICAL THERAPY;ENDOCRINOLOGY","575;234;125;110;94;90;81;76;75;72;71;62;50;49;48;44;39;38;31;30","CANCER;DISEASE;COHORT;POPULATION;RETROSPECTIVE COHORT STUDY;GENE;CONFIDENCE INTERVAL;CHEMOTHERAPY;INCIDENCE (GEOMETRY);PROPORTIONAL HAZARDS MODEL;RANDOMIZED CONTROLLED TRIAL;ADVERSE EFFECT;STAGE (STRATIGRAPHY);LOGISTIC REGRESSION;PROSPECTIVE COHORT STUDY;CLINICAL TRIAL;HEART FAILURE;MAGNETIC RESONANCE IMAGING;OBSERVATIONAL STUDY;ODDS RATIO;PREGNANCY;RADIATION THERAPY","157;116;73;68;65;53;44;38;35;34;34;33;32;31;30;29;29;29;29;26;26;26","INFECTIOUS DISEASE (MEDICAL SPECIALTY);PROSTATE CANCER;HAZARD RATIO;BREAST CANCER;2019-20 CORONAVIRUS OUTBREAK;COLORECTAL CANCER;BLADDER CANCER;EJECTION FRACTION;PROSTATE;CLINICAL ENDPOINT;METASTASIS;IMMUNOTHERAPY;IMATINIB;NEURORADIOLOGY;GENOTYPE;PERCUTANEOUS CORONARY INTERVENTION;CERVICAL CANCER;LIVER TRANSPLANTATION;CONVENTIONAL PCI;DIASTOLE;ENDOMETRIAL CANCER;INFLAMMATORY BOWEL DISEASE;MUTATION;MYELOFIBROSIS;NEPHRECTOMY;PHENOTYPE;TOLERABILITY","59;31;29;25;20;20;18;18;17;16;16;13;12;12;11;10;9;9;8;8;8;8;8;8;8;8;8","CORONAVIRUS DISEASE 2019 (COVID-19);PROSTATECTOMY;NILOTINIB;CYSTECTOMY;RUXOLITINIB;NEOADJUVANT THERAPY;ANDROGEN DEPRIVATION THERAPY;CARDIAC RESYNCHRONIZATION THERAPY;DASATINIB;DNA METHYLATION;METASTATIC BREAST CANCER;USTEKINUMAB;BRAIN METASTASIS;FLUDARABINE;KRAS;MACE;PEMBROLIZUMAB;PROSTATE-SPECIFIC ANTIGEN;TICAGRELOR;ACINETOBACTER BAUMANNII;BUSULFAN;CD137;CHIMERIC ANTIGEN RECEPTOR;DIFFUSING CAPACITY;ENDOVASCULAR ANEURYSM REPAIR;HBSAG;HEAD AND NECK SQUAMOUS-CELL CARCINOMA;IMATINIB MESYLATE;INTERNATIONAL PROGNOSTIC SCORING SYSTEM;LDL RECEPTOR;MEPOLIZUMAB;OBETICHOLIC ACID;PROSTATE BIOPSY;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;SECUKINUMAB;SINGLE-NUCLEOTIDE POLYMORPHISM;STROKE VOLUME;VENETOCLAX","59;18;11;9;8;6;5;5;5;5;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","HUMANS;;RETROSPECTIVE STUDIES;FEMALE;MALE;COVID-19;TREATMENT OUTCOME;ADULT;AGED;MIDDLE AGED;PROSTATIC NEOPLASMS;STROKE;PROSPECTIVE STUDIES;ATRIAL FIBRILLATION;HEMORRHAGE;SARS-COV-2;ITALY;URINARY BLADDER NEOPLASMS;CHILD;MAGNETIC RESONANCE IMAGING","382;350;106;100;92;91;70;57;48;46;46;41;36;35;35;34;33;27;23;23","DIAGNOSIS AND TREATMENT OF BLADDER CANCER;EFFICACY AND RESISTANCE IN CML TREATMENT;PROSTATE CANCER RESEARCH AND TREATMENT;CORONAVIRUS DISEASE 2019;ACUTE MYELOID LEUKEMIA;ATRIAL FIBRILLATION;MOLECULAR PATHOGENESIS OF MYELOPROLIFERATIVE DISORDERS;CORONAVIRUS DISEASE 2019 RESEARCH;GYNECOLOGIC ONCOLOGY;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;CANCER IMMUNOTHERAPY;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;RENAL CELL CARCINOMA;DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION;HEPATOCELLULAR CARCINOMA;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;EPILEPSY AND SEIZURES;MANAGEMENT AND TREATMENT OF HEMOPHILIA;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;IMPACT OF COVID-19 ON CANCER PATIENTS AND CARE","21;17;16;14;12;12;12;11;10;9;9;9;9;8;8;7;7;7;6;6","PANDEMIC;STROKE (ENGINE);TREATMENT;2019-20 CORONAVIRUS OUTBREAK;CLINICAL ENDPOINT;DISCONTINUATION;PROSTATE CANCER;CANCER IMAGING;ATRIAL FIBRILLATION;ECHOCARDIOGRAPHY;ETIOLOGY;METASTATIC PROSTATE CANCER;NEURORADIOLOGY;CONCOMITANT;INTERQUARTILE RANGE;LEFT VENTRICULAR FUNCTION;BLADDER CANCER;HEMATOLOGY;METASTATIC BLADDER CANCER;REGIMEN","23;21;20;18;16;15;15;14;13;13;12;12;12;11;11;11;10;10;10;10","PROSTATE CANCER;CANCER PATIENTS;OBSERVATIONAL STUDY;MYELOID LEUKEMIA;CHRONIC MYELOID;ITALIAN SOCIETY;MULTIPLE MYELOMA;PATIENTS TREATED;ATRIAL FIBRILLATION;BLADDER CANCER;BREAST CANCER;COVID- PANDEMIC;HEART FAILURE;RETROSPECTIVE STUDY;PILOT STUDY;COVID- PATIENTS;LOCALLY ADVANCED;CELL CARCINOMA;CHRONIC PHASE;CLINICAL PRACTICE;LIVER TRANSPLANTATION;RETROSPECTIVE ANALYSIS;ENDOMETRIAL CANCER;INTENSIVE CARE;LEUKEMIA PATIENTS;ARTERIAL HYPERTENSION;CERVICAL CANCER;HEPATOCELLULAR CARCINOMA;MULTICENTER RETROSPECTIVE;OVARIAN CANCER","23;21;19;17;13;13;13;13;12;12;12;12;12;12;11;10;10;8;8;8;8;8;7;7;7;6;6;6;6;6","HR CI;MEDIAN AGE;PATIENTS TREATED;RISK FACTORS;SIGNIFICANT DIFFERENCES;LOGISTIC REGRESSION;ADVERSE EVENTS;VIEW LARGEDOWNLOAD;BLOOD PRESSURE;CLINICAL PRACTICE;COVID- PATIENTS;REGRESSION ANALYSIS;MEDIAN FOLLOW-UP;PATIENTS UNDERGOING;BREAST CANCER;HAZARD RATIO;STATISTICALLY SIGNIFICANT;COX REGRESSION;PROSTATE CANCER;MAGNETIC RESONANCE;SARS-COV- INFECTION;CANCER PATIENTS;CONFIDENCE INTERVAL;OBSERVATIONAL STUDY;REGRESSION MODELS;RETROSPECTIVE STUDY;SURVIVAL OS;INCREASED RISK;COVID- PANDEMIC;HEART FAILURE","69;54;48;42;42;40;39;36;35;32;32;32;31;30;29;27;27;26;26;25;25;24;24;24;24;24;24;23;22;22",345,0.46,6.25,7,1,1,0,2,0,1,1,9,1,0,7,1,1,2,3,5,4,0,0,17,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,36,3.58,2149.83,3.08,18,0.5,117.89,0,0,5,2,16,0,1,12,0,27,9,0,0,0,0,0,0,33,3,0,36,0,0,0,0,0,0,0,0,0,"United States;Italy;Germany;Australia;Japan","7;5;2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;42 HEALTH SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;31 BIOLOGICAL SCIENCES;3204 IMMUNOLOGY;3212 OPHTHALMOLOGY AND OPTOMETRY;3215 REPRODUCTIVE MEDICINE;35 COMMERCE, MANAGEMENT, TOURISM AND SERVICES;3505 HUMAN RESOURCES AND INDUSTRIAL RELATIONS;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;4203 HEALTH SERVICES AND SYSTEMS;3101 BIOCHEMISTRY AND CELL BIOLOGY;3107 MICROBIOLOGY;3207 MEDICAL MICROBIOLOGY;3209 NEUROSCIENCES","36;18;8;4;4;4;3;2;2;2;2;2;2;2;2;2;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;CANCER;PATIENT SAFETY;CARDIOVASCULAR;HEMATOLOGY;LUNG;NEUROSCIENCES;BRAIN DISORDERS;AGING;HEART DISEASE;PEDIATRIC;PREVENTION;AUTOIMMUNE DISEASE;BREAST CANCER;NEURODEGENERATIVE;ATHEROSCLEROSIS;BIODEFENSE;CHRONIC LIVER DISEASE AND CIRRHOSIS","35;24;13;12;10;6;6;6;6;5;4;4;4;4;3;3;3;2;2;2","CANCER;CARDIOVASCULAR;NEUROLOGICAL;EYE;INFLAMMATORY AND IMMUNE SYSTEM;MUSCULOSKELETAL;ORAL AND GASTROINTESTINAL;BLOOD;INFECTION;STROKE","9;7;3;2;2;2;2;1;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;7.1 INDIVIDUAL CARE NEEDS;2.4 SURVEILLANCE AND DISTRIBUTION;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.2 CELLULAR AND GENE THERAPIES;6.2 CELLULAR AND GENE THERAPIES;6.4 SURGERY;6.7 PHYSICAL","23;3;2;2;2;1;1;1;1;1;1","BREAST CANCER;LUNG CANCER;MYELOMA;NON-HODGKIN'S LYMPHOMA;BLOOD CANCER;BRAIN TUMOR;LEUKEMIA / LEUKAEMIA;LIVER CANCER;MELANOMA;OVARIAN CANCER","3;2;2;2;1;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;1.4 CANCER PROGRESSION AND METASTASIS;4.1 TECHNOLOGY DEVELOPMENT AND/OR MARKER DISCOVERY;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","8;2;2;1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,14,"FRONTIERS;SPRINGER NATURE;KARGER PUBLISHERS;ZENODO;AMERICAN CHEMICAL SOCIETY;TAYLOR & FRANCIS GROUP","5;3;2;2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;34 CHEMICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3107 MICROBIOLOGY;3207 MEDICAL MICROBIOLOGY;3213 PAEDIATRICS;3215 REPRODUCTIVE MEDICINE;33 BUILT ENVIRONMENT AND DESIGN;3303 DESIGN;3404 MEDICINAL AND BIOMOLECULAR CHEMISTRY;42 HEALTH SCIENCES;52 PSYCHOLOGY","24;9;4;3;2;1;1;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;PREVENTION;CANCER;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DIGESTIVE DISEASES;ASSISTIVE TECHNOLOGY;BIOENGINEERING;CARDIOVASCULAR;HEART DISEASE;HEART DISEASE - CORONARY HEART DISEASE;HEMATOLOGY;PATIENT SAFETY;PEDIATRIC;ARTHRITIS;AUTOIMMUNE DISEASE;BEHAVIORAL AND SOCIAL SCIENCE;BIODEFENSE;BIOTECHNOLOGY;CHRONIC PAIN;COLO-RECTAL CANCER","8;5;4;3;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1","CANCER;CARDIOVASCULAR;INFECTION;INFLAMMATORY AND IMMUNE SYSTEM;REPRODUCTIVE HEALTH AND CHILDBIRTH;SKIN","5;2;1;1;1;1","6.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS;6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES;7.1 INDIVIDUAL CARE NEEDS","7;1;1;1;1","CLINICAL;BIOMEDICAL;HEALTH SERVICES & SYSTEMS","8;1;1","CLINICAL MEDICINE AND SCIENCE;HEALTH SERVICES RESEARCH","10;1","COLON AND RECTAL CANCER;NOT SITE-SPECIFIC CANCER;PROSTATE CANCER","5;4;1","3 GOOD HEALTH AND WELL BEING","2"
"AOUSSN_UMBERTOI",2023,712,19.4901685393258,2.88202247191011,0.276685393258427,0.241573033707865,0.325842696629214,1.98933074684772,1.34931506849315,1.43333333333333,1.42331288343558,0.758426966292135,13,286,139,49,40,0.4,0.2,0.07,0.06,3.35,0.764877865885492,5.28508658568108,0.335674157303371,0.970505617977528,0.482,0.451,0.431,0.426,"DANIELE SANTINI;MASSIMO BRECCIA;CLAUDIO MARIA MASTROIANNI;CARLO CATALANO;FRANCESCO DEL GIUDICE;ANDREA BOTTICELLI;ALESSANDRO SCIARRA;ANTONELLO D’ANDREA;FRANCESCA DE FELICE;GIANCARLO CECCARELLI;CARLO LAVALLE;FRANCESCA FAZIO;CRISTINA CHIMENTI;GENNARO SARDELLA;GABRIELLA D’ETTORRE;ALFONSO PICIOCCHI;ANDREA MINGOLI;MONICA BOCCHIA;ROCCO SIMONE FLAMMIA;MAURIZIO MARTELLI","31;22;19;18;18;17;16;16;15;14;14;13;12;12;11;11;11;10;10;10","GIOVANNI ANTONIO COSSIGA;DOTT. GIOVANNI ANTONIO COSSIGA;FRANCESCA DE FELICE;DANIELE SANTINI;CARLO CATALANO;QUIRINO LAI;MASSIMO BRECCIA;DENIS A. COZZI;PAOLO PALANGE;SILVIA CECCANTI;ALESSANDRO SCIARRA;LUDOVICO MUZII;CLAUDIO MARIA MASTROIANNI;GIOIA MASTROMORO;GIANCARLO CECCARELLI;ANTONELLO D’ANDREA;PAOLO MISSORI;FRANCESCO DEL GIUDICE;DIEGO RIBUFFO;MAGDA GHARBIYA","7;3;2.81;1.69;1.54;1.5;1.5;1.25;1.16;1.14;1.1;1.1;1.09;1.09;1.09;1.05;1;1;1;0.99","DANIELE SANTINI;MASSIMO BRECCIA;CLAUDIO MARIA MASTROIANNI;CARLO CATALANO;FRANCESCO DEL GIUDICE;ANDREA BOTTICELLI;ALESSANDRO SCIARRA;ANTONELLO D’ANDREA;FRANCESCA DE FELICE;GIANCARLO CECCARELLI;CARLO LAVALLE;FRANCESCA FAZIO;CRISTINA CHIMENTI;GENNARO SARDELLA;GABRIELLA D’ETTORRE;ANDREA MINGOLI;ROCCO SIMONE FLAMMIA;MAURIZIO MARTELLI;PIERFRANCESCO LAPOLLA;LUDOVICO MUZII","31;22;19;18;18;17;16;16;15;14;14;13;12;12;11;11;10;10;10;10","GIOVANNI ANTONIO COSSIGA;DOTT. GIOVANNI ANTONIO COSSIGA;FRANCESCA DE FELICE;DANIELE SANTINI;CARLO CATALANO;QUIRINO LAI;MASSIMO BRECCIA;DENIS A. COZZI;PAOLO PALANGE;SILVIA CECCANTI;ALESSANDRO SCIARRA;LUDOVICO MUZII;CLAUDIO MARIA MASTROIANNI;GIOIA MASTROMORO;GIANCARLO CECCARELLI;ANTONELLO D’ANDREA;PAOLO MISSORI;FRANCESCO DEL GIUDICE;DIEGO RIBUFFO;MAGDA GHARBIYA","7;3;2.81;1.69;1.54;1.5;1.5;1.25;1.16;1.14;1.1;1.1;1.09;1.09;1.09;1.05;1;1;1;0.99","GIANCARLO CECCARELLI;CARLO CATALANO;MARIO VENDITTI;FRANCESCO DEL GIUDICE;UGO DE GIORGI;DANIELE SANTINI;CLAUDIO MARIA MASTROIANNI;ANDREA GIANNINI;OTTAVIA D’ORIA;CARLO LAVALLE;DONATELLA CASERTA;GIAMMARCO RAPONI;LUNA GARGANI;MASSIMO BRECCIA;LUDOVICO MUZII;ANTONELLO D’ANDREA;FRANCESCO FERRARA;VALERIA PANEBIANCO;MARINE GOUDELIN;IVAN GENTILE","141;115;98;97;97;96;95;89;89;88;86;86;83;81;80;79;78;70;68;67","FRANCESCO DEL GIUDICE;ANDREA GIANNINI;DANIELE SANTINI;CARLO LAVALLE;CARLO CATALANO;GIANCARLO CECCARELLI;MASSIMO BRECCIA;ANTONELLO D’ANDREA;LUDOVICO MUZII;GIAMMARCO RAPONI;CAMILLA DI DIO;TULLIO GOLIA D’AUGÈ;VIOLANTE DI DONATO;ROCCO SIMONE FLAMMIA;ANDREA GAGGIANO;ANTONIO TUFANO;COSTANTINO LEONARDO;ALESSANDRO SCIARRA;GIUSEPPE MINNITI;ANTONIO GRECO","92;89;89;88;86;86;80;79;77;72;62;62;62;58;51;50;50;49;47;45","DANIELE SANTINI;MASSIMO BRECCIA;FRANCESCO DEL GIUDICE;FRANCESCA DE FELICE;ANTONELLO D’ANDREA;ANDREA BOTTICELLI;ALESSANDRO SCIARRA;MAURIZIO MARTELLI;CARLO CATALANO;CARLO LAVALLE;GENNARO SARDELLA;FRANCESCA FAZIO;CRISTINA CHIMENTI;GIANCARLO CECCARELLI;MARIA TERESA PETRUCCI;ANDREA MINGOLI;PAOLO PALANGE;QUIRINO LAI;ROCCO SIMONE FLAMMIA;ANTONIO TUFANO","24;18;18;17;15;14;14;14;14;14;13;13;12;12;12;10;10;10;10;10","MEDICINE;BIOLOGY;PHYSICS;COMPUTER SCIENCE;CHEMISTRY;ENGINEERING;PSYCHOLOGY;ECONOMICS;MATHEMATICS;SOCIOLOGY;POLITICAL SCIENCE;PHILOSOPHY;BUSINESS;MATERIALS SCIENCE;GEOLOGY;HISTORY;ART;GEOGRAPHY;ENVIRONMENTAL SCIENCE","685;177;72;56;36;33;32;27;25;22;17;12;8;7;4;4;3;3;2","INTERNAL MEDICINE;SURGERY;ONCOLOGY;PATHOLOGY;CARDIOLOGY;RADIOLOGY;GENETICS;GASTROENTEROLOGY;IMMUNOLOGY;ENVIRONMENTAL HEALTH;INTENSIVE CARE MEDICINE;PEDIATRICS;BIOCHEMISTRY;PSYCHIATRY;PALEONTOLOGY;OPTICS;ENDOCRINOLOGY;UROLOGY;NURSING;FAMILY MEDICINE","534;206;141;99;97;87;84;82;77;64;59;54;49;49;40;39;37;32;31;27","CANCER;DISEASE;POPULATION;RETROSPECTIVE COHORT STUDY;COHORT;GENE;CHEMOTHERAPY;CONFIDENCE INTERVAL;RANDOMIZED CONTROLLED TRIAL;RADIATION THERAPY;INCIDENCE (GEOMETRY);TRANSPLANTATION;ADVERSE EFFECT;OBSERVATIONAL STUDY;CLINICAL TRIAL;HEART FAILURE;PROSPECTIVE COHORT STUDY;ANTIBODY;MAGNETIC RESONANCE IMAGING;IMMUNE SYSTEM;QUALITY OF LIFE (HEALTHCARE)","158;104;64;59;53;52;44;39;34;31;30;29;28;28;27;27;27;25;25;24;24","INFECTIOUS DISEASE (MEDICAL SPECIALTY);CLINICAL ENDPOINT;BREAST CANCER;COLORECTAL CANCER;HAZARD RATIO;PROSTATE CANCER;IMMUNOTHERAPY;EJECTION FRACTION;PROSTATE;LIVER TRANSPLANTATION;PERCUTANEOUS CORONARY INTERVENTION;BLADDER CANCER;INFLAMMATORY BOWEL DISEASE;METASTASIS;CHRONIC LYMPHOCYTIC LEUKEMIA;CONVENTIONAL PCI;GENOTYPE;RITUXIMAB;ACUTE CORONARY SYNDROME;BORTEZOMIB","35;33;31;29;26;24;17;16;14;13;13;12;12;12;11;11;11;11;10;10","CORONAVIRUS DISEASE 2019 (COVID-19);PEMBROLIZUMAB;DARATUMUMAB;PROSTATECTOMY;VENETOCLAX;CYSTECTOMY;METASTATIC BREAST CANCER;REGORAFENIB;TRASTUZUMAB;ANTIRETROVIRAL THERAPY;COLONOSCOPY;DASATINIB;FLUDARABINE;IMATINIB MESYLATE;NIVOLUMAB;TICAGRELOR;BENDAMUSTINE;CALPROTECTIN;CARFILZOMIB;HEAD AND NECK SQUAMOUS-CELL CARCINOMA;IDARUBICIN;IGHV@;INTERNATIONAL PROGNOSTIC SCORING SYSTEM;KLEBSIELLA PNEUMONIAE;LYMPHOVASCULAR INVASION;MASTECTOMY;MEROPENEM;NILOTINIB;POMALIDOMIDE;VEDOLIZUMAB","35;10;9;8;8;7;7;6;6;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4",";HUMANS;RETROSPECTIVE STUDIES;MALE;FEMALE;TREATMENT OUTCOME;ADULT;AGED;COVID-19;MIDDLE AGED;PROSPECTIVE STUDIES;ITALY;POSTOPERATIVE COMPLICATIONS;RISK FACTORS;NEOPLASM RECURRENCE, LOCAL;CHILD;MAGNETIC RESONANCE IMAGING;ANTI-BACTERIAL AGENTS;SARS-COV-2;NEOPLASMS","371;339;97;78;73;57;52;50;44;43;39;33;27;26;25;22;21;20;20;19","DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;DIAGNOSIS AND TREATMENT OF BLADDER CANCER;PROSTATE CANCER RESEARCH AND TREATMENT;ATRIAL FIBRILLATION;CORONAVIRUS DISEASE 2019;EFFICACY AND RESISTANCE IN CML TREATMENT;ACUTE MYELOID LEUKEMIA;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;GENOMIC ABERRATIONS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA;LYMPHOID NEOPLASMS;CANCER IMMUNOTHERAPY;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;ANTIPLATELET THERAPY IN CARDIOVASCULAR DISEASE;EPIDEMIOLOGY AND TREATMENT OF HEAD AND NECK CANCER;GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS;GYNECOLOGIC ONCOLOGY;MOLECULAR MECHANISMS OF AMYLOIDOSIS;PANCREATIC CANCER RESEARCH AND TREATMENT;RENAL CELL CARCINOMA","15;13;13;12;11;10;10;9;9;9;9;8;8;7;7;7;7;7;7;7","CLINICAL ENDPOINT;REGIMEN;TREATMENT;INTERQUARTILE RANGE;DISCONTINUATION;STROKE (ENGINE);CARDIAC IMAGING;REFRACTORY (PLANETARY SCIENCE);CONCOMITANT;ECHOCARDIOGRAPHY;METASTATIC COLORECTAL CANCER;PANDEMIC;CARDIOVASCULAR RISK ASSESSMENT;HEMATOLOGY;RADIOTHERAPY;AUTOLOGOUS STEM-CELL TRANSPLANTATION;CANCER IMAGING;DARATUMUMAB;PROGRESSION-FREE SURVIVAL;TOLERABILITY","36;22;19;18;17;15;14;14;13;12;12;12;11;10;10;9;9;9;9;9","OBSERVATIONAL STUDY;CELL CARCINOMA;MULTIPLE MYELOMA;PROSTATE CANCER;PATIENTS TREATED;BREAST CANCER;CANCER PATIENTS;COLORECTAL CANCER;COHORT STUDY;METASTATIC COLORECTAL;RETROSPECTIVE STUDY;HEART FAILURE;STEM CELL;MAGNETIC RESONANCE;MULTICENTER STUDY;MYELOID LEUKEMIA;RETROSPECTIVE OBSERVATIONAL;SQUAMOUS CELL;ATRIAL FIBRILLATION;COVID- PANDEMIC;MULTICENTER RETROSPECTIVE;NEWLY DIAGNOSED;PILOT STUDY;BLADDER CANCER;CHRONIC MYELOID;ITALIAN MULTICENTER;LYMPH NODE;RADICAL PROSTATECTOMY;RETROSPECTIVE ANALYSIS;RISK FACTORS","20;18;18;16;15;13;13;13;11;11;11;10;10;9;9;9;9;9;8;8;8;8;8;7;7;7;7;7;7;7","ADVERSE EVENTS;HR CI;MEDIAN AGE;PATIENTS TREATED;MEDIAN FOLLOW-UP;SIGNIFICANT DIFFERENCES;PRIMARY ENDPOINT;PUBMED SCOPUS;CLINICAL PRACTICE;STATISTICALLY SIGNIFICANT;SURVIVAL OS;RISK FACTORS;STEM CELL;EOSINOPHILIC ESOPHAGITIS;BREAST CANCER;PATIENTS RECEIVED;LOGISTIC REGRESSION;RETROSPECTIVE STUDY;SIGNIFICANT DIFFERENCE;INDUCTION THERAPY;BONE MARROW;COVID- PATIENTS;LYMPH NODE;PROGRESSION-FREE SURVIVAL;CLINICAL OUTCOMES;CONFIDENCE INTERVAL;CARE UNIT;CLINICAL TRIALS;MULTIPLE MYELOMA;PATIENTS PTS","55;51;51;49;44;43;41;40;39;39;38;36;36;35;30;30;29;29;28;27;25;25;25;25;24;24;23;23;23;23",270,0.38,6.51,7.75,1,1,0,2.75,0,1,0,8,1,1,7.5,0,1,2,4,6,3,0,0,8,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,16,4,1373.5,1.73,5,0.31,79.81,0,0,5,1,5,0,0,5,0,13,3,0,0,0,0,0,0,14,2,0,16,0,0,0,0,0,0,0,0,0,"United States;Denmark;Italy;Netherlands;Switzerland","4;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;31 BIOLOGICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;3101 BIOCHEMISTRY AND CELL BIOLOGY;4205 NURSING;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","13;7;6;2;2;2;2;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;HEMATOLOGY;AGING;BRAIN DISORDERS;NEUROSCIENCES;RARE DISEASES;LYMPHOMA;NEURODEGENERATIVE;NUTRITION;PATIENT SAFETY;PREVENTION;ACQUIRED COGNITIVE IMPAIRMENT;ALZHEIMER'S DISEASE;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD);BREAST CANCER;DEMENTIA;PEDIATRIC;AUTOIMMUNE DISEASE","15;12;6;5;4;4;4;4;3;3;3;3;3;2;2;2;2;2;2;1","CANCER;NEUROLOGICAL;METABOLIC AND ENDOCRINE;ORAL AND GASTROINTESTINAL;STROKE","7;3;1;1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;2.4 SURVEILLANCE AND DISTRIBUTION;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS","13;2;1;1;1;1","NON-HODGKIN'S LYMPHOMA;BREAST CANCER;COLON AND RECTAL CANCER;ENDOMETRIAL CANCER;HODGKIN'S DISEASE;LEUKEMIA / LEUKAEMIA","3;2;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;3.3 CHEMOPREVENTION;4.1 TECHNOLOGY DEVELOPMENT AND/OR MARKER DISCOVERY;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","6;1;1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,22,"FRONTIERS;PUBLIC LIBRARY OF SCIENCE;SPRINGER NATURE","20;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3213 PAEDIATRICS;31 BIOLOGICAL SCIENCES;3202 CLINICAL SCIENCES;3105 GENETICS;3211 ONCOLOGY AND CARCINOGENESIS;49 MATHEMATICAL SCIENCES;51 PHYSICAL SCIENCES;3204 IMMUNOLOGY;42 HEALTH SCIENCES;4205 NURSING;4905 STATISTICS;5105 MEDICAL AND BIOLOGICAL PHYSICS;52 PSYCHOLOGY","35;9;8;6;4;4;2;2;1;1;1;1;1;1","CLINICAL RESEARCH;PREVENTION;ANXIETY DISORDERS;BRAIN DISORDERS;INFANT MORTALITY;MENTAL HEALTH;PEDIATRIC;PERINATAL PERIOD - CONDITIONS ORIGINATING IN PERINATAL PERIOD;POST-TRAUMATIC STRESS DISORDER (PTSD);PRETERM, LOW BIRTH WEIGHT AND HEALTH OF THE NEWBORN;GENETICS;CANCER;EMERGING INFECTIOUS DISEASES;HUMAN GENOME;INFECTIOUS DISEASES;BIODEFENSE;BREAST CANCER;IMMUNIZATION;PATIENT SAFETY;RARE DISEASES","15;11;9;9;9;9;9;9;9;9;5;4;3;3;3;2;2;2;2;2","REPRODUCTIVE HEALTH AND CHILDBIRTH;CANCER;INFECTION;INFLAMMATORY AND IMMUNE SYSTEM","9;4;3;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;6.1 PHARMACEUTICALS;2.4 SURVEILLANCE AND DISTRIBUTION;3.4 VACCINES;5.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES;6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES;8.1 ORGANISATION AND DELIVERY OF SERVICES","4;3;2;2;2;1;1;1;1;1","CLINICAL;BIOMEDICAL;HEALTH SERVICES & SYSTEMS","14;2;1","CLINICAL MEDICINE AND SCIENCE","18","BREAST CANCER;NON-HODGKIN'S LYMPHOMA;NOT SITE-SPECIFIC CANCER;STOMACH CANCER","2;1;1;1","3 GOOD HEALTH AND WELL BEING","13"
"AOUSSN_UMBERTOI",2024,646,18.8684210526316,2.6733746130031,0.272445820433437,0.246130030959752,0.301857585139319,1.85300429184549,1.23943661971831,1.41964285714286,1.26623376623377,0.640866873065015,6,238,150,45,34,0.37,0.23,0.07,0.05,1.08,1.1321944282188,4.30433653596468,0.411764705882353,0.972136222910217,0.509,0.511,0.453,0.483,"DANIELE SANTINI;LESLIE CLAIRE LICARI;EUGENIO BOLOGNA;FRANCESCO DEL GIUDICE;RICCARDO AUTORINO;COSIMO DE NUNZIO;COSTANTINO LEONARDO;CARLO LAVALLE;CARMINE DARIO VIZZA;FRANCESCO DITONNO;ANTONELLO D’ANDREA;DIEGO RIBUFFO;LEOPOLDO SPADEA;GIUSEPPE SIMONE;RICCARDO LOMBARDO;MASSIMO BRECCIA;NICOLA PIERUCCI;RENATE PICHLER;WOJCIECH KRAJEWSKI;EDWARD E. CHERULLO","25;24;24;24;22;21;20;17;16;14;14;14;13;13;13;13;12;12;11;11","DIEGO RIBUFFO;LESLIE CLAIRE LICARI;EUGENIO BOLOGNA;FRANCESCA DE FELICE;FEDERICO BILOTTA;COSTANTINO LEONARDO;RICCARDO AUTORINO;LEOPOLDO SPADEA;COSIMO DE NUNZIO;DANIELE SANTINI;FRANCESCO DEL GIUDICE;CARMINE DARIO VIZZA;CARLO SALATI;ANTONELLO D’ANDREA;FEDERICO LO TORTO;MARCO ZEPPIERI;CARLO LAVALLE;GIANCARLO CECCARELLI;LUDOVICO IANNETTI;VIOLANTE DI DONATO","2.35;2.15;1.97;1.75;1.71;1.66;1.63;1.61;1.56;1.55;1.44;1.43;1.35;1.34;1.3;1.23;1.22;1.2;1.12;1.05","DANIELE SANTINI;LESLIE CLAIRE LICARI;EUGENIO BOLOGNA;FRANCESCO DEL GIUDICE;COSTANTINO LEONARDO;CARLO LAVALLE;CARMINE DARIO VIZZA;ANTONELLO D’ANDREA;DIEGO RIBUFFO;LEOPOLDO SPADEA;MASSIMO BRECCIA;NICOLA PIERUCCI;ALESSANDRO SCIARRA;GIORGIO FRANCO;MARCO VALERIO MARIANI;CARLO SALATI;FRANCESCA DE FELICE;GIANCARLO CECCARELLI;MARCO ZEPPIERI;VIOLANTE DI DONATO","25;24;24;24;20;17;16;14;14;13;13;12;11;11;11;11;10;10;10;10","DIEGO RIBUFFO;LESLIE CLAIRE LICARI;EUGENIO BOLOGNA;FRANCESCA DE FELICE;FEDERICO BILOTTA;COSTANTINO LEONARDO;LEOPOLDO SPADEA;DANIELE SANTINI;FRANCESCO DEL GIUDICE;CARMINE DARIO VIZZA;CARLO SALATI;ANTONELLO D’ANDREA;FEDERICO LO TORTO;MARCO ZEPPIERI;CARLO LAVALLE;GIANCARLO CECCARELLI;LUDOVICO IANNETTI;VIOLANTE DI DONATO;VALERIA PANEBIANCO;ANTONIO MINNI","2.35;2.15;1.97;1.75;1.71;1.66;1.61;1.55;1.44;1.43;1.35;1.34;1.3;1.23;1.22;1.2;1.12;1.05;1.04;1.01","EUGENIO NELSON CAVALLARI;ASHISH A. DESHMUKH;ELIZABETH A. STIER;GARY M. CLIFFORD;I. MARY POYNTEN;I. ROSA‐CUNHA;JENNIFER M. ROBERTS;JOEL M. PALEFSKY;LUCIANA LA ROSA;LUIS F. BARROSO;MEGAN A. CLARKE;NAOMI JAY;NICOLAS WENTZENSEN;RICHARD J. HILLMAN;ROSALYN E. PLOTZKER;STEPHEN E. GOLDSTONE;TAMZIN CUMING;VALERIA FINK;YUXIN LIU;EUGENIO BOLOGNA","54;52;52;52;52;52;52;52;52;52;52;52;52;52;52;52;52;52;52;45","EUGENIO NELSON CAVALLARI;EUGENIO BOLOGNA;LESLIE CLAIRE LICARI;GIUSEPPE MINNITI;CRISTINA CHIMENTI;FRANCESCO DEL GIUDICE;LEOPOLDO SPADEA;DANILO TONI;MASSIMO BRECCIA;FABIO MIRALDI;VALERIA PANEBIANCO;DANIELE SANTINI;GENNARO SARDELLA;ANTONELLO D’ANDREA;MARINA ALOI;ANTONIO SANTORO;FEDERICA MOSCUCCI;LUCA D’ANGELO;QUIRINO LAI;GIULIA CATASSI","52;45;37;34;32;26;24;23;23;19;18;17;17;16;16;14;14;14;14;13","EUGENIO BOLOGNA;LESLIE CLAIRE LICARI;FRANCESCO DEL GIUDICE;DANIELE SANTINI;CARLO LAVALLE;GENNARO SARDELLA;ANTONELLO D’ANDREA;DIEGO RIBUFFO;MASSIMO BRECCIA;CARMINE DARIO VIZZA;LEOPOLDO SPADEA;ALESSANDRO SCIARRA;GIORGIO FRANCO;QUIRINO LAI;FRANCESCA DE FELICE;EMILIA SCALZULLI;NICOLA PIERUCCI;VIOLANTE DI DONATO;GIANCARLO CECCARELLI;CARLO CATALANO","31;27;24;22;16;16;13;13;12;12;12;11;11;10;10;8;8;8;8;7","MEDICINE;BIOLOGY;COMPUTER SCIENCE;PHYSICS;PSYCHOLOGY;ENGINEERING;CHEMISTRY;POLITICAL SCIENCE;ECONOMICS;MATHEMATICS;PHILOSOPHY;SOCIOLOGY;GEOLOGY;BUSINESS;HISTORY;GEOGRAPHY;ART;ENVIRONMENTAL SCIENCE;MATERIALS SCIENCE","619;136;60;53;42;29;27;24;22;22;17;14;10;8;8;6;4;3;3","INTERNAL MEDICINE;SURGERY;CARDIOLOGY;ONCOLOGY;RADIOLOGY;PATHOLOGY;INTENSIVE CARE MEDICINE;GENETICS;IMMUNOLOGY;PSYCHIATRY;UROLOGY;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;BIOCHEMISTRY;GENERAL SURGERY;PEDIATRICS;PALEONTOLOGY;CANCER RESEARCH;VIROLOGY;ENDOCRINOLOGY","452;176;102;100;83;81;62;60;55;54;53;49;46;43;40;40;31;26;26;25","CANCER;DISEASE;RETROSPECTIVE COHORT STUDY;COHORT;GENE;POPULATION;RANDOMIZED CONTROLLED TRIAL;CHEMOTHERAPY;HEART FAILURE;MYOCARDIAL INFARCTION;MAGNETIC RESONANCE IMAGING;ATRIAL FIBRILLATION;PREGNANCY;RADIATION THERAPY;CLINICAL TRIAL;ADVERSE EFFECT;ANTIBODY;INCIDENCE (GEOMETRY);STAGE (STRATIGRAPHY);VIRUS","140;94;50;39;39;39;39;31;26;25;23;20;20;19;17;16;16;16;16;16","BREAST CANCER;BLADDER CANCER;PROSTATE CANCER;INFECTIOUS DISEASE (MEDICAL SPECIALTY);IMMUNOTHERAPY;PROSTATE;2019-20 CORONAVIRUS OUTBREAK;METASTASIS;COLORECTAL CANCER;EJECTION FRACTION;HAZARD RATIO;CLINICAL ENDPOINT;NEURORADIOLOGY;PERCUTANEOUS CORONARY INTERVENTION;CONVENTIONAL PCI;INFLAMMATORY BOWEL DISEASE;NEPHRECTOMY;OVARIAN CANCER;MULTICENTER STUDY;LIVER TRANSPLANTATION;REVASCULARIZATION;UNIVARIATE ANALYSIS","30;25;24;22;17;17;14;14;13;12;11;10;10;10;9;9;9;9;8;7;7;7","CORONAVIRUS DISEASE 2019 (COVID-19);UROTHELIAL CARCINOMA;CYSTECTOMY;PROSTATECTOMY;ANDROGEN RECEPTOR;INFLAMMATORY BOWEL DISEASES;NIVOLUMAB;UROTHELIAL CANCER;ANDROGEN DEPRIVATION THERAPY;ENDOVASCULAR ANEURYSM REPAIR;KLEBSIELLA PNEUMONIAE;KRAS;NEOADJUVANT THERAPY;ACINETOBACTER BAUMANNII;ACUTE PROMYELOCYTIC LEUKEMIA;BRCA MUTATION;BREAST RECONSTRUCTION;DASATINIB;DIFFUSING CAPACITY;FRACTIONAL FLOW RESERVE;LYMPHOVASCULAR INVASION;MACE;MILAN CRITERIA;NILOTINIB;PEMBROLIZUMAB;USTEKINUMAB","22;9;7;7;5;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3",";HUMANS;FEMALE;MALE;MIDDLE AGED;AGED;ADULT;RETROSPECTIVE STUDIES;ITALY;TREATMENT OUTCOME;AGED, 80 AND OVER;RISK FACTORS;PROSPECTIVE STUDIES;YOUNG ADULT;ADOLESCENT;CHILD;PROGNOSIS;COVID-19;TIME FACTORS;POSTOPERATIVE COMPLICATIONS","407;236;139;134;105;96;77;63;47;41;28;26;25;25;23;21;16;14;13;12","DIAGNOSIS AND TREATMENT OF BLADDER CANCER;RENAL CELL CARCINOMA;ANTIPLATELET THERAPY IN CARDIOVASCULAR DISEASE;PROSTATE CANCER RESEARCH AND TREATMENT;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;ARTIFICIAL INTELLIGENCE IN MEDICINE;ATRIAL FIBRILLATION;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;GENOMIC STUDIES AND TREATMENT OF OVARIAN CARCINOMA;GYNECOLOGIC ONCOLOGY;MANAGEMENT AND PATHOPHYSIOLOGY OF ABDOMINAL AORTIC ANEURYSMS;MOLECULAR MECHANISMS OF AMYLOIDOSIS;CHOLANGIOCARCINOMA;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;DIAGNOSIS AND MANAGEMENT OF ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY;DIAGNOSIS AND MANAGEMENT OF SJÖGREN'S SYNDROME;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;MANAGEMENT OF VALVULAR HEART DISEASE;PANCREATIC CANCER RESEARCH AND TREATMENT","25;11;9;9;8;8;8;8;8;7;7;7;7;6;6;6;6;6;6;6","TREATMENT;2019-20 CORONAVIRUS OUTBREAK;CARDIAC IMAGING;BLADDER CANCER;PROSTATE CANCER;ATRIAL FIBRILLATION;CLINICAL PRACTICE;METASTATIC PROSTATE CANCER;NEURORADIOLOGY;STROKE (ENGINE);METASTATIC BLADDER CANCER;PANDEMIC;UROTHELIAL CARCINOMA;CLINICAL ENDPOINT;ECHOCARDIOGRAPHY;HEMATOLOGY;IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR;NEOADJUVANT THERAPY;PROSTHETIC VALVES EVALUATION;ANEURYSM SCREENING","22;14;14;13;12;10;10;10;10;10;9;9;9;8;8;8;8;8;8;7","PROSTATE CANCER;ATRIAL FIBRILLATION;PATIENTS UNDERGOING;HEART FAILURE;BLADDER CANCER;OBSERVATIONAL STUDY;CLINICAL PRACTICE;LUNG CANCER;PATIENTS TREATED;CANCER PATIENTS;CLINICAL OUTCOMES;COHORT STUDY;INFLAMMATORY BOWEL;RANDOMIZED CLINICAL;RETROSPECTIVE STUDY;UROTHELIAL CARCINOMA;BREAST CANCER;LOCALLY ADVANCED;MULTICENTER STUDY;AORTIC VALVE;ARTIFICIAL INTELLIGENCE;BOWEL DISEASE;CARDIAC AMYLOIDOSIS;KIDNEY DISEASE;MINIMALLY INVASIVE;RETROSPECTIVE COHORT;RETROSPECTIVE OBSERVATIONAL;BENIGN PROSTATIC;CELL CARCINOMA;CLINICAL TRIAL","19;15;15;14;12;12;10;10;10;9;8;8;8;8;8;8;7;7;7;6;6;6;6;6;6;6;6;5;5;5","PATIENTS TREATED;CLINICAL PRACTICE;RISK FACTORS;PATIENTS UNDERGOING;HEART FAILURE;REGRESSION ANALYSIS;SIGNIFICANT DIFFERENCES;BREAST CANCER;MAGNETIC RESONANCE;CORONARY ARTERY;LOGISTIC REGRESSION;BLADDER CANCER;FINANCIAL TOXICITY;MEDIAN AGE;CONSECUTIVE PATIENTS;LUNG CANCER;OXIDATIVE STRESS;EJECTION FRACTION;HR CI;LEFT VENTRICULAR;PATIENTS UNDERWENT;RETROSPECTIVE STUDY;ADVERSE EVENTS;ATRIAL FIBRILLATION;CATHETER ABLATION;COMPUTED TOMOGRAPHY;DISEASE PROGRESSION;BLOOD PRESSURE;INCLUDED PATIENTS;RESONANCE IMAGING","35;34;33;23;22;22;22;21;21;20;20;19;18;18;17;17;17;16;16;16;16;16;15;15;15;15;15;14;14;14",2,0,96.45,50,1,1.75,0,10,0,0,0,61,0,0,38,0,0,2,5,24,7.5,0,0,6.75,6.75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,7,190,0.12,0,0,48,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,"Switzerland","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","1;1;1;1","CANCER;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HEMATOLOGY;LYMPHOMA;RARE DISEASES","1;1;1;1;1;1","CANCER","1","6.1 PHARMACEUTICALS;6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES","1;1","NON-HODGKIN'S LYMPHOMA","1","5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
